OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	future_work

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC5030591	9/2016	S80-PMC5030591	["caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips."]	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
PMC4785305	3/2016	S25-PMC4785305	['the 2010 institute of medicine (iom) report on dietary reference intakes for Calcium and Vitamin D RECOMMENDED 600\u2005iu to Pregnant women as the recommended daily allowance (rda), the rda being the dose that is projected to allow at least 97.5% of the Pregnant women population to reach the DESIRABLE target 25(Oh)D level ≥50\u2005nmol/l.29this RECOMMENDATION was BASED ON OBSERVATIONAL studies, NONE of which were conducted in the middle east.29CONVERSELY, the Endocrine society 2011 GUIDELINES RECOMMENDED that 1500–2000\u2005iu daily of Vitamin D is NEEDED to reach a target 25(Oh)D level ≥75\u2005nmol/l (a RECOMMENDATION that was graded as weak with moderate quality of evidence).30the american college of obstetricians and gynecologists (acog) does not RECOMMEND screening for Vitamin D level in Pregnancy, and abides by the iom RECOMMENDATIONS.31moreover, the who 2012 guidelines on Vitamin D replacement during Pregnancy DID NOT RECOMMEND vitamin D supplementation as part of Prenatal care.32this was based ON a meta-analysis of Vitamin D trials during Pregnancy, which IDENTIFIED a LIMITED NUMBER of high-quality studies DEMONSTRATING a beneficial EFFECT of supplementation on maternal and neonatal outcomes, and CONCLUDED that FURTHER randomised controlled trials (rcts) ARE NEEDED.33in the uk, HOWEVER, Pregnant women are CONSIDERED AT RISK of Vitamin D deficiency, and supplementation with 400\u2005iu daily is REQUIRED.34\nit is NOT CLEAR WHETHER any of the above RECOMMENDED doses are applicable to non-western populations, with lower baseline Vitamin D levels, such as in lebanon and other middle eastern countries.']	[('FUTURE_WORK', 99), ('IMPORTANT_CONSIDERATION', 289), ('FUTURE_WORK', 338), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 366), ('INCOMPLETE_EVIDENCE', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 437), ('PROBABLE_UNDERSTANDING', 478), ('FUTURE_WORK', 489), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 541), ('FUTURE_WORK', 594), ('FUTURE_WORK', 742), ('FUTURE_WORK', 818), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 920), ('ANOMALY_CURIOUS_FINDING', 998), ('ANOMALY_CURIOUS_FINDING', 998), ('INCOMPLETE_EVIDENCE', 1061), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1113), ('SUPERFICIAL_RELATIONSHIP', 1140), ('INCOMPLETE_EVIDENCE', 1205), ('FUTURE_WORK', 1220), ('FUTURE_WORK', 1264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1288), ('IMPORTANT_CONSIDERATION', 1316), ('INCOMPLETE_EVIDENCE', 1316), ('IMPORTANT_CONSIDERATION', 1327), ('IMPORTANT_CONSIDERATION', 1401), ('FULL_UNKNOWN', 1419), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1429), ('FUTURE_WORK', 1454)]	33	[('CHEBI_31341', 'calcium dihydroxide', 77, 'Calcium'), ('CHEBI_28384', 'vitamin K', 89, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'Vitamin'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('GO_0007565', 'female pregnancy', 250, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 309, 'OH)D'), ('PR_000013502', 'parvalbumin alpha', 311, ')D'), ('UBERON_0005063', 'left ventricular compact myocardium', 455, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 566, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 566, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 766, 'vitamin D'), ('GO_0007565', 'female pregnancy', 785, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('GO_0007565', 'female pregnancy', 902, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 938, 'D'), ('GO_0007565', 'female pregnancy', 967, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1020, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1044, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1297, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1338, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
PMC3702245	6/2013	S57-PMC3702245	['regarding Neurocognitive Development, WHILE ONE STUDY FOUND no association between maternal Vitamin D status during Pregnancy and Neurocognitive function,76a RECENT larger-sized STUDY LINKED maternal Serum 25(Oh)D levels during Pregnancy with Language Development in the offspring.98the results of the above studies SUGGEST that childhood infections, atopy, and Neurocognitive development NEED TO BE included as outcomes of interest following Vitamin D supplementation in Pregnancy, and that clinical trials SHOULD include a RELEVANT group of subjects CONSIDERED to be replete for Vitamin D.\ntaken TOGETHER, the high prevalence of Vitamin D deficiency in Pregnancy and the POSSIBLE multiple POTENTIAL adverse EFFECTS on mother and offspring IDENTIFIED in SEVERAL epidemiologic STUDIES UNDERSCORE the URGENT NEED FOR large randomized controlled TRIALS to identify the amount of Vitamin D supplementation that optimizes Vitamin D status during Pregnancy, and to DETERMINE the EFFECT of supplementation on POTENTIAL adverse conditions ASSOCIATED with Vitamin D deficiency and any POSSIBLE Vitamin D excess.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 184), ('INCOMPLETE_EVIDENCE', 316), ('FUTURE_WORK', 389), ('FUTURE_WORK', 508), ('IMPORTANT_CONSIDERATION', 525), ('IMPORTANT_CONSIDERATION', 552), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 691), ('SUPERFICIAL_RELATIONSHIP', 709), ('INCOMPLETE_EVIDENCE', 741), ('INCOMPLETE_EVIDENCE', 755), ('IMPORTANT_CONSIDERATION', 785), ('IMPORTANT_CONSIDERATION', 800), ('FUTURE_WORK', 807), ('INCOMPLETE_EVIDENCE', 807), ('FUTURE_WORK', 844), ('QUESTION_ANSWERED_BY_THIS_WORK', 960), ('SUPERFICIAL_RELATIONSHIP', 974), ('INCOMPLETE_EVIDENCE', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1077)]	26	[('GO_0007399', 'nervous system development', 10, 'neurocognitive development'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0050905', 'neuromuscular process', 130, 'neurocognitive'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 206, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 243, 'language development'), ('GO_0050905', 'neuromuscular process', 362, 'neurocognitive'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('GO_0007565', 'female pregnancy', 472, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 581, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 631, 'vitamin D'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 877, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 918, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1048, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1086, 'vitamin D')]
PMC3427192	4/2012	S19-PMC3427192	['Biosynthesis Of Vitamin D.\n\nVitamin D THRESHOLDS\nSerum concentrations of 25(Oh)D are CONSIDERED to be a BIOMARKER and INDICATOR of Vitamin D status.44,45ALTHOUGH Vitamin D insufficiency HAS TRADITIONALLY BEEN defined as a Serum 25(Oh)D concentration of 20 to 29 ng/ml,46a panel of experts from the institute of medicine RECENTLY SUGGESTED that Vitamin D INSUFFICIENCY be redefined AS a Serum 25(Oh)D concentration less than 20 ng/ml.47this RECOMMENDATION was based ON INCONCLUSIVE evidence for the threshold of 29 ng/ml and EVIDENCE for adverse Skeletal EFFECTS at thresholds less than 20 ng/ml.47HOWEVER, this revised definition of Vitamin D insufficiency has generated significant CONTROVERSY48,49AND THUS there is presently NO universally ACCEPTED definition for “optimal” 25(Oh)d concentrations INDEPENDENT of Musculoskeletal health.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 118), ('ANOMALY_CURIOUS_FINDING', 151), ('IMPORTANT_CONSIDERATION', 186), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 190), ('INCOMPLETE_EVIDENCE', 320), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 354), ('PROBABLE_UNDERSTANDING', 381), ('FUTURE_WORK', 440), ('ANOMALY_CURIOUS_FINDING', 465), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 524), ('SUPERFICIAL_RELATIONSHIP', 554), ('ANOMALY_CURIOUS_FINDING', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 683), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 697), ('PROBABLE_UNDERSTANDING', 703), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 742), ('INCOMPLETE_EVIDENCE', 742), ('SUPERFICIAL_RELATIONSHIP', 799)]	25	[('GO_0033593', 'BRCA2-MAGE-D1 complex', 0, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 228, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D'), ('UBERON_0001977', 'blood serum', 386, 'serum'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 392, '25(OH)D'), ('UBERON_0004288', 'skeleton', 545, 'skeletal'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 776, '25(OH)'), ('UBERON_0002204', 'musculoskeletal system', 814, 'musculoskeletal')]
PMC5706533	11/2017	S176-PMC5706533	['in the meantime, we ENDORSE the NOTION that WHENEVER feasible, investigators SHOULD report all clinically IMPORTANT outcomes, EVEN in SMALL trials that are individually UNDERPOWERED to detect EFFECTS on such outcomes.45\njohn ioannidis RECENTLY REMARKED that “systematic reviews MAY SOMETIMES be most helpful IF, INSTEAD of focusing on the summary of the evidence, HIGHLIGHT the BIASES that are INVOLVED and what NEEDS to be done to remedy the state-of-the-EVIDENCE in the given field.”46we conclude that there is currently INSUFFICIENT EVIDENCE to guide RECOMMENDATIONS for Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 77), ('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 134), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 235), ('ANOMALY_CURIOUS_FINDING', 244), ('ANOMALY_CURIOUS_FINDING', 244), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 282), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312), ('INCOMPLETE_EVIDENCE', 364), ('PROBLEM_COMPLICATION', 378), ('SUPERFICIAL_RELATIONSHIP', 394), ('FUTURE_WORK', 412), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 523), ('FUTURE_WORK', 554)]	23	[('GO_0007565', 'female pregnancy', 574, 'prenatal'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D')]
PMC5051327	9/2016	S17-PMC5051327	['introduction\nVitamin D is NECESSARY for optimal Skeletal function and deficiency is RELATED to rachitis.1\nit is, HOWEVER, IMPORTANT for bone Metabolism, as well as for optimal function of Striated and Smooth Muscle strength including Heart Muscle, and is RELATED to Postnatal muscle strength.2vitamin D supplementation has a positive IMPACT on muscle strength on Individuals with Vitamin D deficiency.134THE institute of medicine (iom), usa RECOMMENDS daily nutritional intake of Vitamin D of 600\u2005u, BUT OTHERS RECOMMEND higher doses.56a RECENT swedish STUDY SHOWED that the mean nutritional intake of Vitamin D was <200\u2005u/day.7ALTHOUGH Vitamin D is found in low amounts in the diet, mainly in oily fish and egg, the primary source of Vitamin D for Humans is skin conversion to Vitamin D from solar ultraviolet radiation.1pregnant women residing at high latitudes are AT RISK of Vitamin D deficiency BECAUSE of low solar intensity, especially during the winter months.18vitamin D deficiency is common in the nordic countries, ESPECIALLY among those not exposing themselves to the sun.8since fetal Vitamin D levels are directly RELATED to that of their mothers there is also a high LIKELIHOOD of fetal Vitamin D deficiency in our population.9\nBirth asphyxia is ASSOCIATED with Cardiovascular dysfunction, including low Ventricular output, lower left Ventricular Ejection fraction and increased troponin levels.1011congestive Heart failure MAY occur in severe cases of asphyxia.12intrauterine fetal distress is RELATED to an increase in Blood pressure, redistribution and a change in fetal Heart rate pattern.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('IMPORTANT_CONSIDERATION', 122), ('SUPERFICIAL_RELATIONSHIP', 255), ('SUPERFICIAL_RELATIONSHIP', 334), ('INCOMPLETE_EVIDENCE', 401), ('FUTURE_WORK', 441), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504), ('FUTURE_WORK', 511), ('INCOMPLETE_EVIDENCE', 538), ('INCOMPLETE_EVIDENCE', 559), ('ANOMALY_CURIOUS_FINDING', 627), ('IMPORTANT_CONSIDERATION', 868), ('PROBABLE_UNDERSTANDING', 900), ('ANOMALY_CURIOUS_FINDING', 1026), ('SUPERFICIAL_RELATIONSHIP', 1127), ('PROBABLE_UNDERSTANDING', 1181), ('SUPERFICIAL_RELATIONSHIP', 1260), ('INCOMPLETE_EVIDENCE', 1438), ('SUPERFICIAL_RELATIONSHIP', 1509)]	22	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 48, 'skeletal'), ('GO_0008152', 'metabolic process', 141, 'metabolism'), ('UBERON_0002435', 'striatum', 188, 'striated'), ('UBERON_0001135', 'smooth muscle tissue', 201, 'smooth muscle'), ('UBERON_0001133', 'cardiac muscle tissue', 234, 'heart muscle'), ('GO_0007567', 'parturition', 266, 'postnatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 301, 'D'), ('NCBITaxon_1', 'root', 363, 'individuals'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 480, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 735, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'humans'), ('CHEBI_27300', 'vitamin D', 778, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 879, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 978, 'D'), ('CHEBI_27300', 'vitamin D', 1097, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1201, 'vitamin D'), ('GO_0007567', 'parturition', 1242, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 1276, 'cardiovascular'), ('UBERON_0002082', 'cardiac ventricle', 1318, 'ventricular'), ('UBERON_0002082', 'cardiac ventricle', 1349, 'ventricular'), ('UBERON_0000970', 'eye', 1361, 'ejection'), ('UBERON_0000948', 'heart', 1424, 'heart'), ('UBERON_0000178', 'blood', 1535, 'blood'), ('UBERON_0000948', 'heart', 1588, 'heart')]
PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]
PMC3702245	6/2013	S93-PMC3702245	['another RECENT STUDY from the united arab emirates among Pregnant arab women with a high prevalence of Vitamin D deficiency also CONFIRMED that 4000 iu/day of Vitamin D supplementation was SAFE and more EFFECTIVE than 2000 iu/day and 400 iu/day in optimizing Vitamin D status during Pregnancy and in achieving Vitamin D sufficiency at Birth in mothers and offspring.106in the united arab emirates study, the increment from baseline to Delivery was about four-fold higher than expected BASED ON previous pharmacokinetic STUDIES, POSSIBLY RELATED to low baseline Vitamin D status.100this INDICATES that baseline Vitamin D status SHOULD BE taken INTO CONSIDERATION when evaluating Vitamin D supplementation.100,107\nthe FINDINGS of these RECENT intervention STUDIES INDICATE an URGENT NEED for more randomized controlled trials in diverse geographic locations with large sample sizes to identify the Vitamin D intake REQUIRED to optimize Vitamin D status, and TO ASSESS the EFFECT on Pregnancy-related and infant-related COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 189), ('SUPERFICIAL_RELATIONSHIP', 203), ('PROBABLE_UNDERSTANDING', 485), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 528), ('SUPERFICIAL_RELATIONSHIP', 537), ('INCOMPLETE_EVIDENCE', 586), ('FUTURE_WORK', 627), ('IMPORTANT_CONSIDERATION', 643), ('FUTURE_WORK', 648), ('INCOMPLETE_EVIDENCE', 716), ('INCOMPLETE_EVIDENCE', 734), ('INCOMPLETE_EVIDENCE', 762), ('IMPORTANT_CONSIDERATION', 774), ('FUTURE_WORK', 781), ('IMPORTANT_CONSIDERATION', 913), ('QUESTION_ANSWERED_BY_THIS_WORK', 956), ('SUPERFICIAL_RELATIONSHIP', 970), ('PROBLEM_COMPLICATION', 1017)]	21	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('GO_0007567', 'parturition', 335, 'birth'), ('GO_0007567', 'parturition', 435, 'delivery'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 896, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 934, 'vitamin D'), ('GO_0007565', 'female pregnancy', 980, 'pregnancy')]
PMC4973215	8/2016	S12-PMC4973215	['far FEWER STUDIES have EXAMINED the RELATIONSHIP between Cord Blood Vitamin D levels, which MAY more ACCURATELY REFLECT fetal levels of Vitamin D, and neonatal outcomes.14,24GIVEN the racial DISPARITIES SEEN in both Vitamin D deficiency and Perinatal outcomes, Vitamin D HAS BEEN PROPOSED as part of the EXPLANATION for this DISPARITY, PARTICULARLY with regard to fetal growth and sga.8\nINCREASED AWARENESS of the GROWING PREVALENCE of maternal Vitamin D deficiency has LED TO an URGENT NEED for CONSIDERATION of supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 112), ('PROBABLE_UNDERSTANDING', 174), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 280), ('PROBABLE_UNDERSTANDING', 304), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 336), ('IMPORTANT_CONSIDERATION', 387), ('INCOMPLETE_EVIDENCE', 414), ('IMPORTANT_CONSIDERATION', 422), ('SUPERFICIAL_RELATIONSHIP', 470), ('IMPORTANT_CONSIDERATION', 480), ('FUTURE_WORK', 487), ('FUTURE_WORK', 496)]	21	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0036268', 'swimming', 241, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 241, 'perinatal'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 536, 'pregnancy')]
PMC4990268	8/2016	S1116-PMC4990268	['intable 6below, we have offered very brief comments on such implementation CONSIDERATIONS.10.1371/journal.pone.0160562.t006\n\ncaption (table-wrap): table 6\n“best buy” ratings for interventions reviewed.interventionpopulation impactease of Deliverycommentsbreastfeeding—early initiation ✓ ☺large magnitude EFFECT on newborn mortalityiron/ anemia ✓✓✓ ☺LIKELY a significant mortality EFFECT, BUT EVIDENCE is WEAK; clear benefit however for iugr multi-Micronutrient supplementation✓ ☺ ALTHOUGH iugr is reduced , in many low income settings there MAY BE no net benefit; under SOME conditions there MAY BE net harm Calcium ✓✓✓😐 large magnitude EFFECTS but significant logistical barriers at currently recommended dose antenatal Vitamin A ☺ no effects on our outcomes of interest Postnatal Vitamin A ✓ ☺EVIDENCE for IMPACT on early infant deaths in Vitamin-A deficient populationsiodine ✓ ☺major benefit in ↓’d burden of Cognitive disabilitybalanced protein-energy supplementation ✓✓✓😐 significant benefits, but cost & logistical challenges limit scalability deworming ☺ no effects on our outcomes of interest iptp/itns ✓✓✓✓ ☺large magnitude EFFECTS in malarious areastetanus Toxoid ✓ ☺in most settings, coverage is now relatively high; this NEEDS to be sustainedchlorhexidine advance distribution ✓ ☺large magnitude EFFECT on newborn mortality in high nmr populationssyphilis screening & treatment ✓✓✓ ☺relatively inexpensive and straightforward diagnostics and treatmentpmtct ✓😐 high population effective coverage REQUIRES robust services and systemsmisoprostol advance distribution ✓ ☺to ensure SAFETY, Delivery strategy NEEDS to reliably ensure counseling on correct timing of use (i.e.']	[('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 349), ('SUPERFICIAL_RELATIONSHIP', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('INCOMPLETE_EVIDENCE', 392), ('INCOMPLETE_EVIDENCE', 404), ('ANOMALY_CURIOUS_FINDING', 480), ('INCOMPLETE_EVIDENCE', 541), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 592), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 795), ('SUPERFICIAL_RELATIONSHIP', 808), ('SUPERFICIAL_RELATIONSHIP', 1134), ('FUTURE_WORK', 1234), ('SUPERFICIAL_RELATIONSHIP', 1309), ('IMPORTANT_CONSIDERATION', 1508), ('IMPORTANT_CONSIDERATION', 1590), ('FUTURE_WORK', 1616), ('IMPORTANT_CONSIDERATION', 1616)]	21	[('GO_0031078', 'histone deacetylase activity (H3-K14 specific)', 238, 'DeliveryCommentsBreastfeeding'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 447, 'micronutrient'), ('CHEBI_31341', 'calcium dihydroxide', 608, 'Calcium'), ('CHEBI_77082', 'O-adipoylcarnitine(1-)', 616, '✓✓✓😐'), ('CHEBI_33233', 'fundamental particle', 721, 'vitamin A ☺'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 721, 'vitamin A ☺'), ('GO_0007567', 'parturition', 772, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 782, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 841, 'vitamin'), ('PR_000027594', 'histone H3', 841, 'vitamin-A'), ('GO_0050890', 'cognition', 913, 'cognitive'), ('CHEBI_29238', 'tritium atom', 1168, 'toxoid'), ('GO_0007567', 'parturition', 1598, 'delivery')]
PMC5706533	11/2017	S157-PMC5706533	['one of the most ROBUST FINDINGS in our systematic review—which has been PREVIOUSLY REPORTED32—was the beneficial EFFECT of Prenatal Vitamin D on RISK of persistent/recurrent wheeze (or asthma) in offspring, BASED ON data from two large well conducted trials in which wheeze/asthma was the primary outcome.3334this is broadly CONSISTENT with the POSSIBLY positive EFFECT of Vitamin D on severity of illness in Adults with asthma.5before Prenatal Vitamin D CAN be RECOMMENDED as a routine preventive measure against childhood asthma, HOWEVER, FURTHER WORK IS REQUIRED to CLARIFY the minimum effective dose and longer term follow-up to determine IF OBSERVED early EFFECTS on symptoms TRANSLATE into reductions in the incidence of asthma and improvements in Pulmonary function.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 145), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 213), ('INCOMPLETE_EVIDENCE', 325), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 363), ('INCOMPLETE_EVIDENCE', 455), ('FUTURE_WORK', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 532), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 557), ('FUTURE_WORK', 569), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('INCOMPLETE_EVIDENCE', 646), ('SUPERFICIAL_RELATIONSHIP', 661), ('SUPERFICIAL_RELATIONSHIP', 681)]	21	[('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('UBERON_0007023', 'adult organism', 409, 'adults'), ('GO_0007565', 'female pregnancy', 436, 'prenatal'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('UBERON_0002048', 'lung', 754, 'pulmonary')]
PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]
PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
PMC4934634	11/2015	S306-PMC4934634	['WHILE the ESSENTIALITY of adequate Vitamin D during Pregnancy is not DISPUTED, CONTROVERSY exists over the RECOMMENDED dietary intake levels, the mathematical approaches to calculating that level, and the endpoints used to determine REQUIREMENTS; the concentrations of circulating 25(Oh)D that denote deficiency, insufficiency and adequacy status; and WHETHER race, body weight or OTHER factors SHOULD BE TAKEN into account when making dietary RECOMMENDATIONS, similarly, it is NOT CLEAR WHAT Vitamin D supplementation regimens are most EFFECTIVE during Pregnancy; WHETHER mother, child OR both SHOULD BE supplemented; and WHETHER there are long-term CONSEQUENCES of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 381), ('FUTURE_WORK', 395), ('IMPORTANT_CONSIDERATION', 405), ('FUTURE_WORK', 444), ('FULL_UNKNOWN', 478), ('EXPLICIT_QUESTION', 488), ('SUPERFICIAL_RELATIONSHIP', 537), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('FUTURE_WORK', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 623), ('PROBLEM_COMPLICATION', 651)]	18	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 281, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 281, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 493, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnancy')]
PMC5706533	11/2017	S178-PMC5706533	['what is already known on THIS topic\nnumerous randomised trials and systematic reviews of Vitamin D supplementation during Pregnancy HAVE BEEN published, with CONFLICTING results and conclusions\nrecommendations regarding Vitamin D supplementation vary widely among medical and professional organisations, and who currently RECOMMENDS against routine Prenatal Vitamin D supplementation\n\nwhat THIS STUDY adds\nsystematic review and meta-analyses of 43 trials including 8406 participants SHOWED that Prenatal Vitamin D supplementation was ASSOCIATED with increased maternal and cord Serum 25-Hydroxyvitamin D concentrations, increased mean birth weight, reduced the risk of small for Gestational age, reduced the risk of wheeze in offspring, and increased infant length at one year of age\nthere was a LACK OF EVIDENCE OF benefits of Prenatal Vitamin D supplementation for maternal health conditions RELATED to Pregnancy, no effect on other Birth outcomes of PUBLIC HEALTH IMPORTANCE such as Preterm Birth, and SCANT EVIDENCE on safety outcomes\nFEW of the trials were designed to test the EFFECT of Vitamin D on clinical or functional outcomes, and most trials were SMALL and at overall high or UNCERTAIN risk of bias\nthirty five planned or ongoing Prenatal Vitamin D trials COULD contribute an additional 12\u2009530 participants to FUTURE systematic reviews\n\npubmed central:']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('FUTURE_WORK', 322), ('QUESTION_ANSWERED_BY_THIS_WORK', 390), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 534), ('INCOMPLETE_EVIDENCE', 796), ('SUPERFICIAL_RELATIONSHIP', 894), ('IMPORTANT_CONSIDERATION', 953), ('IMPORTANT_CONSIDERATION', 967), ('INCOMPLETE_EVIDENCE', 1005), ('INCOMPLETE_EVIDENCE', 1039), ('SUPERFICIAL_RELATIONSHIP', 1083), ('INCOMPLETE_EVIDENCE', 1160), ('FULL_UNKNOWN', 1189), ('INCOMPLETE_EVIDENCE', 1269), ('FUTURE_WORK', 1323)]	18	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('GO_0007565', 'female pregnancy', 349, 'prenatal'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0007565', 'female pregnancy', 495, 'prenatal'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 584, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 679, 'gestational'), ('GO_0007565', 'female pregnancy', 828, 'prenatal'), ('CHEBI_27300', 'vitamin D', 837, 'vitamin D'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('GO_0007567', 'parturition', 935, 'birth'), ('GO_0007565', 'female pregnancy', 986, 'preterm'), ('GO_0007567', 'parturition', 994, 'birth'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1243, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1252, 'vitamin D')]
PMC5129897	10/2016	S16-PMC5129897	['NEITHER ASSUMPTION holds for Vitamin D. robert heaney OUTLINED the GUIDELINES for Nutrient studies including Vitamin D. the most RELEVANT features are that one SHOULD start with an understanding of the 25(Oh)D concentration–health outcome RELATION, 25(Oh)D concentrations SHOULD BE measured in prospective participants, ONLY those with low concentrations SHOULD BE enrolled, sufficient Vitamin D SHOULD BE given to raise 25(Oh)D concentrations to where a significant beneficial EFFECT is expected, and achieved 25(Oh)D concentrations SHOULD BE measured.2until those steps are followed routinely, FEW Vitamin D clinical TRIALS will report beneficial EFFECTS.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 67), ('PROBABLE_UNDERSTANDING', 67), ('IMPORTANT_CONSIDERATION', 129), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 239), ('FUTURE_WORK', 272), ('INCOMPLETE_EVIDENCE', 320), ('FUTURE_WORK', 355), ('FUTURE_WORK', 396), ('SUPERFICIAL_RELATIONSHIP', 478), ('FUTURE_WORK', 534), ('INCOMPLETE_EVIDENCE', 596), ('FUTURE_WORK', 619), ('SUPERFICIAL_RELATIONSHIP', 649)]	17	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 421, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 427, 'D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 517, 'D'), ('CHEBI_27300', 'vitamin D', 600, 'vitamin D')]
PMC3702245	6/2013	S51-PMC3702245	['further, there is a SUGGESTION of an ASSOCIATION between Vitamin D and Periodontal disease,90and maternal Serum 25(Oh)D < 75 nmol/l during Early Pregnancy HAS BEEN ASSOCIATED with a two-fold INCREASED risk of Periodontal disease.91in a RECENT randomized controlled TRIAL of Vitamin D supplementation from south carolina, Vitamin D supplementation of 4000 iu/day during Pregnancy was ASSOCIATED with a reduction in the risk of combined morbidities, such as Maternal infection, Preterm labor, and Preterm Birth.92\nIN VIEW of the POSSIBLE ASSOCIATION between maternal Vitamin D status and the pattern of fetal growth, pre-eclampsia, Gestational diabetes mellitus, and maternal infection, and the significant POTENTIAL for Perinatal morbidities ASSOCIATED with these conditions, evaluation of Vitamin D nutrition in early Pregnancy and the EFFECT of appropriate supplementation SEEMS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 164), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 512), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 527), ('SUPERFICIAL_RELATIONSHIP', 536), ('INCOMPLETE_EVIDENCE', 705), ('SUPERFICIAL_RELATIONSHIP', 741), ('SUPERFICIAL_RELATIONSHIP', 836), ('ANOMALY_CURIOUS_FINDING', 874), ('FUTURE_WORK', 874)]	16	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001758', 'periodontium', 71, 'periodontal'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D'), ('GO_0051318', 'G1 phase', 139, 'early'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0001758', 'periodontium', 209, 'periodontal'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D'), ('GO_0007565', 'female pregnancy', 369, 'pregnancy'), ('GO_0007618', 'mating', 456, 'maternal'), ('GO_0007565', 'female pregnancy', 476, 'preterm'), ('GO_0007565', 'female pregnancy', 495, 'preterm'), ('GO_0007567', 'parturition', 503, 'birth'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('GO_0007565', 'female pregnancy', 630, 'gestational'), ('GO_0036268', 'swimming', 719, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 719, 'perinatal'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('GO_0007565', 'female pregnancy', 818, 'pregnancy')]
PMC3717170	5/2013	S41-PMC3717170	['THUS, IT IS POSSIBLE that Vitamin D deficiency has a generalized DETRIMENTAL IMPACT on antibacterial responses and MAY THEREFORE play a ROLE in many types of infectious diseases.5an IMPORTANT NOTE by hewison is that current data SUGGEST that this particular Immune Response to Vitamin D is restricted to Primates, UNDERLINING a POTENTIAL ROLE for Vitamin D in the evolution of Primate Immunity, BUT also LIMITING the scope of FURTHER in vivo STUDIES to explore this activity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 229), ('PROBABLE_UNDERSTANDING', 314), ('INCOMPLETE_EVIDENCE', 328), ('SUPERFICIAL_RELATIONSHIP', 338), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 395), ('INCOMPLETE_EVIDENCE', 404), ('FUTURE_WORK', 426)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0006955', 'immune response', 258, 'immune response'), ('UBERON_0002405', 'immune system', 258, 'immune'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 304, 'primates'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 377, 'primate'), ('GO_0007566', 'embryo implantation', 385, 'immunity')]
PMC4600246	10/2015	S14-PMC4600246	['the benefit of Vitamin K on bone IS THOUGHT TO be UNRELATED to increasing bmd BUT RATHER increasing bone strength.19a RECENT meta-analysis HAS SHOWN that vitamin K2(45\u2005mg/day) significantly reduces Hip (77% reduction), vertebral (60% reduction) and all non-vertebral fractures (81% reduction).20whether the results of vitamin K2At a dose of 45\u2005mg CAN be translated to over the counter doses of Vitamin K1(such as 1–5\u2005mg) is STILL a matter of DEBATE, BUT Vitamin K1On its own HAS already BEEN SHOWN to reduce fractures and cancer in a clinical TRIAL, ALTHOUGH more DATA ARE NEEDED TO CONFIRM these benefits.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 347), ('IMPORTANT_CONSIDERATION', 424), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 442), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 450), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 543), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 550), ('FUTURE_WORK', 564), ('INCOMPLETE_EVIDENCE', 583)]	16	[('CHEBI_27300', 'vitamin D', 15, 'vitamin K'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 162, 'K2'), ('UBERON_0001464', 'hip', 198, 'hip'), ('CHEBI_34810', 'Lactitol dihydrate', 326, 'K2at'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 326, 'K2at'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 394, 'vitamin K1'), ('CHEBI_33227', '(E)-cinnamyl alcohol', 454, 'vitamin K1on'), ('PR_000009495', 'keratin, type II cytoskeletal 8', 462, 'K1on')]
PMC4874157	5/2016	S115-PMC4874157	['several other STUDIES SUGGEST that, WHENEVER POSSIBLE, Interferon Β treatment SHOULD BE discontinued prior to Conception.21–28HOWEVER, SIMILAR women in OTHER STUDIES continued to receive treatment modalities throughout Pregnancy.1015–19\ninitially, Vitamin D was given as a supplement to address the paucity women MAY SUFFER from during Pregnancy,29and to attend to the Vitamin D deficiency in the general lebanese population.30more RECENT STUDIES have also SHOWN that maintaining adequate levels of Vitamin D during Pregnancy MIGHT have a PROTECTIVE EFFECT and lower the risk of developing Postpartum relapses.31\npsychological support was CRUCIAL in maintaining the mental well-Being of the mother.32some women exhibited signs of anxiety and depression.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 45), ('FUTURE_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 313), ('IMPORTANT_CONSIDERATION', 317), ('INCOMPLETE_EVIDENCE', 432), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 550), ('IMPORTANT_CONSIDERATION', 639)]	16	[('CHEBI_76163', 'isoxicam', 55, 'interferon β'), ('PR_000008918', 'interferon alpha-5', 55, 'interferon β'), ('GO_0007620', 'copulation', 110, 'conception'), ('GO_0007565', 'female pregnancy', 219, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 590, 'postpartum'), ('GO_0016441', 'posttranscriptional gene silencing', 677, '-being')]
PMC5051327	9/2016	S56-PMC5051327	['Vitamin D deficiency was ASSOCIATED with a significantly shorter Gestational age at Delivery, which is IN LINE WITH OTHER DATA.23furthermore, there SEEMS TO be an inverse RELATION between low active Vitamin D (1,25-Dihydroxy Vitamin D) and meconium-stained Amniotic Fluid, a sign of fetal distress, in Pregnancies complicated by Intrahepatic cholestasis.24\nthe FINDINGS that more than two-third of mothers were Vitamin D deficient during winter/spring season and one-third at summer are CONSISTENT with PREVIOUS reports.2526in THIS STUDY, we used the LIMITS of 25-Oh Vitamin D SUGGESTED by the iom,17BUT the discussion of WHAT levels SHOULD BE CONSIDERED deficient is ONGOING.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 361), ('INCOMPLETE_EVIDENCE', 487), ('INCOMPLETE_EVIDENCE', 503), ('QUESTION_ANSWERED_BY_THIS_WORK', 527), ('INCOMPLETE_EVIDENCE', 551), ('INCOMPLETE_EVIDENCE', 577), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 598), ('EXPLICIT_QUESTION', 622), ('FUTURE_WORK', 634), ('FUTURE_WORK', 644), ('IMPORTANT_CONSIDERATION', 668)]	16	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational'), ('GO_0007567', 'parturition', 84, 'delivery'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 210, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000173', 'amniotic fluid', 257, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 302, 'pregnancies'), ('UBERON_0001226', 'major calyx', 329, 'intrahepatic'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 561, '25-OH'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC2913107	8/2010	S48-PMC2913107	['IF this THEORY is TRUE, the PATH TOWARDS EFFECTIVE PREVENTION – and PERHAPS a treatment EFFECT IF ADEQUATE physiological doses of Vitamin D are given – is so SIMPLE, so SAFE, so INEXPENSIVE, so READILY AVAILABLE and so easy, that it DEFIES IMAGINATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 98), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 194), ('ANOMALY_CURIOUS_FINDING', 233)]	15	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4340999	3/2015	S125-PMC4340999	['this is also the FIRST-ever population-BASED EVIDENCE LINKING low Prenatal sun-RELATED uvb exposure (and lower Vitamin D by PROXY) to ll and the susceptibility to obesity later in Life and also SUGGESTING that late second and early third trimesters MIGHT be a CRITICAL period for the above-mentioned EFFECTS ALTHOUGH such EVIDENCE is non-specific, it WARRANTS FURTHER STUDIES in this AREA.']	[('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 249), ('IMPORTANT_CONSIDERATION', 260), ('SUPERFICIAL_RELATIONSHIP', 300), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('INCOMPLETE_EVIDENCE', 322), ('FUTURE_WORK', 351), ('FUTURE_WORK', 360), ('FUTURE_WORK', 384)]	15	[('GO_0007565', 'female pregnancy', 66, 'prenatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
PMC5952272	5/2018	S14-PMC5952272	['approximately 1 in 68 children aged 8\u2009years living in sites participating in the addm network surveillance areas (usa) met the asd case criteria for the 2012 surveillance year.1some HYPOTHESES were SUGGESTED to explain this increase, such as an increased awareness, improved detection, expanding definition, or an actual increase in incidence or a combination of these FACTORS.2ALTHOUGH both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function–RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.3SEVERAL RECENT STUDIES have put FORWARD hypotheses to explain the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 369), ('ANOMALY_CURIOUS_FINDING', 377), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 440), ('INCOMPLETE_EVIDENCE', 476), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 554), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 634), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 668), ('INCOMPLETE_EVIDENCE', 677), ('FUTURE_WORK', 701), ('SUPERFICIAL_RELATIONSHIP', 748)]	15	[('SO_0000704', 'gene', 392, 'genetic'), ('UBERON_0002405', 'immune system', 538, 'immune'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D'), ('CHEBI_30751', 'formic acid', 594, 'folic acid'), ('GO_0008152', 'metabolic process', 610, 'metabolic'), ('CHEBI_30751', 'formic acid', 773, 'folic acid'), ('CHEBI_27300', 'vitamin D', 788, 'vitamin D')]
PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]
PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
PMC3717170	5/2013	S144-PMC3717170	['THEREFORE, CONFIRMATION of a POTENTIAL beneficial EFFECT of Vitamin D in type 2 diabetes IS NEEDED in trials conducted in well-defined populations (e.g., pre-diabetes and early diabetes) SPECIFICALLY DESIGNED TO TEST the COMPELLING BUT YET UNPROVEN HYPOTHESIS that Vitamin D status is a direct CONTRIBUTOR to the pathogenesis of type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 50), ('FUTURE_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('ANOMALY_CURIOUS_FINDING', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 294)]	14	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC3427192	4/2012	S66-PMC3427192	['in ONE STUDY, modest ASSOCIATIONS were NOTED between several Genes in the Vitamin D pathway and asthma and allergic sensitization in populations enriched for subjects with current asthma.86a separate study of asthmatics also FOUND Haplotype ASSOCIATIONS for Cyp24A1 , the primary enzyme ASSOCIATED with Calcidiol Metabolism, where a 5-point Haplotype was ASSOCIATED with asthma, allergic sensitization, and Vitamin D Metabolites in asthmatic subjects.92while these PRELIMINARY results SUGGEST that Genetic components MAY account for Vitamin D status in subjects with asthma, OTHER STUDIES ARE NEEDED to determine tease out the Genetic vs. environmental UNDERPINNINGS of Vitamin D status in this population.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 39), ('INCOMPLETE_EVIDENCE', 225), ('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 287), ('SUPERFICIAL_RELATIONSHIP', 355), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 485), ('INCOMPLETE_EVIDENCE', 517), ('FUTURE_WORK', 575), ('FUTURE_WORK', 581), ('SUPERFICIAL_RELATIONSHIP', 653)]	13	[('SO_0000704', 'gene', 61, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('SO_0001024', 'haplotype', 231, 'haplotype'), ('PR_000006101', 'cytochrome P450 1A1', 258, 'CYP24A1'), ('CHEBI_17933', 'calcidiol', 303, 'calcidiol'), ('GO_0008152', 'metabolic process', 313, 'metabolism'), ('SO_0001024', 'haplotype', 341, 'haplotype'), ('CHEBI_27300', 'vitamin D', 407, 'vitamin D'), ('CHEBI_25212', 'metabolite', 417, 'metabolites'), ('SO_0000704', 'gene', 498, 'genetic'), ('CHEBI_27300', 'vitamin D', 533, 'vitamin D'), ('SO_0000704', 'gene', 627, 'genetic'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D')]
PMC3470091	9/2012	S20-PMC3470091	['THEREFORE, Vitamin D supplementation in high doses HAS BEEN RECOMMENDED, and oral doses of 20000 or 40000 iu were ASSOCIATED with positive outcomes.6,14moreover, higher oral dose of (6400 iu per day) to Lactating mothers significantly increased Vitamin D status in mothers as well as the Vitamin D content and antirachitic activity of their Milk.14THEREFORE, high doses of Vitamin D, EITHER orally OR through injection, HAS RECENTLY BEEN RECOMMENDED.15-24\na single dose of Vitamin D, administered parenterally, WOULD BE more EFFECTIVE, BECAUSE it is not associated with the NONCOMPLIANCE ASSOCIATED with an oral dose.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 51), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 384), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 438), ('FUTURE_PREDICTION', 511), ('SUPERFICIAL_RELATIONSHIP', 525), ('PROBLEM_COMPLICATION', 536), ('PROBLEM_COMPLICATION', 574), ('SUPERFICIAL_RELATIONSHIP', 588)]	13	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 203, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('UBERON_0001913', 'milk', 341, 'milk'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D')]
PMC3659910	1/2013	S132-PMC3659910	['while there is INTEREST in the ROLE of Vitamin D in the PREVENTION of multiple sclerosis, following epidemiological STUDIES DEMONSTRATING an ASSOCIATION between Vitamin D supplementation and reduced PREVALENCE of the disease, FUTURE RESEARCH, including randomized controlled trials in Pregnant or nonpregnant Individuals, is AWAITED TO CONFIRM OR REFUTE such BENEFIT.']	[('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 226), ('FUTURE_WORK', 325), ('FUTURE_WORK', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('IMPORTANT_CONSIDERATION', 359)]	13	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 285, 'pregnant'), ('NCBITaxon_1', 'root', 309, 'individuals')]
PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4889866	5/2016	S129-PMC4889866	['the result SHOWED no correlation between maternal Vitamin D status and neonatal Tlr9 triggered cytokine response (supplement 2), THOUGH such conclusion NEEDED to be INTERPRETED with CAUTION for the null CORRELATION MIGHT be DUE TO LACK OF POWER OWING TO SMALL number of test samples.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('FUTURE_WORK', 152), ('FULL_UNKNOWN', 165), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 215), ('PROBLEM_COMPLICATION', 224), ('INCOMPLETE_EVIDENCE', 231), ('PROBLEM_COMPLICATION', 231), ('PROBLEM_COMPLICATION', 245), ('INCOMPLETE_EVIDENCE', 254)]	13	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 80, 'TLR9')]
PMC4993554	8/2016	S175-PMC4993554	['although Liver is a rich source of key Nutrients such as Iron and Folate, avoiding it in Pregnancy is RECOMMENDED as it contains a high level of Vitamin A and the upper safer limit is UNCERTAIN.52a high dose of Vitamin A in Pregnancy poses a SERIOUS risk of Birth defects.53ALTHOUGH our study DID NOT provide information on HOW this low awareness of Vitamin A-rich source Food COULD AFFECT Pregnant women’s Food choices, written comments (open text sections of the survey) in the PRESENT STUDY INDICATED that SOME women MAY BE INFLUENCED by some of nonevidence-based information.']	[('FUTURE_WORK', 102), ('FULL_UNKNOWN', 184), ('IMPORTANT_CONSIDERATION', 242), ('ANOMALY_CURIOUS_FINDING', 272), ('INCOMPLETE_EVIDENCE', 293), ('EXPLICIT_QUESTION', 324), ('INCOMPLETE_EVIDENCE', 377), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 480), ('INCOMPLETE_EVIDENCE', 494), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 520), ('SUPERFICIAL_RELATIONSHIP', 527)]	13	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_24870', 'ion', 57, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007567', 'parturition', 258, 'birth'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin A'), ('CHEBI_33290', 'food', 372, 'food'), ('GO_0007565', 'female pregnancy', 390, 'pregnant'), ('CHEBI_33290', 'food', 407, 'food')]
PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
PMC3348565	4/2012	S138-PMC3348565	['ALTHOUGH Vitamin D overload is a theoretical POSSIBILITY, 100\u2008000 iu of Vitamin D3Has BEEN shown to provide the best protection against Vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of Vitamin D.16furthermore, single intramuscular injection of three times this dose (300\u2008000 iu) was safe in treating nutritional rickets in 6–30-month-old children residing in lower socioeconomic regions of sunny istanbul.35higher than RECOMMENDED doses of daily supplementation of Vitamin D (500–1000 iu per day, adding up to 120\u2008000 iu over 3 months) plus additional milk fortified with Vitamin D, HAS BEEN shown not to induce an overload,13including in infants starting with normal ranges of Vitamin D, EVEN when supplementation continued during the summer (in france) and when mothers had Antenatal Vitamin D supplementation.36it is IMPORTANT to note that in our study, where community supplementation was in a population with known high rates of Vitamin D deficiency, 1% of children tested had a Calcifediol concentration greater than 375 nmol/l—THOUGHT UNDESIRABLY high.6ALTHOUGH these did not produce any clinical signs and symptoms, these measurements raise a NEED for CAUTION with doses for population supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 492), ('INCOMPLETE_EVIDENCE', 656), ('ANOMALY_CURIOUS_FINDING', 762), ('IMPORTANT_CONSIDERATION', 893), ('INCOMPLETE_EVIDENCE', 1107), ('PROBLEM_COMPLICATION', 1115), ('ANOMALY_CURIOUS_FINDING', 1133), ('FUTURE_WORK', 1224), ('IMPORTANT_CONSIDERATION', 1233)]	12	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_35646', 'galanthan', 72, 'vitamin D3has'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 72, 'vitamin D3has'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 538, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 645, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 751, 'vitamin D'), ('GO_0007567', 'parturition', 849, 'antenatal'), ('CHEBI_27300', 'vitamin D', 859, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1007, 'vitamin D'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 1057, 'calcifediol')]
PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]
PMC3773018	4/2013	S103-PMC3773018	['FUTURE laboratory STUDIES also SHOULD BE SERIOUSLY CONSIDERED to help BETTER UNDERSTAND the molecular basis UNDERLYING HOW the immunomodulatory EFFECT of Vitamin D and Regulatory EFFECT of the Il4 Gene on Ige Production JOINTLY INFLUENCE the risk of fs.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 108), ('EXPLICIT_QUESTION', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 220), ('SUPERFICIAL_RELATIONSHIP', 228)]	12	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'regulatory'), ('PR_000008989', 'interleukin-1 family member 7', 193, 'IL4'), ('SO_0000704', 'gene', 197, 'gene'), ('GO_0032631', 'interleukin-27 production', 205, 'IgE production'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 205, 'IgE')]
PMC3933171	3/2014	S12-PMC3933171	['introduction\nlow Vitamin D (vitd) status is a risk FACTOR for rickets and HAS BEEN ASSOCIATED with INCREASED prevalence of Respiratory infections and other adverse health outcomes in infants and children.12in response to the CONCERN about widespread childhood vitd deficiency, professional bodies have RECOMMENDED vitd intake of 400\u2005iu/ day for all infants.13the european society for paediatrics gastroenterology, hepatology and nutrition RECOMMENDS 800–1000\u2005iu/day for preterm infants.4based on BIOMARKERS of vitd status MOSTLY in adults, Serum 25-Hydroxyvitamin-D [25(Oh)D] concentration ≥50\u2005nmol/l was also RECOMMENDED.13HOWEVER, the functional benefit of this level is CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 225), ('FUTURE_WORK', 302), ('FUTURE_WORK', 439), ('SUPERFICIAL_RELATIONSHIP', 496), ('PROBABLE_UNDERSTANDING', 522), ('FUTURE_WORK', 610), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 622), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 673)]	12	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 123, 'respiratory'), ('UBERON_0001977', 'blood serum', 540, 'serum'), ('CHEBI_67320', 'majusculamide A', 546, '25-hydroxyvitamin-D'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D')]
PMC4600246	10/2015	S79-PMC4600246	['on THE BASIS of PREVIOUSLY PRESENTED data, Warfarin MAY increase Arterial calcifications and osteoporosis through the inhibition of Vitamin K. LARGER TRIALS SHOULD BE performed to FURTHER ELUCIDATE the negative long-term health CONSEQUENCES of warfarin and IF these CAN PERHAPS be PREVENTED through the institution of supplemental Vitamin K.\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 52), ('FUTURE_WORK', 143), ('FUTURE_WORK', 157), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 188), ('PROBLEM_COMPLICATION', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257), ('INCOMPLETE_EVIDENCE', 266), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 281)]	12	[('CHEBI_10033', 'warfarin', 43, 'warfarin'), ('UBERON_0001637', 'artery', 65, 'arterial'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin K')]
PMC4770602	1/2016	S75-PMC4770602	['[22] IN CONTRAST WITH our results OTHER study SHOWED that low Birth weight is NOTED in infants of mothers supplemented with Vitamin D.\nwe THINKS that some POSSIBLE LIMITATIONS of the present study that SHOULD BE addressed and noted in FUTURE STUDIES are included; unmeasured sun exposure, maternal baseline 25-Oh-D and Preconception, physical activity, local area and early Pregnancy dietary Intake to HELP realize the EFFECT of these FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 202), ('FUTURE_WORK', 235), ('FUTURE_WORK', 402), ('SUPERFICIAL_RELATIONSHIP', 419), ('SUPERFICIAL_RELATIONSHIP', 435)]	12	[('GO_0007567', 'parturition', 62, 'birth'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 307, '25-OH-D'), ('PR_000000164', 'BMP2', 309, '-OH'), ('PR_000006444', 'diacylglycerol kinase delta', 313, 'D'), ('GO_0007565', 'female pregnancy', 319, 'preconception'), ('GO_0007565', 'female pregnancy', 374, 'pregnancy'), ('GO_0007631', 'feeding behavior', 392, 'intake')]
PMC5405075	4/2017	S89-PMC5405075	['moreover, it HAS BEEN PROPOSED that studies SHOULD focus on Vitamin D status in early Pregnancy and supplementary administration SHOULD BE initiated from the first Trimester of Gestation in order to observe the OPTIMAL EFFECT on RISK of childhood asthma, THOUGH EVIDENCE from chawes et al.’s clinical trial DID NOT CONFIRM this NOTION (75).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 44), ('FUTURE_WORK', 129), ('IMPORTANT_CONSIDERATION', 211), ('SUPERFICIAL_RELATIONSHIP', 219), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('INCOMPLETE_EVIDENCE', 328)]	12	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 164, 'trimester'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
PMC5784894	1/2018	S191-PMC5784894	['THIS work THUS establishes Early Life Vitamin D deficiency as a FACTOR that CAN CONTRIBUTE to Adult osteoporosis; offers a POTENTIAL Solution–supplementation of Vitamin D during Pregnancy and infancy; and presents a MODEL system TO IDENTIFY pathways that COULD BE TARGETED in Adult Life to prevent or treat osteoporosis, a GLOBAL health PROBLEM.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 10), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 216), ('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('INCOMPLETE_EVIDENCE', 255), ('FUTURE_WORK', 264), ('IMPORTANT_CONSIDERATION', 323), ('IMPORTANT_CONSIDERATION', 337)]	12	[('UBERON_0001847', 'lobule of pinna', 27, 'early life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_75958', 'solution', 133, 'solution'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('UBERON_0000113', 'post-juvenile adult stage', 276, 'adult life')]
PMC2841444	2/2010	S11-PMC2841444	['the following are SUPPORTED by moderate- to high-quality evidence and STRONGLY RECOMMENDED for lmics:\n• two INTERVENTIONS PREVENT Preterm Births—smoking cessation and Progesterone\n• eight INTERVENTIONS PREVENT stillbirths—balanced protein energy supplementation, screening and treatment of syphilis, intermittant presumptive treatment for malaria during Pregnancy, Insecticide-treated mosquito nets, Birth preparedness, emergency obstetric care, cesarean section for breech presentation, and elective induction for post-term Delivery\n• eleven INTERVENTIONS improve survival of Preterm newborns—prophylactic Steroids in Preterm labor, Antibiotics for prom, Vitamin K supplementation at Delivery, case management of neonatal sepsis and pneumonia, delayed Cord clamping, room air (vs. 100% oxygen) for resuscitation, hospital-based kangaroo mother care, early breastfeeding, thermal care, and Surfactant therapy and application of continued distending pressure to the Lungs for Respiratory Distress syndrome\n\nconclusion\nthe research paradigm for discovery science and intervention development MUST BE BALANCED to address PREVENTION as well as improve morbidity and mortality in all settings.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 70), ('FUTURE_WORK', 79), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 543), ('IMPORTANT_CONSIDERATION', 1090), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1098), ('SUPERFICIAL_RELATIONSHIP', 1118)]	11	[('GO_0007565', 'female pregnancy', 130, 'preterm births'), ('CHEBI_17026', 'progesterone', 167, 'progesterone'), ('GO_0007565', 'female pregnancy', 354, 'pregnancy'), ('CHEBI_24852', 'insecticide', 365, 'insecticide'), ('GO_0007567', 'parturition', 400, 'birth'), ('GO_0007567', 'parturition', 525, 'delivery'), ('GO_0007565', 'female pregnancy', 577, 'preterm'), ('CHEBI_35341', 'steroid', 607, 'steroids'), ('GO_0007565', 'female pregnancy', 619, 'preterm'), ('CHEBI_33282', 'antibacterial agent', 634, 'antibiotics'), ('CHEBI_27300', 'vitamin D', 656, 'vitamin K'), ('GO_0007567', 'parturition', 685, 'delivery'), ('UBERON_0002240', 'spinal cord', 753, 'cord'), ('CHEBI_35195', 'surfactant', 890, 'surfactant'), ('UBERON_0002048', 'lung', 965, 'lungs'), ('UBERON_0003495', 'respiratory system arteriole', 975, 'respiratory distress')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3171895	9/2011	S149-PMC3171895	['FURTHER INVESTIGATIONS are REQUIRED AS the concentrations of these Vitamins REMAIN significantly reduced in women with Preeclampsia, but in the absence OF FURTHER EVIDENCE, routine supplementation with higher dose Vitamin C and E is not RECOMMENDED AS they CAN be POTENTIALLY dangerous in high concentrations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 27), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 155), ('FUTURE_WORK', 237), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 257), ('INCOMPLETE_EVIDENCE', 264)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 67, 'vitamins'), ('GO_0007128', 'meiotic prophase I', 119, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 228, 'E')]
PMC3271033	1/2012	S141-PMC3271033	['we CANNOT RULE OUT the POSSIBILITY that a SMALL NUMBER OF infants WILL be hypocalcemic in the first weeks of Life with this approach, BUT, this APPEARS TO BE UNCOMMON and MAY BE more RELATED to pth function than Vitamin D. further RESEARCH IS NEEDED relative to the etiology of symptomatic hypocalcemia in the first weeks of life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 48), ('FUTURE_PREDICTION', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 183), ('FUTURE_WORK', 231)]	11	[('UBERON_0000104', 'life cycle', 109, 'life'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3702245	6/2013	S19-PMC3702245	['there is a high prevalence of Vitamin D deficiency [Serum 25(Oh) D <50 nmol/l], and as shown intable 1, most women studied (>80%) have Serum 25(Oh)D concentrations <75 nmol/l, which are CONSIDERED “INSUFFICIENT”.8mean Serum 25(Oh)D concentrations are highest and the prevalence of Vitamin D deficiency is lowest in sun-enriched populations,51,57WHILE the lowest mean Serum 25(Oh)d and the highest prevalence of Vitamin D deficiency are REPORTED in sunshine-deprived populations.16,17,50,55,56the high prevalence of low Vitamin D ASSOCIATED with sunshine deprivation and INADEQUATE corrective Vitamin D intake SHOULD RAISE PUBLIC HEALTH CONCERN about the INCREASED RISK of adverse health EFFECTS of low Vitamin D status for the mother and fetus and poor Vitamin D nutrition in the infant at Birth.']	[('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 198), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('INCOMPLETE_EVIDENCE', 436), ('SUPERFICIAL_RELATIONSHIP', 529), ('IMPORTANT_CONSIDERATION', 570), ('FUTURE_WORK', 609), ('IMPORTANT_CONSIDERATION', 616), ('IMPORTANT_CONSIDERATION', 622), ('IMPORTANT_CONSIDERATION', 654), ('SUPERFICIAL_RELATIONSHIP', 687)]	11	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH) D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 141, '25(OH)D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_30778', 'gallic acid', 224, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 230, 'D'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('UBERON_0001977', 'blood serum', 367, 'serum'), ('CHEBI_30778', 'gallic acid', 373, '25(OH)'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 592, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 702, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin D'), ('GO_0007567', 'parturition', 790, 'birth')]
PMC3702245	6/2013	S94-PMC3702245	['BASED ON BIOMARKERS AFFECTED by Vitamin D status, and FINDINGS from observational studies and recent randomized trials, FUTURE STUDIES SHOULD include trial arms to achieve Serum 25(Oh)D concentrations that HAVE BEEN ASSOCIATED with POTENTIAL Extraskeletal benefits8,82,84,94–96of Vitamin D to understand BETTER both the benefits and risks of Vitamin D supplementation to mother and offspring.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 54), ('FUTURE_WORK', 120), ('FUTURE_WORK', 135), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 304)]	11	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001977', 'blood serum', 172, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 181, 'OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D')]
PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]
PMC4113768	7/2014	S1038-PMC4113768	['these data SUGGEST that the RELATED EFFECTS are strong and CONSISTENT across DIFFERENT types of infections, HIGHLIGHTING THE NEED to PREVENT Vitamin D deficiency in Pregnant mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 121), ('FUTURE_WORK', 125), ('SUPERFICIAL_RELATIONSHIP', 133)]	11	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnant')]
PMC4466139	6/2015	S119-PMC4466139	['it is THEREFORE IMPORTANT to correct the deficiency in utero with higher doses in those AT RISK of SERIOUS deficiency and to closely follow these infants re the early detection of diseases RELATED to lack of Vitamin D.\nknowledge of a generalized Vitamin D deficiency and of RELATED RISK FACTORS MAY LEAD TO IMPROVING education and to more effective PUBLIC HEALTH initiatives.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 99), ('SUPERFICIAL_RELATIONSHIP', 189), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 299), ('FUTURE_WORK', 307), ('IMPORTANT_CONSIDERATION', 349)]	11	[('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4514967	12/2014	S87-PMC4514967	['low Cord Blood Vitamin D levels are a PREDICTOR of subsequent infant Respiratory infections.70,71HOWEVER, data from clinical trials are too LIMITED to draw conclusions about the efficacy and SAFETY of Vitamin D supplementation in Pregnancy.72meta-analyses have HIGHLIGHTED THE NEED to extend endpoints in intervention trials of multiple Micronutrients in Pregnancy.30the timing of Nutrient interventions during Pregnancy or before Conception is an IMPORTANT clinical study parameter to CONSIDER in any meta-analysis designed to evaluate the EFFECTS of an intervention or interventions and the OBSERVED effect size.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 273), ('FUTURE_WORK', 277), ('IMPORTANT_CONSIDERATION', 448), ('FUTURE_WORK', 486), ('SUPERFICIAL_RELATIONSHIP', 541), ('INCOMPLETE_EVIDENCE', 593)]	11	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 69, 'respiratory'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 230, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 337, 'micronutrients'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('CHEBI_33284', 'nutrient', 381, 'nutrient'), ('GO_0007565', 'female pregnancy', 411, 'pregnancy'), ('GO_0007620', 'copulation', 431, 'conception')]
PMC5028238	10/2016	S202-PMC5028238	['studies involving moderate Prenatal Vitamin D supplementation HAVE REPORTED no adverse EFFECTS.89THEREFORE, we would not expect Vitamin D to result in slos-RELATED Teratogenic EFFECTS, ALTHOUGH ADDITIONAL STUDIES would BE NEEDED to ascertain the EFFECTS of large doses of Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 87), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 156), ('SUPERFICIAL_RELATIONSHIP', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('FUTURE_WORK', 194), ('FUTURE_WORK', 205), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 246)]	11	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_50905', 'teratogenic agent', 164, 'teratogenic'), ('GO_0007565', 'female pregnancy', 272, 'prenatal'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D')]
PMC5155676	12/2016	S125-PMC5155676	['ALTHOUGH OUR FINDINGS are NOVEL, and MAY enable the development of individualized ADVICE for Antenatal Vitamin D supplementation, there are a NUMBER OF LIMITATIONS which SHOULD BE CONSIDERED in the INTERPRETATION of this study.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FULL_UNKNOWN', 26), ('INCOMPLETE_EVIDENCE', 37), ('FUTURE_WORK', 82), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 152), ('PROBLEM_COMPLICATION', 152), ('FUTURE_WORK', 170), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 198)]	11	[('GO_0007567', 'parturition', 93, 'antenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC5359891	3/2017	S108-PMC5359891	['omission from control group SUPPORTED by usual clinical practiceβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictionsfolic acid400\xa0μgstandard Preconception RECOMMENDATIONIRON12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, THOUGH WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard preconception recommendationprobiotictaking a combination of two Probiotics HAS BEEN LINKED with maintenance of healthy Glucose Metabolism in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 99), ('FUTURE_WORK', 218), ('ANOMALY_CURIOUS_FINDING', 305), ('INCOMPLETE_EVIDENCE', 312), ('PROBABLE_UNDERSTANDING', 380), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 458), ('PROBABLE_UNDERSTANDING', 613), ('INCOMPLETE_EVIDENCE', 755), ('SUPERFICIAL_RELATIONSHIP', 764)]	11	[('CHEBI_85000', '1-octadecenoyl-2-icosatetraenoyl-sn-glycero-3-phosphoethanolamine', 65, '-carotene720'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 116, 'retinol'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'preconception'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_17234', 'glucose', 470, 'glucose'), ('GO_0006006', 'glucose metabolic process', 470, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 492, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 528, 'calcium'), ('GO_0007565', 'female pregnancy', 568, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 744, 'probiotics'), ('CHEBI_17234', 'glucose', 799, 'glucose'), ('GO_0006006', 'glucose metabolic process', 799, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 821, 'pregnancy')]
PMC5513133	7/2017	S264-PMC5513133	['WHILE SOME STUDIES HAVE BEEN able to capture an adequate representation of african american women [96], there is a NEED FOR FURTHER RESEARCH on populations with very low Vitamin D levels to understand THIS OBSERVATION and IDENTIFY FACTORS that PREDISPOSE high-risk groups to pe and its more THREATENING clinical subtypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 115), ('FUTURE_WORK', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 222), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 244), ('IMPORTANT_CONSIDERATION', 291)]	11	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5640793	9/2017	S44-PMC5640793	["the lancet 's 2013 maternal and child nutrition series RECOMMENDS ten nutrition-specific INTERVENTIONS, including sufficient and diverse Foods for adolescent girls and women; iron, Folic Acid, and Calcium supplementation in Pregnancy; good infant and young child Feeding practices; Vitamin A, iron, and preventive zinc supplementation for children; and treatment for moderate and severe acute malnutrition.5strikingly HOWEVER, expanding the coverage of these nutrition-specific INTERVENTIONS to 90% of mothers and children would only reduce stunting by an ESTIMATED 20%.5larger reductions than these REQUIRE increasing access to family Planning, health services for Pregnant women and children, investments in Water and sanitation, social safety nets, girls' education, and women's empowerment.6a pragmatic approach to design community STRATEGIES for stunting reduction MIGHT THEREFORE be to prioritise action on immediate determinants (infection control, nutrition, and care in the first 1000 days) while providing an enabling social environment for changes in more distal determinants, for example by sharing information about health, nutrition, and sanitation entitlements, and bolstering women's agency."]	[('FUTURE_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('ANOMALY_CURIOUS_FINDING', 418), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 556), ('FUTURE_WORK', 600), ('IMPORTANT_CONSIDERATION', 600), ('FUTURE_WORK', 836), ('INCOMPLETE_EVIDENCE', 870), ('PROBABLE_UNDERSTANDING', 876)]	11	[('CHEBI_33290', 'food', 137, 'foods'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 263, 'feeding'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin A'), ('GO_0006260', 'DNA replication', 636, 'planning'), ('GO_0007565', 'female pregnancy', 666, 'pregnant'), ('CHEBI_15377', 'water', 710, 'water')]
PMC5706533	11/2017	S177-PMC5706533	['cautious PROJECTIONS for the next decade SUGGEST that we will eventually know more about Vitamin D in Pregnancy THAN we do now, BUT in the absence of a coordinated effort and funding to conduct large new trials, SOME of the most CRITICAL QUESTIONS about the effectiveness of Prenatal Vitamin D supplementation will PROBABLY REMAIN unanswered in the foreseeable FUTURE.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 229), ('EXPLICIT_QUESTION', 238), ('PROBABLE_UNDERSTANDING', 315), ('INCOMPLETE_EVIDENCE', 324), ('FUTURE_WORK', 361)]	11	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5941617	5/2018	S271-PMC5941617	['at PRESENT, SOME UNANSWERED QUESTIONS REMAIN [CRITICAL times during which supplementation MAY BE most EFFECTIVE, regimen and length of supplementation (continuous or intermittent), gender difference] [227], THUS Vitamin D supplementation to optimize bone mass acquisition SHOULD BE reserved for children AT RISK for deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('EXPLICIT_QUESTION', 28), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('PROBABLE_UNDERSTANDING', 207), ('FUTURE_WORK', 272), ('IMPORTANT_CONSIDERATION', 304)]	11	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S390-PMC5941617	['the EVIDENCES for a pathogenetic ROLE for Vitamin D in ad are STILL CONFLICTING EVEN THOUGH data in favour of such CORRELATION are increasingly stronger with MORE STUDIES in favour BUT OTHERS OPPOSING THIS HYPOTHESIS.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 115), ('FUTURE_WORK', 158), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206)]	11	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC2581757	11/2008	S4-PMC2581757	['THUS, we conclude that the use of Vitamins C and e SHOULD BE CONSIDERED for the Control of certain IMPORTANT biochemical indices during the development of Preeclampsia; HOWEVER, FURTHER STUDIES ARE NEEDED to develop methods for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 51), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('FUTURE_WORK', 178), ('FUTURE_WORK', 186), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 276)]	10	[('CHEBI_27300', 'vitamin D', 34, 'vitamins C'), ('PR_000004900', 'complement C3', 43, 'C'), ('GO_0065007', 'biological regulation', 80, 'control'), ('GO_0007128', 'meiotic prophase I', 155, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 246, 'preeclampsia')]
PMC3004407	12/2010	S159-PMC3004407	["TAKING INTO account Vitamin D's EMERGING ROLE in Immune maintenance throughout the body and the MOUNTING EVIDENCE TO SUPPORT the IMPORTANCE of Vitamin D in maintaining good health, at the very LEAST, women who are deficient in Vitamin D SHOULD BE counseled regarding the risks of Vitamin D deficiency for themselves and their offspring and RECOMMENDED a therapy to ensure Vitamin D adequacy [60–62,68–70]."]	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 129), ('PROBABLE_UNDERSTANDING', 193), ('FUTURE_WORK', 237), ('FUTURE_WORK', 340)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3075531	7/2010	S62-PMC3075531	['WHEREAS FUTURE observational epidemiological studies and Genetic and molecular INVESTIGATIONS WILL be useful to strengthen and refine the HYPOTHESIS, it MIGHT be NECESSARY to do a LARGE randomized TRIAL to establish the SAFETY and efficacy NEEDED to promote large-scale Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 79), ('FUTURE_PREDICTION', 94), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 153), ('IMPORTANT_CONSIDERATION', 162), ('FUTURE_WORK', 180), ('IMPORTANT_CONSIDERATION', 220), ('FUTURE_WORK', 240)]	10	[('SO_0000704', 'gene', 57, 'genetic'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3427192	4/2012	S40-PMC3427192	['HOWEVER, 25(Oh)D concentrations in the non-asthmatic group were significantly higher than PREVIOUSLY-REPORTED average values in african american children.21the childhood asthma management program study, which consisted of a racially diverse population, also FOUND that 24% of Vitamin D deficient subjects were african american, compared with only 7% in the Vitamin D sufficient group.69the FACTORS responsible for the racial DISPARITY in Vitamin D status are UNCLEAR and WARRANT FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 425), ('FULL_UNKNOWN', 459), ('FUTURE_WORK', 471), ('FUTURE_WORK', 479)]	10	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D')]
PMC3702245	6/2013	S6-PMC3702245	['in addition, it is now known to be INVOLVED in Immunomodulation, Cell Proliferation, and Cell Differentiation, and in other physiologic functions in diverse Tissues and Organs, including the Brain, Pancreas, and Heart.6despite the REPORTED high prevalence of Vitamin D deficiency and its POSSIBLE consequences, the criteria for defining an optimal level in the body, and HENCE the amount of Vitamin D intake REQUIRED to maintain adequate levels, is CONTROVERSIAL.3,7,8this overview addresses the CURRENT INFORMATION about Vitamin D function, the GLOBAL BURDEN and POTENTIAL consequences of low Vitamin D status in Pregnancy, and current STRATEGIES to optimize Vitamin D status in Pregnant mothers and their offspring.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 288), ('PROBABLE_UNDERSTANDING', 371), ('IMPORTANT_CONSIDERATION', 408), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 449), ('INCOMPLETE_EVIDENCE', 496), ('IMPORTANT_CONSIDERATION', 546), ('INCOMPLETE_EVIDENCE', 564), ('FUTURE_WORK', 637)]	10	[('GO_0050900', 'leukocyte migration', 47, 'immunomodulation'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 89, 'cell differentiation'), ('UBERON_0000479', 'tissue', 157, 'tissues'), ('UBERON_0000062', 'organ', 169, 'organs'), ('UBERON_0000955', 'brain', 191, 'brain'), ('UBERON_0001264', 'pancreas', 198, 'pancreas'), ('UBERON_0000948', 'heart', 212, 'heart'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 594, 'vitamin D'), ('GO_0007565', 'female pregnancy', 614, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('GO_0007565', 'female pregnancy', 680, 'pregnant')]
PMC3760821	9/2013	S35-PMC3760821	['IMPORTANTLY, this cohort was largely of white european origin and THEREFORE, less AT RISK of Vitamin D deficiency[15]; furthermore, the authors counselled that their FINDINGS SHOULD NOT BE taken to mean that individual 25Ohd concentrations are not an IMPORTANT DETERMINANT of bone health, and, moreover, that their study WAS NOT designed to examine non-bone health outcomes[14].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 175), ('ANOMALY_CURIOUS_FINDING', 186), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 261), ('INCOMPLETE_EVIDENCE', 321), ('ANOMALY_CURIOUS_FINDING', 325)]	10	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 219, '25OHD')]
PMC3798907	8/2013	S153-PMC3798907	['this DISPARITY, in conjunction with RECENT Antenatal intervention DATA [21] EMPHASISES the COMPLEX nature of ASSOCIATIONS between Nutrients and disease and the NEED carefully to CONSIDER the nature of any Vitamin E based Antenatal intervention intended to reduce the LIKELIHOOD of childhood asthma.']	[('ANOMALY_CURIOUS_FINDING', 5), ('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 76), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 109), ('FUTURE_WORK', 160), ('FUTURE_WORK', 178), ('PROBABLE_UNDERSTANDING', 267)]	10	[('GO_0007567', 'parturition', 43, 'antenatal'), ('CHEBI_33284', 'nutrient', 130, 'nutrients'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin E'), ('GO_0007567', 'parturition', 221, 'antenatal')]
PMC4072587	6/2014	S148-PMC4072587	['SOME authors have also SUGGESTED that the cut off for sufficient Vitamin D levels during Pregnancy SHOULD BE as high as 100–150 nmo/l[10],[11], and THEREFORE the PROBLEM of Vitamin D deficiency in vietnam and OTHER south east asian countries MAY BE EVEN more widespread than PREVIOUSLY THOUGHT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 148), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 242), ('ANOMALY_CURIOUS_FINDING', 249), ('INCOMPLETE_EVIDENCE', 275), ('INCOMPLETE_EVIDENCE', 286)]	10	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC4072587	6/2014	S153-PMC4072587	['HOWEVER, SIMILAR FINDINGS in PREVIOUS STUDIES[24],[38],[41],[42],[43]and the INCREASING EVIDENCE for Vitamin D deficiency AS a POTENTIAL environmental risk FACTOR for autism[10],[25],[26]SUGGEST that these ASSOCIATIONS SHOULD NOT BE discounted.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 122), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 206), ('FUTURE_WORK', 219)]	10	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4340999	3/2015	S113-PMC4340999	['Vitamin D insufficiency during Pregnancy is highly PREVALENT in a diverse range of populations living at various latitudes and in both developed and developing societies.29,33the adverse EFFECTS of Vitamin D insufficiency on offspring during development and later in Life HAVE also BEEN extended greatly.29–31from a PUBLIC HEALTH perspective, the POTENTIAL to PREVENT common chronic diseases via low-cost, simple, and SAFE Food fortification is an attractive option.33\nsome POTENTIAL limitations of this study WARRANT CONSIDERATION.']	[('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 272), ('IMPORTANT_CONSIDERATION', 316), ('INCOMPLETE_EVIDENCE', 347), ('SUPERFICIAL_RELATIONSHIP', 360), ('IMPORTANT_CONSIDERATION', 418), ('INCOMPLETE_EVIDENCE', 474), ('FUTURE_WORK', 510), ('FUTURE_WORK', 518)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000104', 'life cycle', 267, 'life'), ('CHEBI_33290', 'food', 423, 'food')]
PMC4405493	4/2015	S178-PMC4405493	['ALTHOUGH OUR STUDY DID NOT DEMONSTRATE an association of Vitamin D Plasma concentration with select clinical outcomes, the prevalence of sub-optimal Vitamin D concentrations in patient plasma EMPHASIZES THE NEED for CONTINUED RESEARCH on hypovitaminosis d in Pregnancy and Reproductive health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 192), ('INCOMPLETE_EVIDENCE', 203), ('FUTURE_WORK', 207), ('FUTURE_WORK', 216)]	10	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0000003', 'reproduction', 273, 'reproductive')]
PMC4417995	4/2015	S186-PMC4417995	['similarly, to devise a STRATEGY for using Vitamin D in the therapy of ad SEEMS at present to be NOT FEASIBLE for DIFFERENT reasons: many CONFOUNDING and unidentified VARIABLES appear in EXISTING STUDIES, and they are OFTEN LIMITED by SMALL numbers of participants, their short durations, and the use of a fixed dose without optimizing for adequate Serum levels.']	[('FUTURE_WORK', 23), ('ANOMALY_CURIOUS_FINDING', 73), ('DIFFICULT_TASK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('PROBLEM_COMPLICATION', 137), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 186), ('PROBABLE_UNDERSTANDING', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 234)]	10	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum')]
PMC4600246	10/2015	S74-PMC4600246	['combining Vitamin K2With an Ace Inhibitor (Perindopril) HAS SHOWN synergistic EFFECTS on hcc recurrence and survival, and THUS this combination SHOULD also BE FURTHER explored.60moreover, ADDITIONAL STUDIES SHOULD BE explored combining Vitamin K2With Acyclic Retinoids, AS this combination HAS also SHOWN positive results on Human Hcc cell lines.69the health benefits of Vitamin K have been summarised inbox 1.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 78), ('PROBABLE_UNDERSTANDING', 122), ('FUTURE_WORK', 144), ('ANOMALY_CURIOUS_FINDING', 156), ('FUTURE_WORK', 159), ('FUTURE_WORK', 188), ('FUTURE_WORK', 207), ('PROBABLE_UNDERSTANDING', 270), ('INCOMPLETE_EVIDENCE', 290)]	10	[('CHEBI_77570', 'tropisetron hydrochloride', 10, 'vitamin K2with'), ('CHEBI_78720', 'tetramethylrhodamine ethyl ester perchlorate', 28, 'ACE inhibitor'), ('CHEBI_8024', 'perindopril', 43, 'perindopril'), ('CHEBI_77570', 'tropisetron hydrochloride', 236, 'vitamin K2with'), ('CHEBI_33333', 'alkylidene group', 251, 'acyclic retinoids'), ('NCBITaxon_9606', 'Homo sapiens', 325, 'human'), ('CL_0000745', 'retina horizontal cell', 331, 'HCC'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin K')]
PMC4691762	12/2015	S18-PMC4691762	['Vitamin D deficiency (currently defined as 25Ohd3<50\u2005nmol/l) has become MORE COMMON in modern communities over time, PRESUMABLY DUE TO INADEQUATE sun exposure resulting from indoor activities and skin cancer CONCERNS.13vitamin d deficiency is common in victoria, australia and also APPEARS TO BE increasing among Pregnant women14and infants.6in addition, the prevalence of infant Vitamin D deficiency was fourfold higher among fully Breastfed infants than fully formula Fed (p<0.001) EVEN at 12\u2005months after solid Food had been introduced.15\nUNLIKE OTHER countries in the northern hemisphere, australia does not RECOMMEND universal Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 72), ('PROBABLE_UNDERSTANDING', 117), ('PROBABLE_UNDERSTANDING', 128), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 282), ('ANOMALY_CURIOUS_FINDING', 484), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 542), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 549), ('FUTURE_WORK', 612)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_63058', '(2R,3S)-EHNA', 43, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 43, '25OHD3'), ('GO_0007565', 'female pregnancy', 313, 'pregnant'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('GO_0007567', 'parturition', 433, 'breastfed'), ('GO_0007631', 'feeding behavior', 470, 'fed'), ('CHEBI_33290', 'food', 514, 'food'), ('CHEBI_27300', 'vitamin D', 632, 'vitamin D')]
PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]
PMC4908484	6/2016	S0-PMC4908484	['protective EFFECTS of 1 Α ,25‐Dihydroxyvitamin D3 on Cultured Neural Cells exposed to catalytic iron\n\nabstractabstract\nRECENT STUDIES have POSTULATED a ROLE for Vitamin D and its receptor on Cerebral function, and anti‐inflammatory, immunomodulatory and Neuroprotective EFFECTS HAVE BEEN DESCRIBED; Vitamin D can inhibit proinflammatory cytokines and Nitric Oxide synthesis during various neurodegenerative insults, and MAY BE CONSIDERED as a POTENTIAL Drug for the treatment of these disorders.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 270), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 288), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 427), ('INCOMPLETE_EVIDENCE', 443)]	10	[('CHEBI_37983', 'sulfur-35 atom', 22, '1'), ('CHEBI_63991', '15-epi-lipoxin B4', 24, 'α ,25‐Dihydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 47, 'D3'), ('CL_0000010', 'cultured cell', 53, 'cultured'), ('CL_0002319', 'neural cell', 62, 'neural cells'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('UBERON_0001893', 'telencephalon', 191, 'cerebral'), ('GO_0019234', 'sensory perception of fast pain', 254, 'neuroprotective'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('CHEBI_16480', 'nitric oxide', 351, 'nitric oxide'), ('GO_0000740', 'nuclear membrane fusion', 351, 'nitric oxide'), ('CHEBI_23888', 'drug', 453, 'drug')]
PMC4934634	11/2015	S266-PMC4934634	['as PREVIOUSLY mentioned, short-term studies GENERALLY AGREE with its SAFETY BUT long-term STUDIES ARE NEEDED to address the QUESTION of WHETHER large bolus Vitamin D supplementation during Pregnancy is ASSOCIATED with any adverse health outcomes in the offspring later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 90), ('EXPLICIT_QUESTION', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('EXPLICIT_QUESTION', 136), ('SUPERFICIAL_RELATIONSHIP', 202)]	10	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('UBERON_0000104', 'life cycle', 272, 'life')]
PMC4934634	11/2015	S305-PMC4934634	['OTHER CONCERNS are the INSUFFICIENT EVIDENCE to determine the EFFECTS of Vitamin D supplementation/fortification on bone health and fracture incidence and that fda RECOMMENDATIONS to include Vitamin D on Food labels MAY ENCOURAGE fortification of Vitamin D in products that would not otherwise necessarily be RECOMMENDED, and lastly, that there is SOME EVIDENCE for POSSIBLE adverse consequences to Vitamin D fortification [107].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 62), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 216), ('FUTURE_WORK', 220), ('FUTURE_WORK', 309), ('INCOMPLETE_EVIDENCE', 348), ('INCOMPLETE_EVIDENCE', 366)]	10	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33290', 'food', 204, 'food'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]
PMC4973215	8/2016	S14-PMC4973215	['THUS, sufficient EVIDENCE is LACKING at this time to RECOMMEND routine Vitamin D supplementation during Pregnancy.12HOWEVER, identification of specific RISK FACTORS for Vitamin D deficiency and the additive EFFECTS of these RISK FACTORS MAY LEAD TO OPPORTUNITIES for targeted supplementation with improved outcomes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 207), ('SUPERFICIAL_RELATIONSHIP', 224), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 241), ('FUTURE_WORK', 249)]	10	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5146866	12/2016	S107-PMC5146866	['our data SHOULD ENCOURAGE pediatricians to supplement infants with Vitamin D ESPECIALLY CONSIDERING the REPORTED POOR COMPLIANCE with the aap’s RECOMMENDATIONS by both, pediatricians and parents [38].']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 16), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 113), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 118), ('FUTURE_WORK', 144)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5510234	7/2017	S78-PMC5510234	['the authors REPORTED that EVEN in regions where Vitamin A deficiency is a PUBLIC HEALTH CONCERN, Vitamin A supplementation for PREVENTION of Prenatal mtct is not RECOMMENDED.58finally a RECENT REVIEW done on the vitamin a supplementation for the reduction of the RISK of mother-to-child transmission of hiv, REPORTED that early observational studies FOUND an ASSOCIATION between Vitamin A deficiency and increased rates of mtct of hiv.']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 127), ('FUTURE_WORK', 162), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 263), ('INCOMPLETE_EVIDENCE', 308), ('INCOMPLETE_EVIDENCE', 350), ('SUPERFICIAL_RELATIONSHIP', 359)]	10	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin A')]
PMC5706533	11/2017	S20-PMC5706533	['we SPECIFICALLY AIMED to estimate the EFFECTS of Vitamin D supplementation during Pregnancy on maternal, neonatal, and infant outcomes, taking into consideration the quality of AVAILABLE evidence and heterogeneity across studies; determine frequencies at which relevant outcome variable data were missing, unreported, or inconsistently reported among trials that were otherwise eligible for inclusion; and IDENTIFY ONGOING or PLANNED STUDIES of Vitamin D supplementation during Pregnancy to project the state of EVIDENCE that COULD accrue in the next decade.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 177), ('FUTURE_WORK', 406), ('IMPORTANT_CONSIDERATION', 415), ('FUTURE_WORK', 426), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 526)]	10	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 478, 'pregnancy')]
PMC5941617	5/2018	S144-PMC5941617	['OTHER authors and GUIDELINES for central europe RECOMMENDED Vitamin D supplementation in preterm infants at higher dosages (400–1000\xa0iu/day) THAN those SUGGESTED for healthy term newborns [1,9,20,126], BUT such an intake SHOULD NOT BE prolonged over the THEORETICAL term (40\xa0weeks of post-Conceptional age) due to the POTENTIAL risk of Vitamin D intoxication [126].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 48), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('FUTURE_WORK', 221), ('INCOMPLETE_EVIDENCE', 254), ('INCOMPLETE_EVIDENCE', 318)]	10	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007620', 'copulation', 289, 'conceptional'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC5941617	5/2018	S729-PMC5941617	['CONSIDERING AVAILABLE EVIDENCE, PARTICULARLY the LACK OF italian studies, at PRESENT we DO NOT RECOMMEND OTHER modalities DIFFERENT from daily or weekly administration of Vitamin D to treat asymptomatic Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('FULL_UNKNOWN', 88), ('FUTURE_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	10	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D')]
PMC5956785	5/2018	S64-PMC5956785	['in the most RECENT review of Vitamin D REQUIREMENTS, the iom CONCLUDED that there was INADEQUATE INFORMATION to make intake RECOMMENDATIONS in RELATION to OTHER biologic ROLES of vitamin d [19].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 97), ('FUTURE_WORK', 124), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 170)]	10	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5995352	6/2018	S38-PMC5995352	['IF low maternal or Cord 25Ohd is LINKED to diminished infant growth, especially of the Long Bones, DESPITE Vitamin D supplementation RECOMMENDATIONS, an IMPORTANT POTENTIAL for enforced PREVENTION STRATEGIES is SUGGESTED, EVEN in populations with low incidence of Vitamin D deficiency rickets.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('ANOMALY_CURIOUS_FINDING', 99), ('FUTURE_WORK', 133), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 186), ('FUTURE_WORK', 197), ('INCOMPLETE_EVIDENCE', 211), ('ANOMALY_CURIOUS_FINDING', 222)]	10	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 24, '25OHD'), ('UBERON_0002495', 'long bone', 87, 'long bones'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D')]
PMC1888711	5/2007	S46-PMC1888711	['beneficial EFFECTS on Birth weight and the risk of Postpartum endometritis were SEEN for high-risk women" [22].moderatedietary Vitamin A deficiencyvitamin a supplementation"further EVIDENCE on biologically PLAUSIBLE mechanisms of morbidity reduction such as reduced incidence of sepsis and/or reduced MARKERS of inflammation ARE NEEDED" [60].lowdietary Micronutrient deficienciesmultiple Micronutrient supplementationone trial in tanzania showed no additional effect on markers of infection (C-Reactive Protein) compared with Iron and Folic Acid [15].lowanemia p. falciparum infectionanti-malarial Drugs"Drugs given routinely for malaria during Pregnancy reduce SEVERE Antenatal anaemia in the mother, and are ASSOCIATED with higher Birth weight in the baby and PROBABLY fewer Perinatal deaths.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 181), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 301), ('FUTURE_WORK', 325), ('IMPORTANT_CONSIDERATION', 662), ('SUPERFICIAL_RELATIONSHIP', 710), ('PROBABLE_UNDERSTANDING', 762)]	9	[('GO_0007567', 'parturition', 22, 'birth'), ('GO_0007565', 'female pregnancy', 51, 'postpartum'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 353, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 388, 'micronutrient'), ('PR_000005890', 'crooked neck-like protein 1', 492, 'C-reactive protein'), ('CHEBI_24870', 'ion', 526, 'iron'), ('CHEBI_30751', 'formic acid', 535, 'folic acid'), ('CHEBI_23888', 'drug', 598, 'drugs'), ('CHEBI_23888', 'drug', 604, 'Drugs'), ('GO_0007565', 'female pregnancy', 645, 'pregnancy'), ('GO_0007567', 'parturition', 669, 'antenatal'), ('GO_0007567', 'parturition', 733, 'birth'), ('GO_0036268', 'swimming', 777, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 777, 'perinatal')]
PMC2290997	4/2008	S193-PMC2290997	['NONETHELESS, says lucas, “there are DRAWBACKS to INFERRING that a RELATIONSHIP with any PROXY for the exposure of interest is a RELATIONSHIP with personal uv dose or Vitamin D status.” on the bright side, she adds, our ability to ACCURATELY gauge an Individual’s uv dose history HAS BEEN ENHANCED with the use of silicone rubber casts of the Back of subjects’ Hands.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 279), ('FUTURE_WORK', 288)]	9	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('NCBITaxon_1', 'root', 250, 'individual'), ('UBERON_0001137', 'dorsum', 342, 'back'), ('UBERON_0002398', 'manus', 360, 'hands')]
PMC2581757	11/2008	S200-PMC2581757	['THUS, we conclude that use of Vitamins C and E DEFINITELY Controls certain IMPORTANT biochemical indices during the development of Preeclampsia, and that FURTHER STUDIES ARE NEEDED to DEVELOP STRATEGIES for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 47), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 154), ('FUTURE_WORK', 162), ('FUTURE_WORK', 184), ('FUTURE_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 211), ('IMPORTANT_CONSIDERATION', 255)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamins C'), ('PR_000004900', 'complement C3', 39, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('GO_0065007', 'biological regulation', 58, 'controls'), ('GO_0007128', 'meiotic prophase I', 131, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 225, 'preeclampsia')]
PMC2872349	4/2010	S146-PMC2872349	['this is an IDEAL platform on which TO INVESTIGATE epigenetic Modulation Of Placental Calcium Transport, PARTICULARLY the ROLE of Vitamin D. this SHOULD improve our understanding of the processes INVOLVED in developing osteoporosis, and POTENTIALLY provide a focus for interventions to avert DETRIMENTAL processes by INFLUENCING maternal dietary habits.']	[('IMPORTANT_CONSIDERATION', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 121), ('FUTURE_WORK', 145), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 291), ('SUPERFICIAL_RELATIONSHIP', 316)]	9	[('GO_0061724', 'lipophagy', 61, 'modulation of'), ('GO_0006813', 'potassium ion transport', 75, 'placental calcium transport'), ('UBERON_0001987', 'placenta', 75, 'placental'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3075531	7/2010	S59-PMC3075531	['one option WOULD BE a national or multinational study based on randomization of school districts or other suitable units in regions of low sunlight intensity, PERHAPS including multiple outcomes that MIGHT be AFFECTED by Vitamin D, such as diabetes, obesity, Respiratory infections, and asthma.4546ALTERNATIVELY, high-risk first-degree relatives of individu-als with ms COULD BE targeted in a smaller trial,47ALTHOUGH randomization and compliance COULD BE more CHALLENGING.']	[('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('FUTURE_WORK', 370), ('ANOMALY_CURIOUS_FINDING', 409), ('FUTURE_WORK', 447), ('DIFFICULT_TASK', 461)]	9	[('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 259, 'respiratory')]
PMC3257641	3/2010	S153-PMC3257641	['HOWEVER, the MAJORITY of POTENTIAL adverse offspring health outcomes pertain to low Prenatal Vitamin D status and the EVOLVING EVIDENCE has provided greater IMPETUS for PUBLIC HEALTH EFFORTS to ensure mothers are not frankly Vitamin D deficient (<25 nmol/l) in Pregnancy, ALTHOUGH the value of treating relative Vitamin D insufficiency in Pregnancy is NOT clearly ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 169), ('FUTURE_WORK', 183), ('ANOMALY_CURIOUS_FINDING', 272), ('FULL_UNKNOWN', 352)]	9	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy')]
PMC3296991	2/2012	S98-PMC3296991	['FURTHER RESEARCH is NECESSARY to CONSIDER the behavior of OTHER BIOMARKERS in RELATIONSHIP to Vitamin D status and their POTENTIAL CONTRIBUTION to PREDICTION of neonatal wbbmc.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 64), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3338544	4/2012	S162-PMC3338544	['if FURTHER EVIDENCE CONTINUES to SUPPORT this ASSOCIATION, the Dvd-deficient Mouse MODEL MAY BE utilized to FURTHER EXAMINE the ROLE Vitamin D plays in Brain Development with RELEVANCE to autism.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 108), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 175)]	9	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 63, 'DVD'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'mouse'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007420', 'brain development', 152, 'brain development'), ('UBERON_0000955', 'brain', 152, 'brain')]
PMC3407995	7/2012	S303-PMC3407995	['HOWEVER, one SHOULD CONSIDER the COMPLEX nature of Vitamin D EFFECTS SINCE EITHER deficiency OR excess MAY BE harmful [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 103)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3427192	4/2012	S35-PMC3427192	['HOWEVER, it is IMPORTANT TO NOTE that a large percentage of children were lost to follow-up, and THUS the resulting sample of mothers had higher concentrations of 25(Oh)D and were older, less LIKELY to smoke during Pregnancy, and more educated.63therefore WHILE there MAY BE therapeutic window for vitamin D supplementation in early Life, FURTHER STUDIES ARE NEEDED to more clearly understand the RISKS of high Vitamin D intake and bioavailability during the early childhood years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 192), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 268), ('FUTURE_WORK', 339), ('FUTURE_WORK', 347), ('IMPORTANT_CONSIDERATION', 397)]	9	[('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 306, 'D'), ('UBERON_0000104', 'life cycle', 333, 'life'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D')]
PMC3476426	8/2012	S145-PMC3476426	['basic, Genetic, and epidemiological studies INDICATE a POTENTIAL ROLE of Vitamin D in the PREVENTION of Autoimmune diseases, BUT randomized and controlled TRIALS ARE NECESSARY to establish the clinical efficacy of Vitamin D supplementation in ill or at-RISK subjects [48].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('FUTURE_WORK', 155), ('FUTURE_WORK', 166), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 253)]	9	[('SO_0000704', 'gene', 7, 'genetic'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 104, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3613945	2/2013	S8-PMC3613945	['in VIEW of the HEIGHTENED INTEREST in Vitamin D as a PUBLIC HEALTH TARGET, well-DESIGNED STUDIES that look simultaneously at Vitamin D and its carrier in RELATION to genotypes and adverse health outcome SHOULD BE ENCOURAGED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 53), ('FUTURE_WORK', 67), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 154), ('FUTURE_WORK', 203), ('FUTURE_WORK', 213)]	9	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3613945	2/2013	S314-PMC3613945	['conclusion\nthere is GROWING EVIDENCE that dbp plays a ROLE in Immune modulation, EITHER directly through gc-maf, OR indirectly by INFLUENCING Serum levels of Vitamin D. it is TEMPTING to SPECULATE that dbp operates as a molecular switch between pro- and anti-inflammation and intervention STRATEGIES designed to modify this switch MAY be IMPORTANT in the Control and prevention Of chronic and Infectious Diseases.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 187), ('FUTURE_WORK', 289), ('INCOMPLETE_EVIDENCE', 331), ('IMPORTANT_CONSIDERATION', 338)]	9	[('UBERON_0002405', 'immune system', 62, 'immune'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0001715', 'ectodermal cell fate specification', 355, 'control ... of ... infectious diseases')]
PMC3668200	5/2013	S0-PMC3668200	['comparison of the Serum Vitamin D level between breastfed and formula-Fed infants: several FACTORS which CAN AFFECT Serum Vitamin D concentration\nit is COMMON KNOWLEDGE among pediatricians that exclusively breastfed infants SHOULD BE supplemented with Vitamin D (400 iu/day) BECAUSE Human Breast Milk contains an INADEQUATE amount of Vitamin D. accordingly, choi et al.1)REPORTED a vitamin deficiency in early infants in a comparative study between Breastfed and formula-Fed infants in this issue.']	[('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('FUTURE_WORK', 159), ('FUTURE_WORK', 224), ('PROBABLE_UNDERSTANDING', 275), ('IMPORTANT_CONSIDERATION', 313), ('INCOMPLETE_EVIDENCE', 371)]	9	[('UBERON_0001977', 'blood serum', 18, 'serum'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007631', 'feeding behavior', 70, 'fed'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 283, 'human'), ('UBERON_0001348', 'brown adipose tissue', 289, 'breast milk'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D'), ('GO_0007567', 'parturition', 449, 'breastfed'), ('GO_0007631', 'feeding behavior', 471, 'fed')]
PMC3702245	6/2013	S54-PMC3702245	['Monocytes cultured in Vitamin D-deficient Plasma (Serum 25(Oh)D < 30 nmol/l) SHOWED significantly decreased Tolllike Receptor-mediated Expression of Cathelicidin (p < 0.05) compared with those conditioned in Vitamin D-sufficient Plasma (Serum 25(Oh)D > 75 nmol/l).93CONSISTENT with these in vitro FINDINGS, OBSERVATIONAL clinical DATA FOUND an ASSOCIATION between Vitamin D status in Cord Blood and the RISK of Lower Respiratory Tract infection in the first year of Life.94the risk of Respiratory syncytial Virus bronchiolitis in the first year of Life is increased by six-fold (ci 1.6–24.9) in infants with Cord Blood 25(Oh)D < 50 nmol/l compared with infants with 25(Oh)D > 75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('INCOMPLETE_EVIDENCE', 297), ('INCOMPLETE_EVIDENCE', 307), ('FUTURE_WORK', 330), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 344), ('IMPORTANT_CONSIDERATION', 403)]	9	[('CL_0000576', 'monocyte', 0, 'Monocytes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 108, 'tolllike receptor'), ('GO_0010467', 'gene expression', 135, 'expression'), ('PR_000006009', 'alpha-catulin', 149, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 229, 'plasma'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 384, 'cord'), ('UBERON_0000178', 'blood', 389, 'blood'), ('UBERON_0004905', 'articulation', 411, 'lower respiratory tract'), ('UBERON_0000104', 'life cycle', 466, 'life'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory'), ('NCBITaxon_1', 'root', 507, 'virus'), ('UBERON_0000104', 'life cycle', 548, 'life'), ('UBERON_0002240', 'spinal cord', 608, 'cord'), ('UBERON_0000178', 'blood', 613, 'blood'), ('CHEBI_71657', 'versiconol acetate', 619, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 619, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 666, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 666, '25(OH)D')]
PMC3702245	6/2013	S72-PMC3702245	['the institute of MEDICINE7CONSIDERS a Serum 25(Oh)D concentration >50 nmol/l AS acceptable, WHILE the Endocrine society and Vitamin D EXPERTS RECOMMEND >75 nmol/l.8,99a RECENT STUDY among traditional populations in tanzania with type vi (dark) skin color living in a sun-abundant environment RECOMMENDED a mean Serum 25(Oh)D concentration of 115 nmol/l in nonpregnant Adults and 139 nmol/l in Pregnant women.57the question then is: WHAT Serum concentration of 25(Oh)D is “normal” in Adults, including during Pregnancy?']	[('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 134), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 169), ('FUTURE_WORK', 292), ('EXPLICIT_QUESTION', 432), ('EXPLICIT_QUESTION', 517)]	9	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 102, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'serum'), ('CHEBI_71657', 'versiconol acetate', 317, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 317, '25(OH)D'), ('UBERON_0007023', 'adult organism', 368, 'adults'), ('GO_0007565', 'female pregnancy', 393, 'pregnant'), ('UBERON_0001977', 'blood serum', 437, 'serum'), ('CHEBI_71657', 'versiconol acetate', 460, '25(OH)D'), ('UBERON_0007023', 'adult organism', 483, 'adults'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy')]
PMC3705320	3/2013	S180-PMC3705320	['HOWEVER, SINCE the ROLE of pth as a Vitamin D status BIOMARKER during Pregnancy is UNCLEAR [26], the clinical significance of the APPARENT dose-response EFFECT of Vitamin D on pth REQUIRES FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 53), ('FULL_UNKNOWN', 83), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 153), ('IMPORTANT_CONSIDERATION', 180), ('FUTURE_WORK', 189)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3705320	3/2013	S204-PMC3705320	['the most direct application of the present OBSERVATIONS is to guide the design of FUTURE TRIALS of Vitamin D3 (at doses up to 35,000 iu per week) AIMED at CONFIRMING SAFETY and establishing the health benefits of Antenatal Vitamin D supplementation in south asia, where many POTENTIALLY Vitamin D-responsive outcomes (e.g., infant growth and infectious disease morbidity) are MAJOR PUBLIC HEALTH PRIORITIES.']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 146), ('PROBABLE_UNDERSTANDING', 155), ('IMPORTANT_CONSIDERATION', 166), ('INCOMPLETE_EVIDENCE', 275), ('IMPORTANT_CONSIDERATION', 376), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 396)]	9	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('GO_0007567', 'parturition', 213, 'antenatal'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D')]
PMC3827489	10/2013	S100-PMC3827489	['it is NOT KNOWN, however, HOW much amount of Vitamin D supplementation is NEEDED for korean children and Pregnant women in order to maintain adequate concentrations of vitamin D. CONSIDERING the high prevalence of Vitamin D insufficiency or deficiency in koreans, ESPECIALLY children and adolscents6,22-24), this ISSUE NEEDS TO BE addressed URGENTLY by FUTURE STUDIES.']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 26), ('IMPORTANT_CONSIDERATION', 74), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 264), ('PROBLEM_COMPLICATION', 313), ('IMPORTANT_CONSIDERATION', 319), ('IMPORTANT_CONSIDERATION', 341), ('FUTURE_WORK', 353)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3829803	11/2013	S175-PMC3829803	['in aggregate, these OBSERVATIONS SUGGEST that Vitamin A and its derivatives MAY play an IMPORTANT ROLE in Antiviral Responses BUT demonstrate clearly that mechanistic studies are ESSENTIAL to fully UNDERSTAND and exploit this POTENTIAL.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('IMPORTANT_CONSIDERATION', 179), ('FUTURE_WORK', 198), ('INCOMPLETE_EVIDENCE', 226)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin A'), ('GO_0002901', 'mature B cell apoptotic process', 106, 'antiviral responses')]
PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
PMC3991049	11/2013	S69-PMC3991049	['the RECOMMENDED daily intake of Vitamin D is 200 iu/day in the united states, australia, new zealand and canada.18–20in the uk, the daily recommended dose is 400 iu/day.21HISTORICALLY, Vitamin D supplementation during Pregnancy WAS THOUGHT TO be a risk factor for Supravalvular stenosis in infants, which was BASED ON a 1964 case report.22\nDIFFERENT STUDIES SUGGESTED that the daily use 1000 iu,23–272000 iu,284000 iu,29and 6400 iu30would HELP to eliminate Vitamin D insufficiency without apparent toxicity in Pregnant women and their infants.']	[('FUTURE_WORK', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 309), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('INCOMPLETE_EVIDENCE', 350), ('INCOMPLETE_EVIDENCE', 358), ('FUTURE_WORK', 439)]	9	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy'), ('UBERON_2000442', 'supraneural bone', 264, 'supravalvular'), ('CHEBI_27300', 'vitamin D', 457, 'vitamin D'), ('GO_0007565', 'female pregnancy', 510, 'pregnant')]
PMC4171568	9/2014	S142-PMC4171568	['THEREFORE, the RELATIONSHIP between Vitamin D and schizophrenia NEEDS FURTHER INVESTIGATION, EVEN THOUGH a RECENT review of the EVIDENCE CONCLUDED that adequate levels of Vitamin D are needed for normal Brain Development and function and furthermore that at-risk groups SHOULD BE offered supplementation [112].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 64), ('FUTURE_WORK', 70), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 137), ('FUTURE_WORK', 270)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007420', 'brain development', 203, 'brain development'), ('UBERON_0000955', 'brain', 203, 'brain')]
PMC4377870	3/2015	S104-PMC4377870	['as a result, meta-analysis of Vitamin E EFFECTS on asthma outcomes is EQUIVOCAL; it is LIKELY that supplementation with physiological concentrations of Α-Tocopherol in the context of a background diet low in Γ-Tocopherol, MAY BE MOST beneficial in asthma and FURTHER RESEARCH testing this HYPOTHESIS IS REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 259), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 300), ('IMPORTANT_CONSIDERATION', 303)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamin E'), ('CHEBI_27725', 'butin', 152, 'α-tocopherol'), ('CHEBI_27725', 'butin', 208, 'γ-tocopherol')]
PMC4405493	4/2015	S20-PMC4405493	['RECENT observational and randomized control trials have ATTEMPTED TO investigate THIS ISSUE, but there REMAINS LIMITED GUIDANCE on the management of Vitamin D deficiency during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 56), ('INCOMPLETE_EVIDENCE', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 111), ('FUTURE_WORK', 119)]	9	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC4427001	4/2015	S150-PMC4427001	['conclusions\nour study in Pregnant women of central european population DID NOT REPLICATE sporadic PREVIOUS FINDINGS of significantly decreased levels of Vitamin D in Gdm Pregnancy; HOWEVER, results SEEM TO BE criteria-sensitive (who versus iadpsg) and the topic WARRANTS FURTHER STUDY.']	[('INCOMPLETE_EVIDENCE', 71), ('ANOMALY_CURIOUS_FINDING', 75), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 198), ('FUTURE_WORK', 262), ('FUTURE_WORK', 271)]	9	[('GO_0007565', 'female pregnancy', 25, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0070477', 'endospore core', 166, 'GDM'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC4448820	5/2015	S289-PMC4448820	['ALTHOUGH NEW DATA ARE NEEDED to FURTHER ELUCIDATE the magnitude of these RELATIONS, IT IS CLEAR that Vitamin A has multiple Genetically MEDIATED EFFECTS on the Immune Response via the activities of atra.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 9), ('FUTURE_WORK', 9), ('FUTURE_WORK', 32), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 136), ('SUPERFICIAL_RELATIONSHIP', 145)]	9	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('SO_0000704', 'gene', 124, 'genetically'), ('GO_0006955', 'immune response', 160, 'immune response'), ('UBERON_0002405', 'immune system', 160, 'immune')]
PMC4586450	10/2015	S544-PMC4586450	['overall, the diets of children in the alspac were adequate for most Nutrients, with the NOTABLE EXCEPTION of Vitamin D. at age 1.5 years and age 3.5 years, all of the alspac children were found to be below the united kingdom dietary recommendations for Vitamin D intake, and children who had low intakes at age 1.5 years were twice as LIKELY to have low intakes at age 3.5 years.24ALTHOUGH it HAS BEEN RECOMMENDED for 25 years or more that children aged <5 years SHOULD BE given Vitamin D supplements,93only a minority in either the alspac24or the national surveys actually were supplemented.101it IS POSSIBLE that a fortification program COULD be a good option to improve this situation.']	[('ANOMALY_CURIOUS_FINDING', 88), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 335), ('ANOMALY_CURIOUS_FINDING', 379), ('INCOMPLETE_EVIDENCE', 393), ('FUTURE_WORK', 402), ('FUTURE_WORK', 463), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 639)]	9	[('CHEBI_33284', 'nutrient', 68, 'nutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 479, 'vitamin D')]
PMC4600246	10/2015	S12-PMC4600246	['a broad amount of DATA SEEMS to INDICATE substantial POTENTIAL for supplementary Vitamin K. HOWEVER, currently FEW GUIDELINES RECOMMEND Vitamin K therapy for PREVENTION or treatment of osteoporosis.']	[('FUTURE_WORK', 18), ('ANOMALY_CURIOUS_FINDING', 23), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 115), ('FUTURE_WORK', 126), ('SUPERFICIAL_RELATIONSHIP', 158)]	9	[('CHEBI_27300', 'vitamin D', 81, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin K')]
PMC4684854	12/2015	S54-PMC4684854	['these iom RECOMMENDATIONS for REQUIRED Vitamin D intake HAVE BEEN put into SERIOUS question [42], HOWEVER, AS a significant statistical ERROR HAS BEEN identified in the way their recommendations were arrived AT [43].']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 107), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 208)]	9	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4764019	1/2016	S83-PMC4764019	['african nationals living under ancestral conditions exhibit Vitamin D status values in the middle of this range (ie, approximately 46 ng/ml).16\nin conclusion, WHILE one cannot say that the barker HYPOTHESIS HAS BEEN definitively ESTABLISHED for each of the delayed Vitamin D inadequacy outcomes DESCRIBED HERE, it would SEEM that the PRUDENT course, both for oneself as an Individual and for one’s patients and clients, is to assume the applicability of the HYPOTHESIS and, accordingly, to ensure a Vitamin D status approximating that of ancestral Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 295), ('QUESTION_ANSWERED_BY_THIS_WORK', 305), ('ANOMALY_CURIOUS_FINDING', 320), ('FUTURE_WORK', 334), ('INCOMPLETE_EVIDENCE', 458)]	9	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('NCBITaxon_1', 'root', 373, 'individual'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 548, 'humans')]
PMC4848664	4/2016	S132-PMC4848664	['the Folic Acid ul MAY BE MISINTERPRETED as an “upper limit”, but SHOULD ONLY BE CONSIDERED a tolerable upper intake level for Individuals with a Vitamin B-12 deficiency.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('FUTURE_WORK', 65), ('INCOMPLETE_EVIDENCE', 72), ('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 80)]	9	[('CHEBI_30751', 'formic acid', 4, 'folic acid'), ('NCBITaxon_1', 'root', 126, 'individuals'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin B')]
PMC4934634	11/2015	S89-PMC4934634	['ALTHOUGH the amount of Vitamin D provided through the Supplement is lower than the current rdas set by EITHER the iom or Endocrine society, this study SHOULD provide new INSIGHTS into HOW Periconceptional dietary interventions CAN IMPACT Female and Male Fertility, a RESEARCH area that is presently LACKING.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FUTURE_WORK', 151), ('INCOMPLETE_EVIDENCE', 170), ('EXPLICIT_QUESTION', 184), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 231), ('INCOMPLETE_EVIDENCE', 267), ('INCOMPLETE_EVIDENCE', 299)]	9	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 54, 'supplement'), ('UBERON_0005063', 'left ventricular compact myocardium', 121, 'Endocrine'), ('GO_0007565', 'female pregnancy', 188, 'periconceptional'), ('GO_0007601', 'visual perception', 238, 'female ...'), ('GO_0007141', 'male meiosis I', 249, 'male fertility')]
PMC4973215	8/2016	S94-PMC4973215	['Vitamin D supplementation during Pregnancy HAS BEEN SHOWN to positively AFFECT Cord Blood Vitamin D levels at Birth.43,44studies of Vitamin D supplementation during Pregnancy THUS FAR HAVE SHOWN CONFLICTING results with respect to Birth weight and reduction of sga.43,45,46,47,48adequately powered and randomized controlled trials of vitamin d supplementation during Pregnancy ARE NEEDED TO ASSESS the IMPACT of supplementation on sga as well as the APPROPRIATE dose and timing of supplementation.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('FUTURE_WORK', 377), ('FUTURE_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 402), ('IMPORTANT_CONSIDERATION', 450)]	9	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy'), ('GO_0007567', 'parturition', 231, 'birth'), ('GO_0007565', 'female pregnancy', 367, 'pregnancy')]
PMC5385921	4/2017	S131-PMC5385921	['in FUTURE STUDIES, it will be OF INTEREST to explore the CRITICAL window during which low Vitamin D MAY CONTRIBUTE to asd RISK – it is FEASIBLE that exposure in the first few years of Life MAY also CONTRIBUTE to adverse Brain outcomes.']	[('FUTURE_WORK', 3), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 135), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 198)]	9	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000104', 'life cycle', 184, 'life'), ('UBERON_0000955', 'brain', 220, 'brain')]
PMC5513133	7/2017	S231-PMC5513133	['the ROLE of Fish Oils in pe REMAINS UNCERTAIN and SIMILARLY poses a CHALLENGE in determining an isolated EFFECT of Vitamin D supplementation, UNLESS studies are designed such that they CONSIDER this.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 28), ('FULL_UNKNOWN', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('DIFFICULT_TASK', 68), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 185)]	9	[('CHEBI_39279', 'halomethane', 12, 'fish oils'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5537904	7/2017	S151-PMC5537904	['OUR finding that the ASSOCIATION between Cord Blood 25(Oh)D and Birthweight varies according to maternal bmi MUST BE REPLICATED in OTHER studies, including intervention trials, TO DETERMINE IF Vitamin D supplementation RECOMMENDATIONS to modify Birthweight SHOULD BE bmi-specific.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('FUTURE_WORK', 219), ('FUTURE_WORK', 257)]	9	[('UBERON_0009472', 'axilla', 41, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('GO_0007596', 'blood coagulation', 64, 'birthweight'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007596', 'blood coagulation', 245, 'birthweight')]
PMC5634602	10/2017	S150-PMC5634602	['the OPTIMAL dose of Vitamin D supplementation for preterm infants during the early Neonatal Period WARRANTS FURTHER INVESTIGATION, but it is REASONABLE and SAFE to RECOMMEND daily supplementation in addition to dietary intake with 800 iu of Vitamin D to high-risk preterm infants while hospitalized in the nicu in order to TARGET a level of 25(Oh)D that is >75 nmol/l, AS we HAVE SHOWN this to improve bone health defined by dexa in this AT-RISK population.']	[('IMPORTANT_CONSIDERATION', 4), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 141), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 164), ('FUTURE_WORK', 323), ('PROBABLE_UNDERSTANDING', 369), ('INCOMPLETE_EVIDENCE', 375), ('IMPORTANT_CONSIDERATION', 438)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0007221', 'neonate stage', 83, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 344, 'OH)D')]
PMC5659607	10/2017	S151-PMC5659607	['combining this KNOWLEDGE with OUR FINDINGS from THIS combined analysis, SHOWING that Vitamin D supplementation has a PROTECTIVE EFFECT on childhood asthma/recurrent wheeze, makes Vitamin D a very PROMISING Nutrient for FUTURE PREVENTION of Immune-mediated disorders.']	[('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 128), ('PROBABLE_UNDERSTANDING', 196), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 226)]	9	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('UBERON_0002405', 'immune system', 240, 'immune')]
PMC5664622	9/2017	S13-PMC5664622	['IN LIGHT OF the ONGOING DEBATE on the OPTIMAL Vitamin D concentration in Pregnant women, MOST EXPERTS are of the OPINION that the 25(Oh)D concentration in maternal Blood SHOULD exceed 30 ng/ml [2,8,9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 89), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 170), ('IMPORTANT_CONSIDERATION', 170)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5679631	11/2017	S15-PMC5679631	['given that Intestinal Microbiotic Homeostasis MAY BE an IMPORTANT FACTOR in the PREVENTION of Immune mediated diseases and that Vitamin D status is a MODIFIABLE FACTOR, FURTHER INVESTIGATION of the IMPACT of Postnatal Vitamin D supplementation SHOULD BE conducted in older infants.']	[('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 150), ('SUPERFICIAL_RELATIONSHIP', 161), ('FUTURE_WORK', 169), ('SUPERFICIAL_RELATIONSHIP', 198), ('FUTURE_WORK', 244)]	9	[('UBERON_0000160', 'intestine', 11, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 22, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 22, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007567', 'parturition', 208, 'postnatal'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC5941617	5/2018	S211-PMC5941617	['a RECENT GLOBAL CONSENSUS RECOMMENDATIONS on prevention and management of nutritional rickets DEFINED Vitamin D deficiency AS Serum 25(Oh)D\u2009<\u2009\xa012\xa0ng/ml, CONSIDERING the increased incidence of rickets with Serum 25(Oh)D levels under this THRESHOLD [28].']	[('INCOMPLETE_EVIDENCE', 2), ('IMPORTANT_CONSIDERATION', 9), ('PROBABLE_UNDERSTANDING', 16), ('FUTURE_WORK', 26), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 153), ('PROBABLE_UNDERSTANDING', 237)]	9	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 211, '25(OH ... D')]
PMC5941617	5/2018	S300-PMC5941617	['taken TOGETHER, all these data INDICATE that Vitamin D status MIGHT have SOME INFLUENCE on conditioning the incidence and severity of SOME but not all type of Respiratory infections and that more information are REQUIRED before drawing any firm conclusion on THIS topic.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 134), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('QUESTION_ANSWERED_BY_THIS_WORK', 259)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 159, 'respiratory')]
PMC5941617	5/2018	S511-PMC5941617	['DIFFERENTLY, sacn CONFIRMED that obese People are AT RISK of low Serum 25(Oh)D concentrations, but HIGHLIGHTED that CURRENTLY EVIDENCE is INSUFFICIENT to RECOMMEND for obese Individuals different reference Nutrient intake of Vitamin D from that PROPOSED for the general uk population [25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 138), ('FUTURE_WORK', 154), ('INCOMPLETE_EVIDENCE', 245)]	9	[('NCBITaxon_10088', 'Mus <genus>', 39, 'people'), ('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('NCBITaxon_1', 'root', 174, 'individuals'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC5941617	5/2018	S674-PMC5941617	['HOWEVER, as FEW STUDIES SHOWED that Vitamin D supplementation improves clinical parameters in patients with active tuberculosis or hiv infection, MORE rigorous and extensive STUDIES ARE NEEDED to EVALUATE the ROLE of Vitamin D supplementation in infectious diseases, CONSIDERING also the setting of care, children’s age and nutritional status, POTENTIAL co-infections and compliance with Anti-infective therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 146), ('FUTURE_WORK', 174), ('QUESTION_ANSWERED_BY_THIS_WORK', 196), ('SUPERFICIAL_RELATIONSHIP', 209), ('IMPORTANT_CONSIDERATION', 267), ('INCOMPLETE_EVIDENCE', 344)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('CHEBI_59132', 'antigen', 388, 'anti')]
PMC5956785	5/2018	S210-PMC5956785	['additionally, IMPROVED UNDERSTANDING of Vitamin D NEEDS in children with chronic arthritis will HELP TO CLARIFY the ROLE of Vitamin D in the UNDERLYING disease processes so that therapies that target specific Vitamin D responsive Immune pathways CAN be developed.']	[('FUTURE_WORK', 14), ('FUTURE_WORK', 23), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 50), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 141), ('FUTURE_WORK', 246), ('INCOMPLETE_EVIDENCE', 246)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0002405', 'immune system', 230, 'immune')]
BMJ_2010_Apr_29_340_c1640	4/2010	S100-BMJ_2010_Apr_29_340_c1640	['the first trimester is also a sensitive period with regard to Prenatal Thymocyte differentiation, with Animal STUDIES SHOWING that chemicals such as Dioxin CAN alter this process, disrupt the development of central tolerance, and LEAD TO increased auto-reactive Peripheral T Cells.49FURTHERMORE, indirect EFFECTS of Vitamin D SHOULD BE CONSIDERED.']	[('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 230), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('FUTURE_WORK', 326), ('FUTURE_WORK', 336)]	8	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CL_0000893', 'thymocyte', 71, 'thymocyte'), ('NCBITaxon_33208', 'Metazoa', 103, 'animal'), ('CHEBI_4553', 'dihydroanhydropodorhizol', 149, 'dioxin'), ('CL_0000111', 'peripheral neuron', 262, 'peripheral T cells'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin D')]
PMC2606998	6/2007	S84-PMC2606998	['from this perspective, the most STRIKING result from THIS STUDY was the CONSIDERABLY lower than RECOMMENDED intakes of Folate and Vitamin\u2009D, both before and during Pregnancy, EVEN when PROBABLE UNDERREPORTING was taken INTO ACCOUNT.']	[('ANOMALY_CURIOUS_FINDING', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('ANOMALY_CURIOUS_FINDING', 72), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 175), ('PROBABLE_UNDERSTANDING', 185), ('PROBLEM_COMPLICATION', 194), ('INCOMPLETE_EVIDENCE', 219)]	8	[('CHEBI_30863', '5-azaorotic acid', 119, 'folate'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC2679409	5/2009	S500-PMC2679409	['ANY FUTURE STUDIES of Vitamin A supplementation MUST FOCUS on HIGH-RISK women, assess the most APPROPRIATE Vitamin type and dosage, and show that the intervention is both SAFE for the mother and fetus, and EFFECTIVE.']	[('IMPORTANT_CONSIDERATION', 0), ('FUTURE_WORK', 4), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 62), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 171), ('SUPERFICIAL_RELATIONSHIP', 206)]	8	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 107, 'vitamin')]
PMC2831604	1/2010	S79-PMC2831604	["the POTENTIAL for adverse events on medium to high dose ics is USUALLY LIMITED to a small reduction in growth velocity of approximately 1 cm in the first year of treatment which is not progressive over time and can be measured by a stadiometer.20,21\nin children who are REQUIRED to receive high dose Corticosteroids, age appropriate dietary Intake of Calcium and Vitamin D SHOULD BE reviewed with the child's care givers (evidence d) and slit lamp Eye examination and bone densitometry SHOULD BE CONSIDERED (evidence d)."]	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 270), ('FUTURE_WORK', 373), ('FUTURE_WORK', 486), ('IMPORTANT_CONSIDERATION', 486), ('FUTURE_WORK', 496)]	8	[('CHEBI_50850', 'etabonate ester', 300, 'corticosteroids'), ('GO_0007631', 'feeding behavior', 341, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 351, 'calcium'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0000970', 'eye', 448, 'eye')]
PMC2873552	4/2010	S137-PMC2873552	['these results are SUGGESTIVE that Vitamin D MIGHT have been INVOLVED in the alteration of risk of disease and abnormal development and CONSEQUENTLY in the Genetic adaptation of modern Humans, BUT validation from FURTHER STUDY IS NECESSARY.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('FUTURE_WORK', 212), ('FUTURE_WORK', 226), ('FUTURE_WORK', 229)]	8	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 155, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 184, 'humans')]
PMC2963768	10/2010	S141-PMC2963768	['if Vitamin D deficiency is CONFIRMED AS a RISK FACTOR for pneumonia, INTERVENTIONS to improve maternal-infant Vitamin D status COULD reduce THE GLOBAL BURDEN of alri, the single most IMPORTANT cause of early childhood death in the world (58).']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('FUTURE_WORK', 69), ('INCOMPLETE_EVIDENCE', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 140), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 183)]	8	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC3004407	12/2010	S156-PMC3004407	['given RECENT DISCOVERIES that LINK Vitamin D with the innate Immune System [6], it is not UNREASONABLE to predict that deficiencies during fetal development COULD have lasting sequelae on the child, NOT ONLY in terms of bone mineralization, BUT ALSO in terms of Immune Development that becomes the basis for later derangements SEEN with long-latency diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and certain cancers [59].']	[('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 157), ('ANOMALY_CURIOUS_FINDING', 199), ('ANOMALY_CURIOUS_FINDING', 241), ('INCOMPLETE_EVIDENCE', 327)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007566', 'embryo implantation', 61, 'immune'), ('UBERON_0002405', 'immune system', 61, 'immune system'), ('GO_0001822', 'kidney development', 262, 'immune development'), ('UBERON_0002405', 'immune system', 262, 'immune')]
PMC3034879	12/2010	S192-PMC3034879	['optimally, Vitamin D sufficiency SHOULD BE guaranteed during fetal Life AS the FINDINGS of the PRESENT STUDY SUGGEST that the CONSEQUENCES of POOR Vitamin D status during the fetal period cannot be totally reverted by Postnatal Vitamin D supplementation.']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 126), ('IMPORTANT_CONSIDERATION', 142)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 218, 'postnatal'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3277098	12/2011	S198-PMC3277098	['IN SUMMARY, the CONTRARY epidemiological OBSERVATIONS between Serum status (GENERALLY PROTECTIVE) and Oral exposure (supplementation increasing allergy risk in MANY STUDIES) HIGHLIGHT the uncertainty surrounding Vitamin D in Allergy Development and precludes population RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 174), ('FUTURE_WORK', 270)]	8	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('UBERON_0000165', 'mouth', 102, 'oral'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 225, 'allergy development')]
PMC3356951	4/2012	S32-PMC3356951	['[614–16] the local Production Of 1,25(Oh)2D MAY BE responsible for Regulating up to 200 Genes[17] that MAY facilitate MANY of the pleiotropic health benefits that HAVE BEEN REPORTED for Vitamin D.[38914]\n\nVitamin D deficiency: prevalence\nvdd HAS BEEN historically defined and RECENTLY RECOMMENDED by the institute of medicine (iom) AS a 25(Oh)D of less than 0.8 iu.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 285), ('PROBABLE_UNDERSTANDING', 332)]	8	[('GO_0008283', 'cell proliferation', 19, 'production of ... )2D'), ('CHEBI_37958', 'dye', 33, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 35, '25(OH)2D'), ('GO_0065007', 'biological regulation', 67, 'regulating'), ('SO_0000704', 'gene', 88, 'genes'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 205, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 337, '25(OH)D')]
PMC3427192	4/2012	S52-PMC3427192	['in these sub-analyses, Vitamin D3Supplementation was ASSOCIATED with a decreased risk of exacerbations compared with Placebo, with a relative risk of 0.17.75similarly, in a more RECENT randomized, double-blind 6-mo trial where 800 µg of inhaled Budesonide was administered daily to a small group of 48 children with asthma in the presence or absence of 500 iu/day of Vitamin D3, children receiving supplemental Vitamin D did not have a reduction in 25(Oh)D during the winter months and also had a reduced risk of asthma exacerbations triggered by acute Respiratory Viral infections.73these INITIAL FINDINGS SUGGEST that Vitamin D supplementation MAY have therapeutic benefit children with asthma, ALTHOUGH ADDITIONAL randomized, double-blind, placebo-controlled STUDIES ARE NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 607), ('INCOMPLETE_EVIDENCE', 646), ('ANOMALY_CURIOUS_FINDING', 697), ('FUTURE_WORK', 706), ('FUTURE_WORK', 762)]	8	[('CHEBI_52915', 'phosphatediyl group', 23, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 23, 'vitamin D3supplementation'), ('CHEBI_26130', 'biological pigment', 117, 'placebo'), ('CHEBI_3219', 'bupropion', 245, 'budesonide'), ('CHEBI_33279', 'vitamin D5', 367, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 367, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 449, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 455, 'D'), ('UBERON_0001004', 'respiratory system', 553, 'respiratory'), ('NCBITaxon_1', 'root', 565, 'viral'), ('CHEBI_27300', 'vitamin D', 620, 'vitamin D')]
PMC3458940	9/2012	S160-PMC3458940	['THUS, the ROLES for the tra/rar target Genes IDENTIFIED in THIS STUDY in the aforementioned Renal anomalies ASSOCIATED to post-Natal Vitamin A deficiency DESERVE FURTHER studies.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 162)]	8	[('SO_0000704', 'gene', 39, 'genes'), ('UBERON_0002113', 'kidney', 92, 'renal'), ('GO_0007567', 'parturition', 127, 'natal'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]
PMC3668200	5/2013	S1-PMC3668200	['ALTHOUGH the authors STATED SOME exclusion criteria, the study lacks SOME guidelines for CONSIDERATIONS in the evaluation of Vitamin D deficiency, especially those pertaining to FACTORS that can AFFECT the Vitamin concentration in the body.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 69), ('FUTURE_WORK', 89), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 206, 'vitamin')]
PMC3668200	5/2013	S52-PMC3668200	['Vitamin D concentration is AFFECTED by many Genetic, dietary, and environmental FACTORS; THEREFORE, it is RECOMMENDED that researchers CONSIDER the relative and EFFECTIVE FACTORS when performing STUDIES concerning Vitamin D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBABLE_UNDERSTANDING', 89), ('FUTURE_WORK', 106), ('FUTURE_WORK', 135), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 195)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('SO_0000704', 'gene', 44, 'genetic'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3702245	6/2013	S17-PMC3702245	['the institute of medicine in the us in its RECENT report RECOMMENDS that a Serum 25(Oh)D concentration of 50 nmol/l (20 ng/ml) is adequate for calcium absorption and bone health in Adults, including Pregnant women, in the us and canada.7HOWEVER, new clinical guidelines from the endocrine society RECOMMEND maintaining a Serum 25(Oh)D concentration >75 nmol/l (30 ng/ml) in order to maximize calcium absorption and bone health, and for POTENTIAL Extraskeletal benefits noted in observational studies.8many RECENT STUDIES13,15–17,48–57that evaluated Vitamin D nutrition during Pregnancy in different geographic locations REPORTED wide VARIATION in Vitamin D status depending on latitude, season, sunlight exposure behavior, and Vitamin D intake (table 1).']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 297), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 506), ('INCOMPLETE_EVIDENCE', 620), ('DIFFICULT_TASK', 634)]	8	[('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 81, '25(OH)D'), ('UBERON_0007023', 'adult organism', 181, 'adults'), ('GO_0007565', 'female pregnancy', 199, 'pregnant'), ('UBERON_0001977', 'blood serum', 321, 'serum'), ('CHEBI_71657', 'versiconol acetate', 327, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 327, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 446, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 576, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin D')]
PMC3702245	6/2013	S40-PMC3702245	['randomized controlled STUDIES including larger sample sizes and repeated Vitamin D measurements during Pregnancy WILL BE NEEDED to CONFIRM the RELATIONSHIP between Vitamin D supplementation and fetal growth.82\n\nmaternal COMPLICATIONS\nOBSERVATIONAL studies REPORTED an ASSOCIATION between maternal Vitamin D status during Pregnancy and development of pre-eclampsia, which has both a Genetic and an immunologic pathogenesis.']	[('FUTURE_WORK', 22), ('FUTURE_WORK', 113), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 143), ('PROBLEM_COMPLICATION', 220), ('INCOMPLETE_EVIDENCE', 234), ('INCOMPLETE_EVIDENCE', 256), ('SUPERFICIAL_RELATIONSHIP', 268)]	8	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('SO_0000704', 'gene', 382, 'genetic')]
PMC3702245	6/2013	S62-PMC3702245	['these RECOMMENDATIONS are based MOSTLY ON STUDIES from the us and MAY not be applicable worldwide DUE TO DIFFERENCES in baseline Vitamin D status,100particularly in populations where severe Vitamin D deficiency is PREVALENT.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 32), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 66), ('PROBLEM_COMPLICATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 214)]	8	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC3702245	6/2013	S73-PMC3702245	['WHILE the DEBATE and studies to identify OPTIMAL Serum 25(Oh)D concentration CONTINUE, it is PRUDENT to monitor Vitamin D status and develop STRATEGIES to ensure AT LEAST a minimum Serum 25(Oh)D concentration of 50 nmol/l in Pregnant women, especially in an environment where Vitamin D deficiency is endemic.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 77), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_WORK', 141), ('PROBABLE_UNDERSTANDING', 162)]	8	[('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001977', 'blood serum', 181, 'serum'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('GO_0007565', 'female pregnancy', 225, 'pregnant'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
PMC3702245	6/2013	S96-PMC3702245	['in VIEW of the high prevalence of low Vitamin D status in Pregnancy worldwide, INTERVENTION trials to identify optimal Vitamin D status and the REQUIRED SAFE Vitamin D intake COULD BE an IMPORTANT part of PUBLIC HEALTH STRATEGY to improve the health of mothers, and the short-term and long-term outcomes for their offspring.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 175), ('IMPORTANT_CONSIDERATION', 187), ('IMPORTANT_CONSIDERATION', 205), ('FUTURE_WORK', 219)]	8	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3717170	5/2013	S208-PMC3717170	['CONTINUING RESEARCH IS NEEDED to BETTER UNDERSTAND the RELATIONSHIPS between Vitamin D and Extraskeletal health and to determine the OPTIMAL dose of Vitamin D for Individuals BASED ON age, health conditions, and other FACTORS.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 133), ('SUPERFICIAL_RELATIONSHIP', 175), ('SUPERFICIAL_RELATIONSHIP', 218)]	8	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 91, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('NCBITaxon_1', 'root', 163, 'individuals')]
PMC3739737	8/2013	S176-PMC3739737	['FURTHER REFINEMENTS to the MODEL, such as combined with second hit exposures, MAY BE NECESSARY to MORE adequately MODEL the EFFECTS of Vitamin D deficiency in Human populations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 85), ('ANOMALY_CURIOUS_FINDING', 98), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC3760821	9/2013	S184-PMC3760821	['in conclusion, the FINDING that Vitamin D DEPENDENT processes MAY BE negatively IMPACTED by maternal nutritional status and obesity in a t1dm cohort is a significant one and provides FURTHER EVIDENCE that population-based INTERVENTIONS aimed at reducing obesity and improving pre-Pregnancy and Gestational Vitamin D status ARE NEEDED.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 80), ('FUTURE_WORK', 183), ('INCOMPLETE_EVIDENCE', 183), ('FUTURE_WORK', 222), ('FUTURE_WORK', 323)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 280, 'pregnancy'), ('GO_0007565', 'female pregnancy', 294, 'gestational'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC3773018	4/2013	S82-PMC3773018	['OF NOTE, OUR FINDINGS from the stratified analyses SUGGESTED stronger ASSOCIATIONS between low Vitamin D status and high RISK of fs among children Born Preterm, which NEEDS to be FURTHER explored in a larger sample.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 167), ('FUTURE_WORK', 179), ('INCOMPLETE_EVIDENCE', 179)]	8	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('GO_0007565', 'female pregnancy', 152, 'preterm')]
PMC3829803	11/2013	S256-PMC3829803	['THIS is the FIRST work to DEMONSTRATE the antiviral EFFECT of Vitamin A on Muv and MAY CONTRIBUTE to better treatment OPTIONS for Muv.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 87), ('FUTURE_WORK', 118)]	8	[('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'MuV'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'MuV')]
PMC3873449	12/2013	S44-PMC3873449	['the results SHOULD provide a BETTER UNDERSTANDING of the maternal FACTORS that INFLUENCE Vitamin D status during Pregnancy and help in raising AWARENESS as well as SUGGESTING STRATEGIES to prevent Vitamin D deficiency in china.']	[('FUTURE_WORK', 12), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 143), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 175)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC4113768	7/2014	S817-PMC4113768	['the CORRELATIONS between dbp levels and several amino acid transporters SUGGEST that Vitamin D Delivery MAY BE IMPORTANT for Placental function, but FURTHER WORK is now REQUIRED to establish WHETHER these ASSOCIATIONS are causal.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 111), ('FUTURE_WORK', 149), ('IMPORTANT_CONSIDERATION', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007567', 'parturition', 95, 'delivery'), ('UBERON_0001987', 'placenta', 125, 'placental')]
PMC4169453	9/2014	S188-PMC4169453	['KEEPING IN MIND RECENT LITERATURE, TO address the QUESTION of the lowest EFFECTIVE and SAFE Vitamin D dose NEEDED to observe health BENEFITS for both Lactating mother and Breastfed offspring, a higher Vitamin D doses would be chosen and evaluated in our rct (1500 iu/d vs. 2000 iu/d vs. 3000 iu/d).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('EXPLICIT_QUESTION', 50), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 87), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 132)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 150, 'lactating'), ('GO_0007567', 'parturition', 171, 'breastfed'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4251419	12/2014	S149-PMC4251419	['most RECENT Vitamin D supplementation TRIALS use Vitamin D3, SUGGESTING that any DIFFERENCES between d2and d3do NOT ACCOUNT for the DIFFERENT findings from OBSERVATIONAL and Vitamin D supplementation trials.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('ANOMALY_CURIOUS_FINDING', 112), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('INCOMPLETE_EVIDENCE', 156)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 49, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 49, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4256222	12/2014	S145-PMC4256222	['FURTHER STUDIES on this subject ARE NEEDED, BUT such STUDIES MUST BE conducted in study populations large enough to allow for INVESTIGATION of seasonal variation, subdivision of fractures and further stratification of study participants by Vitamin D status.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 66), ('FUTURE_WORK', 126)]	8	[('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4417995	4/2015	S4-PMC4417995	['as of today, the ROLE of Vitamin D in ad is FAR FROM CLEAR; ADDITIONAL STUDIES ARE PARTICULARLY NEEDED in order to confirm the PROMISING therapeutic ROLE of Vitamin D supplementation in childhood ad.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('FULL_UNKNOWN', 44), ('FUTURE_WORK', 60), ('FUTURE_WORK', 71), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 149)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4586451	10/2015	S18-PMC4586451	['this has LED to dietary RECOMMENDATIONS for Pregnancy that limit concentrated sources of Vitamin A and stress the IMPORTANCE of periconceptional Folic Acid supplementation, which HAS BEEN SHOWN to be PROTECTIVE against Neural Tube defects.4\nTHERE IS EVIDENCE that optimal fetal Neurodevelopment is DEPENDENT on specific Nutrients supplied by the mother mainly from dietary sources; these MAY include Long-Chain polyunsaturated Fatty Acids (lc-pufas) such as Docosahexaenoic Acid (Dha), an N-3 Fatty Acid, and arachidonic acid, an N-6 Fatty Acid.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('FUTURE_WORK', 24), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 298), ('INCOMPLETE_EVIDENCE', 388)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_30751', 'formic acid', 145, 'folic acid'), ('UBERON_0001049', 'neural tube', 219, 'neural tube'), ('GO_0007399', 'nervous system development', 278, 'neurodevelopment'), ('CHEBI_33284', 'nutrient', 320, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 400, 'long-chain'), ('CHEBI_35366', 'fatty acid', 427, 'fatty acids'), ('CHEBI_36003', 'decenoic acid', 458, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 480, 'DHA'), ('CHEBI_35245', 'GDP-galactose', 489, 'n-3 fatty acid'), ('CHEBI_18320', '1,4-dithiothreitol', 530, 'n-6'), ('CHEBI_35366', 'fatty acid', 534, 'fatty acid')]
PMC4684854	12/2015	S136-PMC4684854	['one researcher has SUGGESTED that the dietary REQUIREMENT during Pregnancy and Lactation MAY actually be as high as 6000\u2009iu/day [108], BUT most researchers have concluded, with OUR CURRENT KNOWLEDGE, that a supplemental Vitamin D intake of 4000\u2009iu/day is OPTIMAL [30].']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 181), ('FUTURE_WORK', 189), ('IMPORTANT_CONSIDERATION', 255)]	8	[('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('GO_0007595', 'lactation', 79, 'lactation'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4691762	12/2015	S20-PMC4691762	['objectives\nwith the ultimate GOAL of developing improved PUBLIC HEALTH GUIDELINES for Vitamin D supplementation of infants, we AIM TO DETERMINE IF Vitamin D supplementation in infants from 6 to 8\u2005weeks of age LEADS to a reduction in the following during the first year of Life:\nchallenge-proven Food allergy\nlower Respiratory infections\nFood sensitisation\ndoctor diagnosed eczema\nvitamin D deficiency\n\nmethods and analysis\n\ndesign\nvitality is a double-blind, randomised, placebo-controlled trial of Vitamin D supplementation during the first year of Life.']	[('IMPORTANT_CONSIDERATION', 29), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 71), ('FUTURE_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('SUPERFICIAL_RELATIONSHIP', 209)]	8	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0000104', 'life cycle', 272, 'life'), ('CHEBI_33290', 'food', 295, 'food'), ('UBERON_0001004', 'respiratory system', 314, 'respiratory'), ('CHEBI_33290', 'food', 337, 'Food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 388, 'D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('UBERON_0000104', 'life cycle', 550, 'life')]
PMC4778858	3/2016	S100-PMC4778858	['HOWEVER, CAUTION for too much Vitamin D supplementation SHOULD BE raised AS ONE STUDY DETERMINED higher concentrations of neonatal 25-Ohd are POSSIBLY ASSOCIATED with an elevated risk of becoming overweight in Adult Life [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 56), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 131, '25-OHD'), ('UBERON_0000113', 'post-juvenile adult stage', 210, 'adult life')]
PMC4859539	5/2016	S10-PMC4859539	['the LACK OF association between Vitamin D status and Cathelicidin in THIS STUDY MAY BE DUE TO the NARROW RANGE in OBSERVED 25(Oh)D values and WARRANTS ADDITIONAL STUDIES for further observation.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 87), ('PROBLEM_COMPLICATION', 98), ('INCOMPLETE_EVIDENCE', 114), ('FUTURE_WORK', 142), ('FUTURE_WORK', 151)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 53, 'cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D')]
PMC4930210	7/2016	S21-PMC4930210	['a RECENT systematic REVIEW of Vitamin D supplementation in Pregnancy CONCLUDED that EVIDENCE is currently INSUFFICIENT TO SUPPORT DEFINITE clinical RECOMMENDATIONS regarding Vitamin D supplementation in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 106), ('PROBLEM_COMPLICATION', 106), ('PROBABLE_UNDERSTANDING', 130), ('FUTURE_WORK', 148)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC4930210	7/2016	S135-PMC4930210	['OUR FINDINGS are SUPPORTIVE of a GROWING body of LITERATURE SUGGESTING that the RECOMMENDED dose of Vitamin D during Pregnancy is INADEQUATE in preventing Vitamin D deficiency/insufficiency [26].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 60), ('FUTURE_WORK', 80), ('IMPORTANT_CONSIDERATION', 130), ('PROBLEM_COMPLICATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4930210	7/2016	S147-PMC4930210	['THESE FINDINGS EMPHASIZE THE NEED for FURTHER identification of the functional ROLE and clinical SIGNIFICANCE of 3-Epi-25(Oh)D3In the assessment of Vitamin D status in Pregnant women, given the fact that the cut-off for Vitamin D sufficiency in Pregnancy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 97), ('FULL_UNKNOWN', 258)]	8	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 113, '3-epi-25(OH)D3in'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 125, 'D3in'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC4934634	11/2015	S261-PMC4934634	['ALTHOUGH both single and daily doses of Vitamin D3Seem to be SAFE, CAUTION SHOULD BE CONSIDERED when supplementing at these high doses in Pregnant women, PARTICULARLY if baseline Vitamin D status is sufficient.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 61), ('FUTURE_WORK', 67), ('INCOMPLETE_EVIDENCE', 67), ('FUTURE_WORK', 75), ('FUTURE_WORK', 85), ('ANOMALY_CURIOUS_FINDING', 154), ('IMPORTANT_CONSIDERATION', 154)]	8	[('CHEBI_64387', 'thiosultap(1-)', 40, 'vitamin D3seem'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4944244	7/2016	S27-PMC4944244	['healthcare workers USUALLY ENCOURAGE Pregnant women to increase calcium intake BUT they are LESS AWARE that without sufficient Vitamin D, calcium intake will not have much EFFECT ESPECIALLY during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 97), ('SUPERFICIAL_RELATIONSHIP', 172), ('ANOMALY_CURIOUS_FINDING', 179)]	8	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnancy')]
PMC4990268	8/2016	S1184-PMC4990268	['BUT current RECOMMENDED dose imposes IMPORTANT logistical DIFFICULTIES.antenatal vitamin aroutine supplementation not indicated BUT in Vitamin A deficient populations screening for night blindness and treating such cases with Vitamin A CAN be RECOMMENDED.Postnatal vitamin abenefit expected in Vitamin A deficient populations (e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 37), ('DIFFICULT_TASK', 58), ('PROBLEM_COMPLICATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 236), ('FUTURE_WORK', 243)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A'), ('GO_0007567', 'parturition', 255, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin A')]
PMC4992225	8/2016	S281-PMC4992225	['also, SINCE more than 95\xa0% of the mothers had lower than 30\xa0ng/ml Serum 25-Hydroxyvitamin D concentration, it is NOT CLEAR IF the same results WOULD BE OBSERVED in mothers with higher levels of 25-Hydroxyvitamin D. THEREFORE, we SUGGEST FURTHER clinical TRIALS, using 2000\xa0iu Vitamin D on a larger population, mothers with high levels of depression, and high Serum 25-Hydroxyvitamin D concentrations.']	[('PROBLEM_COMPLICATION', 6), ('FULL_UNKNOWN', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('FUTURE_PREDICTION', 143), ('INCOMPLETE_EVIDENCE', 152), ('PROBABLE_UNDERSTANDING', 215), ('INCOMPLETE_EVIDENCE', 229), ('FUTURE_WORK', 237)]	8	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 72, '25-hydroxyvitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 194, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('UBERON_0001977', 'blood serum', 359, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 365, '25-hydroxyvitamin D')]
PMC5014971	8/2016	S108-PMC5014971	['EVEN researchers SKEPTICAL of the causality of Vitamin D EFFECTS on Pregnancy outcomes POINT to a knowledge deficit that NEEDS ADDRESSING, ESPECIALLY in areas such as maternal and neonatal infections (e.g., [21]).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 121), ('IMPORTANT_CONSIDERATION', 121), ('FUTURE_WORK', 127), ('IMPORTANT_CONSIDERATION', 139)]	8	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5062906	10/2016	S47-PMC5062906	['THESE FINDINGS IMPLICATE a ROLE for Vitamin D in determining epigenetic state and HIGHLIGHT the NEED FOR FURTHER STUDY to determine the mechanism and POTENTIAL LINKS to health and disease.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 96), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5340372	3/2017	S144-PMC5340372	['ALTHOUGH poor Lung function performance and an INCREASED RISK of Respiratory Tract infection were RELATED to relatively low cord Serum Vitamin D levels, FURTHER extrapolating the EFFECTS of Vitamin d on the Respiratory function of the general infant population MIGHT STILL BE DIFFICULT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 153), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 261), ('FUTURE_WORK', 267), ('DIFFICULT_TASK', 276)]	8	[('UBERON_0002048', 'lung', 14, 'lung'), ('UBERON_0000065', 'respiratory tract', 65, 'respiratory tract'), ('UBERON_0001977', 'blood serum', 129, 'serum'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 190, 'vitamin'), ('UBERON_0001004', 'respiratory system', 207, 'respiratory')]
PMC5372327	3/2017	S3-PMC5372327	['it REMAINS UNCLEAR WHETHER the RECOMMENDED doses are sufficient for the wide array of OTHER EFFECTS of Vitamin D. the vidi trial performed in finland is the FIRST large randomised controlled study for evaluation of the EFFECTS of different Vitamin D supplemental doses in infancy on:\nbone strength\ninfections and immunity\nallergy, atopy and asthma\nCognitive development\nGenetic Regulation Of Mineral Homeostasis\n\nmethods/design\nvidi, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2\xa0weeks to 24\xa0months.']	[('FULL_UNKNOWN', 3), ('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('FUTURE_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 219)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0050890', 'cognition', 348, 'cognitive'), ('SO_0000704', 'gene', 370, 'genetic'), ('GO_1900046', 'regulation of hemostasis', 378, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 392, 'mineral')]
PMC5418719	5/2017	S98-PMC5418719	['CONSIDERING the high prevalence of Vitamin D deficiency in Pregnant mothers, sufficient Vitamin D supply in preterm infants COULD BE IMPORTANT to quickly correct the fetal low Plasma levels of Vitamin D. a Vitamin D intake of 800\xa0iu to 1000\xa0iu per day during first Months Of Life is RECOMMENDED BASED ON european GUIDELINES [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 133), ('FUTURE_WORK', 283), ('PROBABLE_UNDERSTANDING', 295), ('ANOMALY_CURIOUS_FINDING', 301), ('PROBABLE_UNDERSTANDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 176, 'plasma'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0005445', 'segment of pes', 265, 'months of life')]
PMC5513133	7/2017	S265-PMC5513133	['DESPITE the clear ASSOCIATION of Serum deficiency with pe, a better understanding of the variable IMPACT of supplementation IS NEEDED to identify POTENTIAL of Genetic and environmental INTERACTIONS, as well as pre-Conception data TO IDENTIFY the CRITICAL time window for therapeutic potential of Vitamin D, if any.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 230), ('IMPORTANT_CONSIDERATION', 246)]	8	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('SO_0000704', 'gene', 159, 'genetic'), ('GO_0007620', 'copulation', 214, 'conception'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]
PMC5546866	8/2017	S151-PMC5546866	['OUR FINDINGS SUGGEST that analysis of Snps MAY have an IMPORTANT ROLE in identifying high-risk categories of Individuals who are LIKELY to REQUIRE higher doses of Vitamin D to achieve repletion, and STUDIES ARE NEEDED to establish clinical approaches to Vitamin D supplementation that are centered on individual characteristics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 129), ('IMPORTANT_CONSIDERATION', 139), ('FUTURE_WORK', 199)]	8	[('SO_0000694', 'SNP', 38, 'SNPs'), ('NCBITaxon_1', 'root', 109, 'individuals'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5941617	5/2018	S168-PMC5941617	['intermittent Vitamin D administration MAY BE CONSIDERED in case of reduced compliance with daily supplementation, BUT ACTUAL EVIDENCE IS INSUFFICIENT to RECOMMEND a PREFERRED doses and interval.']	[('INCOMPLETE_EVIDENCE', 38), ('FUTURE_WORK', 45), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 137), ('FUTURE_WORK', 153), ('PROBABLE_UNDERSTANDING', 165)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC5941617	5/2018	S199-PMC5941617	['particularly, Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING vitamin D Metabolism (table\xa07) (see “Extraskeletal actions of Vitamin D” for specific RECOMMENDATIONS).']	[('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 84), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 195), ('FUTURE_WORK', 291)]	8	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_23888', 'drug', 189, 'drugs'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 213, 'D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 213, 'D metabolism'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC5941617	5/2018	S405-PMC5941617	['furthermore, the use of Vitamin D supplementation for primary PREVENTION of allergic diseases REMAINS an attractive AREA OF STUDY, BUT CURRENT KNOWLEDGE and EVIDENCE DOES NOT ALLOW to RECOMMEND it in routine use.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 157), ('DIFFICULT_TASK', 166), ('FUTURE_WORK', 184)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S431-PMC5941617	['ALTHOUGH SOME SUGGESTIVE and encouraging data on epidemiological observational studies and pilot clinical studies of intervention, the LACK OF EVIDENCE deriving by rcts DOES NOT ALLOW to ENCOURAGE treatment with Cholecalciferol or other Vitamin D Metabolites in patients with t1dm or subjects at higher RISK.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 135), ('DIFFICULT_TASK', 169), ('FUTURE_WORK', 187), ('IMPORTANT_CONSIDERATION', 303)]	8	[('CHEBI_52550', 'theopalauamide', 212, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_25212', 'metabolite', 247, 'metabolites')]
PMC5952272	5/2018	S146-PMC5952272	['it is IMPORTANT TO MENTION in this context that the PREVALENCE of autism in somali children Born in sweden was FOUND TO BE 3 to 4 times higher than in the non-somali group (0.7% vs 0.19%).39as somalis have high levels of Melanin, during migration to northern latitudes, such as sweden, they would REQUIRE 5 to 10 times more uv-b exposure than light-skinned Individuals OR an ALTERNATIVE Vitamin D source, such as from the diet or supplementation.40moreover, saad et al41reported that 57% Vitamin D deficient and 30% insufficient patients who received Vitamin D3 (300\u2009iu/kg/day not to exceed 5000\u2009iu/day) for 3\u2009months SHOWED significant improved outcomes (80.72 %), which were MAINLY in the sections of the childhood autism rating scale (cars) and aberrant behaviour checklist subscales that measure behaviour, stereotypy, Eye contact, and attention span.']	[('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 52), ('ANOMALY_CURIOUS_FINDING', 111), ('FUTURE_WORK', 297), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 375), ('INCOMPLETE_EVIDENCE', 617), ('PROBABLE_UNDERSTANDING', 676)]	8	[('GO_0007567', 'parturition', 92, 'born'), ('CHEBI_25179', 'melanins', 221, 'melanin'), ('NCBITaxon_1', 'root', 357, 'individuals'), ('CHEBI_27300', 'vitamin D', 387, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 488, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 551, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 551, 'vitamin D3'), ('UBERON_0000970', 'eye', 822, 'eye')]
PMC2996405	11/2010	S163-PMC2996405	['DESPITE the consistence of this RELATIONSHIP, TO OUR KNOWLEDGE studies CONNECTING schizophrenia and Vitamin D at a molecular level are NOT YET AVAILABLE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 135), ('FUTURE_WORK', 139)]	7	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3004407	12/2010	S22-PMC3004407	['AS a result of the CONCERN regarding the prevalence of Vitamin D deficiency among Pregnant women receiving care at community health centers, and TO CLARIFY earlier scientific STUDIES which REPORTED that a majority of african-american and hispanic women are Vitamin D deficient [34–40], a cross-sectional study of Pregnant women presenting at a community health center network in south carolina at latitude 32°n was designed and implemented.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 145), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'pregnant')]
PMC3257641	3/2010	S139-PMC3257641	['OTHER CANDIDATE diseases that REQUIRE FURTHER RESEARCH with regard to the POTENTIAL ROLE of Prenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 84)]	7	[('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3277098	12/2011	S207-PMC3277098	['RANDOMIZED control TRIALS are ultimately REQUIRED to determine the EFFECTS of Vitamin D supplementation on the developing Immune System, and any POTENTIAL ROLE in preventing allergic disease.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 155)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune system')]
PMC3348565	4/2012	S139-PMC3348565	['the SPECULATIVE negative ROLE of fluctuations is Vitamin D NEEDS to be CONSIDERED with CAUTION UNTIL FURTHER EVIDENCE is available.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 25), ('FUTURE_WORK', 59), ('FUTURE_WORK', 71), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 95), ('INCOMPLETE_EVIDENCE', 101)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3356951	4/2012	S88-PMC3356951	['[68] another example of Extrarenal Regulation of 1α-hydroxylase is that the increased Production Of 1,25(Oh)2D by Keratinocytes in wounds[69] THEREFORE provides a good ESTIMATE of Vitamin D status, BUT Regulation of 1α-hydroxylase activity SHOULD also BE CONSIDERED.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('FUTURE_WORK', 240), ('ANOMALY_CURIOUS_FINDING', 252), ('FUTURE_WORK', 255)]	7	[('UBERON_0001691', 'external ear', 24, 'extrarenal'), ('GO_0065007', 'biological regulation', 35, 'regulation'), ('GO_0034205', 'amyloid-beta formation', 86, 'production of ... 2D'), ('CHEBI_82784', 'PVP38-Ag NP', 100, '1,25(OH)2D'), ('CL_0000312', 'keratinocyte', 114, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0065007', 'biological regulation', 202, 'regulation')]
PMC3356951	4/2012	S151-PMC3356951	['primary hyperparathyroidism and vdd NEED treatment with Vitamin D.[103]\n\ncaption (table-wrap): table 2\n\ntreatment and prevention STRATEGIES[103]\n\nnoncalcemic benefits of Vitamin D\nescp RECOMMENDS prescribing Vitamin D supplementation for fall PREVENTION and do not RECOMMEND supplementation beyond RECOMMENDED daily NEEDS for the purpose of preventing Cardiovascular disease or death or improving quality of life.']	[('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 129), ('FUTURE_WORK', 185), ('SUPERFICIAL_RELATIONSHIP', 243), ('FUTURE_WORK', 265), ('FUTURE_WORK', 298), ('IMPORTANT_CONSIDERATION', 316)]	7	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 352, 'cardiovascular')]
PMC3407995	7/2012	S283-PMC3407995	['the authors CONCLUDED that Vitamin D deficiency is high among Pregnant urban pakistani women and their newborns and is a PUBLIC HEALTH PROBLEM that NEEDS URGENT ATTENTION [137].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 135), ('FUTURE_WORK', 148), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 161)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnant')]
PMC3424155	8/2012	S210-PMC3424155	['furthermore, the literature SHOWS SOME RELATIONSHIP between Vitamin D deficiency and Adipose Tissue Development, and OTHER STUDIES SHOULD evaluate such EFFECTS, and the transgenerational EFFECTS.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 39), ('FUTURE_WORK', 117), ('FUTURE_WORK', 131), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 187)]	7	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 85, 'adipose tissue development'), ('UBERON_0001013', 'adipose tissue', 85, 'adipose tissue')]
PMC3532199	11/2012	S25-PMC3532199	['a NUMBER OF SUBSEQUENT STUDIES reviewed by czeizel [9] and munger [10] have CONTINUED to SUGGEST that Folic Acid and/or OTHER Micronutrients or vitamins, including Vitamin A and Vitamin B6, MAY BE IMPORTANT in the etiology of clefts as well.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('FUTURE_WORK', 76), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 190), ('IMPORTANT_CONSIDERATION', 197)]	7	[('CHEBI_30751', 'formic acid', 102, 'folic acid'), ('CHEBI_33839', 'macromolecule', 126, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('CHEBI_33237', 'vitamin D4', 178, 'vitamin B6')]
PMC3613945	2/2013	S243-PMC3613945	['ongoing interventional trials with Vitamin D and ASSOCIATION studies with larger cohorts MAY offer FURTHER OPPORTUNITY to explore an INTERACTIVE ROLE of dbp Snps with Vitamin D in ms.\n\namyotrophic lateral sclerosis\namyotrophic lateral sclerosis (als) is another neuropathy of UNKNOWN etiology that is characterized by the progressive loss of Motor Neurons in the Brain and spinal Cord, leading to debilitating, USUALLY fatal, muscle atrophy180.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 145), ('FULL_UNKNOWN', 276), ('INCOMPLETE_EVIDENCE', 411)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000694', 'SNP', 157, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CL_0000100', 'motor neuron', 342, 'motor neurons'), ('UBERON_0000955', 'brain', 363, 'brain'), ('UBERON_0002240', 'spinal cord', 380, 'cord')]
PMC3659910	1/2013	S173-PMC3659910	['HOWEVER this RECOMMENDED level, which was LARGELY ARBITRARILY set, SEEMS TO BE LESS HELPFUL to improve the nutritional Vitamin D status of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('ANOMALY_CURIOUS_FINDING', 67), ('FUTURE_PREDICTION', 73), ('IMPORTANT_CONSIDERATION', 79)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnant')]
PMC3659910	1/2013	S194-PMC3659910	['FUTURE STUDIES are ESSENTIAL to determine the true Vitamin D REQUIREMENT during Pregnancy NOT ONLY for maternal Skeletal preservation and fetal Skeletal Formation, BUT ALSO for fetal “Imprinting" that MAY AFFECT Neurodevelopment, Immune function and chronic disease SUSCEPTIBILITY soon after Birth as well as later in Life.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 90), ('FUTURE_PREDICTION', 201), ('SUPERFICIAL_RELATIONSHIP', 205), ('IMPORTANT_CONSIDERATION', 266)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0004288', 'skeleton', 112, 'skeletal'), ('GO_0001501', 'skeletal system development', 144, 'skeletal formation'), ('UBERON_0004288', 'skeleton', 144, 'skeletal'), ('GO_0071514', 'genetic imprinting', 184, 'imprinting'), ('GO_0007399', 'nervous system development', 212, 'neurodevelopment'), ('UBERON_0002405', 'immune system', 230, 'immune'), ('GO_0007567', 'parturition', 292, 'birth'), ('UBERON_0000104', 'life cycle', 318, 'life')]
PMC3672018	5/2013	S41-PMC3672018	['ALTHOUGH mechanisms RELATING low Perinatal Vitamin D to later obesity are NOT WELL KNOWN, PROPOSED mediators include epigenetic changes leading to initiation of Adipogenesis, or induction of permanent functional changes in Hypothalamic Appetite Regulation [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('GO_0036268', 'swimming', 33, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 33, 'perinatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 161, 'adipogenesis'), ('UBERON_0001898', 'hypothalamus', 223, 'hypothalamic'), ('GO_0034205', 'amyloid-beta formation', 236, 'appetite regulation')]
PMC3702245	6/2013	S63-PMC3702245	['a review of the FEW previous randomized controlled TRIALS of Vitamin D supplementation during Pregnancy INDICATES that doses of 400–1600 iu/day were INSUFFICIENT in achieving a mean Serum 25(Oh)D concentration ≥50 nmol/l in most of the studies.41in a RECENT Vitamin D supplementation TRIAL from the uk, a multiethnic group of 180 Pregnant women were randomized at 27 weeks’ Gestation to receive a single Oral dose of 200,000 iu of Vitamin D, daily supplementation of 800 iu, or no treatment.33the median Serum 25(Oh)D concentration in the 800 iu/day group at study entry was 26 nmol/l (interquartile range 22–37), and the median 25(Oh)D concentration at delivery following supplementation was 42 nmol/l (interquartile range 31–76).']	[('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 51), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149), ('INCOMPLETE_EVIDENCE', 251), ('INCOMPLETE_EVIDENCE', 284)]	7	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 188, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('GO_0007565', 'female pregnancy', 330, 'pregnant'), ('GO_0007565', 'female pregnancy', 374, 'gestation'), ('UBERON_0000165', 'mouth', 404, 'oral'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D'), ('UBERON_0001977', 'blood serum', 504, 'serum'), ('CHEBI_71657', 'versiconol acetate', 510, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 510, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 629, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 629, '25(OH)D')]
PMC3705320	3/2013	S201-PMC3705320	['NONETHELESS, increases in the mean calcium concentration (within the normal range) and suppression of pth secretion among Pregnant women receiving the higher-dose regimen (70,000 iu initial dose followed by weekly doses of 35,000 iu) HIGHLIGHTED the physiological IMPACT of the intervention and the NEED to cautiously address POTENTIAL Pregnancy-specific sensitivities to Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 264), ('FUTURE_WORK', 299), ('INCOMPLETE_EVIDENCE', 299), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0007565', 'female pregnancy', 122, 'pregnant'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3739737	8/2013	S160-PMC3739737	['the lack of a marked behavioural phenotype in the avd MODEL in the male sprague-dawley Rat MAY have IMPORTANT IMPLICATIONS for FUTURE Animal models exploring the biological mechanisms that MAY underpin the epidemiological ASSOCIATIONS between low Vitamin D and adverse Brain outcomes.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 110), ('FUTURE_WORK', 127), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 222)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 87, 'rat'), ('NCBITaxon_33208', 'Metazoa', 134, 'animal'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0000955', 'brain', 269, 'brain')]
PMC3760821	9/2013	S159-PMC3760821	['THESE FINDINGS SUPPORT the CONTENTION that measurement of Vitamin D levels prior to, and during Pregnancy, SHOULD BE RECOMMENDED, and that Vitamin D supplementation be initiated when deficiency is CONFIRMED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('FUTURE_WORK', 107), ('FUTURE_WORK', 117), ('INCOMPLETE_EVIDENCE', 197)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3809191	1/2013	S64-PMC3809191	['ALTHOUGH there is NO CONSENSUS for routine Vitamin D screening in Pregnancy, being ALERT about the vitamin\xa0d deficiency and its symptoms and optimising when NECESSARY by replacement and/or through taking lifestyle measures MAY BE RECOMMENDED to prevent the Birth of Vitamin D-deficient infants from Vitamin D-deficient mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 157), ('INCOMPLETE_EVIDENCE', 223), ('FUTURE_WORK', 230)]	7	[('CHEBI_28384', 'vitamin K', 43, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007567', 'parturition', 257, 'birth'), ('CHEBI_28384', 'vitamin K', 266, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 266, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3827489	10/2013	S87-PMC3827489	['taken TOGETHER, THESE FINDINGS SUGGEST that PUBLIC HEALTH INTERVENTIONS such as outdoor activity and Vitamin D supplementation, which enhance Vitamin D status, MAY improve the health of adolescents with Metabolic PROBLEMS.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 58), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 213)]	7	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0008152', 'metabolic process', 203, 'metabolic')]
PMC4072587	6/2014	S156-PMC4072587	['our results STRENGTHEN the EVIDENCE for giving Vitamin D supplementation during Pregnancy and HIGHLIGHT the NEED FOR FURTHER RESEARCH to explore the IMPACT of supplementation on longer term child growth and developmental outcomes, PARTICULARLY with regard to language.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 108), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 149), ('IMPORTANT_CONSIDERATION', 231)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC4113768	7/2014	S1828-PMC4113768	['in SOME of the elderly subjects lower Plasma 25(Oh)D levels coexisting with high alkaline phosphatase activity MAY INDICATE developing osteomalacia.taking INTO ACCOUNT lower Plasma 25(Oh)D, 1,25(Oh)D and calcium levels among the MAJORITY of centenarians, the sufficient Vitamin D and calcium supplementation SHOULD be systematically APPLIED also in the oldest old.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 155), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 308), ('SUPERFICIAL_RELATIONSHIP', 333)]	7	[('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 45, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 174, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC4113768	7/2014	S2049-PMC4113768	['conclusions: Vitamin D status in ireland has improved immensely in ireland over the past 40 years, but TARGETED PUBLIC HEALTH policies of low-dose supplementation ARE NEEDED TO address AT-RISK groups, and mandated fortification to SAFE levels SHOULD maintain Vitamin D adequacy in the population.']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 112), ('FUTURE_WORK', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 174), ('IMPORTANT_CONSIDERATION', 185), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 243)]	7	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC4377870	3/2015	S108-PMC4377870	['dietary intake of Vitamin E lower than RECOMMENDED dietary intakes HAS BEEN REPORTED in Pregnant women with a family history of allergic disease [88] and RECENT work in Animal MODELS has HIGHLIGHTED Α-Tocopherol MAY BE IMPORTANT for allergic mothers in Pregnancy.']	[('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 219)]	7	[('CHEBI_27300', 'vitamin D', 18, 'vitamin E'), ('GO_0007565', 'female pregnancy', 88, 'pregnant'), ('NCBITaxon_33208', 'Metazoa', 169, 'animal'), ('CHEBI_27725', 'butin', 199, 'α-tocopherol'), ('GO_0007565', 'female pregnancy', 253, 'pregnancy')]
PMC4380518	9/2014	S65-PMC4380518	['IN CONTRAST, our data SUPPORT INVESTIGATION into higher doses of Vitamin D in subgroups at high RISK IF BENEFITS are demonstrated by ONGOING TRIALS in Pregnancy of achieving higher 25(Oh)D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 96), ('FUTURE_PREDICTION', 101), ('IMPORTANT_CONSIDERATION', 104), ('INCOMPLETE_EVIDENCE', 133)]	7	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D')]
PMC4427001	4/2015	S153-PMC4427001	['POTENTIALLY beneficial EFFECT of Vitamin D supplementation and the PLAUSIBLE pathogenic ROLE of 25(Oh)D deficiency in the subsequent development of diabetes mellitus type 2 in women with gdm history HAS to be FURTHER explored considering the ROLE of Vitamin D in Modulating Insulin sensitivity and Glucose Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 209), ('SUPERFICIAL_RELATIONSHIP', 242)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0065007', 'biological regulation', 263, 'modulating'), ('PR_000045358', 'insulin family protein', 274, 'insulin'), ('CHEBI_17234', 'glucose', 298, 'glucose'), ('GO_0006006', 'glucose metabolic process', 298, 'glucose metabolism')]
PMC4466139	6/2015	S116-PMC4466139	['the RELATIONSHIP between 25Ohd levels, ethnicity and supplementation in Pregnancy SUGGESTS a ROLE for Genetic DETERMINANTS for Vitamin D status and STRESSES the IMPORTANCE of Vitamin D integration in preventative STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 161), ('FUTURE_WORK', 213)]	7	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 25, '25OHD'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('SO_0000704', 'gene', 102, 'genetic'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC4595656	10/2015	S119-PMC4595656	['FUTURE DIRECTIONS and conclusions\nin LIGHT of the ACCUMULATING Animal and in vitro EVIDENCE to DATE, it is LIKELY that Vitamin D plays a ROLE in hippocampal development in vivo .']	[('FUTURE_WORK', 0), ('PROBABLE_UNDERSTANDING', 37), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 107), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('NCBITaxon_33208', 'Metazoa', 63, 'animal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4600246	10/2015	S9-PMC4600246	['HOWEVER, the RECENTLY updated usa preventive services task force (uspstf) has RECENTLY STATED that there is INSUFFICIENT EVIDENCE that Calcium and Vitamin D PREVENT a fracture in Premenopausal women or in men who have not experienced a fracture and now RECOMMENDS against daily supplementation with 400\u2005iu or less of Vitamin D3 and 1000\u2005mg or less of calcium for the primary prevention of fractures in non-institutionalised Postmenopausal women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 157), ('FUTURE_WORK', 253)]	7	[('CHEBI_22313', 'alkaline earth metal atom', 135, 'calcium'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 179, 'premenopausal'), ('CHEBI_33279', 'vitamin D5', 317, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 317, 'vitamin D3'), ('GO_0007595', 'lactation', 424, 'postmenopausal')]
PMC4624803	10/2015	S17-PMC4624803	['EVEN IF it is PROBABLE that the Vitamin D levels of the mother is close to the levels of the foetus, it is of INTEREST to compare these results with a study of Vitamin D levels in the child AS a hypothetical RISK FACTOR for later development of adhd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 14), ('ANOMALY_CURIOUS_FINDING', 110), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 190), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4689556	12/2015	S142-PMC4689556	['we FOUND NO CONSISTENT evidence for a treatment effect on overall or disease-specific unscheduled healthcare utilisation in the first three years, ALTHOUGH it should be NOTED that neither of the intervention regimens resulted in adequate Vitamin D levels in mothers or Cord Blood, JUDGED by current international Vitamin D RECOMMENDATIONS [36,37].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ANOMALY_CURIOUS_FINDING', 147), ('ANOMALY_CURIOUS_FINDING', 169), ('PROBABLE_UNDERSTANDING', 281), ('FUTURE_WORK', 323)]	7	[('CHEBI_27300', 'vitamin D', 238, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D')]
PMC4689556	12/2015	S183-PMC4689556	['ALTHOUGH our confidence in the findings is LIMITED by the SMALL SAMPLE size, these data SUGGEST that IF Prenatal Vitamin D is used to promote improved child health outcome, then a Postnatal component to treatment, and/or or higher doses MAY BE NEEDED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 237), ('FUTURE_WORK', 244)]	7	[('GO_0007565', 'female pregnancy', 104, 'prenatal'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 180, 'postnatal')]
PMC4691762	12/2015	S113-PMC4691762	['restricting the trial to infants with Vitamin D deficiency would REQUIRE a smaller trial, HOWEVER it would be UNETHICAL to randomise these infants to placebo thereby not treating with Vitamin D. the use of Vitamin D supplements in the placebo group is ANOTHER POTENTIAL ISSUE HOWEVER we are collecting sufficient data regarding Feeding practices, Supplement use and sun exposure to account for this.']	[('FUTURE_WORK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('DIFFICULT_TASK', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 260), ('PROBLEM_COMPLICATION', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 276)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_16158', 'steroid sulfate', 347, 'supplement')]
PMC4889866	5/2016	S93-PMC4889866	['THUS, when addressing the IMPACT of Prenatal Vitamin D status on various outcomes, it MIGHT be IMPORTANT to CONSIDER that Vitamin D levels in the Pregnant mothers and Cord Blood MIGHT not always correspond uniformly.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 108), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 178)]	7	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant'), ('UBERON_0002240', 'spinal cord', 167, 'cord'), ('UBERON_0000178', 'blood', 172, 'blood')]
PMC4889866	5/2016	S127-PMC4889866	['finally, ALTHOUGH PRESENT STUDY had OBSERVED an ASSOCIATION between Prenatal Vitamin D status and Viral tlrs-triggered response (Tlr3 and Tlr7/8, both of which recognize Viral rna), the EFFECT of Vitamin D on cpg Double Stranded dna motif (Tlr9) of the Viral Genome also DEMANDS FURTHER EXPLORATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 186), ('IMPORTANT_CONSIDERATION', 271), ('FUTURE_WORK', 279)]	7	[('GO_0007565', 'female pregnancy', 68, 'prenatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('NCBITaxon_1', 'root', 98, 'viral'), ('PR_000001155', 'Toll-like receptor 4', 129, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 138, 'TLR7'), ('NCBITaxon_1', 'root', 170, 'viral'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('SO_0000985', 'double', 213, 'double stranded'), ('PR_000001155', 'Toll-like receptor 4', 240, 'TLR9'), ('NCBITaxon_1', 'root', 253, 'viral'), ('SO_0001026', 'genome', 259, 'genome')]
PMC4896250	4/2016	S6132-PMC4896250	['SINCE THESE studies were very HETEROGENEOUS and the retrospective or the observational cohort studies, large randomized controlled TRIALS ARE NEEDED to determine WHETHER Vitamin D supplementation MAY BE beneficial in the PREVENTION of ar.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('DIFFICULT_TASK', 30), ('FUTURE_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 221)]	7	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4930210	7/2016	S19-PMC4930210	['a combined analysis of two randomized clinical trials of 494 Pregnant women taking 400, 2000, and 4000 iu/day Vitamin D during Pregnancy SHOWED that Vitamin D supplementation of 4000 iu/day was more EFFECTIVE in achieving Serum concentrations ≥ 80 nmol/l than 400 and 2000 iu/day in all women and their neonates REGARDLESS OF race, SUGGESTING that the current dietary RECOMMENDATION in the absence of supplementation in Pregnancy MAY not be OPTIMAL [9].']	[('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 199), ('INCOMPLETE_EVIDENCE', 312), ('INCOMPLETE_EVIDENCE', 332), ('FUTURE_WORK', 368), ('INCOMPLETE_EVIDENCE', 430), ('IMPORTANT_CONSIDERATION', 441)]	7	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('GO_0007565', 'female pregnancy', 420, 'pregnancy')]
PMC4934634	11/2015	S291-PMC4934634	['with large percentages of Individuals having INSUFFICIENT Vitamin D levels, this RAISES the QUESTION of WHETHER fortification EFFORTS SHOULD BE increased.']	[('IMPORTANT_CONSIDERATION', 45), ('EXPLICIT_QUESTION', 81), ('EXPLICIT_QUESTION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('EXPLICIT_QUESTION', 104), ('FUTURE_WORK', 126), ('FUTURE_WORK', 134)]	7	[('NCBITaxon_1', 'root', 26, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4944244	7/2016	S10-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care workers to determine their level of knowledge RELATED to Vitamin D, AS they are front liner in detecting the hypovitaminosis d.\n\nbackground\nmalaysia is rich with sunshine, a MAJOR source of Vitamin D. HOWEVER, a study by moy [1] among a cohort of malays SHOWED that 67.9\xa0% had insufficient Vitamin D especially in women, with Serum mean concentration of 25(Oh)D of 36.2\u2009±\u200913.4\xa0nmol/l in women and 56.2\u2009±\u200918.9\xa0nmol/l in men.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 309)]	7	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0001977', 'blood serum', 381, 'serum'), ('CHEBI_71657', 'versiconol acetate', 409, '25(OH)D')]
PMC4944244	7/2016	S230-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care staff to assess the level of knowledge RELATED to Vitamin D. in addition, THIS RESEARCH AIMED to create the AWARENESS on the IMPORTANCE of Vitamin D to patient.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('IMPORTANT_CONSIDERATION', 163), ('IMPORTANT_CONSIDERATION', 180)]	7	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4949006	7/2016	S195-PMC4949006	['there is NO GOOD current EVIDENCE to SHOW value in supplementation for iron and vitamins A, B6, B12, A, e, or D at this time, ALTHOUGH there are many SUGGESTIVE STUDIES for Vitamin D. all Pregnant women SHOULD BE ENCOURAGED to eat a balanced diet rich in fresh or frozen fruits and vegetables, high-quality Carbohydrates including whole grains, and with a good mix of proteins from beans, lean meats, fish, and seafood.']	[('FULL_UNKNOWN', 9), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 150), ('FUTURE_WORK', 203), ('FUTURE_WORK', 213)]	7	[('PR_000004370', 'asialoglycoprotein receptor 2', 89, 'A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 92, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 96, 'B12'), ('PR_000004370', 'asialoglycoprotein receptor 2', 101, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 110, 'D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnant'), ('CHEBI_16646', 'carbohydrate', 307, 'carbohydrates')]
PMC4989298	8/2016	S376-PMC4989298	['the use of Vitamin D supplementation for the primary PREVENTION of allergic diseases REMAINS an attractive TOPIC of study, BUT CURRENT KNOWLEDGE and AVAILABLE EVIDENCE does not warrant its RECOMMENDATION [129].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 149), ('FUTURE_WORK', 189)]	7	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC5051327	9/2016	S11-PMC5051327	['IF OUR FINDINGS are SUPPORTED by FURTHER STUDIES, PREFERABLY on SEVERE Birth asphyxia, Vitamin D supplementation/sun exposure in Pregnancy MAY lower the risk of subsequent Birth asphyxia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 64), ('INCOMPLETE_EVIDENCE', 139)]	7	[('GO_0007567', 'parturition', 71, 'birth'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC5064894	10/2016	S194-PMC5064894	['IF SHOWN to reduce the RISK of ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia MAY BE a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-associated morbidity and mortality in young infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 160), ('PROBABLE_UNDERSTANDING', 169), ('FUTURE_WORK', 197), ('IMPORTANT_CONSIDERATION', 216)]	7	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('GO_0007565', 'female pregnancy', 80, 'postpartum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 122, 'antenatal care')]
PMC5133057	10/2016	S108-PMC5133057	['it is IMPORTANT TO NOTE that EVEN IF the reduction occurs with more intensity in the second and third quarter due to Plasma volume expansion and increased Vitamin A transfer from the mother to the fetus, special ATTENTION throughout Pregnancy is NECESSARY, PARTICULARLY in the first trimester, when the major changes in the Fetal Development occur.']	[('IMPORTANT_CONSIDERATION', 6), ('ANOMALY_CURIOUS_FINDING', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 257)]	7	[('UBERON_0001969', 'blood plasma', 117, 'plasma'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('GO_0007565', 'female pregnancy', 233, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 324, 'fetal development')]
PMC5155676	12/2016	S124-PMC5155676	['AS such, young Pregnant women MIGHT PARTICULARLY REQUIRE ADVICE on the need for, and compliance with, Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 36), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 49), ('IMPORTANT_CONSIDERATION', 49), ('FUTURE_WORK', 57)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnant'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5351212	3/2017	S10-PMC5351212	['conclusions\nthis work RAISES the POSSIBILITY that early dietary supplementation with Vitamin D MAY open NEW AVENUES for a successful attenuation or EVEN PREVENTION of Neurodevelopmental disorders following maternal inflammation during Pregnancy.']	[('EXPLICIT_QUESTION', 22), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 95), ('FULL_UNKNOWN', 104), ('FUTURE_WORK', 108), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 153)]	7	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007399', 'nervous system development', 167, 'neurodevelopmental'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy')]
PMC5371920	3/2017	S137-PMC5371920	['Vitamin D supplementation APPEARED SAFE; THESE FINDINGS SUPPORT current RECOMMENDATIONS in uk and elsewhere, and MAY SUGGEST the basis for more stratified approaches to Vitamin D supplementation in Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 35), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 56), ('FUTURE_WORK', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 117)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy')]
PMC5385921	4/2017	S124-PMC5385921	['furthermore, neonatal Vitamin D deficiency HAS been PREVIOUSLY ASSOCIATED with an increased risk of schizophrenia.36asd and schizophrenia are KNOWN to share Genetic risk variants;37our findings provide ADDITIONAL EVIDENCE of the shared risk ARCHITECTURE between these two Neurodevelopmental disorders.']	[('IMPORTANT_CONSIDERATION', 43), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 142), ('FUTURE_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 241)]	7	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000704', 'gene', 157, 'genetic'), ('GO_0007399', 'nervous system development', 272, 'neurodevelopmental')]
PMC5405075	4/2017	S29-PMC5405075	['the IMPACT of Vitamin D exposure in utero\nthe DEPENDENCE of the developing fetus on maternal Vitamin D status TOGETHER with the REPORTED extra Skeletal function of the hormone and Vitamin D deficiency EPIDEMIC during the last years led to FURTHER INVESTIGATION of the CONSEQUENCES of maternal Vitamin D insufficiency on Pregnancy outcomes (6,29,30).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 201), ('FUTURE_WORK', 239), ('PROBLEM_COMPLICATION', 268)]	7	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('UBERON_0004288', 'skeleton', 143, 'skeletal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
PMC5452160	4/2017	S237-PMC5452160	['CONSIDERING the high prevalence of iron, zinc, Vitamin A, b12, and Folate deficiencies, and PREVIOUSLY presented results on Iodine deficiency in this study population [63], INTERVENTIONS to promote the strengthening of anc, and access and adherence to nutrition and health interventions are URGENTLY NEEDED [64,65].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 173), ('IMPORTANT_CONSIDERATION', 291), ('FUTURE_WORK', 300)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 67, 'folate'), ('CHEBI_24859', 'iodine atom', 124, 'iodine')]
PMC5539754	8/2017	S30-PMC5539754	['due to the seasonal nature of 25Ohd concentrations in many parts of the world [32], and the OBSERVED ASSOCIATIONS between Vitamin D and Insulin resistance, it WOULD seem PRUDENT to HYPOTHESISE that seasonal variation of Glucose Homeostasis MAY BE MEDIATED through 25Ohd.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 101), ('FUTURE_PREDICTION', 159), ('IMPORTANT_CONSIDERATION', 170), ('FUTURE_WORK', 181), ('INCOMPLETE_EVIDENCE', 240), ('SUPERFICIAL_RELATIONSHIP', 247)]	7	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 30, '25OHD'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('PR_000045358', 'insulin family protein', 136, 'insulin'), ('CHEBI_17234', 'glucose', 220, 'glucose'), ('GO_0042593', 'glucose homeostasis', 220, 'glucose homeostasis'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 264, '25OHD')]
PMC5941617	5/2018	S20-PMC5941617	['the main OBJECTIVE is to give RECOMMENDATIONS regarding the PREVENTION and treatment of Vitamin D deficiency in italian children and adolescents (0–18\xa0years), CONSIDERING both the Skeletal and Extra-Skeletal EFFECTS of Vitamin D and POTENTIAL RISK FACTORS in specific subgroups of children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FUTURE_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 243)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0004288', 'skeleton', 180, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 193, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC5941617	5/2018	S125-PMC5941617	['regarding the PREFERRED form of Vitamin D for supplementation, the national institute for health and care excellence GUIDELINE RECOMMENDED Vitamin D drops in infants and young children [114], WHILE other international scientific societies DID NOT make any SPECIFIC RECOMMENDATION.']	[('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 117), ('FUTURE_WORK', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('INCOMPLETE_EVIDENCE', 239), ('FUTURE_WORK', 256), ('FUTURE_WORK', 265)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5941617	5/2018	S537-PMC5941617	['AS literature SHOWS CONTRASTING results because of DIFFERENT methods and study designs, MORE STUDIES ARE NEEDED to define the ROLE of Vitamin D in pathogenesis and severity of depression, particularly in the pediatric age.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 126)]	7	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5941617	5/2018	S568-PMC5941617	['we do not RECOMMEND routine screening of Serum 25(Oh)D levels in all Pregnant and breastfeeding women, BUT we SUGGEST to CONSIDER Vitamin D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation.']	[('FUTURE_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 110), ('FUTURE_WORK', 121), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 210)]	7	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 47, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5941617	5/2018	S648-PMC5941617	['Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING Vitamin D Metabolism (table\xa07).']	[('FUTURE_WORK', 17), ('IMPORTANT_CONSIDERATION', 17), ('PROBABLE_UNDERSTANDING', 37), ('IMPORTANT_CONSIDERATION', 70), ('PROBABLE_UNDERSTANDING', 116), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 181)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_23888', 'drug', 175, 'drugs'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0008152', 'metabolic process', 201, 'metabolism')]
PMC5941617	5/2018	S672-PMC5941617	['we SUGGEST the evaluation of Vitamin D status ONLY in patients affected by tuberculosis or hiv infection, AS they MAY BENEFIT from Vitamin D supplementation, in particular due to concomitant treatments that INFLUENCE Vitamin D Metabolism.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 207)]	7	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0008152', 'metabolic process', 227, 'metabolism')]
PMC5941617	5/2018	S720-PMC5941617	['we SUGGEST to CONSIDER serum 25(Oh)D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation, and/or with specific conditions POSSIBLY AFFECTING Pregnancy course (table\xa09).']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 68), ('ANOMALY_CURIOUS_FINDING', 107), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 205)]	7	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy')]
PMC5956785	5/2018	S24-PMC5956785	['an updated, systematic analysis of pertinent literature SHOULD help to FURTHER REFINE understanding of the RELATIONSHIPS between Vitamin D and juvenile arthritis, contribute to optimizing management of vitamin d status in children with arthritis, and CLARIFY Vitamin D’s POTENTIAL ROLE in MEDIATING disease pathogenesis.']	[('FUTURE_WORK', 56), ('FUTURE_WORK', 71), ('SUPERFICIAL_RELATIONSHIP', 107), ('FUTURE_WORK', 251), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 281), ('SUPERFICIAL_RELATIONSHIP', 289)]	7	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC2151954	10/2007	S171-PMC2151954	['with respect to seasonally-fluctuating exposures that MAY UNDERLIE THESE FINDINGS, we SPECULATE that low Prenatal Vitamin D is a CANDIDATE that WARRANTS closer inspection [4].']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 129), ('FUTURE_WORK', 144)]	6	[('GO_0007565', 'female pregnancy', 105, 'prenatal'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC2290997	4/2008	S80-PMC2290997	['researchers are now seeking to understand HOW much uvr/Vitamin D is NEEDED to lower the risk of diabetes and WHETHER this is a FACTOR ONLY in high-risk groups.']	[('EXPLICIT_QUESTION', 42), ('FUTURE_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('EXPLICIT_QUESTION', 109), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 134)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC2290997	4/2008	S115-PMC2290997	['so when you ESTIMATE the number of deaths LIKELY to be attributable to uv light or Vitamin D, it does is not APPEAR TO BE the BEST policy to ADVISE People to simply keep out of the sun just to prevent skin cancer.”\nto maximize protection against cancer, grant RECOMMENDS raising 25(Oh)D levels to between 40 and 60 ng/ml.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 42), ('ANOMALY_CURIOUS_FINDING', 109), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 141), ('FUTURE_WORK', 260)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'people'), ('CHEBI_71657', 'versiconol acetate', 279, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 279, '25(OH ... D')]
PMC2779500	11/2009	S46-PMC2779500	['[31] maintain that Prenatal supplementation of Vitamins B, C, and e SHOULD BE continued DUE TO their MANY REPORTED positive EFFECTS on maternal and fetal health.']	[('FUTURE_WORK', 68), ('PROBABLE_UNDERSTANDING', 88), ('PROBLEM_COMPLICATION', 88), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamins B'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 47, 'vitamins B'), ('CHEBI_18245', 'carboxylato group', 59, 'C'), ('PR_000004900', 'complement C3', 59, 'C')]
PMC2798111	12/2010	S99-PMC2798111	['THUS, OUR FINDINGS in THIS STUDY and our earlier studies [4,32] SUPPORT the RECENT aap RECOMMENDATION of starting Vitamin D supplementation in all breastfed infants within the first few days after Delivery [26].']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 76), ('FUTURE_WORK', 87)]	6	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'delivery')]
PMC2841444	2/2010	S499-PMC2841444	['although the quality of the trials is variable and FURTHER STUDIES ARE NEEDED, these data SUGGEST a POSSIBLE ROLE for Antenatal maternal Vitamin K administration as a means of reducing RISKS of pvh and mortality in preterm infants.']	[('FUTURE_WORK', 51), ('FUTURE_WORK', 59), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 185)]	6	[('GO_0007567', 'parturition', 118, 'antenatal'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin K')]
PMC2872349	4/2010	S143-PMC2872349	['this SUPPORTS the general NEED for a programme of interventional research aimed at improving general dietary quality among women before Conception and during Pregnancy, in addition to studies that EVALUATE the TARGETING of specific Micronutrients such as Vitamin D and Calcium.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 26), ('INCOMPLETE_EVIDENCE', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 197), ('FUTURE_WORK', 210)]	6	[('GO_0007620', 'copulation', 136, 'conception'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 232, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 269, 'calcium')]
PMC3034879	12/2010	S201-PMC3034879	['it SEEMS UNLIKELY, THEREFORE, that IMPROVING Vitamin D intake merely in infancy would revert the CONSEQUENCES of POOR Vitamin D status during the Fetal Period.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 19), ('FUTURE_WORK', 35), ('PROBLEM_COMPLICATION', 97), ('IMPORTANT_CONSIDERATION', 113)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002375', 'cricoid cartilage', 146, 'fetal period')]
PMC3034879	12/2010	S202-PMC3034879	['based ON these OBSERVATIONS, ADDITIONAL EFFORTS SHOULD BE MADE to improve Vitamin D status during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('FUTURE_WORK', 29), ('FUTURE_WORK', 40), ('FUTURE_WORK', 48)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
PMC3075531	7/2010	S63-PMC3075531	['a test of the HYPOTHESIS that Vitamin D COULD reduce ms risk WILL REQUIRE the administration of relatively high doses of Vitamin D to hundreds of thousands of young adults for several years, and careful monitoring for UNFORESEEN ADVERSE EFFECTS is MANDATORY.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_PREDICTION', 61), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 218), ('IMPORTANT_CONSIDERATION', 248)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC3103150	3/2011	S131-PMC3103150	['LARGER STUDIES and meta-analysis SHOULD BE conducted to CONFIRM the FINDINGS of the PRESENT study and develop RECOMMENDATIONS for Vitamin D supplementation for Pregnant and Lactating women and young infants.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 33), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 68), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('FUTURE_WORK', 110)]	6	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnant'), ('GO_0007594', 'puparial adhesion', 173, 'lactating')]
PMC3257641	3/2010	S4-PMC3257641	['the EVIDENCE to date SUPPORTS that women SHOULD BE monitored and treated for Vitamin D deficiency during Pregnancy BUT OPTIMAL and upper limit Serum 25(Oh)D levels during Pregnancy are NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('IMPORTANT_CONSIDERATION', 119), ('FULL_UNKNOWN', 185)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('CHEBI_71657', 'versiconol acetate', 149, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 149, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3257641	3/2010	S160-PMC3257641	['to examine the POTENTIAL long term EFFECTS of low Vitamin D on offspring health, randomized controlled trials STUDIES MAY NOT BE feasible, particularly for RARE diseases with later onset such as schizophrenia.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 35), ('FUTURE_WORK', 110), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 156)]	6	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3257641	3/2010	S161-PMC3257641	['for these studies, observational studies will NEED to include seasonal variation in Vitamin D status, POTENTIALLY CONFOUNDING by other seasonal factors such as infection, and also deseasonalized interpersonal variation in Ingested Vitamin D or uvr-derived Vitamin D. with regard to these deaseasonalized MARKERS of Vitamin D status, it is highly LIKELY that Vitamin d status in Pregnancy will be CORRELATED with Ingested or uvr-derived Vitamin D exposure for mothers preceding Pregnancy and offspring after Pregnancy.']	[('FUTURE_WORK', 46), ('INCOMPLETE_EVIDENCE', 102), ('PROBLEM_COMPLICATION', 114), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 346), ('SUPERFICIAL_RELATIONSHIP', 396)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007631', 'feeding behavior', 222, 'ingested'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 358, 'vitamin'), ('GO_0007565', 'female pregnancy', 378, 'pregnancy'), ('GO_0007631', 'feeding behavior', 412, 'ingested'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('GO_0007565', 'female pregnancy', 477, 'pregnancy'), ('GO_0007565', 'female pregnancy', 507, 'pregnancy')]
PMC3272870	12/2011	S45-PMC3272870	['moreover, the usual RECOMMENDATIONS to avoid sun exposure reduces dermal Synthesis Of Vitamin D3Although Vitamin D is UNDOUBTEDLY IMPORTANT for foetal Bone Development, we KNOW that it plays a much wider ROLE in health and disease prevention.']	[('FUTURE_WORK', 20), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 204)]	6	[('GO_0030474', 'spindle pole body duplication', 73, 'synthesis of ... D3Although'), ('CHEBI_83701', '8-PAHSA(1-)', 86, 'vitamin D3Although'), ('PR_000027594', 'histone H3', 86, 'vitamin D3Although'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048539', 'bone marrow development', 151, 'bone development')]
PMC3277098	12/2011	S60-PMC3277098	['this line of argument HIGHLIGHTS that the potency and pharmacokinetics of endogenous and exogenous Vitamin D MAY BE DIFFERENT and that Serum 25(Oh)D, sun exposure and oral Intake SHOULD BE CONSIDERED INDEPENDENTLY of one another.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('FUTURE_WORK', 179), ('FUTURE_WORK', 189), ('SUPERFICIAL_RELATIONSHIP', 200)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 141, '25(OH ... D'), ('GO_0007631', 'feeding behavior', 172, 'intake')]
PMC3277098	12/2011	S197-PMC3277098	['these CONTRASTING results HIGHLIGHT THE NEED for randomised controlled trials (rct) to provide clearer picture of ROLE of Vitamin D during infancy in Regulation of Allergic disease, including uptake, Metabolism and Immunomodulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 150)]	6	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0065007', 'biological regulation', 150, 'regulation'), ('GO_0040011', 'locomotion', 164, 'allergic'), ('GO_0008152', 'metabolic process', 200, 'metabolism'), ('GO_0050900', 'leukocyte migration', 215, 'immunomodulation')]
PMC3296991	2/2012	S102-PMC3296991	['because Vitamin D inadequacy during Gestation and its IMPACTS on offspring bone integrity are of PUBLIC HEALTH CONCERN, FURTHER STUDIES ARE WARRANTED to investigate the COMPLEX mechanisms LINKING in utero Vitamin D status to fetal Bone Development.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 120), ('FUTURE_WORK', 128), ('DIFFICULT_TASK', 169), ('SUPERFICIAL_RELATIONSHIP', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'gestation'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0048539', 'bone marrow development', 231, 'bone development')]
PMC3347007	4/2012	S190-PMC3347007	['we PROPOSE that clinicians SHOULD ENCOURAGE Vitamin D supplementation among Pregnant women, with a SPECIAL FOCUS on vulnerable groups, such as younger, smoking and multiparous women, IN ORDER to improve maternal and fetal health both during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 27), ('FUTURE_WORK', 34), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 107), ('QUESTION_ANSWERED_BY_THIS_WORK', 183)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnant'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC3348565	4/2012	S127-PMC3348565	['AS IN our studies, these INCONSISTENT findings POINT to the existence of COMPLICATED pathways for the function of Vitamin D in disease processes, or simply that the correct effective dose of Vitamin D supplementation NEEDS to be BETTER defined.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 47), ('DIFFICULT_TASK', 73), ('FUTURE_WORK', 217), ('INCOMPLETE_EVIDENCE', 229)]	6	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3348565	4/2012	S133-PMC3348565	['FURTHER QUESTIONS arise with respect to the previous treatment trial in the same region of kabul, which showed that a single high-dose supplementation with 100\u2008000 iu Vitamin D3Given orally to young children, along with Antibiotic treatment at the time of diagnosis, reduced repeat episodes of pneumonia in the subsequent 3 months.3the INCONSISTENT results COULD BE RELATED to the evidence that stimulation of toll-like receptors on Macrophages and Monocytes by Bacterial Antigens is IMPORTANT in up-regulation of Cyp27B1 and the Vitamin D receptor,5which are CRUCIAL in Production Of Cathelicidins in Vitamin-D-depleted Individuals.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 336), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 366), ('IMPORTANT_CONSIDERATION', 484), ('IMPORTANT_CONSIDERATION', 560)]	6	[('CHEBI_67916', '2alpha,3beta,23-trihydroxylup-20(29)-en-28-oic acid', 167, 'vitamin D3given'), ('PR_000001177', 'D(2) dopamine receptor', 175, 'D3given'), ('CHEBI_33282', 'antibacterial agent', 220, 'antibiotic'), ('CL_0000235', 'macrophage', 433, 'macrophages'), ('CL_0000576', 'monocyte', 449, 'monocytes'), ('CHEBI_22695', 'base', 462, 'bacterial'), ('CHEBI_59132', 'antigen', 472, 'antigens'), ('PR_000006101', 'cytochrome P450 1A1', 514, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0030154', 'cell differentiation', 571, 'production of cathelicidins'), ('CHEBI_83326', 'tedizolid phosphate', 602, 'vitamin-D'), ('NCBITaxon_1', 'root', 621, 'individuals')]
PMC3407995	7/2012	S18-PMC3407995	['data was reviewed and summarized to discuss the RELEVANCE of dietary Dha, Vitamin D, Folic Acid and Iodine to Foetal and infant Brain Development and function, to PRESENT EVIDENCE DEMONSTRATING dietary deficiency of these Nutrients in many populations, to highlight the POTENTIAL benefits of maternal supplementation during Pregnancy and/or Lactation on foetal and/or infant outcomes and to include SAFE Intake RECOMMENDATIONS.']	[('IMPORTANT_CONSIDERATION', 48), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 399), ('FUTURE_WORK', 411)]	6	[('CHEBI_17874', 'dihydrozeatin', 69, 'DHA'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_30751', 'formic acid', 85, 'folic acid'), ('CHEBI_24859', 'iodine atom', 100, 'iodine'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 110, 'foetal ...'), ('GO_0007420', 'brain development', 128, 'brain development'), ('UBERON_0000955', 'brain', 128, 'brain'), ('CHEBI_33284', 'nutrient', 222, 'nutrients'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('GO_0007595', 'lactation', 341, 'lactation'), ('GO_0007631', 'feeding behavior', 404, 'intake')]
PMC3427192	4/2012	S47-PMC3427192	['given the LIMITATIONS ASSOCIATED with these epidemiologic studies, randomized controlled TRIALS of Vitamin D ARE NEEDED in children to BETTER UNDERSTAND the causal RELATIONSHIP between Vitamin D status and Respiratory outcomes such as asthma Control in this population.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 89), ('FUTURE_WORK', 109), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 164)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 206, 'respiratory'), ('GO_0065007', 'biological regulation', 242, 'control')]
PMC3427250	8/2012	S117-PMC3427250	['SOME studies SUGGEST that the dietary requirement during Pregnancy and Lactation MAY BE as high as 6000 iu/d[59]and recognize that AT LEAST 1500–2000 iu/d of Vitamin D MAY BE NEEDED in order to maintain a Blood level of 25(Oh)D above 30 ng/ml[24].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 81), ('PROBABLE_UNDERSTANDING', 131), ('INCOMPLETE_EVIDENCE', 168), ('FUTURE_WORK', 175)]	6	[('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0007595', 'lactation', 71, 'lactation'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0000178', 'blood', 205, 'blood'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25(OH)D')]
PMC3427250	8/2012	S130-PMC3427250	['in addition the current Vitamin D content of multivitamins for Pregnancy, 400 iu, do not EVEN comply with the current belgian RECOMMENDATIONS of 800 iu per day, THEREFORE a PRUDENT step SHOULD AT LEAST be to increase the Vitamin D content in multivitamins for Pregnant women to 800 iu.']	[('ANOMALY_CURIOUS_FINDING', 89), ('FUTURE_WORK', 126), ('PROBABLE_UNDERSTANDING', 161), ('FUTURE_WORK', 173), ('FUTURE_WORK', 186), ('PROBABLE_UNDERSTANDING', 193)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 260, 'pregnant')]
PMC3629265	4/2013	S92-PMC3629265	['conclusion\nwe SUGGEST that the amount of Vitamin D supplementation NEEDED to prevent deficiency in infants residing in communities in the temperate region SHOULD BE REVISITED, PARTICULARLY for those at high risk for Prenatal deficiency.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 67), ('IMPORTANT_CONSIDERATION', 67), ('FUTURE_WORK', 155), ('FUTURE_WORK', 165), ('IMPORTANT_CONSIDERATION', 176)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'prenatal')]
PMC3659910	1/2013	S79-PMC3659910	['[18] this RECOMMENDATION MAY BE CONTROVERSIAL BECAUSE very high doses of Vitamin D HAVE long BEEN BELIEVED to cause Birth defects.']	[('FUTURE_WORK', 10), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 46), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007567', 'parturition', 116, 'birth')]
PMC3659910	1/2013	S124-PMC3659910	['the cochrane review CONCLUDED that there is NOT ENOUGH EVIDENCE TO EVALUATE the REQUIREMENTS and EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 80), ('SUPERFICIAL_RELATIONSHIP', 97)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnancy')]
PMC3659910	1/2013	S155-PMC3659910	['testing and treatment for Vitamin D deficiency\nwomen of Reproductive age are ASSUMED TO BE able to obtain the RECOMMENDED intake for ALMOST ALL Vitamins without the use of supplements, and no national organization RECOMMENDS routine Vitamin D supplementation during Pregnancy unless a woman is at nutritional RISK.']	[('PROBABLE_UNDERSTANDING', 77), ('FUTURE_PREDICTION', 85), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 133), ('FUTURE_WORK', 214), ('IMPORTANT_CONSIDERATION', 309)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0000003', 'reproduction', 56, 'reproductive'), ('CHEBI_33277', 'gamma-tocotrienol', 144, 'vitamins'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC3659910	1/2013	S191-PMC3659910	['FURTHER RESEARCH is REQUIRED, PARTICULARLY to establish the dose NEEDED to supplement Pregnant women with pre-existing deficiency and the OPTIMAL Gestation at which Vitamin D supplementation SHOULD BE started.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('IMPORTANT_CONSIDERATION', 30), ('IMPORTANT_CONSIDERATION', 65), ('IMPORTANT_CONSIDERATION', 138), ('IMPORTANT_CONSIDERATION', 191)]	6	[('GO_0007565', 'female pregnancy', 86, 'pregnant'), ('GO_0007565', 'female pregnancy', 146, 'gestation'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC3672018	5/2013	S47-PMC3672018	['to study the INFLUENCE of seasonal variation and timing of fetal exposure in RELATION to later EFFECTS of Vitamin D on health outcomes, one REQUIRES EVEN larger numbers of subjects to be followed over long time.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 140), ('ANOMALY_CURIOUS_FINDING', 149)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3672018	5/2013	S167-PMC3672018	['THUS, AS IT IS CLEAR that Vitamin D status of danes NEEDS to be improved, the danish health authorities currently DEBATE, WHETHER to resume Vitamin D fortification of Food [35].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 6), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('EXPLICIT_QUESTION', 122)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_33290', 'food', 167, 'food')]
PMC3695234	7/2013	S21-PMC3695234	['THUS, the available data highlights the NEED FOR FURTHER ANALYSIS of the ASSOCIATIONS between Vitamin D and atopic diseases in DIFFERENT populations.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 40), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3695234	7/2013	S76-PMC3695234	['these EFFORTS TO CLARIFY the RELATIONSHIP between Vitamin D and ad COULD lead to the IDENTIFICATION of POTENTIAL TARGETS for therapeutic intervention in ad.']	[('FUTURE_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 67), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 103), ('FUTURE_WORK', 113)]	6	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3702245	6/2013	S92-PMC3702245	['the authors also FOUND that maternal Vitamin D supplementation with 4000 iu/day decreased the risk of combined comorbidities, including infection, Preterm Birth, Gestational diabetes, and pre-eclampsia,82and SUGGESTED that ADDITIONAL STUDIES with adequate power for assessment of OTHER endpoints WERE NEEDED.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 208), ('FUTURE_WORK', 223), ('FUTURE_WORK', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 280), ('FUTURE_WORK', 296)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'preterm birth'), ('GO_0007565', 'female pregnancy', 162, 'gestational')]
PMC3705320	3/2013	S15-PMC3705320	['Serum 25-Hydroxyvitamin D concentration ([25(Oh)D]) ≥ 50 nmol/l is ASSOCIATED with Skeletal health benefits [1], BUT SOME data SUGGEST that IMPROVING Vitamin D status to attain Serum [25(Oh)D] ≥ 80 nmol/l MAY enhance a range of Vitamin D-related functions [6,7,8].']	[('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 140), ('INCOMPLETE_EVIDENCE', 205)]	6	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3717170	5/2013	S184-PMC3717170	['WHETHER Vitamin D supplementation MAY positively IMPACT the Aging process REMAINS UNKNOWN and will REQUIRE FURTHER long-term intervention STUDIES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 49), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 99), ('FUTURE_WORK', 107)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007568', 'aging', 60, 'aging')]
PMC3717170	5/2013	S185-PMC3717170	['Vitamin D dietary reference intakes\ndaniel bikle (university of california and va medical center, san francisco) addressed the RECENT institute of medicine (iom) RECOMMENDATIONS for dietary Intake of Vitamin D and EVALUATED WHETHER they were sufficient in the context of EMERGING DATA about the ROLES of Vitamin D and the prevalence of deficiency.']	[('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 162), ('QUESTION_ANSWERED_BY_THIS_WORK', 214), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 190, 'intake'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D')]
PMC3717763	8/2013	S109-PMC3717763	['reports SUGGEST that less than half the midwives and health visitors are aware of the current uk Vitamin D GUIDELINES for ages under 5 years, and RECOMMEND supplementation to parents.29–31additionally, THIS STUDY INDICATES that workload pressures and infrequent contact with mothers CAN also discourage them from promoting hs Vitamins.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 146), ('QUESTION_ANSWERED_BY_THIS_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('INCOMPLETE_EVIDENCE', 283)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D'), ('CHEBI_33277', 'gamma-tocotrienol', 326, 'vitamins')]
PMC3739737	8/2013	S145-PMC3739737	['FUTURE RESEARCH SHOULD investigate the POTENTIAL ROLE of Vitamin D-deficiency on Gaba, and POSSIBLE IMPLICATIONS on Cognition.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_16865', 'gamma-aminobutyric acid', 81, 'GABA'), ('GO_0050890', 'cognition', 116, 'cognition')]
PMC3773018	4/2013	S104-PMC3773018	['IF THESE FINDINGS are REPLICATED in OTHER independent studies, then more ATTENTION to Vitamin D nutrition SHOULD BE given to very young children in the toddler age range, and particularly to those with very low Cord Blood Vitamin D measures and specific genotypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('FUTURE_WORK', 73), ('FUTURE_WORK', 106)]	6	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0009472', 'axilla', 211, 'cord blood'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC3773018	4/2013	S105-PMC3773018	['overall, THIS STUDY UNDERSCORES THE NEED to simultaneously CONSIDER both Cord Blood and Postnatal Vitamin D levels, along with Genetic susceptibility, in the development of fs and Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 32), ('FUTURE_WORK', 36), ('FUTURE_WORK', 59), ('IMPORTANT_CONSIDERATION', 59)]	6	[('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007567', 'parturition', 88, 'postnatal'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic'), ('CHEBI_33290', 'food', 180, 'food')]
PMC3991049	11/2013	S22-PMC3991049	['Vitamin D supplementation during Pregnancy REMAINS CONTROVERSIAL and the current RECOMMENDED REQUIREMENT for Vitamin D during Pregnancy (200–400 iu/d) has LITTLE scientific SUPPORT.']	[('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 173)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC4045304	2/2014	S243-PMC4045304	['these studies INDICATE that maternal mcs, particularly diabetes, MAY BE ASSOCIATED with Neurodevelopmental PROBLEMS in children and Vitamin D supplementation early in childhood SHOULD BE given further CONSIDERATION in treatment of asd [103–105].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 177), ('FUTURE_WORK', 201)]	6	[('GO_0007399', 'nervous system development', 88, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4113768	7/2014	S599-PMC4113768	['this NOVEL FINDING SUPPORTED an A priori HYPOTHESIS that low uvb exposure and low Vitamin D status have an etiologic ROLE in Food allergy.']	[('FULL_UNKNOWN', 5), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 32), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 117)]	6	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_33290', 'food', 125, 'food')]
PMC4113768	7/2014	S1460-PMC4113768	['this study SUPPORTS a POTENTIAL ROLE for Vitamin D in cvd development, HOWEVER FURTHER RESEARCH IS REQUIRED to establish causality.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 99)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S1979-PMC4113768	['THEREFORE, we SHOULD PAY more ATTENTION to Food as a natural source of Vitamin D.\n\n2.90.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 14), ('IMPORTANT_CONSIDERATION', 14), ('IMPORTANT_CONSIDERATION', 21), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30)]	6	[('CHEBI_33290', 'food', 43, 'food'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4113768	7/2014	S2088-PMC4113768	['the ESTIMATED average Vitamin D REQUIREMENT from all dietary sources is STRONGLY EVIDENCE-BASED and SHOULD represent the target total daily amount for everyone including Supplement users.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 32), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 81), ('FUTURE_WORK', 100), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 170, 'supplement')]
PMC4113768	7/2014	S2135-PMC4113768	['the IDENTIFIED DETERMINANTS of Serum 25(Oh)D MAY CONTRIBUTE to tailor EVIDENCE-BASED RECOMMENDATIONS for optimizing Vitamin D status to specific target groups.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 70), ('FUTURE_WORK', 85)]	6	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 37, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4169453	9/2014	S20-PMC4169453	['the RECOMMENDED Vitamin D intake VARIES from 400 iu/d to 2000 iu/d[7],[12]–[16], BUT supplementation using less than 1000 iu/d MAY BE INADEQUATE for maintaining an “optimal” 25(Oh)D level[17].']	[('FUTURE_WORK', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 134), ('PROBLEM_COMPLICATION', 134)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 174, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 180, 'D')]
PMC4169453	9/2014	S223-PMC4169453	['the INFLUENCE of Vitamin D status and bone mass in nursing women MIGHT BE evaluated FURTHER BUT higher Vitamin D doses are NECESSARY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 71), ('FUTURE_WORK', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 123)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4231606	10/2013	S157-PMC4231606	['specifically, RECOMMENDING Vitamin D supplementation for children AT RISK of Dental caries MAY result in a decrease in the overall PREVALENCE of s-ecc and, ULTIMATELY, reduce THE BURDEN on pediatric day surgery centres.']	[('FUTURE_WORK', 14), ('IMPORTANT_CONSIDERATION', 66), ('FUTURE_PREDICTION', 91), ('IMPORTANT_CONSIDERATION', 131), ('FUTURE_PREDICTION', 156), ('IMPORTANT_CONSIDERATION', 175)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 77, 'dental')]
PMC4292819	1/2015	S277-PMC4292819	['HOWEVER, as fish and shellfish are IMPORTANT CONTRIBUTORS of Fatty Acids, Vitamin D, proteins, and minerals, it is ADVISABLE that women of child-Bearing age receive proper GUIDANCE to choose the right types of fish from nonpolluted waters.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('FUTURE_WORK', 115), ('IMPORTANT_CONSIDERATION', 115), ('FUTURE_WORK', 172)]	6	[('CHEBI_35366', 'fatty acid', 61, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007567', 'parturition', 145, 'bearing')]
PMC4377879	3/2015	S141-PMC4377879	['there DOES NOT APPEAR TO BE EVIDENCE to RECOMMEND supplementation with Vitamins C and E.\n\n7.']	[('INCOMPLETE_EVIDENCE', 6), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 40)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamins C'), ('PR_000004900', 'complement C3', 80, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'E')]
PMC4490503	6/2015	S308-PMC4490503	['FURTHER rcts are CRUCIAL to determining WHETHER Vitamin D has a ROLE in pathophysiology of gdm and WHETHER supplementation has a ROLE in preventing gdm [129].']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('SUPERFICIAL_RELATIONSHIP', 129)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4499946	7/2015	S42-PMC4499946	['the primary AIM is TO INVESTIGATE the EFFECT of maternal Vitamin D supplementation on infant length at 1 year of age, but the trial also provides an OPPORTUNITY to study a range of OTHER POTENTIAL Vitamin D–responsive outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('INCOMPLETE_EVIDENCE', 187)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC4598849	10/2015	S80-PMC4598849	['the FINDINGS SUGGESTED that Vitamin D supplements during Pregnancy SHOULD BE ENCOURAGED, BUT with CAUTION.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 13), ('FUTURE_WORK', 67), ('FUTURE_WORK', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
PMC4600246	10/2015	S36-PMC4600246	['DESPITE the fact that Vitamin K1Has a beneficial EFFECT on cac in older men and women, LARGER STUDIES powered for clinical end points (stroke, Myocardial infarction and death) ARE NEEDED TO ASSESS the risks and benefits of Vitamin K therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('FUTURE_WORK', 87), ('FUTURE_WORK', 176), ('FUTURE_WORK', 187)]	6	[('CHEBI_26871', 'terpene alkaloid', 22, 'vitamin K1has'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 30, 'K1has'), ('UBERON_0002349', 'myocardium', 143, 'myocardial'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin K')]
PMC4627942	10/2015	S221-PMC4627942	["caption (table-wrap): table 5\n\ntackling malnutrition – prevention EFFORTS: findings from indepth studieshdss siteyearauthorsmain findingsbandim hdss, guinea-bissau2004nielsen et al.during civil war, Vitamin A supplementation for children helped reduce mortality.bandim hdss, guinea-bissau2005nielsen et al.during civil war, supplementary Feeding programme helped reduce mortality in children.filabavi hdss, vietnam2009nga et al.fortification with multiple Micronutrients of biscuits provided in schools reduced risk of anaemia and of iron and zinc deficiencies by 40%.nouna hdss, burkina faso2003müller et al.no significant impact of Zinc supplementation for children on height-for-age, weight-for-age, and weight-for-height scores.kintampo hdss, ghana2007newton et al.no positive EFFECT of Vitamin A supplements in combination with vaccines during the first few months of Life.farafenni hdss, gambia2013van der merwe et al.fish oil supplementation had no effect on growth, Intestinal integrity, morbidity, or cognitive development.kilifi hdss, kenya2010akech et al.use of low-dose hypotonic Fluid resuscitation for children who develop shock AS a result of SEVERE malnutrition has poor outcomes in terms of persistent shock, oliguria, and high case fatality.agincourt hdss, south africa2003deen et al.introduction of who guidelines in two hospitals strengthened the management of malnutrition.kintampo hdss, ghana2006tchum et al.vitamin a supplementation increased Liver reserves of mothers during the Postpartum period, with EFFECTS persisting for at least five months.niakhar hdss, senegal2006ly et al.provision of high energy, Nutrient-dense Food supplements to infants aged between four and seven months contributed to decreased Postpartum weight loss in their mothers.west kiang hdss, gambia2011hawkesworth et al.Nutrient supplementation during Pregnancy had little effect on infants’ risk of cardiovascular disease.west kiang hdss, gambia2009hawkesworth et al.protein-energy supplementation of mothers during Pregnancy had no effect on the Blood pressure of their children in adolescence.west kiang hdss, gambia2009prentice et al.Calcium supplementation for Pregnant mothers had no effect on foetal and infant growth.west kiang hdss, gambia2010jarjou et al.women given Calcium Supplements while Pregnant had lower bone Mineral content, bone area and bone Mineral density at the Hip during the 12-month Lactation period than other women.dikgale hdss, south africa2002nthangeni et al.the majority of People with type 2 diabetes had poor Glycaemic Control and were obese or had high blood pressure and were given poor advice by health educators.africa centre hdss, south africa2002o'donnell et al.agencies working to tackle a flood disaster in bangladesh in 1998 achieved MIXED results in terms of meeting international disaster response standards."]	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 781), ('PROBABLE_UNDERSTANDING', 1143), ('IMPORTANT_CONSIDERATION', 1158), ('SUPERFICIAL_RELATIONSHIP', 1527), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2776)]	6	[('CHEBI_27300', 'vitamin D', 199, 'vitamin A'), ('GO_0007631', 'feeding behavior', 338, 'feeding'), ('CHEBI_33839', 'macromolecule', 456, 'micronutrients'), ('CHEBI_33340', 'zinc group element atom', 634, 'zinc'), ('CHEBI_27300', 'vitamin D', 791, 'vitamin A'), ('UBERON_0000104', 'life cycle', 873, 'life'), ('UBERON_0000160', 'intestine', 974, 'intestinal'), ('UBERON_0006314', 'bodily fluid', 1092, 'fluid'), ('UBERON_0002107', 'liver', 1466, 'liver'), ('GO_0007565', 'female pregnancy', 1503, 'postpartum'), ('CHEBI_33284', 'nutrient', 1631, 'nutrient'), ('CHEBI_33290', 'food', 1646, 'food'), ('GO_0007565', 'female pregnancy', 1734, 'postpartum'), ('CHEBI_33284', 'nutrient', 1819, 'Nutrient'), ('GO_0007565', 'female pregnancy', 1851, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2016, 'pregnancy'), ('UBERON_0000178', 'blood', 2047, 'blood'), ('CHEBI_31341', 'calcium dihydroxide', 2137, 'Calcium'), ('GO_0007565', 'female pregnancy', 2165, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 2276, 'calcium'), ('CHEBI_33341', 'titanium atom', 2284, 'supplements'), ('GO_0007565', 'female pregnancy', 2302, 'pregnant'), ('CHEBI_46662', 'mineral', 2326, 'mineral'), ('CHEBI_46662', 'mineral', 2362, 'mineral'), ('UBERON_0001464', 'hip', 2385, 'hip'), ('GO_0007595', 'lactation', 2409, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 2505, 'people'), ('GO_0051162', 'L-arabitol metabolic process', 2542, 'glycaemic control')]
PMC4632418	10/2015	S115-PMC4632418	['in words, there is a CONNECTION between Glucose Metabolism and Vitamin D pathways, EVEN IF FURTHER STUDIES based on larger population ARE NEEDED to get more evidence about the topic.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('FUTURE_WORK', 91), ('FUTURE_WORK', 99), ('FUTURE_WORK', 134)]	6	[('CHEBI_17234', 'glucose', 40, 'glucose'), ('GO_0006006', 'glucose metabolic process', 40, 'glucose metabolism'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4684854	12/2015	S137-PMC4684854	["as discussed, individual Vitamin D indices CAN be INFLUENCED by various DETERMINANTS DESPITE specific levels of supplementation; it is THUS the author's RECOMMENDATION that a personalized medical approach be taken via individual screening for 25(Oh)D as a routine part of Preconception and Prenatal care."]	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 85), ('PROBABLE_UNDERSTANDING', 135), ('FUTURE_WORK', 153)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('GO_0007565', 'female pregnancy', 272, 'preconception'), ('GO_0007565', 'female pregnancy', 290, 'prenatal')]
PMC4689556	12/2015	S167-PMC4689556	['given that SOME observational studies SUGGEST adverse child Respiratory health outcomes are ASSOCIATED with very high maternal Vitamin D level during Pregnancy, empiric data ARE NEEDED before high dose Prenatal Vitamin D supplementation CAN be routinely RECOMMENDED [44].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 92), ('FUTURE_WORK', 174), ('INCOMPLETE_EVIDENCE', 237), ('FUTURE_WORK', 254)]	6	[('UBERON_0001004', 'respiratory system', 60, 'respiratory'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'prenatal'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4691762	12/2015	S120-PMC4691762	['the vitality trial will also enable a FUTURE evaluation of WHETHER Postnatal Vitamin D supplementation is ASSOCIATED with IMPROVED bone health in later childhood—the historical basis of widespread Postnatal Vitamin D supplementation, which REMAINS essentially UNTESTED.']	[('FUTURE_WORK', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 260)]	6	[('GO_0007567', 'parturition', 67, 'postnatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'postnatal'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC4764019	1/2016	S36-PMC4764019	['pregnancy complications\none of the most STRIKING and SURPRISING findings to emerge from the finnish Birth cohort study DESCRIBED PREVIOUSLY was the fact that 20+ years after their infancy exposure to Vitamin D, women in the cohort who, as Adults, became Pregnant exhibited an APPROXIMATE 50% reduction in risk of Preeclampsia in their own first Pregnancies,8once again, relative to women who had not received the then RECOMMENDED 2000 iu/d of Vitamin D in infancy.']	[('ANOMALY_CURIOUS_FINDING', 40), ('ANOMALY_CURIOUS_FINDING', 53), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 418)]	6	[('GO_0007567', 'parturition', 100, 'birth'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0007023', 'adult organism', 239, 'adults'), ('GO_0007565', 'female pregnancy', 254, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 313, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 345, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D')]
PMC4770602	1/2016	S66-PMC4770602	['[20] also, ROLE of Vitamin D in the PREVENTION of Preeclampsia is SUPPORTED by two clinical TRIALS, HOWEVER, in one of these STUDIES as an uncontrolled trial, supplementation with a multivitamin/Mineral supplement and halibut Liver oil provided at 20 week Gestation reduced the odds of Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 66), ('FUTURE_WORK', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 125)]	6	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 50, 'preeclampsia'), ('CHEBI_46662', 'mineral', 195, 'mineral'), ('UBERON_0002107', 'liver', 226, 'liver'), ('GO_0007565', 'female pregnancy', 256, 'gestation'), ('GO_0007128', 'meiotic prophase I', 286, 'preeclampsia')]
PMC4770602	1/2016	S78-PMC4770602	['THEREFORE, ADDITIONAL well-designed, prospective, randomized TRIALS of supplementation with good sample size that control for dietary exposure will BE NECESSARY to determine a POTENTIAL ROLE for Vitamin D in the PREVENTION of Preeclampsia.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 186), ('SUPERFICIAL_RELATIONSHIP', 212)]	6	[('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 226, 'preeclampsia')]
PMC4800340	5/2016	S56-PMC4800340	['THIS STUDY SHOWED that Prenatal Vitamin D-mediated epigenetic Regulation in Tslp increased the RISK of wheezing in children.77more Human STUDIES ARE NEEDED to substantiate the ROLE of epigenetic Regulation by Nutrients in the growing epidemic of Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0007565', 'female pregnancy', 23, 'prenatal'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'regulation'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 76, 'TSLP'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('GO_0065007', 'biological regulation', 195, 'regulation'), ('CHEBI_33284', 'nutrient', 209, 'nutrients'), ('CHEBI_33290', 'food', 246, 'food')]
PMC4889866	5/2016	S15-PMC4889866	['GIVEN the IMPORTANT Immune Modulatory ROLE of Vitamin D, the LINK between toll-like receptors- (tlrs-) mediated Innate Immunity and Vitamin D DESERVES in-depth INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 61), ('IMPORTANT_CONSIDERATION', 142), ('FUTURE_WORK', 160)]	6	[('GO_0051452', 'intracellular pH reduction', 20, 'immune modulatory'), ('UBERON_0002405', 'immune system', 20, 'immune'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0045087', 'innate immune response', 112, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4896250	4/2016	S4160-PMC4896250	['FURTHER ELUCIDATION of the ROLE of Vitamin D in hdm sensitization MAY hold PROFOUND IMPLICATIONS for the prevention and treatment of ad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 66), ('IMPORTANT_CONSIDERATION', 75), ('IMPORTANT_CONSIDERATION', 84)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4930210	7/2016	S28-PMC4930210	['our AIMS in the CURRENT STUDY were TO DETERMINE: a) if Pregnant women were Consuming the RECOMMENDED Vitamin D through diet alone or through diet and supplements, and b) IF Pregnant women can achieve the current reference range Vitamin D status when their reported dietary intake of Vitamin D met the current RECOMMENDATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('FUTURE_WORK', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('FUTURE_WORK', 309)]	6	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('GO_0007631', 'feeding behavior', 75, 'consuming'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnant'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC4930210	7/2016	S168-PMC4930210	['WHILE the current canadian cancer society RECOMMENDATIONS [38] are to avoid sun exposure or failing that, use of sunscreen at all times when out in the sun, our participants undoubtedly were getting sunlight exposure AS SEEN by a seasonal variation in 25(Oh)D.\nin CONCLUSION, we FOUND a 20% rate of Vitamin D insufficiency (<75 nmol/l) in a large, well-nourished cohort of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 42), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 220), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 279)]	6	[('CHEBI_71657', 'versiconol acetate', 252, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 252, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('GO_0007565', 'female pregnancy', 373, 'pregnant')]
PMC4930210	7/2016	S172-PMC4930210	['THESE FINDINGS, together with EXISTING DATA, HIGHLIGHT THE NEED for re-evaluation of our current Vitamin D RECOMMENDATIONS for Pregnant women residing in countries with higher latitude.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 55), ('FUTURE_WORK', 59), ('FUTURE_WORK', 107)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnant')]
PMC4934634	11/2015	S10-PMC4934634	['over the past two decades, it HAS BEEN WELL ACCEPTED that Vitamin D is a pro-hormone, and suboptimal Vitamin D status HAS been increasingly LINKED to a broad range of diseases including, cancer, diabetes, Cardiovascular disease, and Autoimmune disorders.']	[('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 140)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 205, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 233, 'autoimmune')]
PMC4934634	11/2015	S81-PMC4934634	['this FINDING COULD IMPACT doctor’s RECOMMENDATION of what are CONSIDERED OPTIMAL Vitamin D levels when women of different ethnic groups undergo ivf.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 19), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4934634	11/2015	S97-PMC4934634	['IN CONTRAST TO iom RECOMMENDATIONS, the endocrine society RECOMMENDS a Vitamin D intake of AT LEAST 600 iu/day, BUT states that 1500–2000 iu/day MAY BE needed for Pregnant or Lactating females to maintain a 25(Oh)D level ≥ 30 ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 58), ('PROBABLE_UNDERSTANDING', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnant'), ('GO_0007594', 'puparial adhesion', 175, 'lactating'), ('CHEBI_71657', 'versiconol acetate', 207, '25(OH)D')]
PMC4944244	7/2016	S225-PMC4944244	['finally, AWARENESS of high PREVALENCE and DANGERS of hypovitaminosis d during Pregnancy NEEDS TO be highlighted to health care workers so that they are better informed of FACTORS INFLUENCING Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 9), ('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 42), ('FUTURE_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 171), ('SUPERFICIAL_RELATIONSHIP', 179)]	6	[('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4949006	7/2016	S148-PMC4949006	['SOME STUDIES REPORT higher long-bone density in fetuses of women with adequate amounts of Vitamin D,115,116but the numbers are SMALL.117the general RECOMMENDATION is 1000 to 2000 mg/d of supplementation, BUT there are no AGREED-UPON levels for sufficiency or insufficiency in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204), ('INCOMPLETE_EVIDENCE', 221)]	6	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy')]
PMC4973215	8/2016	S92-PMC4973215	['this corresponds to the WELL-KNOWN ASSOCIATION that women with higher bmi TEND to Deliver infants with higher Birth weights.40,41,42\nfurthermore, identification and recognition of women and infants at high risk of Vitamin D deficiency and sga CAN LEAD TO OPPORTUNITIES for risk modification and reduction in adverse outcomes.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 247), ('FUTURE_WORK', 255)]	6	[('GO_0007567', 'parturition', 82, 'deliver'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4990268	8/2016	S295-PMC4990268	['as with all supplementation STRATEGIES to prevent the COMPLICATIONS ASSOCIATED with Micronutrient deficiencies, the IMPACT of supplementation in the Antenatal Period will DEPEND ON the overall Vitamin A status of the population and the special demands that Pregnancy makes on Vitamin A reserves.']	[('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 84, 'micronutrient'), ('GO_0007567', 'parturition', 149, 'antenatal'), ('UBERON_0006721', 'alisphenoid bone', 149, 'antenatal period'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin A'), ('GO_0007565', 'female pregnancy', 257, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A')]
PMC4997421	8/2016	S93-PMC4997421	['FOUND a significantly increased RISK of spontaneous Preterm Delivery, maternal anemia, and Pregnancy-induced hypertension when Retinol levels were below 0.70 µmol/l, and BASED ON those functional EFFECTS RECOMMEND a level of 0.70 µmol/l to define Vitamin A deficiency in Pregnancy [3].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 170), ('QUESTION_ANSWERED_BY_THIS_WORK', 170), ('SUPERFICIAL_RELATIONSHIP', 196), ('FUTURE_WORK', 204)]	6	[('GO_0007565', 'female pregnancy', 52, 'preterm'), ('GO_0007567', 'parturition', 60, 'delivery'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 127, 'retinol'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin A'), ('GO_0007565', 'female pregnancy', 271, 'pregnancy')]
PMC4997421	8/2016	S139-PMC4997421	['MORE RESEARCH IS NEEDED to determine WHAT type of INTERVENTIONS will be best for specific populations, ESPECIALLY the low-income and minority populations that bear a greater BURDEN of Vitamin A inadequacy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('EXPLICIT_QUESTION', 37), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 103), ('IMPORTANT_CONSIDERATION', 174)]	6	[('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 192, 'A')]
PMC4998950	4/2016	S46-PMC4998950	['AS Vitamin D deficiency in Pregnancy is both PREVALENT and treatable, FURTHER INVESTIGATION of this ASSOCIATION IS NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 45), ('FUTURE_WORK', 70), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 100), ('FUTURE_WORK', 112)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'pregnancy')]
PMC5014971	8/2016	S102-PMC5014971	['in SUPPORT of the endocrine society RECOMMENDATIONS, SOME researchers POINT to the LIKELY higher circulating levels of 25-Oh-D in our ancestors that relied PRIMARILY on Photosynthetic Production Of Vitamin D, arguing that our Vitamin D Metabolism is adapted to high endogenous production [17,18].']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 36), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 83), ('PROBABLE_UNDERSTANDING', 156)]	6	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 119, '25-OH-D'), ('GO_0010264', 'myo-inositol hexakisphosphate biosynthetic process', 169, 'photosynthetic'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 184, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007601', 'visual perception', 226, 'vitamin D'), ('GO_0008152', 'metabolic process', 236, 'metabolism')]
PMC5024513	9/2016	S127-PMC5024513	['the summary results SHOW that there MAY BE areas of CONCERN in adolescent’s nutritional intake during Pregnancy, PARTICULARLY COMPARED to us RECOMMENDATIONS, with regard to calcium, Vitamin D, Vitamin E, Folate, potassium and magnesium.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 52), ('IMPORTANT_CONSIDERATION', 113), ('ANOMALY_CURIOUS_FINDING', 126), ('FUTURE_WORK', 141)]	6	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 204, 'folate')]
PMC5028238	10/2016	S94-PMC5028238	['one POSSIBLE biological EXPLANATION that fits with the literature-derived mechanism (figure 3) is that slos patients spent less time outdoors thereby reducing their Ultraviolet b exposure (another CRITICAL REQUIREMENT for Vitamin D Synthesis).55\n\nGenetic understanding of slos-inducing Dhcr7 mutations: IMPLICATIONS for FUTURE WORK\n\nchanging our understanding of slos genetics using large-scale Genomics studies\nusing exac,24we were able to compare the frequencies of Dhcr7 slos-inducing mutations in the slos population (extracted from the literature) and the assumed-healthy exac population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 197), ('IMPORTANT_CONSIDERATION', 206), ('IMPORTANT_CONSIDERATION', 303), ('FUTURE_WORK', 320)]	6	[('CHEBI_75275', 'tetradecyl sulfonic acid', 165, 'ultraviolet'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 230, 'D synthesis'), ('SO_0000704', 'gene', 247, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 286, 'DHCR7'), ('SO_0001026', 'genome', 395, 'genomics'), ('PR_000006474', 'ATP-dependent RNA helicase A', 468, 'DHCR7')]
PMC5045784	10/2016	S93-PMC5045784	['given the LIMITATIONS of a MODEST sample size of our study, we PROPOSE that our data combined with others for a meta-analysis MAY BE WARRANTED before CONSIDERATION of interventional trials of Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 126), ('FUTURE_WORK', 133), ('FUTURE_WORK', 150)]	6	[('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC5062906	10/2016	S16-PMC5062906	['WHILE the biological IMPORTANCE of these subtle changes REMAINS UNCLEAR, they WARRANT AN INVESTIGATION of epigenome-wide EFFECTS of maternal Vitamin D depletion.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 21), ('FULL_UNKNOWN', 56), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 121)]	6	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5062906	10/2016	S250-PMC5062906	['ALTHOUGH Vitamin D deficiency HAS BEEN LINKED to adverse Pregnancy/Birth outcomes [14,46–52], there is currently NO STANDARD practice of screening women for Vitamin D deficiency during Pregnancy nor are there standard RECOMMENDATIONS beyond Prenatal Vitamins for supplementation during this CRITICAL time [53,54].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 218), ('IMPORTANT_CONSIDERATION', 291)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 57, 'pregnancy ...'), ('GO_0007567', 'parturition', 67, 'birth'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 250, 'vitamins')]
PMC5064894	10/2016	S11-PMC5064894	['discussion\nIF SHOWN to reduce the RISK of viral ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia may be a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-ASSOCIATED morbidity and mortality in young infants.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 34), ('PROBABLE_UNDERSTANDING', 186), ('FUTURE_WORK', 214), ('IMPORTANT_CONSIDERATION', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('GO_0007565', 'female pregnancy', 88, 'prenatal'), ('GO_0007565', 'female pregnancy', 97, 'postpartum'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 139, 'antenatal care')]
PMC5084016	10/2016	S132-PMC5084016	['DESPITE the LACK OF CONSENSUS on adequate intakes among DIFFERENT countries (table 3), supplementation with Vitamin D is RECOMMENDED for all Pregnant women at a dose of 600 iu/day (15 µg/day) [57].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC5084041	10/2016	S31-PMC5084041	['population-representative data on Vitamin D status during Pregnancy IS NEEDED to evaluate the POTENTIAL NEED for new PUBLIC-HEALTH policies and to provide reliable data on potential RISK groups for Vitamin D deficiency.']	[('FUTURE_WORK', 68), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 104), ('IMPORTANT_CONSIDERATION', 117), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 182)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5084041	10/2016	S157-PMC5084041	['these results SUGGEST that TARGETED PUBLIC HEALTH INTERVENTION to treat and prevent Vitamin D deficiency in these RISK groups IS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 27), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 114), ('FUTURE_WORK', 126)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC5146866	12/2016	S80-PMC5146866	['WHILE a Vitamin D level of 20\xa0ng/ml IS CONSIDERED sufficient, maintenance of 30\xa0ng/ml is RECOMMENDED for better health in children and Adults [24] DESPITE the LACK OF CLEAR EVIDENCE of an OPTIMAL concentration of Vitamin D for bone and general health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adults'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC5146866	12/2016	S108-PMC5146866	['moreover, DUE TO the high LIKELIHOOD of Vitamin D insufficiency/deficiency at Birth, FURTHER STUDIES MAY be REQUIRED to determine the ROLE of implementing Vitamin D supplementation with respect to the cb Vitamin D status.']	[('PROBLEM_COMPLICATION', 10), ('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5155676	12/2016	S17-PMC5155676	['NONETHELESS, the institute of medicine (iom) has SUGGESTED that risk of Vitamin D insufficiency, DEFINED as a 25(Oh)D less than 50 nmol/l, SHOULD BE avoided during Pregnancy (5), and this is SUPPORTED by the RECENT global consensus on the prevention of rickets (6).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 97), ('FUTURE_WORK', 139), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 208)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC5155676	12/2016	S136-PMC5155676	['FUTURE STUDIES SHOULD AIM to determine appropriate doses to enable consistent repletion of 25(Oh)D during Pregnancy, and OUR FINDINGS SUPPORT the NOTION that clinical approaches to Vitamin D repletion MAY BE informed by individual characteristics.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 121), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 201)]	6	[('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 93, '(OH ... D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC5359891	3/2017	S92-PMC5359891	['the intervention\nthe nutritional intervention Preconception and during Pregnancy to maintain healthy Glucose Metabolism and offspring health (nipper) intervention comprises: (1) a Micronutrient-enriched nutritional drink containing myo-inositol, Vitamin D, riboflavin, Vitamin B6, Vitamin B12And zinc together with standard Folic Acid, Iodine, calcium, β-Carotene and iron; the quantities PROPOSED are either standard amounts (Myo-Inositol [54]), enhanced amounts that are available in over-the-counter products (Vitamins b6, b12, riboflavin), RECOMMENDED daily allowance amounts in uk for Pregnant women (Vitamin D, zinc, Folic Acid, Iodine) or minimal amounts for Micronutrients LINKED with POTENTIAL DETRIMENTAL EFFECTS at higher doses (Iron, Β-Carotene, Calcium) and (2) Probiotics (containing lactobacillus rhamnosus ncc 4007 (cgmcc 1.3724) also known as lpr and bifidobacterium animalis Sp.']	[('INCOMPLETE_EVIDENCE', 389), ('FUTURE_WORK', 544), ('SUPERFICIAL_RELATIONSHIP', 681), ('INCOMPLETE_EVIDENCE', 693), ('IMPORTANT_CONSIDERATION', 703), ('SUPERFICIAL_RELATIONSHIP', 715)]	6	[('GO_0007565', 'female pregnancy', 46, 'Preconception'), ('GO_0007565', 'female pregnancy', 71, 'Pregnancy'), ('CHEBI_17234', 'glucose', 101, 'Glucose'), ('GO_0006006', 'glucose metabolic process', 101, 'Glucose Metabolism'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 180, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 269, 'vitamin B6'), ('CHEBI_10124', 'zolmitriptan', 281, 'vitamin B12and'), ('CHEBI_30751', 'formic acid', 324, 'folic acid'), ('CHEBI_24859', 'iodine atom', 336, 'iodine'), ('CHEBI_23042', 'carotene', 355, 'carotene'), ('CHEBI_25435', 'mutagen', 427, 'myo-inositol'), ('CHEBI_33277', 'gamma-tocotrienol', 513, 'vitamins'), ('GO_0007565', 'female pregnancy', 590, 'pregnant'), ('CHEBI_27300', 'vitamin D', 606, 'vitamin D'), ('CHEBI_30751', 'formic acid', 623, 'folic acid'), ('CHEBI_24859', 'iodine atom', 635, 'iodine'), ('CHEBI_33839', 'macromolecule', 666, 'micronutrients'), ('CHEBI_24870', 'ion', 740, 'iron'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 746, 'β-carotene'), ('CHEBI_22313', 'alkaline earth metal atom', 758, 'calcium'), ('CHEBI_26346', 'prostaglandins J', 775, 'probiotics'), ('NCBITaxon_10088', 'Mus <genus>', 893, 'sp')]
PMC5405075	4/2017	S98-PMC5405075	['moreover, any intervention SHOULD BE individualized to initial maternal Vitamin D status and be followed up, SINCE a u -curve ASSOCIATION between Vitamin D circulating levels and IMPACT on allergy and Human health HAS BEEN also PROPOSED (83,84).']	[('FUTURE_WORK', 27), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 126), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 228)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 201, 'human')]
PMC5418719	5/2017	S16-PMC5418719	['WHILE Breast Milk Feeding is currently RECOMMENDED as a source of early nutrition in full and preterm infants, an infant diet with Breast Milk alone does not contain enough Vitamin D. the definition of Vitamin D sufficiency in preterm infants is STILL CONTROVERSIAL; optimal Vitamin D status is BASED ON the Vitamin D concentrations for multiple health outcomes in Adults with a target value for 25(Oh)D levels >30\xa0ng/ml [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 39), ('IMPORTANT_CONSIDERATION', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('QUESTION_ANSWERED_BY_THIS_WORK', 295), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('UBERON_0001348', 'brown adipose tissue', 6, 'breast milk'), ('GO_0007614', 'short-term memory', 13, 'milk'), ('GO_0007631', 'feeding behavior', 18, 'feeding'), ('UBERON_0001348', 'brown adipose tissue', 131, 'breast milk'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('UBERON_0007023', 'adult organism', 365, 'adults'), ('CHEBI_71657', 'versiconol acetate', 396, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 396, '25(OH ... D')]
PMC5418719	5/2017	S101-PMC5418719	['preterm infants with radiologic evidence of rickets or high alkaline phosphatase (>800\xa0iu/l) are GENERALLY given the upper intake total of 800\xa0iu/day of Vitamin D. DESPITE Vitamin D supplementation, it is DIFFICULT to maintain the RECOMMENDED daily Vitamin D intake from dietary in preterm infants, and there are FEW EVIDENCE-based data to support Vitamin D supplementation to meet a desired Serum 25(Oh)D ACCORDING to Vitamin D status at Birth in preterm infants.']	[('PROBABLE_UNDERSTANDING', 97), ('ANOMALY_CURIOUS_FINDING', 164), ('DIFFICULT_TASK', 205), ('FUTURE_WORK', 231), ('INCOMPLETE_EVIDENCE', 313), ('SUPERFICIAL_RELATIONSHIP', 406)]	6	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('UBERON_0001977', 'blood serum', 392, 'serum'), ('CHEBI_71657', 'versiconol acetate', 398, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 401, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('GO_0007567', 'parturition', 439, 'birth')]
PMC5426325	4/2017	S27-PMC5426325	['we DID NOT identify OTHER abrupt societal changes during 1983–1988 that POTENTIALLY COULD INFLUENCE our results, neither in relation to fortification practices in other Food products for Consumption(31,32), nor in relation to Margarine intake in the danish population(33)or in relation to national RECOMMENDATIONS for Vitamin D supplementation to Pregnant women or infants.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('FUTURE_WORK', 298)]	6	[('CHEBI_33290', 'food', 169, 'food'), ('GO_0007631', 'feeding behavior', 187, 'consumption'), ('CHEBI_6784', 'mestranol', 226, 'margarine'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0007565', 'female pregnancy', 347, 'pregnant')]
PMC5426325	4/2017	S122-PMC5426325	['by comparing Individuals from entire adjacent Birth cohorts that were, or were not, exposed to extra Vitamin D from Margarine fortification Prenatally only, but all unexposed thereafter, we ASSUME that all POTENTIAL CONFOUNDERS are equally distributed in both groups, and HENCE that control for CONFOUNDING is not NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('INCOMPLETE_EVIDENCE', 206), ('PROBLEM_COMPLICATION', 216), ('PROBABLE_UNDERSTANDING', 272), ('PROBLEM_COMPLICATION', 295), ('FUTURE_WORK', 314)]	6	[('NCBITaxon_1', 'root', 13, 'individuals'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_6784', 'mestranol', 116, 'margarine'), ('GO_0019230', 'proprioception', 140, 'prenatally')]
PMC5513133	7/2017	S210-PMC5513133	['smoking MAY BE an IMPORTANT CONFOUNDER and SHOULD BE CONSIDERED in studies LINKING Vitamin D to pe.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 18), ('PROBLEM_COMPLICATION', 28), ('FUTURE_WORK', 43), ('FUTURE_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5513133	7/2017	S269-PMC5513133	['FUTURE STUDIES SHOULD include follow up from the pre-Conception period until Delivery to ELUCIDATE the mechanisms and INTERACTIONS which DRIVE Vitamin D status, response, and onset of pe to inform population-specific dose RECOMMENDATIONS.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('FUTURE_WORK', 89), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 137), ('FUTURE_WORK', 222)]	6	[('GO_0007620', 'copulation', 53, 'conception'), ('GO_0007567', 'parturition', 77, 'delivery'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC5524288	7/2017	S120-PMC5524288	['this INDICATES that IMPROVING the Vitamin D status of non-white women, who are known to have PARTICULARLY low Vitamin D concentrations, COULD DRAMATICALLY decrease racial DISPARITIES in ptb rates.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 20), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_PREDICTION', 136), ('ANOMALY_CURIOUS_FINDING', 142), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5537904	7/2017	S180-PMC5537904	['we used season of Birth as a crude measurement of sun exposure because we DID NOT have direct measures of uvb-synthesized Vitamin D, and THUS our results for the relative CONTRIBUTION of Oral Intake versus sun exposure SHOULD BE INTERPRETED with CAUTION.']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 171), ('FUTURE_WORK', 219), ('FULL_UNKNOWN', 229), ('INCOMPLETE_EVIDENCE', 246)]	6	[('GO_0007567', 'parturition', 18, 'birth'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('UBERON_0000165', 'mouth', 187, 'oral'), ('GO_0007631', 'feeding behavior', 192, 'intake')]
PMC5546866	8/2017	S145-PMC5546866	['AS SUCH, CONFIRMATION of THESE FINDINGS in severely Vitamin D–deficient women IS NEEDED AS IT IS POSSIBLE that women with specific genotypes were selectively excluded by this inclusion criterion.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 78), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 91)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5634437	10/2017	S228-PMC5634437	['THEREFORE, the harmful EFFECTS we OBSERVED for Haloperidol COULD BE due to the elevated 7-Dehydrocholesterol levels and not a reduction in Vitamin D. further mechanism-based STUDIES ARE REQUIRED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 174), ('FUTURE_WORK', 182)]	6	[('CHEBI_5613', 'haloperidol', 47, 'haloperidol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 88, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5634602	10/2017	S148-PMC5634602	['OTHER authors have RECOMMENDED loading doses to more quickly improve Vitamin D status in AT RISK populations, a STRATEGY that MERITS FURTHER INVESTIGATION [57].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 19), ('IMPORTANT_CONSIDERATION', 89), ('FUTURE_WORK', 112), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 133)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5638722	8/2017	S105-PMC5638722	['BUT we PROPOSE that, MORE prospective STUDIES regarding to the RELATIONSHIP of Vitamin D and sepsis in premature infants ARE NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 21), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 63), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5638722	8/2017	S114-PMC5638722	['DUE TO the absence of Serum Vitamin D levels of the mothers who have premature Deliveries, the results obtained give ONLY INDIRECT DATA about maternal morbidities and Vitamin D. epidemiologic STUDIES ARE NEEDED for investigating the POSSIBLE maternal EFFECTS of low Vitamin D levels during Pregnancy.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 122), ('FUTURE_WORK', 192), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'deliveries'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC5664622	9/2017	S94-PMC5664622	['REGARDLESS, DESPITE Vitamin/Mineral supplementation in Pregnancy, maternal intake of Vitamin D REMAINS below the RECOMMENDED levels, MOSTLY BECAUSE 75% of the multi-component Supplements for Pregnant women which are available in poland contain small amount of Vitamin D (5–10 µg) [14], as compared to the recommended dose of 37.5–50 µg [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 95), ('FUTURE_WORK', 113), ('PROBABLE_UNDERSTANDING', 133), ('PROBABLE_UNDERSTANDING', 140)]	6	[('CHEBI_33229', 'vitamin (role)', 20, 'vitamin'), ('CHEBI_46662', 'mineral', 28, 'mineral'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 175, 'supplements'), ('GO_0007565', 'female pregnancy', 191, 'pregnant'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D')]
PMC5732505	12/2017	S178-PMC5732505	['HOWEVER, randomised controlled TRIALS ARE REQUIRED in specific RISK groups of Vitamin D deficiency TO CLARIFY if Vitamin D supplementation AFFECTS the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 139), ('IMPORTANT_CONSIDERATION', 151)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5941617	5/2018	S103-PMC5941617	['in 2016 the united kingdom scientific advisory committee on nutrition (sacn) reviewed THE EVIDENCE on Vitamin D and health and RECOMMENDED that Serum 25(Oh)D levels of all children and adolescents in the united kingdom SHOULD NOT fall below 10\xa0ng/ml (a so-CALLED “population PROTECTIVE level”) at any time of the year to protect Musculoskeletal health.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 90), ('FUTURE_WORK', 127), ('FUTURE_WORK', 219), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 275)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('UBERON_0002204', 'musculoskeletal system', 329, 'musculoskeletal')]
PMC5941617	5/2018	S232-PMC5941617	['the administration of a single large dose of Vitamin D\u2009>\u2009300000\xa0iu is not RECOMMENDED, BECAUSE MAY cause high risk of Vitamin D intoxication with hypercalciuria and hypercalcemia, AS CONFIRMED by RECENT STUDIES [191–195].']	[('FUTURE_WORK', 74), ('PROBLEM_COMPLICATION', 87), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 180), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 196)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5941617	5/2018	S394-PMC5941617	['a RECENT large STUDY FOUND NO EVIDENCE that Genetically determined reduction in 25(Oh)D levels conferred an increased risk for ad, SUGGESTING that EFFORTS to increase Vitamin D are UNLIKELY to reduce risks of the atopic disease [349].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 131), ('FUTURE_WORK', 147), ('PROBABLE_UNDERSTANDING', 181)]	6	[('SO_0000704', 'gene', 44, 'genetically'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC5941617	5/2018	S472-PMC5941617	['AS Vitamin D is an IMPORTANT KEY DETERMINANT of bone mass acquisition, SOME authors RECOMMENDED Vitamin D supplementation during winter and spring in all cd children and adolescents to optimize bone recovery [432].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 71), ('FUTURE_WORK', 84)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC5941617	5/2018	S613-PMC5941617	['MORE STUDIES, particularly rcts, ARE NEEDED to confirm the PROMISING ROLE of Vitamin D in the promotion of the GLOBAL health of children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 111)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]
PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]
PMC6011374	6/2018	S10-PMC6011374	['a POSSIBLE ASSOCIATION between fetal sex, Vitamin D status and gdm provides FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 76), ('EXPLICIT_QUESTION', 84), ('FUTURE_WORK', 98), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC6011374	6/2018	S122-PMC6011374	['a POSSIBLE CONNECTION between fetal sex, Vitamin D status and Pregnancy complications REVEALS FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 86), ('FUTURE_WORK', 94), ('FUTURE_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 170)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC2290997	4/2008	S130-PMC2290997	['“many elderly, ESPECIALLY those living in nursing homes, are Vitamin D deficient, [EVEN] those living in areas CONSIDERED to have adequate sunshine.”\nmany EXPERTS are now RECOMMENDING a middle-ground approach that focuses on modest sun exposures.']	[('IMPORTANT_CONSIDERATION', 15), ('ANOMALY_CURIOUS_FINDING', 83), ('IMPORTANT_CONSIDERATION', 111), ('PROBABLE_UNDERSTANDING', 155), ('FUTURE_WORK', 171)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC2290997	4/2008	S138-PMC2290997	['“current OBSERVATIONS of widespread Vitamin D insufficiency SHOULD NOT BE ATTRIBUTED ONLY to sun protection STRATEGIES,” says lucas.']	[('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 85), ('FUTURE_WORK', 108)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC2606998	6/2007	S120-PMC2606998	['ACCORDING TO the PRESENT STUDY there is a NEED to expand this FOCUS and include Selenium, Folate and Vitamin\u2009D too.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('FUTURE_WORK', 42), ('IMPORTANT_CONSIDERATION', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 62)]	5	[('CHEBI_27568', 'selenium atom', 80, 'selenium'), ('CHEBI_30863', '5-azaorotic acid', 90, 'folate'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC2685863	5/2009	S14-PMC2685863	['WHEREAS the institute of medicine RECOMMENDS 200 international units of Vitamin D per day (iu/day) for People under age 50, including Pregnant and Lactating women and infants, hollis wrote in the december 2007 issue of the journal of bone and Mineral research that as much as 6,000 iu/day MIGHT be NEEDED to maintain adequate Blood levels of the Vitamin in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 34), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 298), ('IMPORTANT_CONSIDERATION', 298)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'people'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('GO_0007594', 'puparial adhesion', 147, 'lactating'), ('CHEBI_46662', 'mineral', 243, 'Mineral'), ('UBERON_0000178', 'blood', 326, 'blood'), ('CHEBI_33229', 'vitamin (role)', 346, 'vitamin')]
PMC2963768	10/2010	S107-PMC2963768	['to FURTHER EXPLAIN the APPARENT ‘Vitamin D paradox’ in south asia (3), a range of hypothetical mechanisms CAN BE PROPOSED (table 3).']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 11), ('ANOMALY_CURIOUS_FINDING', 23), ('FUTURE_WORK', 106), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3257641	3/2010	S132-PMC3257641	['this is a DIFFICULT BUT IMPORTANT AREA to research [101,102,103,104], with Animal work indicting transient Prenatal Vitamin D deficiency is ASSOCIATED with subtle alterations in Learning and Memory functions in Adult Rats [105].']	[('DIFFICULT_TASK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 24), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 140)]	5	[('NCBITaxon_33208', 'Metazoa', 75, 'animal'), ('GO_0007565', 'female pregnancy', 107, 'prenatal'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007612', 'learning', 178, 'learning'), ('GO_0007613', 'memory', 191, 'memory'), ('UBERON_0007023', 'adult organism', 211, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 217, 'rats')]
PMC3257641	3/2010	S158-PMC3257641	['CARE IS also NEEDED at the trial design and implementation stages to reduce the POSSIBILITY of POTENTIAL contamination of the placebo or lower dose Vitamin D group by additional subject-initiated Vitamin D supplementation or increased uvr exposure.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 95)]	5	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3271033	1/2012	S159-PMC3271033	['OUR FINDINGS SUPPORT current GUIDELINES to begin Vitamin D supplementation of 400 iu/day to all Breast-Fed infants in the first week of Life and to FURTHER ENCOURAGE the provision of adequate Vitamin D to Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 29), ('FUTURE_WORK', 148), ('FUTURE_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'breast'), ('UBERON_0000310', 'breast', 96, 'breast'), ('GO_0007631', 'feeding behavior', 103, 'fed'), ('UBERON_0000104', 'life cycle', 136, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007565', 'female pregnancy', 205, 'pregnant')]
PMC3296991	2/2012	S83-PMC3296991	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to racial DISPARITIES in fetal growth and bone mineralization [20,21], although ADDITIONAL RESEARCH IS WARRANTED in this area.']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 70), ('FUTURE_WORK', 140), ('FUTURE_WORK', 151)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene')]
PMC3347007	4/2012	S27-PMC3347007	['the danish national Birth cohort (dnbc) offers information on Vitamin D intake in danish Pregnant women as well as information on socio-demographic and lifestyle factors, and is THEREBY an excellent OPPORTUNITY TO investigate POTENTIAL DETERMINANTS of Vitamin D intake.']	[('PROBABLE_UNDERSTANDING', 178), ('FUTURE_WORK', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 211), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 236)]	5	[('GO_0007567', 'parturition', 20, 'Birth'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC3347007	4/2012	S137-PMC3347007	['the most common doses of Vitamin D in supplements were 10 µg and 5 µg, INDICATING that the available supplements in denmark all have doses of 5 and 10 µg Vitamin D. low dose supplements make it DIFFICULT for the women to obtain the RECOMMENDED dose of Vitamin D. all Vitamin D supplements aimed at Pregnant women SHOULD THEREFORE contain 10 µg.']	[('INCOMPLETE_EVIDENCE', 71), ('DIFFICULT_TASK', 194), ('FUTURE_WORK', 232), ('FUTURE_WORK', 313), ('PROBABLE_UNDERSTANDING', 320)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 298, 'pregnant')]
PMC3347028	3/2012	S220-PMC3347028	['unanswered questions and direction of FUTURE RESEARCH endeavors\nthere are many UNANSWERED QUESTIONS about Vitamin D’s “true” ROLE during Pregnancy: at no other time during the Lifecycle is 25(Oh)D so closely LINKED with 1,25(Oh)2D [6].']	[('FUTURE_WORK', 38), ('ANOMALY_CURIOUS_FINDING', 79), ('EXPLICIT_QUESTION', 90), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0000104', 'life cycle', 176, 'lifecycle'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 222, '25(OH)2D')]
PMC3356951	4/2012	S4-PMC3356951	['CURRENT STUDIES SUGGEST that we MAY NEED more Vitamin D than presently RECOMMENDED to prevent chronic disease.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 71)]	5	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3356951	4/2012	S147-PMC3356951	['caption (table-wrap): table 1\n\nrecommended dietary intakes of Vitamin D for patients AT RISK for Vitamin D deficiency[103]\nescp SUGGESTS that the maintenance tolerable upper limits (ul) of Vitamin D, which is not to BE exceeded without medical supervision, SHOULD BE 1000 iu/d for infants up to 6 months, 1500 iu/d for infants from 6 months to 1 year, AT LEAST 2500 iu/d for children aged 1–3 years, 3000 iu/d for children aged 4–8 years, and 4000 iu/d for everyone over 8 years.']	[('IMPORTANT_CONSIDERATION', 85), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 216), ('FUTURE_WORK', 257), ('PROBABLE_UNDERSTANDING', 352)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC3356951	4/2012	S177-PMC3356951	['MORE RESEARCH is REQUIRED to RECOMMEND screening Individuals who are not AT RISK for deficiency or to prescribe Vitamin D to attain the noncalcemic BENEFIT for Cardiovascular protection.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 73), ('IMPORTANT_CONSIDERATION', 148)]	5	[('NCBITaxon_1', 'root', 49, 'individuals'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 160, 'cardiovascular')]
PMC3407995	7/2012	S435-PMC3407995	['their RECOMMENDATION was 37.5–50 μg 1500–2000 iu) per day in Pregnant and Lactating women with Vitamin D deficiency [172].table 1includes RECOMMENDATIONS from various health agencies and governments around the world.Nutrients-04-00799-t001_table 1\n\ncaption (table-wrap): table 1\n\nVitamin D intake RECOMMENDATIONS during Pregnancy and Lactation.agency/governmentrecommendationuk—for the elderly, Pregnant & Lactating women [173]dietary reference values 10 µg/day (400 iu/day)uk department of health 2007—for Pregnant and Lactating women [45]10 µg/day (400 iu/day)uk national institute of health and clinical excellence guideline review panel 2007 [45]all women SHOULD BE informed about the IMPORTANCE for their own and their baby’s health of maintaining adequate Vitamin D stores during Pregnancy and whilst Breast feeding and may choose to take 400 iu/day.canadian paediatric society [45]50 μg/day (2000 iu/day) throughout Pregnancyfederal department of health canada [45]5 μg/day (200 iu/day) for Pregnant and Breast-feeding womeneuropean commission [45]10 μg/day (400 iu/day) during Pregnancyworld health organisation 2004 [45]5 μg/day (200 iu/day) during Pregnancythe institute of medicine us 2010 [172,174]15 μg/day (600 iu/day) in Pregnant and Lactating womenus Endocrine task force on Vitamin D 2011 [174]37.5–50 μg/day (1500–2000 iu) in Pregnant and Lactating women with Vitamin D deficiency.']	[('FUTURE_WORK', 6), ('FUTURE_WORK', 138), ('FUTURE_WORK', 297), ('FUTURE_WORK', 660), ('IMPORTANT_CONSIDERATION', 689)]	5	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('GO_0007594', 'puparial adhesion', 74, 'lactating'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33284', 'nutrient', 216, 'nutrients'), ('CHEBI_28384', 'vitamin K', 280, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy'), ('GO_0007595', 'lactation', 334, 'lactation'), ('GO_0007565', 'female pregnancy', 395, 'pregnant'), ('GO_0007594', 'puparial adhesion', 406, 'lactating'), ('GO_0007565', 'female pregnancy', 507, 'pregnant'), ('GO_0007594', 'puparial adhesion', 520, 'lactating'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0007565', 'female pregnancy', 786, 'pregnancy'), ('UBERON_0000310', 'breast', 807, 'breast'), ('GO_0007565', 'female pregnancy', 923, 'pregnancyFederal'), ('GO_0007565', 'female pregnancy', 998, 'pregnant'), ('UBERON_0000310', 'breast', 1011, 'breast'), ('GO_0014065', 'phosphatidylinositol 3-kinase signaling', 1085, 'pregnancyWorld'), ('GO_0036240', 'septal periplasm', 1158, 'pregnancyThe'), ('GO_0007565', 'female pregnancy', 1236, 'pregnant'), ('GO_0007594', 'puparial adhesion', 1249, 'lactating'), ('GO_0009790', 'embryo development', 1267, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1267, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 1291, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1291, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1344, 'pregnant'), ('GO_0007594', 'puparial adhesion', 1357, 'lactating'), ('CHEBI_27300', 'vitamin D', 1378, 'vitamin D')]
PMC3407995	7/2012	S492-PMC3407995	['maternal supplementation with Dha, Vitamin D, Folic Acid and Iodine within RECOMMENDED SAFE intake quantities in a large segment of the population that is currently DEFICIENT in these Nutrients, COULD significantly prevent many Brain and Central Nervous System malfunctions and EVEN enhance Brain Development and function in future generations.']	[('FUTURE_WORK', 75), ('IMPORTANT_CONSIDERATION', 87), ('IMPORTANT_CONSIDERATION', 165), ('INCOMPLETE_EVIDENCE', 195), ('ANOMALY_CURIOUS_FINDING', 278)]	5	[('CHEBI_17874', 'dihydrozeatin', 30, 'DHA'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_30751', 'formic acid', 46, 'folic acid'), ('CHEBI_24859', 'iodine atom', 61, 'iodine'), ('CHEBI_33284', 'nutrient', 184, 'nutrients'), ('UBERON_0000955', 'brain', 228, 'brain'), ('UBERON_0001017', 'central nervous system', 238, 'central nervous system'), ('GO_0007420', 'brain development', 291, 'brain development'), ('UBERON_0000955', 'brain', 291, 'brain')]
PMC3427192	4/2012	S58-PMC3427192	['THUS, Vitamin D MAY have therapeutic EFFECTIVENESS in Adults with asthma, but MORE STUDIES ARE CLEARLY NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 78), ('FUTURE_WORK', 83)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adults')]
PMC3427192	4/2012	S70-PMC3427192	['BECAUSE of the LIMITATIONS of OBSERVATIONAL studies which include CONFOUNDING by indication, definitive RECOMMENDATIONS for Vitamin D in subjects with asthma across the Lifespan cannot be made.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 66), ('FUTURE_WORK', 104)]	5	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0000104', 'life cycle', 169, 'lifespan')]
PMC3427250	8/2012	S119-PMC3427250	['HOWEVER, the Vitamin D content of multivitamins for Pregnant women in belgium is ONLY 400 iu INDICATING EVEN this RECOMMENDATION is not followed as Pregnant women only take one Multivitamin pill a day.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 81), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 104), ('FUTURE_WORK', 114)]	5	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('GO_0007565', 'female pregnancy', 148, 'pregnant'), ('CHEBI_7025', 'mupirocin', 177, 'multivitamin')]
PMC3427250	8/2012	S124-PMC3427250	['the UNCOVERING of the magnitude of Vitamin D deficiency in Pregnant women in belgium (and western europe) SHOULD BE translated into NEW RESEARCH in order to fill the huge KNOWLEDGE GAP CONCERNING the adequate amount of Vitamin D to prevent and treat Vitamin D deficient Pregnant women.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 106), ('INCOMPLETE_EVIDENCE', 132), ('FULL_UNKNOWN', 171), ('PROBLEM_COMPLICATION', 185)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0007565', 'female pregnancy', 270, 'pregnant')]
PMC3427250	8/2012	S133-PMC3427250	['WHILE several observational studies POINT to CORRELATIONS between Vitamin D insufficiency and maternal and neonatal ill health, EXPERIMENTAL EVIDENCE from supplementation clinical trials IS NEEDED to inform health policy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 128), ('FUTURE_WORK', 187)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3470091	9/2012	S93-PMC3470091	['moreover, additional clinical trial STUDIES will HAVE TO BE CONDUCTED to determine the EFFECT of mega doses of Vitamin D on other health-related parameters such as the FACTORS RELATED to Metabolic syndrome as well as inflammatory MARKERS.']	[('FUTURE_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 230)]	5	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0008152', 'metabolic process', 187, 'metabolic')]
PMC3472720	8/2012	S69-PMC3472720	['it is THEREFORE LIKELY that his/her Immune and Nervous Systems BENEFITED from Vitamin D’s WELL-DESCRIBED anti-inflammatory actions [23].']	[('PROBABLE_UNDERSTANDING', 6), ('PROBABLE_UNDERSTANDING', 16), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 90), ('INCOMPLETE_EVIDENCE', 95)]	5	[('UBERON_0002405', 'immune system', 36, 'immune'), ('UBERON_0001016', 'nervous system', 47, 'nervous systems'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3476426	8/2012	S11-PMC3476426	['HOWEVER, FUTURE STUDIES looking at a POTENTIAL ROLE of Vitamin D in the pathophysiology and treatment of autism ARE WARRANTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3476426	8/2012	S150-PMC3476426	['HOWEVER, FUTURE STUDIES looking at a POTENTIAL ROLE of Vitamin D in the pathophysiology and treatment of autism ARE WARRANTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3552819	12/2012	S208-PMC3552819	['THEREFORE, upward deflections in the Serum and Urine BIOMARKERS of Calcium Homeostasis signaled a NEED TO BE cautious about the transient EFFECTS of large sudden influxes of Vitamin D, and the risk of dose-dependent toxicity.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('FUTURE_WORK', 98), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 138)]	5	[('UBERON_0001977', 'blood serum', 37, 'serum'), ('UBERON_0001088', 'urine', 47, 'urine'), ('GO_0055073', 'cadmium ion homeostasis', 67, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3641012	4/2013	S18-PMC3641012	['uncertainty surrounding Vitamin D REQUIREMENTS in Pregnancy has LED TO DIVERGENT dose RECOMMENDATIONS; for example, the unicef Antenatal Micronutrient formulation contains 200\xa0iu/day [11], the canadian paediatric society has SUGGESTED 2000\xa0iu/day [12], and hollis et al.']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 86), ('INCOMPLETE_EVIDENCE', 225)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0007567', 'parturition', 127, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 137, 'micronutrient')]
PMC3651971	5/2013	S26-PMC3651971	['in a study of healthy chinese mothers and newborns, a positive RELATIONSHIP was OBSERVED between Cord Blood Retinol level and motor skill achievements by age 2.17in indonesia, newborn Vitamin A supplementation resulted in modest improvement in Motor Development scores after 3\u2005years,18while Vitamin A supplementation to hiv-positive tanzanian women exerted no detectable changes in infant Psychomotor Development.19there REMAINS, HOWEVER, a NEED FOR ADDITIONAL causal data on early Life Vitamin A exposure and Neurocognitive and motor function.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 421), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 430), ('FUTURE_WORK', 441)]	5	[('UBERON_0002240', 'spinal cord', 97, 'cord'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 244, 'motor development'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin A'), ('GO_0030324', 'lung development', 389, 'psychomotor development'), ('UBERON_0000104', 'life cycle', 482, 'life'), ('CHEBI_27300', 'vitamin D', 487, 'vitamin A'), ('GO_0050905', 'neuromuscular process', 510, 'neurocognitive')]
PMC3659910	1/2013	S192-PMC3659910	['RECOMMENDATIONS SHOULD BE made on informing women of the IMPORTANCE of maintaining adequate Vitamin D stores in Pregnancy, PARTICULARLY for those at greatest RISK of Vitamin D deficiency.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 123), ('IMPORTANT_CONSIDERATION', 158)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC3691177	6/2013	S139-PMC3691177	['given the modest EFFECTS on Cord Blood Vitamin D achieved by these INTERVENTIONS, the SAFETY and efficacy of higher dose Prenatal Vitamin D supplementation STRATEGIES NEED TO BE explored.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 86), ('FUTURE_WORK', 156), ('FUTURE_WORK', 167)]	5	[('UBERON_0002240', 'spinal cord', 28, 'cord'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'prenatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3702245	6/2013	S58-PMC3702245	['Vitamin D REQUIREMENT during Pregnancy\nin ORDER TO DETERMINE the Vitamin D REQUIREMENT during Pregnancy, one NEEDS to define the target Serum 25(Oh)D concentration considered as “normal” or “optimal”.']	[('IMPORTANT_CONSIDERATION', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 109), ('IMPORTANT_CONSIDERATION', 109)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 148, 'D')]
PMC3702245	6/2013	S61-PMC3702245	['a target concentration of 75 nmol/l is CONSISTENT with the Cord Blood 25(Oh)D level REPORTED in SOME STUDIES as being PROTECTIVE against lower respiratory infection, wheezing, and eczema in infants.94–96to achieve a target Serum concentration >75 nmol/l, the society RECOMMENDS a daily Vitamin D Intake of 1500–2000 iu.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 118), ('FUTURE_WORK', 267)]	5	[('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 70, '25(OH ... D'), ('UBERON_0001977', 'blood serum', 223, 'serum'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0007631', 'feeding behavior', 296, 'intake')]
PMC3702245	6/2013	S68-PMC3702245	['these two studies and older RESEARCH41INDICATE that, in populations with a high prevalence of SEVERE Vitamin D sufficiency, supplementation up to 1600 iu/day MAY BE inadequate to achieve the RECOMMENDED target Serum 25(Oh)D concentration of 50 nmol/l.7in two RECENT STUDIES from india, which used large single-dose supplementation of 120,000 iu at the fifth and seventh month of Gestation15Or at the second and third trimester,69only 25% and 62%, respectively, achieved a Serum 25(Oh)D concentration >50 nmol/l.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 158), ('FUTURE_WORK', 191), ('INCOMPLETE_EVIDENCE', 259)]	5	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 216, '25(OH)D'), ('GO_0007565', 'female pregnancy', 379, 'gestation15or'), ('UBERON_0001977', 'blood serum', 472, 'serum'), ('CHEBI_71657', 'versiconol acetate', 478, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 478, '25(OH)D')]
PMC3760821	9/2013	S163-PMC3760821	['department of health GUIDELINES in the uk CURRENTLY RECOMMEND Pregnant women to supplement with 10 µg/day to protect against Vitamin D deficiency[29], but this is DISPUTED by SOME[30].']	[('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('INCOMPLETE_EVIDENCE', 175)]	5	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3760821	9/2013	S181-PMC3760821	['clearly, prospective clinical randomised controlled trials of Vitamin D supplementation ARE REQUIRED TO evaluate and CLARIFY the ASSOCIATION between Vitamin D status and Glycaemic Control in t1dm Pregnancy.']	[('FUTURE_WORK', 88), ('IMPORTANT_CONSIDERATION', 92), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('FUTURE_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 129)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 170, 'glycaemic control'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC3798907	8/2013	S7-PMC3798907	['the OBSERVED ASSOCIATIONS between Vitamin E and childhood Respiratory disease are COMPLEX, and the nature and form of nutritional intervention NEED TO BE carefully CONSIDERED before inclusion in trials.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('DIFFICULT_TASK', 82), ('FUTURE_WORK', 143), ('FUTURE_WORK', 164)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('UBERON_0001004', 'respiratory system', 58, 'respiratory')]
PMC3873449	12/2013	S168-PMC3873449	['THEREFORE OTHER EFFECTIVE measures MAY NEED to be taken to improve Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 39)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
PMC3904479	1/2014	S32-PMC3904479	['this CONCEPT was FURTHER PROMOTED by DESCRIBING the RELATIONSHIP between maternal diet, Birth weight, and Vitamin D Receptor genotype alteration, all as a programmer of osteopenia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 25), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 52)]	5	[('GO_0007567', 'parturition', 88, 'birth'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 106, 'vitamin D receptor')]
PMC4034700	5/2014	S137-PMC4034700	['HOWEVER, DESPITE encouraging in vitro DATA and cohort trials, clinical trials aimed to treat women AT RISK of Preeclampsia with Vitamins C and E (poston et al., 2006;rumbold et al., 2006) SHOWED no reduction in the incidence of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('FUTURE_WORK', 38), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 188)]	5	[('GO_0007128', 'meiotic prophase I', 110, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'E')]
PMC4045304	2/2014	S274-PMC4045304	['PLAUSIBLE mechanisms HAVE BEEN put FORWARD to EXPLAIN the palliative ROLE of Vitamin D in children with autism via Dna Repair, anti-inflammatory actions, Autoimmune activities, and increase in Regulatory T Cells or stimulation antioxidant pathways.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0006281', 'DNA repair', 115, 'DNA repair'), ('UBERON_0001442', 'skeleton of manus', 154, 'autoimmune'), ('CL_0000815', 'regulatory T cell', 193, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 193, 'regulatory')]
PMC4072587	6/2014	S16-PMC4072587	['ALTHOUGH the current RECOMMENDED dietary intake of Vitamin D during Pregnancy ranges from 600 to 2000 international units (iu) per day[8], a standardised definition of Vitamin D deficiency during Pregnancy REMAINS CONTROVERSIAL[4],[9],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC4113768	7/2014	S179-PMC4113768	['FURTHER STUDIES assessing the EFFECT of Vitamin D supplementation, and RELATED molecular and Genetic FACTORS, on Colorectal cancer survival ARE WARRANTED.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 101), ('FUTURE_WORK', 140)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('SO_0000704', 'gene', 93, 'genetic'), ('UBERON_0012652', 'colorectum', 113, 'colorectal')]
PMC4113768	7/2014	S502-PMC4113768	['RANDOMIZED controlled TRIALS ARE NEEDED to fully ELUCIDATE the POTENTIAL RELATIONS of Vitamin D with measures of Lung function.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 49), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 73)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0002048', 'lung', 113, 'lung')]
PMC4113768	7/2014	S782-PMC4113768	['RANDOMIZED controlled trials of Vitamin D supplementation MAY BE WARRANTED for infants with low 25(Oh)D during the initial months of Life, BUT careful selection of the regimen with close monitoring of safety for those who reach high 25(Oh)D levels will be NECESSARY.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 58), ('FUTURE_WORK', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('IMPORTANT_CONSIDERATION', 256)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0000104', 'life cycle', 133, 'life'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4113768	7/2014	S828-PMC4113768	['health professionals SHOULD ensure that women at greatest RISK of Vitamin D deficiency are asked about Vitamin D supplementation; (2) nice public health GUIDELINE 11- all infants and young children aged 6 months to 5 years SHOULD take a daily supplement containing Vitamin D.\nwe surveyed 20 mothers and 15 health professionals on the Postnatal wards.']	[('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 21), ('IMPORTANT_CONSIDERATION', 58), ('PROBABLE_UNDERSTANDING', 153), ('FUTURE_WORK', 223)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0007567', 'parturition', 334, 'postnatal')]
PMC4113768	7/2014	S1386-PMC4113768	['robust randomised controlled TRIALS ARE NEEDED to determine WHETHER improving Vitamin D status has a positive EFFECT on Insulin resistance OR OTHER pathophysiological indicators of dm including Beta-Cell function.']	[('FUTURE_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('PR_000045358', 'insulin family protein', 120, 'insulin'), ('CL_0000349', 'extraembryonic cell', 194, 'beta-cell')]
PMC4113768	7/2014	S1536-PMC4113768	['in the FUTURE, Genetic FACTORS MIGHT be taken into ACCOUNT when RECOMMENDING Vitamin D supplementation or Food fortification.']	[('FUTURE_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 51), ('FUTURE_WORK', 64)]	5	[('SO_0000704', 'gene', 15, 'genetic'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_33290', 'food', 106, 'food')]
PMC4113768	7/2014	S1642-PMC4113768	['low-dose Vitamin D supplementation is already RECOMMENDED in older Adults for PREVENTION of fractures and falls, but clinical trials investigating WHETHER higher doses COULD provide additional protection against ari are LACKING.']	[('FUTURE_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('FULL_UNKNOWN', 220)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 67, 'adults')]
PMC4113768	7/2014	S1867-PMC4113768	['with the IMPLICATIONS of a low Vitamin D status KNOWN to include POOR bone and muscle function, establishing STRATEGIES to improve the availability of Vitamin D sources to the population is VITAL.']	[('IMPORTANT_CONSIDERATION', 9), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 65), ('FUTURE_WORK', 109), ('IMPORTANT_CONSIDERATION', 190)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC4113768	7/2014	S1868-PMC4113768	['WHILST Food fortification is a sustainable solution for the PREVENTION of Vitamin D deficiency, the Food industry NEEDS to determine SUITABLE means of carriage IF it is to maximise the effectiveness of fortification.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('FUTURE_WORK', 114), ('IMPORTANT_CONSIDERATION', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	5	[('CHEBI_33290', 'food', 7, 'food'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33290', 'food', 100, 'food')]
PMC4113768	7/2014	S2443-PMC4113768	['FURTHER STUDIES to identify the UNDERLYING mechanisms RELATING to the very high levels of Vitamin D deficiency in tb patients from the horn of africa and indian subcontinent will have IMPLICATIONS for understanding the ROLE of Vitamin D in tb aetiology as well as for the prevention and treatment of active tuberculous disease in these patients.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 184), ('SUPERFICIAL_RELATIONSHIP', 219)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC4113768	7/2014	S2773-PMC4113768	['conclusions: the free and bio-available forms of 25(Oh)D MAY BE a more INFORMATIVE measure of Vitamin D status than total 25(Oh)d. adjustment for dbp phenotype MAY improve this FURTHER.']	[('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 160), ('FUTURE_WORK', 177), ('INCOMPLETE_EVIDENCE', 177)]	5	[('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 122, '25(OH')]
PMC4113768	7/2014	S3328-PMC4113768	['when ADDITIONAL EVIDENCE on EFFECTS RELATED to Vitamin D from OBSERVATIONAL studies with respect to Serum 25(Oh)D level or personal uvb irradiance, the ROLE of skin pigmentation, and laboratory studies of mechanisms, hill’s criteria for causality in a biological system (hill ab.']	[('FUTURE_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 106, '25(OH)D')]
PMC4188019	1/2010	S80-PMC4188019	['AS this was a pilot STUDY, we ONLY measured 25-Oh Vitamin D. in the FUTURE, we will start including other RELEVANT parameters such as medical history, Serum levels of calcium and Parathyroid hormone.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 44, '25-OH'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001977', 'blood serum', 151, 'serum'), ('UBERON_0001132', 'parathyroid gland', 179, 'parathyroid')]
PMC4256222	12/2014	S137-PMC4256222	['furthermore, OBSERVATIONS HAVE SHOWN that infant Vitamin D deficiency CAN be eliminated as early as 9 months Postpartum, IF Vitamin D drops with 10 µg of Vitamin D per day are given as RECOMMENDED[34].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('FUTURE_WORK', 185)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'postpartum'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4383226	2/2015	S27-PMC4383226	['CLINICAL TRIALS ARE NOW NEEDED to CONFIRM these results and investigate HOW effectively Vitamin A prevents malaria.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 9), ('FUTURE_WORK', 34), ('INCOMPLETE_EVIDENCE', 34), ('EXPLICIT_QUESTION', 72)]	5	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A')]
PMC4383226	2/2015	S134-PMC4383226	['given that Vitamin A is fat soluble and CAN be stored in the Liver for long periods of time (blomhoff, 1994;tanumihardjo, 2011), ADDITIONAL RESEARCH IS NEEDED to examine WHETHER regular supplementation has an IMPACT on increased protection.']	[('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 129), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 209)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A'), ('UBERON_0002107', 'liver', 61, 'liver')]
PMC4396835	1/2015	S7-PMC4396835	['conclusions\nthe FINDINGS SUGGEST that low Prenatal Vitamin D MAY act as a risk factor for asd, HOWEVER, there is a NEED FOR replication with larger samples.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('FUTURE_WORK', 115)]	5	[('GO_0007565', 'female pregnancy', 42, 'prenatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4396835	1/2015	S8-PMC4396835	['FUTURE RESEARCH SHOULD study WHETHER OR NOT adequate supplementation of Vitamin D to Pregnant women MIGHT lower the RISK for asd in the offspring.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 116)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant')]
PMC4396835	1/2015	S171-PMC4396835	['FUTURE RESEARCH SHOULD include a larger cohort followed prospectively and also study WHETHER OR NOT adequate supplementation of Vitamin D to Pregnant women MIGHT lower the RISK for asd in the offspring.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 156), ('IMPORTANT_CONSIDERATION', 172)]	5	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC4417995	4/2015	S187-PMC4417995	['THEREFORE systematic supplementation of Vitamin D in childhood ad currently cannot be RECOMMENDED EXCEPT for UNCOMMON cases which MAY prove refractory to traditional therapeutic options.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4488777	5/2015	S12-PMC4488777	['Vitamin D is definitely not a trojan horse in Reproductive health, SINCE there were no adverse effects REPORTED for Vitamin D intake of up to 10,000 iu/day, BUT to PROCLAIM it the golden fleece, MORE EVIDENCE IS NEEDED.']	[('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 195)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0000003', 'reproduction', 46, 'reproductive'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4488777	5/2015	S191-PMC4488777	['Vitamin D is definitely not a trojan horse in Reproductive health since there were no adverse EFFECTS REPORTED for Vitamin D intake of up to 10,000 iu/d [66], BUT to PROCLAIM it the golden fleece, MORE EVIDENCE IS still REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 197)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0000003', 'reproduction', 46, 'reproductive'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4586450	10/2015	S288-PMC4586450	['it PROVED IMPOSSIBLE to incorporate enough Vitamin D–containing foods to cover the RECOMMENDATIONS, implying that Vitamin D–deficient diets are LIKELY to be the norm.32\nin the mid-2000s, there was a great deal of CONTROVERSY about the nutritional content of school meals.']	[('PROBABLE_UNDERSTANDING', 3), ('DIFFICULT_TASK', 10), ('FUTURE_WORK', 83), ('PROBABLE_UNDERSTANDING', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4595656	10/2015	S8-PMC4595656	['IN LIGHT OF the IMPORTANCE of the hippocampus in ltp and spatial Learning, FURTHER INVESTIGATIONS on the early EFFECTS of Vitamin D deprivation on hippocampal development ARE WARRANTED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('FUTURE_WORK', 75), ('SUPERFICIAL_RELATIONSHIP', 111), ('FUTURE_WORK', 171)]	5	[('GO_0007612', 'learning', 65, 'learning'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4595656	10/2015	S106-PMC4595656	['this FINDING POINTS to DIFFERENTIAL EFFECTS of varying concentrations of Vitamin D on Cellular Hippocampal Development and WARRANT FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('FUTURE_WORK', 123)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0045168', 'cell-cell signaling involved in cell fate commitment', 86, 'cellular hippocampal development')]
PMC4595656	10/2015	S121-PMC4595656	['this constitutes a MAJOR lacuna in our overall understanding of the ROLE of Vitamin D in the early development of the hippocampus and is an AVENUE RIPE for EXPLORATION.']	[('IMPORTANT_CONSIDERATION', 19), ('SUPERFICIAL_RELATIONSHIP', 68), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 147), ('QUESTION_ANSWERED_BY_THIS_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4598849	10/2015	S74-PMC4598849	['THUS, FUTURE STUDIES of Vitamin D and growth restriction would BENEFIT from the CONSIDERATION of OTHER Vitamin D family members.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 6), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4600246	10/2015	S10-PMC4600246	['THUS, UNLESS you are an institutionalised Postmenopausal woman or you have already experienced a fracture, the uspstf does not RECOMMEND Calcium and Vitamin D for preventing a first-time fracture, AS there is a LACK OF EVIDENCE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('FUTURE_WORK', 127), ('PROBABLE_UNDERSTANDING', 197), ('INCOMPLETE_EVIDENCE', 211)]	5	[('GO_0007595', 'lactation', 42, 'postmenopausal'), ('CHEBI_22313', 'alkaline earth metal atom', 137, 'calcium'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4632418	10/2015	S135-PMC4632418	['UNTIL then, screening women who are AT RISK of Vitamin D deficiency and supplementation with Vitamin D COULD BE CONSIDERED.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 103), ('INCOMPLETE_EVIDENCE', 103), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4645901	8/2014	S19-PMC4645901	['[2]\nHOWEVER, it is ESSENTIAL to APPRECIATE that RECOMMENDED doses of Vitamin D supplementation are arbitary, and the THRESHOLD for toxicity is far higher.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 32), ('FUTURE_WORK', 48), ('IMPORTANT_CONSIDERATION', 117)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4689556	12/2015	S159-PMC4689556	['HOWEVER, guidance from the national institute for clinical excellence and royal college of obstetricians and gynaecologists in the uk now acknowledge this as a minimum dose for all Pregnant or breastfeeding women and that higher dosing SHOULD BE CONSIDERED in those at high RISK of Vitamin D deficiency [41,42].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 236), ('FUTURE_WORK', 246), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 274)]	5	[('GO_0007565', 'female pregnancy', 181, 'pregnant'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC4689556	12/2015	S185-PMC4689556	['outcomes of a subsequent intervention trial SUGGEST that higher dose Vitamin D, and POSSIBLY combined mother/infant supplementation MAY BE NEEDED for positive health EFFECTS on the child [38].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 132), ('FUTURE_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4691762	12/2015	S106-PMC4691762	['we will not be monitoring Serum 25(Oh)D for safety reasons nor considering the association between 25(Oh)D and outcome frequency given that 400\u2005Iu HAS BEEN SHOWN to be SAFE in term babies,1926preterm infants27and is the current RECOMMENDED dose in the usa, canada, the uk and europe.18\n\ndiscussion\nthe results of the vitality trial will determine WHETHER Vitamin D supplementation has a ROLE in optimising infant Immune health in the first year of Life, reducing the risk of allergic disease and Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 168), ('FUTURE_WORK', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('SUPERFICIAL_RELATIONSHIP', 387)]	5	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25(OH)D'), ('CHEBI_17883', 'hydrogen chloride', 144, 'IU'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin D'), ('UBERON_0002405', 'immune system', 413, 'immune'), ('UBERON_0000104', 'life cycle', 448, 'life'), ('UBERON_0001004', 'respiratory system', 496, 'respiratory')]
PMC4719746	1/2016	S20-PMC4719746	['DESPITE the CONTROVERSIES RELATED to adverse outcomes, and LACK OF EVIDENCE of clear benefits of routine supplementation, most western countries RECOMMEND Vitamin D supplementation during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 145)]	5	[('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy')]
PMC4719746	1/2016	S152-PMC4719746	['the SMALL increase of 25(Oh)D OBSERVED among women with a slight deficiency at baseline who did not receive the recommendation, MAY BE RELATED to usual practices in norway of routinely RECOMMENDING a daily intake of 10\xa0μg Vitamin D as part of Antenatal Care [21].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 135), ('FUTURE_WORK', 185)]	5	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 22, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 243, 'antenatal care')]
PMC4729160	1/2016	S132-PMC4729160	['so in the FUTURE health public policy on Vitamin A SHOULD BE paid more ATTENTION on Pregnant women with pertinent INFLUENCE FACTORS of vad, accordingly, eliminate vad improve the nutritional status of chinese Pregnant women.']	[('FUTURE_WORK', 10), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 49, 'A'), ('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 209, 'pregnant')]
PMC4784858	3/2016	S87-PMC4784858	['EVEN IF national GUIDELINES RECOMMEND the use of dietary supplements to meet REQUIREMENTS for some Nutrients (Folate, Vitamin D, iron or Iodine) during Pregnancy, Nutrient intakes from dietary supplements were not included in the pandiet calculation, like in other studies using diet quality indexes for Pregnancy [11–13].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 17), ('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 77)]	5	[('CHEBI_33284', 'nutrient', 99, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 110, 'folate'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 137, 'iodine'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_33284', 'nutrient', 163, 'nutrient'), ('GO_0007565', 'female pregnancy', 304, 'pregnancy')]
PMC4785305	3/2016	S28-PMC4785305	['rcts of Vitamin D supplementation during Pregnancy\ntwo landmark rcts HAVE BEEN conducted in the usa35and the uk.36hollis et al 35SHOWED that in Pregnant women in the usa, with a baseline 25(Oh)D level around 60\u2005nmol/l, a Vitamin dose of 4000\u2005iu daily allowed 82% of participants to reach a 25(Oh)D level of 80\u2005nmol/l, WHILE ONLY 70% and 50% reached this TARGET in the intermediate (2000\u2005iu daily) and low (400\u2005iu daily) doses, respectively.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 127), ('ANOMALY_CURIOUS_FINDING', 318), ('ANOMALY_CURIOUS_FINDING', 324), ('FUTURE_WORK', 354)]	5	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0007565', 'female pregnancy', 144, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 221, 'vitamin'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D')]
PMC4889866	5/2016	S109-PMC4889866	['FURTHER RESEARCH IS WARRANTED to investigate the mechanism in which maternal Vitamin D status AFFECTS neonatal tlr-RELATED Il-10 response.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 123, 'IL-10')]
PMC4889866	5/2016	S124-PMC4889866	['THUS, FUTURE STUDIES RELATED to the EFFECT of Prenatal Vitamin D level on neonatal Innate Immunity and subsequent health outcomes will NEED to focus on populations with more Vitamin d sufficient Pregnant mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 36), ('FUTURE_WORK', 135)]	5	[('GO_0007565', 'female pregnancy', 46, 'prenatal'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0045087', 'innate immune response', 83, 'innate immunity'), ('CHEBI_33229', 'vitamin (role)', 174, 'vitamin'), ('GO_0007565', 'female pregnancy', 195, 'pregnant')]
PMC4897157	5/2016	S153-PMC4897157	['to CONFIRM the EFFECT of sun exposure during infancy on the development of Allergic Diseases, FURTHER prospective INVESTIGATIONS that measure Serum Vitamin D levels ARE REQUIRED.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 94), ('FUTURE_WORK', 165), ('IMPORTANT_CONSIDERATION', 169)]	5	[('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 75, 'allergic diseases'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4903143	5/2016	S100-PMC4903143	['because of widespread Vitamin D INSUFFICIENCY in many population groups and INCONSISTENT response to fixed doses of Vitamin D supplementation, the authors RECOMMEND testing for 25(Oh)d levels and SUITABLE intervention as REQUIRED [76].']	[('IMPORTANT_CONSIDERATION', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 155), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 221)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 177, '25(OH)')]
PMC4930210	7/2016	S0-PMC4930210	['the current recommended Vitamin D intake guideline for diet and supplements during Pregnancy is not adequate to achieve Vitamin D sufficiency for most Pregnant women\n\nabstract\n\nbackground\nthe aims of THIS STUDY were TO DETERMINE IF Pregnant women consumed the RECOMMENDED Vitamin D through diet alone or through diet and supplements, and if they achieved the current reference range Vitamin D status when their reported dietary intake met the current RECOMMENDATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229), ('FUTURE_WORK', 260), ('FUTURE_WORK', 451)]	5	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 120, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'Pregnant'), ('GO_0007565', 'female pregnancy', 232, 'pregnant'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D')]
PMC4930210	7/2016	S8-PMC4930210	['conclusions\nwe DEMONSTRATED the current rda (600 iu/ day) MAY not be adequate to achieve Vitamin D status >75 nmol/l in SOME Pregnant women who are residing in higher latitudes (calgary, 51°n) in alberta, canada and the current Vitamin D RECOMMENDATIONS for canadian Pregnant women NEED TO be re-evaluated.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 120), ('FUTURE_WORK', 238), ('IMPORTANT_CONSIDERATION', 282)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('GO_0007565', 'female pregnancy', 267, 'pregnant')]
PMC4934634	11/2015	S294-PMC4934634	['a RECENT report by the 2015 dietary guidelines advisory committee NOTED that EVEN with careful Food choices and following RECOMMENDED amounts from each Food group in the (current) usda Food patterns, the rda for Vitamin D cannot be met [103].']	[('INCOMPLETE_EVIDENCE', 2), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 66), ('ANOMALY_CURIOUS_FINDING', 77), ('FUTURE_WORK', 122)]	5	[('CHEBI_33290', 'food', 95, 'food'), ('CHEBI_33290', 'food', 152, 'food'), ('CHEBI_33290', 'food', 185, 'food'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC4934634	11/2015	S303-PMC4934634	['Vitamin D supplementation/fortification HAS also BEEN met with OPPOSITION [107] DUE TO CONCERNS that Vitamin D is a hormone and SHOULD BE treated as such including addressing efficacy, dose and side effects.']	[('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('PROBLEM_COMPLICATION', 80), ('PROBLEM_COMPLICATION', 87), ('FUTURE_WORK', 128)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4969253	8/2016	S80-PMC4969253	['the IMPACT of Prenatal disruption of ra signaling in Adult Airway structure and function HAS BEEN WELL DEMONSTRATED using a MODEL of Vitamin A deficiency in Mice [14].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 98), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 124)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('UBERON_0007023', 'adult organism', 53, 'adult'), ('UBERON_0001005', 'respiratory airway', 59, 'airway'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 157, 'mice')]
PMC4971719	8/2016	S13-PMC4971719	['FUTURE INVESTIGATIONS SHOULD study WHETHER Vitamin D supplementation in early Pregnancy MAY PREVENT Perinatal depressive symptoms.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0036268', 'swimming', 100, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 100, 'perinatal')]
PMC4971719	8/2016	S170-PMC4971719	['IMPORTANT FUTURE AREAS OF RESEARCH would INCLUDE randomized controlled trials of Vitamin D supplementation for women who are screen for depression RISK in early Pregnancy and who are found to have low Vitamin D levels.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 0), ('FUTURE_WORK', 10), ('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 147)]	5	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4989298	8/2016	S359-PMC4989298	['IS the administration of Vitamin D in doses compliant with RECOMMENDED intakes SUGGESTED for the first year of Life RECOMMENDED for the prevention of allergic disease?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 59), ('INCOMPLETE_EVIDENCE', 79), ('FUTURE_WORK', 116), ('EXPLICIT_QUESTION', 166)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 111, 'life')]
PMC5014971	8/2016	S26-PMC5014971	['the two groups also RECOMMEND DIFFERENT levels of Vitamin D supplementation, IN LARGE PART DUE TO the DIFFERENT stable levels of circulating 25-Oh-D they are attempting to obtain.']	[('FUTURE_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 141, '25-OH-D')]
PMC5014971	8/2016	S101-PMC5014971	['the result has been CONFLICTING RECOMMENDATIONS from the iom [14,15] and the Endocrine society [19], ESPECIALLY CONCERNING Vitamin D supplementation and APPROPRIATE levels of circulating 25-Oh-D during Pregnancy (table 4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 112), ('IMPORTANT_CONSIDERATION', 153)]	5	[('UBERON_0005063', 'left ventricular compact myocardium', 77, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 187, '25-OH-D'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC5024513	9/2016	S36-PMC5024513	['HOWEVER the author CONCLUDED that there was SOME consensus in the AVAILABLE LITERATURE that Pregnant adolescents had intakes of energy, iron, Folate, Calcium, Vitamin E and magnesium which were below the dietary RECOMMENDED intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 66), ('FUTURE_WORK', 212)]	5	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_30863', '5-azaorotic acid', 142, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 150, 'calcium'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin E')]
PMC5051327	9/2016	S57-PMC5051327	['the daily RECOMMENDED intake of Vitamin D is 600\u2005iu/day in the usa5since the late 1990s in france, there HAVE been official RECOMMENDATIONS of 1000\u2005u vitamin d/day from 32\u2005weeks of Gestation or 100\u2005000 or 200\u2005000\u2005iu as a single dose at 32\u2005weeks in order to lower COMPLICATIONS in newborns.27\nCalcium Homeostasis In the Heart is IMPORTANT for the Contractility and function of the Heart.']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 105), ('FUTURE_WORK', 124), ('PROBLEM_COMPLICATION', 263), ('IMPORTANT_CONSIDERATION', 328)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 181, 'gestation'), ('CHEBI_31341', 'calcium dihydroxide', 292, 'Calcium'), ('GO_0007605', 'sensory perception of sound', 292, 'Calcium'), ('GO_0042592', 'homeostatic process', 300, 'homeostasis in'), ('GO_0007605', 'sensory perception of sound', 319, 'heart'), ('UBERON_0000948', 'heart', 319, 'heart'), ('GO_0006936', 'muscle contraction', 346, 'contractility'), ('GO_0007605', 'sensory perception of sound', 380, 'heart'), ('UBERON_0000948', 'heart', 380, 'heart')]
PMC5064894	10/2016	S163-PMC5064894	['THIS will TEST the core mechanistic HYPOTHESIS that IMPROVEMENTS in Vitamin D status via maternal Vitamin D supplementation reduce the RISK of ari among infants in dhaka.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 52), ('IMPORTANT_CONSIDERATION', 135)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5084016	10/2016	S133-PMC5084016	['in women AT RISK for Vitamin D deficiency, the RECOMMENDATIONS SHOULD BE reach 1000–2000 iu/day.']	[('IMPORTANT_CONSIDERATION', 9), ('FUTURE_WORK', 47), ('IMPORTANT_CONSIDERATION', 47), ('FUTURE_WORK', 63), ('IMPORTANT_CONSIDERATION', 63)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5084016	10/2016	S135-PMC5084016	['GIVEN the INFLUENCE of sunlight exposure on Vitamin D Metabolism, ATTENTION to ethnic groups with hyper-Pigmented skin or with little exposure to sunlight SHOULD BE paid also during Lactation.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 66), ('FUTURE_WORK', 155)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 44, 'vitamin D metabolism'), ('CHEBI_26130', 'biological pigment', 104, 'pigmented'), ('GO_0007595', 'lactation', 182, 'lactation')]
PMC5095257	11/2016	S85-PMC5095257	['FURTHER STUDIES ARE REQUIRED to investigate the ASSOCIATION of Perinatal Vitamin D status and the RISK for aad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 98)]	5	[('GO_0036268', 'swimming', 63, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 63, 'perinatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5095257	11/2016	S97-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period coupled with Vitamin D deficiency leading to dysregulation of innate immunity COULD BE the POTENTIAL initial triggers for the eventual development of aad, ALTHOUGH this REQUIRES FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 240)]	5	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5129897	10/2016	S0-PMC5129897	['estimated economic BENEFIT of increasing 25-Hydroxyvitamin D concentrations of canadians to or above 100\xa0nmol/l\n\nabstractabstract\nMOUNTING EVIDENCE from observational and clinical TRIALS INDICATES that optimal Vitamin D reduces the RISK of many diseases.']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 130), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 232)]	5	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 41, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC5129897	10/2016	S188-PMC5129897	['according to a consensus Vitamin D position statement published by 7 joint health organizations in the uk, enjoying the sun safely, while taking care not to burn, CAN HELP to provide the benefits of Vitamin D without unduly raising the risk of skin cancer.99HOWEVER, sun exposure in the uk as well as in canada is a RECOMMENDATION for ONLY 5–7\xa0months of the year(except for People traveling to sun destinations during winter months).']	[('INCOMPLETE_EVIDENCE', 163), ('FUTURE_WORK', 167), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('FUTURE_WORK', 316), ('INCOMPLETE_EVIDENCE', 335)]	5	[('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 25, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 374, 'people')]
PMC5146866	12/2016	S10-PMC5146866	['OUR FINDINGS RAISE a QUESTION regarding the adequacy of the aap RECOMMENDED Vitamin D supplementation REQUIREMENTS without knowing the infant’s Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('EXPLICIT_QUESTION', 13), ('EXPLICIT_QUESTION', 21), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007567', 'parturition', 164, 'birth')]
PMC5146866	12/2016	S24-PMC5146866	['DESPITE numerous publications that explored Vitamin D status in cb, FURTHER RESEARCH is REQUIRED to determine the LIKELIHOOD for detection of Vitamin D insufficiency in cb of infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 114)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5340372	3/2017	S131-PMC5340372	['more INVESTIGATION is REQUIRED to FURTHER understand the ROLE of Vitamin D for the PREVENTION of Respiratory Tract infection in infancy.']	[('FUTURE_WORK', 5), ('IMPORTANT_CONSIDERATION', 22), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 83)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 97, 'respiratory tract')]
PMC5372327	3/2017	S2-PMC5372327	['MANY countries apply Vitamin D supplementation STRATEGIES in infants, but the guidelines are NOT BASED ON scientific EVIDENCE and AIM at PREVENTION of rickets.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 47), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 130), ('SUPERFICIAL_RELATIONSHIP', 137)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5418719	5/2017	S12-PMC5418719	['HOWEVER, NO CONSENSUS RECOMMENDATION for Vitamin D deficiency was made specifically for preterm infants, BECAUSE FEW DATA on bone mineralization rates in utero are reported.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('FUTURE_WORK', 22), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5418719	5/2017	S102-PMC5418719	['this LACK OF EVIDENCE has resulted in VARYING practices among neonatologists, and CONTROVERSY REMAINS about the thresholds and STRATEGIES for Vitamin D intake of 800\xa0iu among vlbw infants earlier in Life.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 127)]	5	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0000104', 'life cycle', 199, 'life')]
PMC5513133	7/2017	S236-PMC5513133	['FUTURE INVESTIGATIONS SHOULD CONSIDER concurrently measuring Vdbp levels and calculated free Vitamin D levels when CONSIDERING the ROLE of Vitamin D in pe [18].']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 115), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('PR_000017279', 'testis-specific basic protein Y 1', 61, 'VDBP'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5513133	7/2017	S242-PMC5513133	['STUDIES with longitudinal study design carefully controlling for temporal sequences of changes in Vitamin D levels in women with pe ARE NEEDED to identify the ROLE of Vitamin D and any POTENTIAL Mediators in the pathway LINKING Vitamin D to pe.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 132), ('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 220)]	5	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_35222', 'inhibitor', 195, 'mediators'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC5524288	7/2017	S116-PMC5524288	['THESE FINDINGS SUGGEST that IMPROVEMENTS in Vitamin D status MAY decrease the DISPARITY in ptb rates between race/ethnic groups.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('FUTURE_WORK', 28), ('FUTURE_PREDICTION', 61), ('IMPORTANT_CONSIDERATION', 78)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5524288	7/2017	S117-PMC5524288	['additionally, for women with a prior ptb, the substantial decrease in recurrent ptb RISK (80%) for ≥40 ng/ml vs. <20 ng/ml INDICATES that IMPROVING Vitamin D status in this HIGH RISK subgroup COULD sizably reduce ptb rates.']	[('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 123), ('FUTURE_WORK', 138), ('IMPORTANT_CONSIDERATION', 173), ('FUTURE_PREDICTION', 192)]	5	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5537904	7/2017	S21-PMC5537904	['PRIOR STUDIES VARY strongly in methodology, PARTICULARLY in regard to assessment of Prenatal Vitamin D intake, timing and source of 25(Oh)D measurements, a method for assessing neonatal adiposity, and CONSIDERATION of OTHER contributing factors such as maternal obesity.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	5	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 138, 'D')]
PMC5546866	8/2017	S14-PMC5546866	['antenatal Vitamin D supplementation is now RECOMMENDED for all Pregnant women in many national GUIDELINES (1–3) AS SEVERE maternal Vitamin D deficiency CAN result in symptomatic neonatal hypocalcemia (4).']	[('FUTURE_WORK', 43), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 112), ('IMPORTANT_CONSIDERATION', 115), ('INCOMPLETE_EVIDENCE', 152)]	5	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnant'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5634602	10/2017	S115-PMC5634602	['this, coupled with the LACK OF dangerously high levels or clinical side EFFECTS REPORTED with dosing between 400–1600 iu in preterm infants, lead us to argue for CONSIDERATION of and ADDITIONAL EVALUATION of the 800 iu dose of Vitamin D in addition to Vitamin D from diet sources in this high-risk hospitalized patient population.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 80), ('FUTURE_WORK', 162), ('FUTURE_WORK', 183)]	5	[('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC5634602	10/2017	S146-PMC5634602	['ALTERNATIVELY, the risks of RECOMMENDATION of too low a dose MAY have significant IMPACT on Individual and population health with disease outcomes ASSOCIATED with low Vitamin D status, including hypocalcemic seizures, growth restriction, fractures, and elevation of Serum Parathyroid hormone [53–55].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 28), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 82), ('SUPERFICIAL_RELATIONSHIP', 147)]	5	[('NCBITaxon_1', 'root', 92, 'individual'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001977', 'blood serum', 266, 'serum'), ('UBERON_0001132', 'parathyroid gland', 272, 'parathyroid')]
PMC5659607	10/2017	S125-PMC5659607	['finally, vdaart included a large group of african-american women in the trial, who are WELL-KNOWN to have a higher RISK of developing asthma and allergy[25] and had lower Vitamin D levels at randomization COMPARED to the OTHER ethnic groups[12].']	[('FUTURE_WORK', 87), ('PROBABLE_UNDERSTANDING', 92), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]
PMC5659607	10/2017	S154-PMC5659607	['Prenatal care STRATEGIES targeted at raising Vitamin D levels in Pregnant women SHOULD THEREFORE BE CONSIDERED.']	[('FUTURE_WORK', 14), ('FUTURE_WORK', 80), ('PROBABLE_UNDERSTANDING', 87), ('ANOMALY_CURIOUS_FINDING', 97), ('FUTURE_WORK', 100)]	5	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnant')]
PMC5706533	11/2017	S173-PMC5706533	['although we intend to update this review regularly (the platform for FUTURE real time dissemination is STILL TO BE DETERMINED), we project LIMITED aggregate gains from the 35 MOSTLY SMALL TRIALS of Prenatal Vitamin D supplementation trials that are registered as completed, ongoing, or planned.']	[('FUTURE_WORK', 69), ('FULL_UNKNOWN', 103), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 182)]	5	[('GO_0007565', 'female pregnancy', 198, 'prenatal'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5941617	5/2018	S173-PMC5941617	['ON THE CONTRARY, OTHER societies systematically RECOMMENDED Vitamin D supplementation in children and adolescents during winter months [13,20,115] or throughout the whole year IF reduced sun exposure during summer [20,115].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('FUTURE_WORK', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC5941617	5/2018	S197-PMC5941617	['indeed, Serum 25(Oh)D evaluation SHOULD BE reserved to subjects AT RISK for Vitamin D deficiency, BUT INDICATIONS for 25(Oh)D measurement significantly VARY among different societies (table\xa08) [9,11,13,15,20–23,27,30].']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 102), ('DIFFICULT_TASK', 152)]	5	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC5941617	5/2018	S226-PMC5941617	['the global CONSENSUS on nutritional rickets RECOMMENDED the administration of 2000\xa0iu/day of Vitamin D in patients aged less than 1\xa0year, 3000–6000\xa0iu/day in patients aged 1 to 12\xa0years and 6000\xa0iu/day in patients older than 12\xa0years for a minimum of 3\xa0months, EVEN IF some children MAY require a longer treatment duration [28].']	[('PROBABLE_UNDERSTANDING', 11), ('FUTURE_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 261), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 266), ('INCOMPLETE_EVIDENCE', 283)]	5	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5941617	5/2018	S400-PMC5941617	['HOWEVER, it HAS BEEN SUGGESTED that in patients with a more SEVERE ad, unresponsive to common therapy and with low Serum 25(Oh)D levels, a trial of Vitamin D supplementation CAN BE CONSIDERED [352].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 60), ('FUTURE_WORK', 174), ('FUTURE_WORK', 181)]	5	[('UBERON_0001977', 'blood serum', 115, 'serum'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 127, 'D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5941617	5/2018	S510-PMC5941617	['more RECENTLY, united arab emirates GUIDELINES also RECOMMENDED Vitamin D supplementation in obese children and adolescents (1200–2000\xa0iu/day DEPENDING ON severity of obesity, season and sun exposure) throughout the year IF sufficient Skin Synthesis if Vitamin D is not ensured during winter [27].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 36), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0009697', 'salicylic acid biosynthetic process', 235, 'skin synthesis'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC5941617	5/2018	S517-PMC5941617	['AT PRESENT, CONSIDERING that obese italian children have higher prevalence of Vitamin D deficiency and insufficiency then normal weight Individuals, we SUGGEST in obese children and adolescents vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 247)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_1', 'root', 136, 'individuals'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 202, 'D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
PMC5941617	5/2018	S608-PMC5941617	['nutritional rickets cases are STILL REPORTED in italy, THUS adequate national STRATEGIES to prevent Vitamin D deficiency ARE NEEDED.']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 55), ('FUTURE_WORK', 78), ('FUTURE_WORK', 121)]	5	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5941617	5/2018	S655-PMC5941617	['intermittent administration of Vitamin D MAY BE CONSIDERED in children and adolescents with POOR compliance with daily treatment (i.e.']	[('INCOMPLETE_EVIDENCE', 41), ('FUTURE_WORK', 48), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 92), ('PROBLEM_COMPLICATION', 92)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5941617	5/2018	S683-PMC5941617	['Serum 25(Oh)D evaluation MAY BE CONSIDERED in children with SEVERE ad unresponsive to common therapy and multiple RISK FACTORS for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 32), ('IMPORTANT_CONSIDERATION', 60), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S715-PMC5941617	['we RECOMMEND against Vitamin D treatment to improve patient’s performance CONSIDERING the LIMITED and CONFLICTING AVAILABLE EVIDENCE.']	[('FUTURE_WORK', 3), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 114)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5956785	5/2018	S186-PMC5956785	['long-term cohort STUDIES CAN FURTHER CLARIFY the RELATIONSHIP between Vitamin D concentration and disease duration or frequency of relapse.']	[('FUTURE_WORK', 17), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5956785	5/2018	S257-PMC5956785	['INVESTIGATING Genetic, nutritional and environmental factors that INFLUENCE Vitamin D in jia COULD HELP inform ways in which Vitamin D status INFLUENCES the occurrence and activity of jia.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC5956785	5/2018	S283-PMC5956785	['INVESTIGATING the Genetic and environmental ROLE that Vitamin D plays in the PREVENTION and Control of jia in the same children will HELP to tease out the multifaceted ROLE played by Vitamin D in this disease.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 77), ('FUTURE_WORK', 133), ('SUPERFICIAL_RELATIONSHIP', 168)]	5	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0065007', 'biological regulation', 92, 'control'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC6011374	6/2018	S91-PMC6011374	['furthermore, there MAY BE POSSIBLE fetal sex specific DIFFERENCES in Vitamin D status WORTH CONSIDERING in FUTURE STUDIES.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('IMPORTANT_CONSIDERATION', 86), ('FUTURE_WORK', 107)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC2290997	4/2008	S136-PMC2290997	['in the near FUTURE, Vitamin D and health GUIDELINES regarding sun exposure MAY NEED TO BE revised.']	[('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 41), ('INCOMPLETE_EVIDENCE', 75), ('FUTURE_WORK', 79)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC2405769	5/2008	S13-PMC2405769	['background\nmultivitamin-Mineral supplementation is RECOMMENDED before and during Pregnancy to ensure adequate intake of several KEY Nutrients including Folate, iron, and more RECENTLY Vitamin D – all of which have IMPORTANCE among Pregnant women, women of Childbearing age, and during Fetal Development [1-6].']	[('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 128), ('INCOMPLETE_EVIDENCE', 175), ('IMPORTANT_CONSIDERATION', 214)]	4	[('CHEBI_46662', 'mineral', 24, 'mineral'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('CHEBI_33284', 'nutrient', 132, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 152, 'folate'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 231, 'pregnant'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 256, 'childbearing'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 285, 'fetal development')]
PMC2716336	7/2009	S162-PMC2716336	['HOWEVER, because Vitamin C is Water-soluble and heat labile, RECOMMENDATIONS MUST STRESS the IMPORTANCE of the retention of Vitamin C during Food Preparation and cooking.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 93)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin C'), ('CHEBI_15377', 'water', 30, 'water'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin C'), ('CHEBI_33290', 'food', 141, 'food'), ('GO_0007631', 'feeding behavior', 141, 'food preparation')]
PMC2798111	12/2010	S19-PMC2798111	['with THIS KNOWLEDGE, IT IS CLEAR that Vitamin D supplementation of the breastfedinfant is NECESSARY and RECOMMENDED by the american academy of pediatrics and the canadian pediatrics society [5,25].']	[('PROBABLE_UNDERSTANDING', 5), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 90), ('FUTURE_WORK', 104)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC2798111	12/2010	S98-PMC2798111	['UNTIL it can be determined WHAT amount of Vitamin D supplementation in mothers will effectively and SAFELY increase and/or maintain the Vitamin D status in her breastfed infant, we MUST rely on Vitamin D supplementation of the infant to prevent deficiency.']	[('FUTURE_WORK', 0), ('EXPLICIT_QUESTION', 27), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC2872349	4/2010	S93-PMC2872349	['ADDITIONAL EVIDENCE SUPPORTING a ROLE for maternal Vitamin D status was obtained in the southampton women’s survey, when maternal Vitamin D concentrations again CORRELATED with neonatal bone mass [41].']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 161)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC2874518	6/2010	S121-PMC2874518	['the PATTERN of dietary supplement use in our cohort, with most women taking Supplements (mainly Folic Acid) in the first Trimester, is expected because there is no national RECOMMENDATION in england for routine Supplement-taking during Pregnancy apart from Folic Acid in the first trimester and Vitamin D for Pregnant women in ‘high-RISK’ groups.30there is no national RECOMMENDATION to take multivitamin and Mineral supplements at any stage during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 173), ('IMPORTANT_CONSIDERATION', 333), ('FUTURE_WORK', 369)]	4	[('CHEBI_33341', 'titanium atom', 76, 'supplements'), ('CHEBI_30751', 'formic acid', 96, 'folic acid'), ('GO_0009294', 'DNA mediated transformation', 121, 'trimester'), ('CHEBI_16158', 'steroid sulfate', 211, 'supplement'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy'), ('CHEBI_30751', 'formic acid', 257, 'folic acid'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'pregnant'), ('CHEBI_46662', 'mineral', 409, 'mineral'), ('GO_0007565', 'female pregnancy', 449, 'pregnancy')]
PMC2963768	10/2010	S19-PMC2963768	["summary of studies of Vitamin D status of infants and children aged 1 month to <5 years in bangladesh, pakistan, and indiastudyparticipantslocationlatitudeseasonno.mean 25(Oh)d (nmol/l)categorical descriptions of Vitamin D statuscombs et al ., 2008 (9)aged 1-5 years; no clinical signs of ricketschakaria subdistrict, cox's bazar, bangladesh21°nunknown15868.3\n25(Oh)D <25 nmol/l in 6% (10/158)\n25(Oh)D <37.5 nmol/l in 21% (33/158)fischer et al ., 1999 (10)cases in case-control study of rickets; aged 10-120 monthschakaria subdistrict, bangladesh21°nunknown1450\nrange 17.5-162.5 nmol/l\n25(Oh)D <35 nmol/l in 2/14 (14%).controlschakaria subdistrict, bangladesh21°nunknown1362.5\nrange 55-87.5 nmol/l\nnone with 25(Oh)D <35 nmol/latiq et al ., 1998 (11)aged 6 weeks-11 months; immunization clinickarachi, pakistan25°nnovember-march2324.5\n25(Oh)D <25 nmol/l in 52% (throughout the year)april-october4840.7agarwal et al ., 2002 (12)aged 9-24 months; high-pollution areamorigate, delhi, india28°nmarch-april2631\n25(oh)d <30 nmol/l in 35%aged 9-24 months; low-pollution areagurgaon, delhi, india28°nmarch-april3168\n25(Oh)D <30 nmol/l in 0%bhalala et al ., 2007 (13)healthy breastfed infants aged 3 monthsmumbai, india18°nthroughout the year3545.5\n25(Oh)D <62.5 nmol/l in 80%tiwari and puliyel, 2004 (14)aged 9-30 months living in impoverished neighbourhoodssundernagari, delhi, india28°njanuary4796.3\n25(Oh)D <35 nmol/l in 2%rajiv colony, delhi, india28°nfebruary4923.8\n25(Oh)D <35nmol/l in 82.9%rajiv colony, delhi, india28°naugust4817.8\n25(Oh)D <35 nmol/l in 84.0%gurgaon, delhi, india28°naugust5219.2\n25(Oh)D <35 nmol/l in 82.0%wayse et al ., 2004 (15)healthy controls in case-control study; aged <5 yearsindapur, india17°nmay-june7038.4\n25(Oh)D <22.5 nmol/l in 31%\n25(Oh)D <50 nmol/l in 61%\nknowledge of the Vitamin D status of young children and infants IS NEEDED to DESIGN STUDIES targeting the aetiologic mechanisms and POTENTIAL health IMPLICATIONS of deficiency."]	[('FUTURE_WORK', 1851), ('FUTURE_WORK', 1864), ('INCOMPLETE_EVIDENCE', 1919), ('IMPORTANT_CONSIDERATION', 1936)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_37972', 'phosphorus-32 atom', 169, '25'), ('CHEBI_17792', 'organohalogen compound', 172, 'OH'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 360, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 394, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 588, '(OH)D'), ('CHEBI_71657', 'versiconol acetate', 708, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 711, 'OH ... D'), ('CHEBI_71657', 'versiconol acetate', 834, '25(OH)D'), ('PR_000006880', 'extracellular matrix protein 2', 834, '25 ... OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1110, 'OH)D'), ('CHEBI_71657', 'versiconol acetate', 1239, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1393, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1399, 'D'), ('CHEBI_71657', 'versiconol acetate', 1462, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1531, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1596, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1733, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1761, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1804, 'vitamin D')]
PMC2963768	10/2010	S20-PMC2963768	['a case-control study on the ASSOCIATION between acute Lower Respiratory Tract infection (alri) and Vitamin D status in infants and young children conducted in zakiganj subdistrict of sylhet district in bangladesh, during january-february 2008, provided an OPPORTUNITY to gain PRELIMINARY INSIGHTS into the Vitamin D status of infants in northeastern rural bangladesh (4).']	[('SUPERFICIAL_RELATIONSHIP', 28), ('FUTURE_WORK', 256), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 288)]	4	[('UBERON_0004905', 'articulation', 54, 'lower respiratory tract'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC2963768	10/2010	S154-PMC2963768	['THEREFORE, RECOMMENDATIONS for universal Antenatal and/or infant Vitamin D supplementation in bangladesh BASED ON biochemical data ALONE would be premature.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 131)]	4	[('GO_0007567', 'parturition', 41, 'antenatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3004407	12/2010	S12-PMC3004407	['THESE FINDINGS RAISE the ISSUE of adequacy of current Vitamin D RECOMMENDATIONS for Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 15), ('PROBLEM_COMPLICATION', 25), ('FUTURE_WORK', 64)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnant')]
PMC3004407	12/2010	S21-PMC3004407	['THEORETICALLY, women at lower latitudes, DESPITE darker pigmentation, SHOULD have less Vitamin D deficiency because of the greater LIKELIHOOD of effective sunlight exposure to induce endogenous Vitamin d synthesis [33].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 41), ('FUTURE_WORK', 70), ('PROBABLE_UNDERSTANDING', 131)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
PMC3034879	12/2010	S15-PMC3034879	['FURTHER ATTENTION SHOULD BE PAID to improving Vitamin D status during Pregnancy.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 18), ('IMPORTANT_CONSIDERATION', 28)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC3034879	12/2010	S180-PMC3034879	['HOWEVER, the number of d3users was very low ( n \u2009=\u200912), which MEANS that FURTHER comparison between DIFFERENT forms of Vitamin D is not justified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 62), ('FUTURE_WORK', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100)]	4	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3103150	3/2011	S41-PMC3103150	['these definitions are based ON recent RECOMMENDATIONS regarding classification of Vitamin D status in children, developed after consideration of BIOMARKERS such as changes in alp, bone density and calcium absorption at varying concentrations of 25Ohd16.']	[('ANOMALY_CURIOUS_FINDING', 28), ('ANOMALY_CURIOUS_FINDING', 28), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_63310', 'mycinamicin IV(1+)', 245, '25OHD16')]
PMC3257641	3/2010	S79-PMC3257641	['Human STUDIES ARE NEEDED AS inter-species variation in Vitamin D REQUIREMENTS and Metabolism MAY occur [55].']	[('FUTURE_WORK', 6), ('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 65), ('INCOMPLETE_EVIDENCE', 93)]	4	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0008152', 'metabolic process', 82, 'metabolism')]
PMC3257641	3/2010	S106-PMC3257641	['NEVERTHELESS, in two studies in Pigs, Vitamin D administration to two sows at doses that achieved Serum 25(Oh)D levels, APPROXIMATING RECOMMENDED Human levels, was ASSOCIATED with Coronary lesions in offspring at six weeks [74,75].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 120), ('FUTURE_WORK', 134), ('SUPERFICIAL_RELATIONSHIP', 164)]	4	[('NCBITaxon_10088', 'Mus <genus>', 32, 'pigs'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('NCBITaxon_9606', 'Homo sapiens', 146, 'human'), ('UBERON_0005985', 'coronary vessel', 180, 'coronary')]
PMC3271033	1/2012	S160-PMC3271033	['LARGER STUDIES ARE NEEDED in diverse populations at various latitudes to FURTHER characterize the RELATIONSHIP between Vitamin D supplementation and bone Mineral content.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('FUTURE_WORK', 73), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_46662', 'mineral', 154, 'mineral')]
PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
PMC3347007	4/2012	S6-PMC3347007	['we PROPOSE that clinicians ENCOURAGE Vitamin D supplementation among Pregnant women, with SPECIAL FOCUS on vulnerable groups such as the young, smokers and multiparous women, in order to improve maternal and fetal health both during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 27), ('IMPORTANT_CONSIDERATION', 90), ('IMPORTANT_CONSIDERATION', 98)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('GO_0007565', 'female pregnancy', 243, 'pregnancy')]
PMC3347007	4/2012	S10-PMC3347007	['sun exposure MAY also increase the risk of skin cancer and it MAY THEREFORE be problematic to ENCOURAGE sun exposure as the only source of Vitamin D [2].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 62), ('PROBABLE_UNDERSTANDING', 66), ('FUTURE_WORK', 94)]	4	[('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3347007	4/2012	S21-PMC3347007	['the definition of optimal Vitamin D status and optimal intake level of Vitamin D HAVE BEEN subject to much DEBATE, and RECOMMENDATIONS VARY between countries.']	[('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('FUTURE_WORK', 119), ('DIFFICULT_TASK', 135)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3347007	4/2012	S28-PMC3347007	['this information CAN HELP identify women AT RISK of insufficient Vitamin D intake and POTENTIALLY Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 41), ('INCOMPLETE_EVIDENCE', 86)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3347007	4/2012	S184-PMC3347007	['determinants of Vitamin D insufficiency MUST BE TAKEN INTO CONSIDERATION in making RECOMMENDATIONS on Vitamin D intake in Pregnancy, to include more vulnerable groups that MAY BE at higher risk of deficiency.']	[('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 48), ('FUTURE_WORK', 83), ('INCOMPLETE_EVIDENCE', 172)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC3347028	3/2012	S225-PMC3347028	['MORE WORK IS WARRANTED in this AREA to understand the POSSIBLE ROLE of Vitamin D deficiency in preeclampsia.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3348565	4/2012	S23-PMC3348565	['in children, Serum Calcifediol concentrations SHOULD BE maintained at 50 nmol/l (20 ng/ml) or greater for Skeletal benefits.6vitamin D deficiency rickets in children younger than 5 years is an endemic PROBLEM in developing countries, ranging from 5–45%, EVEN where sunlight is abundant,1,2,7,8and has also re-emerged in SOME developed countries.7,9\nin People, the main source of Vitamin D is through the action of ultraviolet b radiation on 7-Dehydrocholesterol in the skin, with small amounts derived from dietary sources.']	[('FUTURE_WORK', 46), ('PROBLEM_COMPLICATION', 201), ('ANOMALY_CURIOUS_FINDING', 254), ('INCOMPLETE_EVIDENCE', 320)]	4	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 19, 'calcifediol'), ('UBERON_0004288', 'skeleton', 106, 'skeletal'), ('PR_000006444', 'diacylglycerol kinase delta', 133, 'D'), ('NCBITaxon_10088', 'Mus <genus>', 352, 'people'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 441, '7-dehydrocholesterol')]
PMC3356951	4/2012	S143-PMC3356951	['[102] among women younger than 75 years, there is a lower RISK for early amd with higher Vitamin D levels, with a threshold EFFECT at 15.22 ng/l Serum 25 (Oh)D.\n\nrecommendation guidelines: endocrine society of clinical practice\n\ndiagnostic procedure\nescp RECOMMEND screening for vdd in Individuals at risk for deficiency and not for patients who are not AT RISK.']	[('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 124), ('FUTURE_WORK', 255), ('IMPORTANT_CONSIDERATION', 354)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_71657', 'versiconol acetate', 151, '25 (OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 151, '25 (OH)D'), ('NCBITaxon_1', 'root', 286, 'individuals')]
PMC3356951	4/2012	S146-PMC3356951	["[103]\n\nrecommended dietary intakes of Vitamin D\nescp SUGGESTS that obese children and Adults on Anticonvulsant medications, Glucocorticoids, antifungals such as Ketoconazole, and medications for aids SHOULD BE given at least two to three times more Vitamin D for their age group to satisfy their body's Vitamin D REQUIREMENT[table 1]."]	[('INCOMPLETE_EVIDENCE', 53), ('FUTURE_WORK', 200), ('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 313)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adults'), ('CHEBI_35624', 'azaspiro compound', 96, 'anticonvulsant'), ('CHEBI_36597', 'phthalazine', 124, 'glucocorticoids'), ('CHEBI_47519', 'ketoconazole', 161, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC3407995	7/2012	S290-PMC3407995	['HOWEVER, because Vitamin D intake is highly CORRELATED with the Intake of Long Chain N -3 Fatty Acids in the norwegian diet, the authors cautioned that further RESEARCH IS NEEDED to disentangle the separate EFFECTS of these Nutrients.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 207)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007631', 'feeding behavior', 64, 'intake'), ('CHEBI_25098', 'lyxoside', 74, 'long chain n -3 fatty acids'), ('CHEBI_33284', 'nutrient', 224, 'nutrients')]
PMC3424155	8/2012	S209-PMC3424155	['FURTHER STUDIES are NECESSARY TO CLARIFY the IMPACT of maternal Vitamin D restriction on the Renal function of offspring.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002113', 'kidney', 93, 'renal')]
PMC3427192	4/2012	S72-PMC3427192	['FURTHER mechanistic STUDIES ARE also NEEDED to understand the mechanisms by which Vitamin D exerts its EFFECTS both in healthy Individuals and subjects with chronic inflammatory disorders such as asthma.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 20), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 103)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('NCBITaxon_1', 'root', 127, 'individuals')]
PMC3427250	8/2012	S116-PMC3427250	['the adequate intake of Vitamin D during Pregnancy and Lactation is UNKNOWN, ALTHOUGH it APPEARS TO BE greater than the current dietary RECOMMENDATIONS of 400 iu/d or 10 µg/d[58].']	[('FULL_UNKNOWN', 67), ('ANOMALY_CURIOUS_FINDING', 76), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 135)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0007595', 'lactation', 54, 'lactation')]
PMC3427250	8/2012	S118-PMC3427250	['as those authors recognize that the EVIDENCE to propose such Intakes IS SCARCE and as long as the health benefits of having Serum 25(Oh)D levels higher than 30 ng/ml are NOT clearly ESTABLISHED particularly in Pregnant women, the belgian superior health council STILL RECOMMENDS a Vitamin D supplement of 20 µg/day or 800 iu during Pregnancy[58].']	[('INCOMPLETE_EVIDENCE', 36), ('FULL_UNKNOWN', 170), ('IMPORTANT_CONSIDERATION', 262), ('FUTURE_WORK', 268)]	4	[('GO_0007631', 'feeding behavior', 61, 'intakes'), ('UBERON_0001977', 'blood serum', 124, 'serum'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 132, '(OH ... D'), ('GO_0007565', 'female pregnancy', 210, 'pregnant'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('GO_0007565', 'female pregnancy', 332, 'pregnancy')]
PMC3427250	8/2012	S122-PMC3427250	['in addition to the UNCERTAINTY CONCERNING the optimal Vitamin D intakes preventing Vitamin D deficiency, there exists also a LACK OF RECOMMENDATIONS to treat Vitamin D deficient Pregnant women.']	[('FULL_UNKNOWN', 19), ('PROBLEM_COMPLICATION', 31), ('INCOMPLETE_EVIDENCE', 125), ('FUTURE_WORK', 133)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC3465343	10/2012	S190-PMC3465343	['moreover, EFFECTS of partial INSTEAD of absolute deprivation of Vitamin A on Spine malformation SHOULD also BE examined.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin A'), ('UBERON_0001013', 'adipose tissue', 77, 'spine')]
PMC3504157	11/2012	S23-PMC3504157	['MANY health providers NOW RECOMMEND nhps including Prenatal Vitamins, iron supplementation, calcium, and Vitamin D for a range of RECOGNIZED indications including deficiency states such as rickets and anemia, as well as illnesses such as multiple sclerosis.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 22), ('FUTURE_WORK', 26), ('PROBABLE_UNDERSTANDING', 130)]	4	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 60, 'vitamins'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC3552819	12/2012	S10-PMC3552819	['these PRELIMINARY DATA SUPPORT the FURTHER INVESTIGATION of Antenatal Vitamin D3 regimens involving doses of ≤70,000 iu in regions where maternal-infant Vitamin D deficiency is common.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 35)]	4	[('GO_0007567', 'parturition', 60, 'antenatal'), ('CHEBI_33279', 'vitamin D5', 70, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 70, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3635901	4/2013	S41-PMC3635901	['finally, because (no-longer-just-a-)Vitamin D has several physiological properties INVOLVED with the Innate Immune Defense Against Tb, the ROLE of this Vitamin in the treatment of tb SHOULD BE evaluated, especially when ASSOCIATED with autoimmunity [18].']	[('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 139), ('FUTURE_WORK', 183), ('SUPERFICIAL_RELATIONSHIP', 220)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0048017', 'inositol lipid-mediated signaling', 101, 'innate immune defense against TB'), ('UBERON_0002405', 'immune system', 108, 'immune'), ('CHEBI_33229', 'vitamin (role)', 152, 'vitamin')]
PMC3659910	1/2013	S10-PMC3659910	['clearly, FURTHER INVESTIGATION is REQUIRED into the EFFECTS of Vitamin D, of Vitamin D supplementation, and of Vitamin D analogs for IMPROVEMENT in Human health generally and mothers and children specifically.']	[('FUTURE_WORK', 9), ('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 52), ('FUTURE_WORK', 133)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 148, 'human')]
PMC3659910	1/2013	S11-PMC3659910	['THIS REVIEW discusses Vitamin D Metabolism, dietary REQUIREMENTS and RECOMMENDATIONS and IMPLICATIONS of Vitamin D deficiency during Pregnancy and Lactation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 52), ('FUTURE_WORK', 69), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 22, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0007595', 'lactation', 147, 'lactation')]
PMC3659910	1/2013	S61-PMC3659910	['in the united states staple Foods like milk, breakfast cereals and margarines are artificially fortified with Vitamin D.[14] AT PRESENT, the number and variety of Vitamin D fortified foods available on the market DIFFERS significantly between countries and is ATTRIBUTED to the country-specific policies on Food fortification which are NOT YET unified.']	[('INCOMPLETE_EVIDENCE', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('SUPERFICIAL_RELATIONSHIP', 260), ('FUTURE_WORK', 336)]	4	[('CHEBI_33290', 'food', 28, 'foods'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_33290', 'food', 307, 'food')]
PMC3659910	1/2013	S157-PMC3659910	['one approach is to CONSIDER Serum testing in patients at high RISK for Vitamin D deficiency BUT treating without testing those at lower RISK.']	[('FUTURE_WORK', 19), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 136)]	4	[('UBERON_0001977', 'blood serum', 28, 'serum'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3659910	1/2013	S158-PMC3659910	['the BASIS for these RECOMMENDATIONS was made BEFORE IT WAS POSSIBLE to measure the circulating concentration of 25-Hydroxyvitamin D [25(Oh) D], the INDICATOR of nutritional Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 4), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 112, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3659910	1/2013	S185-PMC3659910	['HOWEVER, getting 25(Oh) D levels consistently above 75 nmol/l (30 ng/ml) MAY REQUIRE AT LEAST 1500-2000 iu/day of Vitamin D. if a mother is Vitamin D deficient, Breast Milk is not a good source of Vitamin D, so infants need to be given Vitamin D supplementation until they are weaned.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73), ('FUTURE_WORK', 77), ('PROBABLE_UNDERSTANDING', 85)]	4	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 24, 'D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('UBERON_0000310', 'breast', 161, 'breast'), ('UBERON_0001913', 'milk', 168, 'milk'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC3659910	1/2013	S186-PMC3659910	['also women are ENCOURAGED to continue to take Vitamin D supplements after Pregnancy to HELP PROTECT against health PROBLEMS such as osteoporosis.']	[('IMPORTANT_CONSIDERATION', 15), ('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 115)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC3659910	1/2013	S189-PMC3659910	['the current LACK OF EVIDENCE of benefit for women at lower RISK of Vitamin D deficiency points to the NEED FOR FURTHER RESEARCH into Vitamin D supplementation in Pregnant women with clinical neonatal and infant end-points under SCRUTINY.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 59), ('FUTURE_WORK', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007565', 'female pregnancy', 162, 'pregnant')]
PMC3659910	1/2013	S193-PMC3659910	["SENSIBLE sun exposure and education of the public about the beneficial EFFECTS of some limited sun exposure to satisfy their body's Vitamin D REQUIREMENTS SHOULD BE implemented."]	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 142), ('FUTURE_WORK', 155)]	4	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3672018	5/2013	S7-PMC3672018	['discussion\nthe results of the study will contribute to our CURRENT understanding of the SIGNIFICANCE of supplementation with Vitamin D. more specifically, they will enable new RESEARCH in related fields, including interventional research designed to assess supplementation NEEDS for different subgroups of Pregnant women.']	[('INCOMPLETE_EVIDENCE', 59), ('IMPORTANT_CONSIDERATION', 88), ('FUTURE_WORK', 176), ('IMPORTANT_CONSIDERATION', 273)]	4	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('GO_0007565', 'female pregnancy', 306, 'pregnant')]
PMC3702245	6/2013	S4-PMC3702245	['introduction\nVitamin D deficiency in Pregnancy is widespread in many parts of the world,1and there is an ASSOCIATION between low Vitamin D status and multiple POTENTIAL adverse outcomes of Pregnancy.2–5therefore, Vitamin D nutrition in Pregnancy SHOULD BE of GLOBAL HEALTH INTEREST.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 159), ('FUTURE_WORK', 246), ('IMPORTANT_CONSIDERATION', 259)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC3702245	6/2013	S31-PMC3702245	['RANDOMIZED controlled TRIALS with large sample sizes ARE NEEDED to assess the EFFECT of maternal Vitamin D supplementation on fetal Bone Development.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0048539', 'bone marrow development', 132, 'bone development')]
PMC3713405	7/2013	S211-PMC3713405	['in addition, it also SUGGESTS that FURTHER STUDY on the temporal window of Vitamin D deficiency would be EXTREMELY INFORMATIVE.']	[('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 105), ('INCOMPLETE_EVIDENCE', 115)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3717170	5/2013	S74-PMC3717170	['ADDITIONAL RESEARCH that addresses the IMPACT of Vitamin D on Immune Homeostasis during Pregnancy and its EFFECTS during early infancy and later childhood becomes ESSENTIAL.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 163)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0055090', 'acylglycerol homeostasis', 62, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy')]
PMC3717170	5/2013	S77-PMC3717170	['Vitamin D and obesity\nigor n. sergeev (south dakota state university) DISCUSSED the POSSIBILITY of integrating Vitamin D supplementation with current STRATEGIES in the PREVENTION and treatment of obesity.']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 84), ('FUTURE_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3717170	5/2013	S92-PMC3717170	['ADDITIONAL STUDIES ARE WARRANTED to evaluate this approach from a safety POINT OF VIEW and to identify the OPTIMAL levels of Calcium and Vitamin D intakes in obesity.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 73), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 125, 'calcium'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3717170	5/2013	S112-PMC3717170	['from their unpublished secondary analysis, rutten and colleagues conclude that THERE IS EVIDENCE SUGGESTING that Vitamin D plays a ROLE in the Lung pathology of patients with copd, which requires FURTHER INVESTIGATION.']	[('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 131), ('FUTURE_WORK', 196)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0002048', 'lung', 143, 'lung')]
PMC3717170	5/2013	S173-PMC3717170	['HOWEVER, some recent DATA SUGGEST that low Vitamin D PREDICTS an accelerated increase in fat mass and incident obesity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC3717170	5/2013	S186-PMC3717170	['RECOMMENDATIONS for the appropriate amount of Vitamin D to be taken for OPTIMAL health—BE it for Musculoskeletal strength OR for the numerous nonskeletal presumptive benefits of Vitamin D—remain contentious.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 97, 'musculoskeletal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3717170	5/2013	S187-PMC3717170	['there is GENERAL CONSENSUS that the earlier RECOMMENDATION of 400 iu of Vitamin D/day was INSUFFICIENT.']	[('PROBABLE_UNDERSTANDING', 9), ('FUTURE_WORK', 44), ('IMPORTANT_CONSIDERATION', 90), ('PROBLEM_COMPLICATION', 90)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3717763	8/2013	S9-PMC3717763	['this scheme provides low-income families in the uk with fixed-value Food vouchers and vitamin coupons for eligible women and young children.1vitamin coupons can be exchanged for branded hs vitamin tablets for women (70\u2005mg Vitamin C, 10\u2005µg Vitamin D and 400\u2005µg Folic Acid daily during Pregnancy, and one year Postpartum) and drops for children (233\u2005µg Vitamin A, 20\u2005µg Vitamin C, and 7.5\u2005µg Vitamin D3 daily between\n\ncaption (boxed-text)\nwhat is already known on THIS topic\ncurrent uk GUIDANCE is that vulnerable groups of Pregnant and breastfeeding women and young children SHOULD take Vitamin Supplements (including Vitamins A, c and d) to protect against the greater RISK of Birth defects and poor health outcomes in later Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 462), ('FUTURE_WORK', 484), ('FUTURE_WORK', 574), ('IMPORTANT_CONSIDERATION', 669)]	4	[('CHEBI_33290', 'food', 68, 'food'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('CHEBI_30751', 'formic acid', 260, 'folic acid'), ('GO_0007565', 'female pregnancy', 284, 'pregnancy'), ('GO_0007565', 'female pregnancy', 308, 'postpartum'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin C'), ('CHEBI_33279', 'vitamin D5', 390, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 390, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 522, 'pregnant'), ('CHEBI_33229', 'vitamin (role)', 586, 'vitamin'), ('CHEBI_33341', 'titanium atom', 594, 'supplements'), ('CHEBI_27300', 'vitamin D', 617, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 626, 'A'), ('GO_0007567', 'parturition', 677, 'birth'), ('UBERON_0000104', 'life cycle', 725, 'life')]
PMC3760821	9/2013	S40-PMC3760821	['THESE FINDINGS led the study authors to CONCLUDE that population level INTERVENTIONS to reduce bmi would be expected to decrease the prevalence of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 71), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC3760821	9/2013	S165-PMC3760821	['in 2011, the uk scientific advisory committee on nutrition decided, based on NEW DATA, including the iom report of dietary reference values, that there is now SUFFICIENT evidence for an update on Vitamin D, which is expected june 2014[3].']	[('FULL_UNKNOWN', 77), ('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 159), ('IMPORTANT_CONSIDERATION', 159)]	4	[('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3773018	4/2013	S69-PMC3773018	['AS SUCH, IT IS POSSIBLE that SOME of the children in this study did not consume 1,000 ml Vitamin D-fortified formula per day, and were not Fed additional Vitamin D supplements to meet the RECOMMENDED intake of 400 iu/day for infants, children, and adolescents (30).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('FUTURE_WORK', 188)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007631', 'feeding behavior', 139, 'fed'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC3814422	10/2013	S124-PMC3814422	['for instance, it HAS BEEN SUGGESTED that there is a NEED to DISTINGUISH between Serum 25(Oh)D and EFFECTS of Vitamin D supplementation, the former being a prohormone representing a physiological state that is only relevant at extremely high or low levels, and the latter representing the non-physiological action of interest4.']	[('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('UBERON_0001977', 'blood serum', 80, 'serum'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 86, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3827489	10/2013	S5-PMC3827489	['it is RECOMMENDED that all infants, children, and adolescents have a minimum daily intake of 400 iu (10 µg) of Vitamin D. SINCE the vitamin d status of the newborn is highly RELATED to maternal Vitamin D levels, optimal Vitamin D levels in the mother during Pregnancy SHOULD BE maintained.']	[('FUTURE_WORK', 6), ('PROBABLE_UNDERSTANDING', 122), ('SUPERFICIAL_RELATIONSHIP', 174), ('FUTURE_WORK', 268)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy')]
PMC3827489	10/2013	S97-PMC3827489	['RECOMMENDATION of Vitamin D supplementation for infants, children, and adolescents\nRECENTLY, the american academy of pediatrics (aap) RECOMMENDED that all infants (beginning soon after Birth), children, and adolescents have a minimum daily intake of 400 iu (10 µg) of Vitamin D74), which is two times the previous recommended dose of Vitamin D supplementation SUGGESTED in a 2003 clinical report from the aap.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 83), ('FUTURE_WORK', 134), ('INCOMPLETE_EVIDENCE', 360)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007567', 'parturition', 185, 'birth'), ('CHEBI_33279', 'vitamin D5', 268, 'vitamin D74'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D')]
PMC3873449	12/2013	S187-PMC3873449	['ON THE BASIS of THESE FINDINGS, it SEEMS logical that Pregnant women SHOULD routinely be supplemented with Vitamin D in china.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('ANOMALY_CURIOUS_FINDING', 35), ('FUTURE_WORK', 69)]	4	[('GO_0007565', 'female pregnancy', 54, 'pregnant'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3991049	11/2013	S80-PMC3991049	['we NEED rct of Vitamin D supplementation with measurement of 25-Hydroxyvitamin D to determine the baseline status, the level achieved on supplementation with appropriate design to avoid any CONFOUNDER, and TO ASSESS WHAT is the appropriate level of Vitamin D during Pregnancy and in newborns with no complications or toxicity through out.']	[('FUTURE_WORK', 3), ('PROBLEM_COMPLICATION', 190), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('EXPLICIT_QUESTION', 216)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 61, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC4045304	2/2014	S271-PMC4045304	['MORE RESEARCH IS also NEEDED to FURTHER investigate quantitative Genetic variations in various components of the Vitamin D system.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 22), ('FUTURE_WORK', 32)]	4	[('SO_0000704', 'gene', 65, 'genetic'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4106226	7/2014	S45-PMC4106226	['the authors conclude that PUBLIC HEALTH MESSAGE on the IMPORTANCE of Vitamin D status especially in diabetic children and adolescents, SHOULD BE disseminated to the public.']	[('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 55), ('FUTURE_WORK', 135)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S136-PMC4113768	['FURTHER ANALYSIS is underway to assess POSSIBLE EXPLANATIONS for these varying RELATIONSHIPS between Vitamin D status and bone geometry by ethnicity and bone site.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 79)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4113768	7/2014	S473-PMC4113768	['high intakes (above RECOMMENDED daily amounts) of Vitamin A HAVE BEEN REPORTED to counteract the EFFECTS of Vitamin D (including EFFECTS in rcts).']	[('FUTURE_WORK', 20), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4113768	7/2014	S683-PMC4113768	['poorer Vitamin D status in māori MAY REFLECT darker skin tone or inequitable supply of oral Vitamin D. primary care practitioners SHOULD BE aware of the availability and common use of high-dose Vitamin D preparations, and SHOULD ask about over-the-counter Supplement use before prescribing Pharmaceutical Vitamin D in those of advanced aged.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('FUTURE_WORK', 130), ('FUTURE_WORK', 222)]	4	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 256, 'supplement'), ('CHEBI_52217', 'pharmaceutical', 290, 'pharmaceutical'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D')]
PMC4113768	7/2014	S1879-PMC4113768	['conclusions: THIS STUDY has IMPORTANT IMPLICATIONS for the FUTURE of Food fortification in helping to raise the Vitamin D status of the population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 38), ('FUTURE_WORK', 59)]	4	[('CHEBI_33290', 'food', 69, 'food'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4113768	7/2014	S2386-PMC4113768	['ANOTHER implication MIGHT BE that Serum 25-Ohd measurements during summertime SHOULD BE repeated during wintertime, OR that a higher threshold for Vitamin D deficiency ( i.e.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	4	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_72765', 'verruculogen', 40, '25-OHD'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC4113768	7/2014	S2441-PMC4113768	['healthcare providers SHOULD BE AWARE that Vitamin D deficiency is LIKELY to be currently under-diagnosed in tb patients.']	[('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 21), ('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 66)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4113768	7/2014	S2465-PMC4113768	['of the participants who did not take Supplements, none achieved the current uk RECOMMENDED dietary intake of 400 iu Vitamin D per day for those AT RISK of deficiency; and for the supplement users the RECOMMENDATION was ONLY achieved by one Person in spring and 2 People in summer and autumn.']	[('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 144), ('FUTURE_WORK', 200), ('INCOMPLETE_EVIDENCE', 219)]	4	[('CHEBI_33341', 'titanium atom', 37, 'supplements'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 240, 'person'), ('NCBITaxon_10088', 'Mus <genus>', 263, 'people')]
PMC4169453	9/2014	S203-PMC4169453	['it is JUSTIFIED to RECOMMEND Vitamin D supplementation in breastfeeding women BASED ON their NEEDS and separately in Breastfed infants.']	[('IMPORTANT_CONSIDERATION', 6), ('FUTURE_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 93)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007567', 'parturition', 117, 'breastfed')]
PMC4169453	9/2014	S243-PMC4169453	['FURTHER STUDIES of Vitamin D supplementation during Lactation are NECESSARY to determine the OPTIMAL dosing for nursing women when taking into account maternal NEEDS.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 66), ('IMPORTANT_CONSIDERATION', 93), ('IMPORTANT_CONSIDERATION', 160)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007595', 'lactation', 52, 'lactation')]
PMC4302429	1/2015	S211-PMC4302429	['WHETHER high-dose Vitamin D has a PROTECTIVE EFFECT in combination with Antibiotics remains TO BE studied.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('FUTURE_WORK', 92)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_33282', 'antibacterial agent', 72, 'antibiotics')]
PMC4329745	10/2014	S12-PMC4329745	['IN ORDER to obtain a better estimation of the Vitamin D status in iran, STUDIES encompassing different populations in various age and sex groups ARE REQUIRED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('FUTURE_WORK', 72), ('FUTURE_WORK', 145), ('IMPORTANT_CONSIDERATION', 149)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4380518	9/2014	S6-PMC4380518	['conclusions\nongoing trials of Vitamin D supplementation during Pregnancy SHOULD CONSIDER POTENTIAL EFFECT MODIFICATION by race/ethnicity.']	[('FUTURE_WORK', 73), ('FUTURE_WORK', 80), ('INCOMPLETE_EVIDENCE', 89), ('PROBLEM_COMPLICATION', 99)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
PMC4380518	9/2014	S66-PMC4380518	['FUTURE ANALYSES of health EFFECTS of Vitamin D status in this population are PLANNED but beyond the scope of THIS analysis.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('FUTURE_WORK', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 109)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4380518	9/2014	S69-PMC4380518	['ONGOING TRIALS of Vitamin D supplementation during Pregnancy SHOULD CONSIDER EFFECT MODIFICATION by race/ethnicity.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 61), ('FUTURE_WORK', 68), ('PROBLEM_COMPLICATION', 77)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC4383226	2/2015	S7-PMC4383226	['FUTURE STUDIES focusing on climate seasonality, Placental malaria and hiv ARE NEEDED to characterize better the ASSOCIATION between Vitamin A and malaria infection in DIFFERENT settings.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	4	[('UBERON_0001987', 'placenta', 48, 'placental'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin A')]
PMC4383226	2/2015	S36-PMC4383226	['multiple clinical TRIALS in infants and young children have also IDENTIFIED PROTECTIVE EFFECTS from Vitamin A supplementation against illness (number and time to first clinical episode, risk of febrile illness, Spleen enlargement, and mean parasite density) (shankar et al., 1999;zeba et al., 2008) and death caused by malaria (fawzi et al., 1999;varandas et al., 2001;mwanga-amumpaire et al., 2012).']	[('FUTURE_WORK', 18), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin A'), ('UBERON_0002106', 'spleen', 211, 'spleen')]
PMC4383226	2/2015	S112-PMC4383226	['ADDITIONAL RESEARCH MAY BE WARRANTED on the IMPACT of Vitamin A supplementation in young children with known Prenatal exposure to malaria.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 11), ('FUTURE_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('GO_0007565', 'female pregnancy', 109, 'prenatal')]
PMC4383226	2/2015	S148-PMC4383226	['FURTHER RESEARCH IS NEEDED to evaluate POTENTIAL INTERACTIONS between Vitamin A, hiv and malaria infection.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A')]
PMC4392531	3/2015	S89-PMC4392531	['HOWEVER, DUE TO the high amount of Vitamin A and e to protect Fatty Acids, the POSSIBILITY of hypervitaminosis SHOULD BE taken into account.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 79), ('FUTURE_WORK', 111)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acids')]
PMC4417995	4/2015	S179-PMC4417995	['topical therapy\ncertain OBSERVATIONS FURTHER aimed at clarifying the ROLE of topical Vitamin D analogues.']	[('INCOMPLETE_EVIDENCE', 24), ('FUTURE_WORK', 37), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 69)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4417995	4/2015	S188-PMC4417995	['ADDITIONAL STUDIES, with adequate sample size, dose adjustment based on target Serum Vitamin D levels, longer duration of treatment, standardization of ad severity assessment, and adequate correction for CONFOUNDING FACTORS such as sun/uvb exposure and Food Intake, ARE CURRENTLY MUCH NEEDED.']	[('FUTURE_WORK', 0), ('PROBLEM_COMPLICATION', 204), ('FUTURE_WORK', 266), ('FUTURE_WORK', 270)]	4	[('UBERON_0001977', 'blood serum', 79, 'serum'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_33290', 'food', 253, 'food'), ('GO_0007631', 'feeding behavior', 253, 'food intake')]
PMC4448820	5/2015	S1243-PMC4448820	['● the wg explored aspects of these INTERACTIONS on BIOMARKERS of specific Nutrients including iron, Vitamin A, hemoglobin, zinc, Iodine, Folate, and Vitamins b-6, b-12, c, and d.\n\nwg RECOMMENDATIONS:\n\none or more biomarkers of inflammation SHOULD BE measured in assessments of Micronutrient status in populations with a known or suspected moderate-to-high prevalence of inflammation.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 51), ('FUTURE_WORK', 183), ('FUTURE_WORK', 240)]	4	[('CHEBI_33284', 'nutrient', 74, 'nutrients'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 129, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 137, 'folate'), ('CHEBI_33277', 'gamma-tocotrienol', 149, 'vitamins'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 277, 'micronutrient')]
PMC4466139	6/2015	S46-PMC4466139	['the analysis was also performed CONSIDERING AS sufficient Vitamin D levels ≥50 nmol/l, AS insufficient levels between 25 nmol/l and 50 nmol/l, and as deficient levels <25 nmol/l, as RECOMMENDED by the institute of medicine [14].']	[('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 87), ('FUTURE_WORK', 182)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4466139	6/2015	S102-PMC4466139	['our results SHOW that few migrant mothers are supplemented with Vitamin D during Pregnancy, especially in the last month, SUGGESTING that more extensive PREVENTION and education programs SHOULD be adopted.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 153), ('FUTURE_WORK', 187)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC4488777	5/2015	S189-PMC4488777	['couples with Serum concentration exceeding 50 nmol/l have a higher CHANCE of Conception, but this DOES NOT REGARD all patients, where ESPECIALLY males SHOULD BE supplemented with Vitamin D from the beginning of the therapy.']	[('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 98), ('ANOMALY_CURIOUS_FINDING', 134), ('FUTURE_WORK', 151)]	4	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('GO_0007620', 'copulation', 77, 'conception'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4586450	10/2015	S528-PMC4586450	['uptake of Vitamin D supplements was low, IN LINE WITH national surveys and DESPITE RECOMMENDATIONS that all children aged 1–5 years SHOULD receive them.']	[('INCOMPLETE_EVIDENCE', 41), ('ANOMALY_CURIOUS_FINDING', 75), ('FUTURE_WORK', 83), ('FUTURE_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4624803	10/2015	S96-PMC4624803	['from a THEORETICAL POINT OF VIEW, in foetal Life and during early childhood, the immature Brain SHOULD BE more vulnerable to environmental INFLUENCES like Vitamin D deficiency [3,4].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0000955', 'brain', 90, 'brain'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4632418	10/2015	S8-PMC4632418	['HOWEVER, well-designed randomized controlled TRIALS ARE NEEDED to elicit the clear EFFECT of Vitamin D supplementation on PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4632418	10/2015	S134-PMC4632418	['HOWEVER, well-designed randomized controlled TRIALS ARE NEEDED to determine the explicit EFFECT of Vitamin D supplementation on PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 89), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4689556	12/2015	S186-PMC4689556	['in that context FURTHER DATA are AWAITED from two larger randomised controlled trials, vdarrt [53] and abcvitamind [54], to establish WHETHER higher dose daily Prenatal Vitamin D supplementation will IMPACT on child health outcomes.']	[('FUTURE_WORK', 16), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('SUPERFICIAL_RELATIONSHIP', 200)]	4	[('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4691762	12/2015	S1-PMC4691762	['countries in the northern hemisphere RECOMMEND universal infant Vitamin D supplementation to optimise early Vitamin D levels, DESPITE the absence of large TRIALS proving SAFETY or efficacy for any disease outcome.']	[('FUTURE_WORK', 37), ('ANOMALY_CURIOUS_FINDING', 126), ('FUTURE_WORK', 155), ('IMPORTANT_CONSIDERATION', 170)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4719746	1/2016	S154-PMC4719746	['compared with no change or a small increase in 25(Oh)D concentrations in women with adequate levels or mild Vitamin D deficiency, this DIFFERENTIAL change may INDICATE a beneficial EFFECT of the RECOMMENDATIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 181), ('FUTURE_WORK', 195)]	4	[('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 53, 'D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4764019	1/2016	S14-PMC4764019	['the RELATION to Vitamin D inadequacy SHOULD BE understood simply as just one of the conditions that, when met, together LEAD TO expression of the diseases CONCERNED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 155)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4770602	1/2016	S25-PMC4770602	['and FURTHER prospective longitudinal STUDIES or randomized controlled trials to assess the POTENTIAL EFFECT of Vitamin D supplementation on adverse Pregnancy outcomes are SUGGESTED.']	[('FUTURE_WORK', 4), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 171)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy')]
PMC4770602	1/2016	S80-PMC4770602	['and FURTHER TRIALS ARE NEEDED to FURTHER CLARIFY the EFFECT of calcium supplementation, Vitamin D supplementation, or both on reduce the incidence of Preeclampsia.']	[('FUTURE_WORK', 4), ('FUTURE_WORK', 12), ('FUTURE_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 150, 'preeclampsia')]
PMC4785305	3/2016	S16-PMC4785305	['caption (boxed-text)\nstrengths and limitations of this study\n\nTHIS is the FIRST randomised controlled trial (rct) in the middle east directly addressing the applicability of the institute of medicine RECOMMENDATIONS in this specific population, and assessing the EFFECT of Vitamin D supplementation on neonatal bone Mineral content.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 74), ('FUTURE_WORK', 200), ('SUPERFICIAL_RELATIONSHIP', 263)]	4	[('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_46662', 'mineral', 316, 'mineral')]
PMC4832516	10/2015	S136-PMC4832516	['similarly, NO information was AVAILABLE on maternal residential location, individually-measured sunshine exposure, or Vitamin D supplementation during Pregnancy, HOWEVER EVEN the youngest participant in the uk biobank (aged 38 in our analysis) was Conceived during a time when Gestational Vitamin D supplementation was not RECOMMENDED in the uk.']	[('FULL_UNKNOWN', 11), ('ANOMALY_CURIOUS_FINDING', 162), ('ANOMALY_CURIOUS_FINDING', 170), ('FUTURE_WORK', 323)]	4	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0070268', 'cornification', 248, 'conceived'), ('GO_0007565', 'female pregnancy', 277, 'gestational'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D')]
PMC4896250	4/2016	S3018-PMC4896250	['FURTHER INVESTIGATIONS are NECESSARY to identify the RELATIONSHIPS between fia and Vitamin D.\n\nA210 TRIGGERING factors of atopic dermatitis by severity\n\nyoon ha hwang\n\nbusan st.mary’s hospital, south korea\nbackground : atopic dermatitis is exacerbated by several triggering factors, which are Allergens, stress, infections climates and so on.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('PR_000004050', 'ankyrin repeat domain-containing protein 6', 95, 'A210'), ('CHEBI_33663', 'cyclic hydrocarbon', 293, 'allergens')]
PMC4896250	4/2016	S4493-PMC4896250	['for PREVENTION and treatment of asthma, an intervention study in asthmatic children with low serum Vitamin D level, and a Vitamin D study ASSESSED the OPTIMAL delivery and safety of its supplementation IS NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 138), ('IMPORTANT_CONSIDERATION', 151), ('FUTURE_WORK', 202)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4930210	7/2016	S14-PMC4930210	['the iom has RECOMMENDED a 25(Oh)D cut point of >50 nmol/l to define Vitamin D sufficiency, AS this level is ASSOCIATED with PREVENTION of the bone manifestations of Vitamin D deficiency (rickets and osteomalacia) for 97.5% of canadians and americans.']	[('FUTURE_WORK', 12), ('PROBABLE_UNDERSTANDING', 91), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 124)]	4	[('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 32, 'D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC4934634	11/2015	S85-PMC4934634	['ADDITIONAL clinical TRIALS in ethnically diverse populations with differing baseline Vitamin D levels ARE NEEDED to BETTER DELINEATE the EFFECT of Vitamin D status on Assisted Reproductive technology outcomes.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 102), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 167, 'assisted reproductive')]
PMC4934634	11/2015	S132-PMC4934634	['WHILE Vitamin D supplementation to women with Gestational diabetes improved Metabolic parameters, what IS NEEDED are clinical trials investigating the extent to WHICH Vitamin D supplementation decreases adverse Perinatal outcomes ASSOCIATED with Gestational diabetes including macrosomia, Respiratory distress, and Postnatal hypoglycemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 161), ('SUPERFICIAL_RELATIONSHIP', 230)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'gestational'), ('GO_0008152', 'metabolic process', 76, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal'), ('GO_0007565', 'female pregnancy', 246, 'gestational'), ('UBERON_0001004', 'respiratory system', 289, 'respiratory'), ('GO_0007567', 'parturition', 315, 'postnatal')]
PMC4934634	11/2015	S171-PMC4934634	['Vitamin D supplementation is a low cost intervention strategy and ADDITIONAL clinical TRIALS powered to determine the EFFECTS of Vitamin D on Preeclampsia PREVENTION and treatment ARE clearly WARRANTED.']	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 155), ('FUTURE_WORK', 180)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 142, 'preeclampsia')]
PMC4934634	11/2015	S253-PMC4934634	['also, studies powered TO DETERMINE the EFFECT of separate ethnic groups’ varying baseline Vitamin D levels on 25(Oh)D levels after different Vitamin D supplementation doses will provide more concrete INFORMATION for individualized RECOMMENDATIONS during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 200), ('FUTURE_WORK', 231)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 112, '(OH)D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy')]
PMC4934634	11/2015	S292-PMC4934634	['MANY countries currently mandate the fortification of certain Foods with Vitamin D, e.g., 100 iu/cup milk in the united states, 30–45 iu/ 100 ml Milk in canada, and edible oil spreads (Margarine) in australia, HOWEVER, a large proportion of dietary intakes are STILL below RECOMMENDED levels [100,101].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 210), ('IMPORTANT_CONSIDERATION', 261), ('FUTURE_WORK', 273)]	4	[('CHEBI_33290', 'food', 62, 'foods'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001913', 'milk', 145, 'milk'), ('CHEBI_6784', 'mestranol', 185, 'margarine')]
PMC4944244	7/2016	S21-PMC4944244	['[12] REVEALED that ethnic minorities (asian) SHOULD BE RECOMMENDED for biochemical screening in early Pregnancy, followed by supplement if low levels of Vitamin D was FOUND.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 45), ('FUTURE_WORK', 55), ('INCOMPLETE_EVIDENCE', 167)]	4	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4944244	7/2016	S229-PMC4944244	['dietary Intake of Food containing Vitamin D was found to reduce hypovitaminosis D. nutrition education NEEDS TO BE EMPHASIZED among Pregnant women, ESPECIALLY those of malay and indian ethnicity, who Consume little or no milk, and those who work at desk jobs as INDICATED by high education levels.']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 109), ('IMPORTANT_CONSIDERATION', 148), ('INCOMPLETE_EVIDENCE', 262)]	4	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_33290', 'food', 18, 'food'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 80, 'D'), ('GO_0007565', 'female pregnancy', 132, 'pregnant'), ('GO_0007631', 'feeding behavior', 200, 'consume')]
PMC4971719	8/2016	S171-PMC4971719	['such FUTURE RESEARCH SHOULD also explore any POTENTIAL INTERACTION between inflammatory cytokines and Vitamin D on depression symptoms.']	[('FUTURE_WORK', 5), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 55)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4973215	8/2016	S7-PMC4973215	['conclusion:\nidentification of RISK FACTORS (black race, medicaid status, obesity and lack of Prenatal Vitamin use) CAN LEAD TO OPPORTUNITIES for targeted Prenatal Vitamin supplementation to reduce the risk of neonatal Vitamin D deficiency and sga status.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('FUTURE_WORK', 127)]	4	[('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 102, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC4976416	7/2016	S69-PMC4976416	['[50]\n\nrecommended dose of Vitamin E\nin case of Vitamin E, the RECOMMENDED intake (6–10 mg of Α-Tocopherol or the equivalent) is BASED SOLELY ON an ESTIMATE of how much Tocopherol the average Person Consumes.']	[('FUTURE_WORK', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 147)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin E'), ('CHEBI_27725', 'butin', 93, 'α-tocopherol'), ('CHEBI_27013', 'tocopherol', 168, 'tocopherol'), ('NCBITaxon_10088', 'Mus <genus>', 191, 'person'), ('GO_0007631', 'feeding behavior', 198, 'consumes')]
PMC4989298	8/2016	S334-PMC4989298	['Vitamin D\nthe PURPOSE of THIS document is to CONSIDER the administration of Vitamin D for the primary prevention of allergies on the basis of the AVAILABLE SCIENTIFIC EVIDENCE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('FUTURE_WORK', 45), ('INCOMPLETE_EVIDENCE', 146)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4989298	8/2016	S357-PMC4989298	['IS the administration of Vitamin D in doses higher than RECOMMENDED intakes for the first year of Life RECOMMENDED for the prevention of allergic diseases?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 56), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 154)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life')]
PMC4993554	8/2016	S113-PMC4993554	['Vitamins and other supplements in Pregnancy\nwomen’s awareness about the RECOMMENDATIONS for Supplements in Pregnancy was explored, including vitamins and other RECOMMENDED supplements (Folic Acid and Iodine), as well as those Vitamins for which there were DANGERS ASSOCIATED with excessive doses (Vitamin A, Vitamin D, and Vitamin B6).']	[('FUTURE_WORK', 72), ('FUTURE_WORK', 160), ('IMPORTANT_CONSIDERATION', 256), ('SUPERFICIAL_RELATIONSHIP', 264)]	4	[('CHEBI_28371', 'vitamin K epoxide', 0, 'Vitamins'), ('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 92, 'supplements'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('CHEBI_30751', 'formic acid', 185, 'folic acid'), ('CHEBI_24859', 'iodine atom', 200, 'iodine'), ('CHEBI_33277', 'gamma-tocotrienol', 226, 'vitamins'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 305, 'A'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 323, 'vitamin B6'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 331, 'B6')]
PMC4997421	8/2016	S123-PMC4997421	['we also INVESTIGATED the IMPACT of OTHER socioeconomic indicators on Vitamin A status that have not been WELL explored, including Food insecurity and Snap use.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('FUTURE_WORK', 105)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('CHEBI_33290', 'food', 130, 'food'), ('PR_000015329', 'stannin', 150, 'SNAP')]
PMC5014971	8/2016	S87-PMC5014971	['regarding the level of circulating 25-Hydroxyvitamin D below which there is CONCERN for Vitamin D deficiency, respondents were ROUGHLY split between below 20\u2009ng/ml (50\u2009nmol/l) and 32\u2009ng/ml (80\u2009nmol/l) AS the level at which they would RECOMMEND a higher supplementation dose of vitamin d (46.5% versus 40.6%).']	[('IMPORTANT_CONSIDERATION', 76), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 201), ('FUTURE_WORK', 234)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 35, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5014971	8/2016	S121-PMC5014971	['the Endocrine society CONSIDERS Pregnant and Lactating women AS HIGH-risk groups for Vitamin D insufficiency and RECOMMENDS universal screening [19].']	[('PROBABLE_UNDERSTANDING', 22), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 113)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 4, 'Endocrine'), ('GO_0007565', 'female pregnancy', 32, 'pregnant'), ('GO_0007594', 'puparial adhesion', 45, 'lactating'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5045149	9/2016	S143-PMC5045149	['it is PRUDENT at this time to CONSIDER diverse combinations of Nutrients from a variety of natural Food sources, although SOME specific Nutrients, such as Omega-3 Fatty Acids or Vitamin C, as treatment modalities [45,46].']	[('FUTURE_WORK', 6), ('IMPORTANT_CONSIDERATION', 6), ('FUTURE_WORK', 30), ('INCOMPLETE_EVIDENCE', 122)]	4	[('CHEBI_33284', 'nutrient', 63, 'nutrients'), ('CHEBI_33290', 'food', 99, 'food'), ('CHEBI_33284', 'nutrient', 136, 'nutrients'), ('CHEBI_30823', 'oleate', 155, 'omega'), ('CHEBI_35366', 'fatty acid', 163, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin C')]
PMC5084016	10/2016	S213-PMC5084016	['NOTABLY, the values recorded in italy [25,53] DIFFER from those RECOMMENDED by the italian GUIDELINES [7] from 40% (Iodine) to 85% (Vitamin D).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('FUTURE_WORK', 64), ('PROBABLE_UNDERSTANDING', 91)]	4	[('CHEBI_24859', 'iodine atom', 116, 'iodine'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5085625	9/2016	S125-PMC5085625	['CONSEQUENTLY, these authors RECOMMENDED to conduct a well-designed randomized controlled trial to examine the exact ROLE of Vitamin D supplementation in the PREVENTION of Gdm [49].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 157)]	4	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('GO_0070477', 'endospore core', 171, 'GDM')]
PMC5133057	10/2016	S128-PMC5133057	['moreover, considering the high prevalence of vad OBSERVED in THIS STUDY, as well as its IMPACT on the Pregnancy process, there is a NEED FOR regular assessment of the nutritional status of Prenatal Vitamin A in teens in order to achieve early diagnosis and proper management of this nutritional deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('SUPERFICIAL_RELATIONSHIP', 88), ('FUTURE_WORK', 132)]	4	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 189, 'prenatal'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin A')]
PMC5146866	12/2016	S15-PMC5146866	['HOWEVER, the clinical practice guidelines published by the Endocrine society RECOMMENDS that 30\xa0ng/ml of Vitamin D in children and Adults SHOULD BE CONSIDERED sufficient and classifies levels below 20\xa0ng/ml (50\xa0nmol/l) and 21–29\xa0ng/ml (55–75\xa0nmol/l) as deficient and insufficient, respectively [10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 77), ('FUTURE_WORK', 138), ('IMPORTANT_CONSIDERATION', 148)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 59, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 131, 'adults')]
PMC5155676	12/2016	S18-PMC5155676	['indeed MANY national GUIDELINES RECOMMEND universal Antenatal Vitamin D supplementation to prevent Vitamin D INSUFFICIENCY (7–9).']	[('INCOMPLETE_EVIDENCE', 7), ('PROBABLE_UNDERSTANDING', 21), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 109)]	4	[('GO_0007567', 'parturition', 52, 'antenatal'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC5240436	1/2017	S120-PMC5240436	['FURTHER clinical TRIALS supplementing single Nutrients (efas, Vitamin A or zinc) MAY BE CRUCIAL in isolating the IMPACT of each Nutrient on maternal infections.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('CHEBI_33284', 'nutrient', 45, 'nutrients'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33284', 'nutrient', 128, 'nutrient')]
PMC5385921	4/2017	S7-PMC5385921	['because Gestational Vitamin D deficiency is readily preventable with SAFE, inexpensive and readily available supplementation, this RISK FACTOR WARRANTS CLOSER SCRUTINY.']	[('IMPORTANT_CONSIDERATION', 69), ('SUPERFICIAL_RELATIONSHIP', 131), ('FUTURE_WORK', 143), ('FUTURE_WORK', 152)]	4	[('GO_0007565', 'female pregnancy', 8, 'gestational'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC5418719	5/2017	S13-PMC5418719	['the european GUIDELINE on daily Vitamin D supplementation RECOMMEND 800 to 1000\xa0iu/day for preterm infants, WHILE western countries RECOMMEND 400\xa0iu/day [3].']	[('PROBABLE_UNDERSTANDING', 13), ('FUTURE_WORK', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('FUTURE_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5513133	7/2017	S2-PMC5513133	['evidence of the ROLE of Vitamin D status and supplementation in the etiology and PREVENTION of pe is reviewed in THIS ARTICLE along with identification of research gaps to inform FUTURE STUDIES.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 113), ('FUTURE_WORK', 179)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5537904	7/2017	S170-PMC5537904	['HOWEVER, this dose also exceeds the united states national academy of sciences Food and nutrition board tolerable upper limit of 4000 iu/day of Vitamin D for pregnant women [63], and THEREFORE cannot be RECOMMENDED based SOLELY on the present results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 183), ('FUTURE_WORK', 203), ('INCOMPLETE_EVIDENCE', 221)]	4	[('CHEBI_33290', 'food', 79, 'Food'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC5537904	7/2017	S173-PMC5537904	['continued RESEARCH into the IMPLICATIONS of Cord Blood 25(Oh)D status IS NEEDED to guide RECOMMENDATIONS for Prenatal Vitamin D intake.']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 28), ('FUTURE_WORK', 70), ('FUTURE_WORK', 89)]	4	[('UBERON_0002240', 'spinal cord', 44, 'cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5634602	10/2017	S14-PMC5634602	['MANY aspects of clinical application of Vitamin D supplementation in the smallest preterm infants NEED additional SUPPORTIVE EVIDENCE.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 98), ('INCOMPLETE_EVIDENCE', 114), ('FUTURE_WORK', 125)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5634602	10/2017	S18-PMC5634602	['this RECOMMENDATION is BASED, IN PART, off of work by priemel et al evaluating bone mineralization defects and Vitamin D deficiency in Iliac Crest bone of Adults [3].']	[('FUTURE_WORK', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 30)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_4300127', 'nuchal crest', 135, 'iliac crest'), ('UBERON_0007023', 'adult organism', 155, 'adults')]
PMC5634602	10/2017	S19-PMC5634602	['the authors of THIS PAPER HOWEVER, CONCLUDE that doses of supplementation of Vitamin D SHOULD ensure 25(Oh)D levels of 75 nmol/l to maintain Skeletal health.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 87)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 107, 'D'), ('UBERON_0004288', 'skeleton', 141, 'skeletal')]
PMC5634602	10/2017	S25-PMC5634602	['*formula Fed infants taking <1 liter of formula2008[5]aap—committee on nutrition preterm infants vlbw200–400 iu>50 nmol/l (targeting bone health)discharge Vitamin D RECOMMENDED for breastfed infants 400 iu, for formula Fed 200–400 iu2013[6]aap—committee on nutrition preterm infants>1500g400–1000 iu>50 nmol/l (targeting bone health)tolerating full enteral feeds2013[6]world health organization Preterm infants400–1000 iulow and middle-income countrieswho[7]institute of medicine infants 0–6 months400 iu>50 nmol/l (targeting bone health)under assumption of minimal sunlight2011[8]esphagan preterm infants800–1000 iu>80 nmol/lstable Growing, 1000 to 1800 grams2010[4]pediatric Endocrine society breastfed infants, or those taking <1lformula/day400 iu>50 nmol/l (desire ADDITIONAL STUDIES to determine IF >80 nmol/l is OPTIMAL)800 iu for high risk populations i.e.']	[('FUTURE_WORK', 165), ('FUTURE_WORK', 769), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 801), ('IMPORTANT_CONSIDERATION', 818)]	4	[('GO_0007631', 'feeding behavior', 9, 'fed'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007631', 'feeding behavior', 219, 'fed'), ('GO_0007128', 'meiotic prophase I', 395, 'Preterm'), ('GO_0001947', 'heart looping', 633, 'Growing'), ('UBERON_0005063', 'left ventricular compact myocardium', 677, 'Endocrine')]
PMC5664622	9/2017	S87-PMC5664622	['the RECOMMENDED levels of Vitamin D were FOUND in ONLY 5% of the Pregnant women in germany [20], and 16.5% in ukraine [22].']	[('FUTURE_WORK', 4), ('INCOMPLETE_EVIDENCE', 41), ('ANOMALY_CURIOUS_FINDING', 50), ('INCOMPLETE_EVIDENCE', 50)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnant')]
PMC5679631	11/2017	S161-PMC5679631	['the INFLUENCE of Postnatal Vitamin D supplementation MERITS to BE analyzed in a larger group of older infants and with extensive microbial profiling approach.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 53), ('ANOMALY_CURIOUS_FINDING', 63)]	4	[('GO_0007567', 'parturition', 17, 'postnatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5812027	2/2018	S24-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and neonatal Birth size is NOT CLEAR and WARRANTS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 88)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 60, 'birth')]
PMC5812027	2/2018	S30-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and risk of Miscarriage NEEDS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FUTURE_WORK', 71), ('FUTURE_WORK', 77)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 59, 'miscarriage')]
PMC5941617	5/2018	S53-PMC5941617	['the standardization, also RETROSPECTIVELY, SHOULD help to develop FUTURE Vitamin D GUIDELINES [59,60].']	[('INCOMPLETE_EVIDENCE', 26), ('FUTURE_WORK', 43), ('FUTURE_WORK', 66), ('PROBABLE_UNDERSTANDING', 83)]	4	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5941617	5/2018	S105-PMC5941617	['in 2016 also the european Food safety authority (efsa) revised dietary reference values for Vitamin D. CONSIDERING a Serum 25(Oh)D levels of 20\xa0ng/ml AS a SUITABLE target value, under conditions of minimal cutaneous Vitamin D synthesis efsa RECOMMENDED an adequate intake of 400\xa0iu/day for infants aged 7–11\xa0months and of 600\xa0iu/day for children aged 1–17\xa0years [26].']	[('PROBABLE_UNDERSTANDING', 103), ('PROBABLE_UNDERSTANDING', 150), ('IMPORTANT_CONSIDERATION', 155), ('FUTURE_WORK', 241)]	4	[('CHEBI_33290', 'food', 26, 'Food'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 100, 'D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 123, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC5941617	5/2018	S122-PMC5941617	['the same RECOMMENDATION HAS BEEN worldwide PROPOSED also by an expert position statement on Vitamin D in childhood [1], the department of nutrition for health and development of the world health organization [116], the espghan [19], the european academy of pediatrics [30], and the Vitamin D GUIDELINES for united arab emirates [27] and central europe [20].']	[('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 292)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC5941617	5/2018	S141-PMC5941617	['in 2013 the aap RECOMMENDED a daily Vitamin D intake of 200–400\xa0iu for vlbw infants, AS their smaller size MAY LEAD TO a lower need for Vitamin D to ensure adequate Serum 25(Oh)D levels.']	[('FUTURE_WORK', 16), ('PROBABLE_UNDERSTANDING', 85), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 111)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_71657', 'versiconol acetate', 171, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 177, 'D')]
PMC5941617	5/2018	S174-PMC5941617	['following the publication of sacn review of the EVIDENCE on Vitamin D and health [25], public health england advised that uk children aged 1 to 4\xa0years should receive Vitamin D supplementation at 400\xa0iu/day, and older children and adolescents SHOULD take a daily supplement containing 400\xa0iu of Vitamin D in autumn and winter to PROTECT bone and muscle health because it is DIFFICULT to meet this intake from dietary sources.']	[('INCOMPLETE_EVIDENCE', 48), ('FUTURE_WORK', 243), ('SUPERFICIAL_RELATIONSHIP', 329), ('DIFFICULT_TASK', 374)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5941617	5/2018	S176-PMC5941617	['adolescents are at INCREASED RISK for Vitamin D deficiency [79], THUS the society for adolescent health and medicine RECOMMENDED continuous Vitamin D supplementation (600\xa0iu daily for healthy adolescents, and at LEAST 1000\xa0iu daily for adolescents at risk for Vitamin D deficiency or insufficiency) in addition to Vitamin D received through the diet or via sun exposure [21].']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 65), ('FUTURE_WORK', 117), ('PROBABLE_UNDERSTANDING', 212)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 314, 'vitamin D')]
PMC5941617	5/2018	S190-PMC5941617	['individuals on Anticonvulsants, oral Corticosteroids, Antimicotics and Antiretroviral Drugs SHOULD receive AT LEAST 2–3 times more Vitamin D than the daily REQUIREMENT RECOMMENDED for age, in agreement with the endocrine society [11] and the aap [23].']	[('FUTURE_WORK', 92), ('PROBABLE_UNDERSTANDING', 107), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 168)]	4	[('CHEBI_37540', 'arabinarate(2-)', 15, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 37, 'corticosteroids'), ('CHEBI_33282', 'antibacterial agent', 54, 'antimicotics'), ('CHEBI_33656', 'antiaromatic compound', 71, 'antiretroviral drugs'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S398-PMC5941617	['FOR THESE REASONS AT PRESENT Vitamin D supplementation as adjunctive standard therapy for ad cannot be RECOMMENDED in all the affected children [351].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 18), ('FUTURE_WORK', 103)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5941617	5/2018	S402-PMC5941617	['again, we NEED clinical data SHOWING that restoring normal levels of Vitamin D one CAN obtain significant variation in severity especially IF evaluated by standardized methods (symptom score, scoring atopic dermatitis or equivalent).']	[('FUTURE_WORK', 10), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5941617	5/2018	S406-PMC5941617	['DATA from ongoing intervention trials ARE WARRANTED to establish the extent of Vitamin D POTENTIALLY preventive EFFECT, along with the best timing and dose of an intervention.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 89), ('SUPERFICIAL_RELATIONSHIP', 112)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5941617	5/2018	S412-PMC5941617	['there is THE NEED for rcts to validate these HYPOTHESES and to evaluate the POSSIBILITY of primary prevention and treatment of Food allergies with Vitamin D [355–357].']	[('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 76)]	4	[('CHEBI_33290', 'food', 127, 'food'), ('GO_0007631', 'feeding behavior', 127, 'food'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 155, 'D')]
PMC5941617	5/2018	S422-PMC5941617	['IF data of OBSERVATIONAL studies in general population in infancy are ENCOURAGING, in the daisy study, conducted in subjects at higher RISK, the Vitamin D nutritional intake in the first years of Life as well as the Serum 25(Oh)D levels at 9\xa0months of age were not associated with the development of Autoantibodies or with the progression to t1dm [381].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('FUTURE_WORK', 70), ('IMPORTANT_CONSIDERATION', 135)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 216, 'serum'), ('CHEBI_71657', 'versiconol acetate', 222, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 222, '25 ... OH ... D'), ('GO_0044308', 'axonal spine', 300, 'autoantibodies')]
PMC5941617	5/2018	S473-PMC5941617	['nice GUIDELINES ADVICE that People with cd MAY NEED to receive Calcium and Vitamin D supplementation if their dietary intake is insufficient [433].']	[('PROBABLE_UNDERSTANDING', 5), ('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 47)]	4	[('NCBITaxon_10088', 'Mus <genus>', 28, 'people'), ('CHEBI_22313', 'alkaline earth metal atom', 63, 'calcium'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S503-PMC5941617	['the Endocrine society [11], united arab emirates GUIDELINES [27] and the society for adolescent health and medicine [21] RECOMMENDED to screen all obese children and adolescents AS they are at INCREASED RISK for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 49), ('FUTURE_WORK', 121), ('PROBABLE_UNDERSTANDING', 178), ('IMPORTANT_CONSIDERATION', 193)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 4, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S560-PMC5941617	['SUGGESTED that a Vitamin D intake of AT LEAST 4000\xa0iu/day SHOULD BE CONSIDERED in all Pregnant women to maintain Serum 25(Oh)D levels ≥40\xa0ng/ml [513,514].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 37), ('FUTURE_WORK', 58), ('FUTURE_WORK', 68)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnant'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 119, '25(OH)D')]
PMC5941617	5/2018	S606-PMC5941617	['in the case of Vitamin D insufficiency, particularly in subjects AT RISK for Vitamin D deficiency, we RECOMMENDED starting Vitamin D supplementation according to the modalities and REQUIREMENTS RECOMMENDED for age.']	[('IMPORTANT_CONSIDERATION', 65), ('FUTURE_WORK', 102), ('IMPORTANT_CONSIDERATION', 181), ('FUTURE_WORK', 194)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5941617	5/2018	S642-PMC5941617	['individuals on Anticonvulsants, oral Corticosteroids, Antimicotics and Antiretroviral Drugs SHOULD receive AT LEAST 2–3 times more Vitamin D than the daily REQUIREMENT RECOMMENDED for age.']	[('FUTURE_WORK', 92), ('PROBABLE_UNDERSTANDING', 107), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 168)]	4	[('CHEBI_37540', 'arabinarate(2-)', 15, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 37, 'corticosteroids'), ('CHEBI_33282', 'antibacterial agent', 54, 'antimicotics'), ('CHEBI_33656', 'antiaromatic compound', 71, 'antiretroviral drugs'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S692-PMC5941617	['HOWEVER, we RECOMMEND to maintain Vitamin D intake for age and to treat Vitamin D deficiency IF FOUND.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 96)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5941617	5/2018	S695-PMC5941617	['we RECOMMEND continuous Vitamin D supplementation at higher doses THAN those RECOMMENDED for age (AT LEAST 1000–1500\xa0iu/day).']	[('FUTURE_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('FUTURE_WORK', 77), ('PROBABLE_UNDERSTANDING', 98)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S696-PMC5941617	['we RECOMMEND to treat Vitamin D deficiency with daily Vitamin D at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('FUTURE_WORK', 91), ('PROBABLE_UNDERSTANDING', 147)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5941617	5/2018	S711-PMC5941617	['if an obese Individual does not receive Vitamin D supplementation and has a sedentary indoor lifestyle with consequent reduced sun exposure, Serum 25(Oh)D evaluation MAY BE CONSIDERED to confirm Vitamin D deficiency and start adequate treatment.']	[('INCOMPLETE_EVIDENCE', 166), ('ANOMALY_CURIOUS_FINDING', 170), ('FUTURE_WORK', 173), ('IMPORTANT_CONSIDERATION', 173)]	4	[('NCBITaxon_1', 'root', 12, 'individual'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('CHEBI_71657', 'versiconol acetate', 147, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 147, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S712-PMC5941617	['in obese subjects with Vitamin D deficiency we RECOMMEND Vitamin D treatment at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('FUTURE_WORK', 104), ('PROBABLE_UNDERSTANDING', 160)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC5941617	5/2018	S728-PMC5941617	['in subjects with asymptomatic Vitamin D deficiency assuming Drugs interfering with Vitamin D Metabolism (Anticonvulsants, oral Corticosteroids, antifungals like Ketoconazole, Anti-retroviral Drugs) we RECOMMEND Vitamin D treatment at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FUTURE_WORK', 258), ('PROBABLE_UNDERSTANDING', 314)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_23888', 'drug', 60, 'drugs'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 83, 'vitamin D metabolism'), ('CHEBI_37540', 'arabinarate(2-)', 105, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 127, 'corticosteroids'), ('CHEBI_47519', 'ketoconazole', 161, 'ketoconazole'), ('CHEBI_59132', 'antigen', 175, 'anti'), ('CHEBI_23888', 'drug', 191, 'drugs'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC5941617	5/2018	S730-PMC5941617	['in case of detection of asymptomatic Vitamin D insufficiency [25(Oh)D between 20 and 29\xa0ng/ml], particularly in subjects AT RISK for vitamin d deficiency, we RECOMMENDED to start Vitamin D supplementation according to the modalities and REQUIREMENTS RECOMMENDED for age.']	[('IMPORTANT_CONSIDERATION', 121), ('FUTURE_WORK', 158), ('IMPORTANT_CONSIDERATION', 237), ('FUTURE_WORK', 250)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5956785	5/2018	S208-PMC5956785	['ADDITIONAL STUDIES investigating Vitamin D intake from all sources (both Food and supplements) are REQUIRED to determine IF children with chronic arthritis REQUIRE additional Vitamin D to maintain Serum concentrations in comparison to healthy children.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('IMPORTANT_CONSIDERATION', 156)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_33290', 'food', 73, 'food'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0001977', 'blood serum', 197, 'serum')]
PMC5956785	5/2018	S258-PMC5956785	['UNDERSTANDING IF Genetic variants increase the risk of disease development will HELP tailor Vitamin D management in individual patients and CONTRIBUTE to improving Control of disease activity and improve outcomes.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('SO_0000704', 'gene', 17, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'control')]
PMC5956785	5/2018	S261-PMC5956785	['this first step is IMPORTANT for the development of FUTURE STUDIES leading to the exploration of POTENTIAL OPTIMAL target concentrations of Vitamin D for the reduction of inflammation in children with chronic arthritis.']	[('IMPORTANT_CONSIDERATION', 19), ('FUTURE_WORK', 52), ('INCOMPLETE_EVIDENCE', 97), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC1888711	5/2007	S48-PMC1888711	['routine daily or weekly Antenatal iron or iron plus Folic Acid supplementation MAY BE of benefit, especially where pre-Gestational iron deficiency and anaemia are prevalent" [26].moderatedietary Vitamin A deficiencyvitamin A supplementation"FURTHER EVIDENCE on the effectiveness of adding Vitamin A to Iron and Folic Acid for treatment of anaemia IS NEEDED" [60].']	[('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 241), ('FUTURE_WORK', 347)]	3	[('GO_0007567', 'parturition', 24, 'antenatal'), ('CHEBI_30751', 'formic acid', 52, 'folic acid'), ('GO_0007565', 'female pregnancy', 119, 'gestational'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 223, 'A'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin A'), ('CHEBI_24870', 'ion', 302, 'iron'), ('CHEBI_30751', 'formic acid', 311, 'folic acid')]
PMC2582131	11/2008	S115-PMC2582131	['longitudinal STUDIES with serial measurements of maternal Plasma 25-[Oh] D concentrations, indices of Insulin sensitivity and secretion ARE NEEDED to ELUCIDATE the mechanisms and patho-physiological consequences of maternal Vitamin D deficiency during Pregnancy.']	[('FUTURE_WORK', 13), ('FUTURE_WORK', 136), ('FUTURE_WORK', 150)]	3	[('UBERON_0001969', 'blood plasma', 58, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 65, '25-[OH] D'), ('PR_000045358', 'insulin family protein', 102, 'insulin'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('GO_0007565', 'female pregnancy', 252, 'pregnancy')]
PMC2606998	6/2007	S73-PMC2606998	['when ASSUMING a 20% UNDERREPORTING before Pregnancy, the RECOMMENDATION for Vitamin\u2009E and iron intake was met, but Intake of Folate, Selenium and Vitamin\u2009D remained below ri for non-Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBLEM_COMPLICATION', 20), ('FUTURE_WORK', 57)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('GO_0007631', 'feeding behavior', 115, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_27568', 'selenium atom', 133, 'selenium'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnant')]
PMC2779500	11/2009	S127-PMC2779500	['literature ESTIMATES forand λa\nit HAS BEEN RECOMMENDED that dietary Vitamin C intake for all Individuals exceed 200 mg per day [41].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('FUTURE_WORK', 43)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin C'), ('NCBITaxon_1', 'root', 93, 'individuals')]
PMC3034879	12/2010	S191-PMC3034879	['given that more than 20% of the infants had S-25-Ohd below 50 nmol/l, DESPITE compliance with supplementation, higher intake of vitamin D is RECOMMENDED in order to obtain all the POTENTIAL health benefits of Vitamin D [43,44].']	[('ANOMALY_CURIOUS_FINDING', 70), ('FUTURE_WORK', 141), ('INCOMPLETE_EVIDENCE', 180)]	3	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 44, 'S-25-OHD'), ('PR_000001900', 'neuropilin-1', 44, 'S-25-OHD'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 136, 'D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3257641	3/2010	S49-PMC3257641	['recent RECOMMENDATIONS SUGGEST that the lower level of Vitamin D adequacy SHOULD BE a Serum 25(Oh)D level of 75–80 nmol/l.']	[('FUTURE_WORK', 7), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 74)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 92, '25(OH ... D')]
PMC3257641	3/2010	S157-PMC3257641	['such trials NEED TO carefully CONSIDER the safety profile of the interventional Vitamin D administration provided.']	[('IMPORTANT_CONSIDERATION', 12), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3272870	12/2011	S51-PMC3272870	['Vitamin D is LIKELY SAFE during Pregnancy and Breast feeding when taken by mouth in RECOMMENDED amounts, that is 10 mcg (400 usp units) of Vitamin D daily in normal Pregnancy.']	[('PROBABLE_UNDERSTANDING', 13), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 84)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('UBERON_0000310', 'breast', 46, 'breast'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy')]
PMC3274449	12/2011	S39-PMC3274449	['ACCORDING TO the national policy, children from 6-59 mo SHOULD BE supplemented with Vitamin A every 6 months and mothers SHOULD receive a Vitamin A dose within 2 months after delivary.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 56), ('FUTURE_WORK', 121)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC3347007	4/2012	S11-PMC3347007	['dietary Vitamin D intake is very LIMITED and THEREFORE supplementation is NEEDED to avoid Vitamin D deficiency during sun-deprived periods.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 45), ('FUTURE_WORK', 74)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3347007	4/2012	S134-PMC3347007	['when the study was conducted there were no formal RECOMMENDATIONS from the danish national board of health on use of Vitamin D supplements during Pregnancy, and both the number of users and the supplement dose MAY THEREFORE be higher today.']	[('FUTURE_WORK', 50), ('INCOMPLETE_EVIDENCE', 210), ('PROBABLE_UNDERSTANDING', 214)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC3347007	4/2012	S145-PMC3347007	['we FOUND Supplements to contribute substantially to Vitamin D intake, but a large group of women STILL did not reach the RECOMMENDED level of intake.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 121)]	3	[('CHEBI_33341', 'titanium atom', 9, 'supplements'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC3356951	4/2012	S7-PMC3356951	['AS few Foods contain Vitamin D, guidelines RECOMMENDED supplementation at SUGGESTED daily Intake and tolerable upper limit levels.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 43), ('INCOMPLETE_EVIDENCE', 74)]	3	[('CHEBI_33290', 'food', 7, 'foods'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007631', 'feeding behavior', 90, 'intake')]
PMC3356951	4/2012	S57-PMC3356951	['[52] american association of paediatricians (aap) RECOMMENDS that exclusively and partially Breastfed infants MUST BE supplemented with 400 iu of Vitamin D per day,[5253] the RECOMMENDED daily allowance for this Nutrient during infancy.']	[('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 110), ('FUTURE_WORK', 175)]	3	[('GO_0007567', 'parturition', 92, 'breastfed'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_33284', 'nutrient', 212, 'nutrient')]
PMC3356951	4/2012	S92-PMC3356951	['[9] SINCE Vitamin D is fat soluble, orlistat and Cholestyramine CAN reduce its absorption and SHOULD BE taken several hours apart from it.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 64), ('FUTURE_WORK', 94)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_3647', 'chlorpromazine', 49, 'Cholestyramine')]
PMC3356951	4/2012	S144-PMC3356951	['Serum circulating 25-Hydroxyvitamin D [25(Oh) D] level SHOULD BE measured to evaluate Vitamin D status in patients who are AT RISK for vdd.']	[('FUTURE_WORK', 55), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 123)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 18, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 39, '25(OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3356951	4/2012	S174-PMC3356951	['very few Foods contain Vitamin D THEREFORE GUIDELINES RECOMMENDED supplementation of Vitamin D at tolerable ul levels.']	[('PROBABLE_UNDERSTANDING', 33), ('PROBABLE_UNDERSTANDING', 43), ('FUTURE_WORK', 54)]	3	[('CHEBI_33290', 'food', 9, 'foods'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3407995	7/2012	S432-PMC3407995	['Vitamin D\ncurrently there are NO CONSISTENT RECOMMENDATIONS amongst or EVEN within countries for Vitamin D intake during Pregnancy and Lactation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('FUTURE_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 71)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'pregnancy'), ('GO_0007595', 'lactation', 135, 'lactation')]
PMC3409554	7/2012	S42-PMC3409554	['calf and pork Liver have a high content of Iron with a good bioavailability, but the danish health authorities ADVISE Pregnant women not to consume pork Liver and pork Liver paté due to the high content of Vitamin A, which POSSIBLY MAY cause malformations in the fetus [18].']	[('FUTURE_WORK', 111), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 232)]	3	[('UBERON_0002107', 'liver', 14, 'liver'), ('CHEBI_24870', 'ion', 43, 'iron'), ('GO_0007565', 'female pregnancy', 118, 'pregnant'), ('UBERON_0002107', 'liver', 153, 'liver'), ('UBERON_0002107', 'liver', 168, 'liver'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A')]
PMC3409554	7/2012	S111-PMC3409554	['CONSEQUENTLY, Ferrous Iron supplements SHOULD BE taken between meals, preferably with fruit juice containing Vitamin C [38], which enhances absorption, WHEREAS Milk, coffee, and tea inhibit absorption.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152)]	3	[('CHEBI_5014', 'fenvalerate', 14, 'ferrous iron'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin C'), ('UBERON_0001913', 'milk', 160, 'milk')]
PMC3427192	4/2012	S71-PMC3427192	['ultimately, randomized, double-blind, Placebo-controlled STUDIES ARE NEEDED in asthma populations to sort out causal RELATIONSHIPS between Vitamin D status and outcomes and to develop RECOMMENDATIONS for treatment.']	[('FUTURE_WORK', 57), ('SUPERFICIAL_RELATIONSHIP', 117), ('FUTURE_WORK', 184)]	3	[('CHEBI_26130', 'biological pigment', 38, 'placebo'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3427250	8/2012	S126-PMC3427250	['THEREFORE, there is an URGENT NEED of randomised controlled trials of Vitamin D supplementation to investigate the maternal and neonatal health benefits of correcting Vitamin D deficiency during Pregnancy[24].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 23), ('FUTURE_WORK', 30)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy')]
PMC3427250	8/2012	S128-PMC3427250	['the current Vitamin D RECOMMENDATIONS for Pregnant women are clearly INSUFFICIENT to prevent and EVEN more to treat Vitamin D deficient Pregnant women.']	[('FUTURE_WORK', 22), ('PROBLEM_COMPLICATION', 69), ('ANOMALY_CURIOUS_FINDING', 97)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnant')]
PMC3427250	8/2012	S129-PMC3427250	['UNTIL the adequate treatment of Vitamin D deficient Pregnant women is established, a safe approach MAY BE to correct Vitamin D deficiency by TARGETING Pregnant women at high risk of severe Vitamin D deficiency.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 99), ('FUTURE_WORK', 141)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnant'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC3458940	9/2012	S10-PMC3458940	['such a catalogue will guide FURTHER STUDIES on molecular mediators of endogenous tra/rars during Kidney Development and in RELATION to Renal defects ASSOCIATED with Vitamin A deficiency.']	[('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 149)]	3	[('GO_0001822', 'kidney development', 97, 'kidney development'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0002113', 'kidney', 135, 'renal'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin A')]
PMC3470091	9/2012	S92-PMC3470091	['further STUDIES ARE NEEDED to evaluate the EFFECT of Postpartum supplementation of Vitamin D on antirachitic FACTOR of the mother’s Milk, and infant’s health indexes.']	[('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 109)]	3	[('GO_0007565', 'female pregnancy', 53, 'postpartum'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0001913', 'milk', 132, 'milk')]
PMC3472720	8/2012	S56-PMC3472720	['additionally, we SHOULD perform a transgenerational study in order to assess WHETHER the f2generation is positively AFFECTED by a high dose of Vitamin D delivered to the f0generation.']	[('FUTURE_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC3515553	12/2012	S181-PMC3515553	['caption (supplementary-material): table s5\n\nASSOCIATION of maternal genotype at Snps RELATED to Vitamin B-12 Metabolism with offspring iq at age 8, stratified by Maternal Pregnancy RECOMMENDED daily amount (rda) of Vitamin B-12.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 85), ('FUTURE_WORK', 181)]	3	[('SO_0000694', 'SNP', 80, 'SNPs'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin B'), ('GO_0009235', 'cobalamin metabolic process', 96, 'vitamin B-12 metabolism'), ('PR_000017269', 'ventral anterior homeobox 2', 96, 'vitamin B-12'), ('GO_0007618', 'mating', 162, 'maternal'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 215, 'vitamin B-12')]
PMC3552819	12/2012	S18-PMC3552819	['the AIM was to generate PRELIMINARY pharmacokinetic (pk) and safety data to inform the design of supplementation regimens for use in FUTURE larger-scale TRIALS of Antenatal Vitamin D supplementation in bangladesh.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 24), ('FUTURE_WORK', 133)]	3	[('GO_0007567', 'parturition', 163, 'antenatal'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3641012	4/2013	S236-PMC3641012	['FURTHER clinical DATA are REQUIRED before conclusive statements can be made regarding the APPROPRIATENESS of high-dose Antenatal Vitamin D supplementation.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 90)]	3	[('GO_0007567', 'parturition', 119, 'antenatal'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3659910	1/2013	S8-PMC3659910	['the CURRENTLY RECOMMENDED supplementation amount of Vitamin D is NOT SUFFICIENT to maintain a value of 25 Hydroxy Vitamin D above 30 ng/ml, during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 14), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_45557', 'sec-butyl group', 103, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 122, 'D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC3659910	1/2013	S89-PMC3659910	['MOST Prenatal Vitamins have around 400 iu of Vitamin D, and MOST health groups RECOMMEND taking no more than 2,000 iu of the Vitamin in supplement form daily.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 60), ('FUTURE_WORK', 79)]	3	[('GO_0007565', 'female pregnancy', 5, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 14, 'vitamins'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 125, 'vitamin')]
PMC3659910	1/2013	S159-PMC3659910	['[4142] endocrine society issues practice guideline on Vitamin D and the GUIDELINE RECOMMEND that clinicians screen for Vitamin D deficiency in People AT RISK for deficiency, including obese Individuals, blacks, Pregnant and Lactating women, and patients with malabsorption syndromes.']	[('PROBABLE_UNDERSTANDING', 72), ('FUTURE_WORK', 82), ('IMPORTANT_CONSIDERATION', 150)]	3	[('CHEBI_28384', 'vitamin K', 54, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 143, 'people'), ('NCBITaxon_1', 'root', 190, 'individuals'), ('GO_0007565', 'female pregnancy', 211, 'pregnant'), ('GO_0007594', 'puparial adhesion', 224, 'lactating')]
PMC3659910	1/2013	S172-PMC3659910	['there is NO dietary RECOMMENDED intake (dri) for Vitamin D. what IS KNOWN today is that for a Pregnant woman, the adequate intake for Vitamin D is 200 iu per day.']	[('FULL_UNKNOWN', 9), ('FUTURE_WORK', 20), ('INCOMPLETE_EVIDENCE', 65)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3659910	1/2013	S177-PMC3659910	["current nice GUIDANCE STATES clearly that Pregnant women are informed, at their first Antenatal booking, of the IMPORTANCE of adequate Vitamin D during Pregnancy and after, to maintain their own and their baby's health."]	[('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 112)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('GO_0007567', 'parturition', 86, 'antenatal'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy')]
PMC3668200	5/2013	S21-PMC3668200	['although an infant is formula Fed, it cannot be automatically ASSUMED that the infant is adequately supplied with Vitamin D. the daily amount of formula Feeding SHOULD BE taken INTO CONSIDERATION.']	[('PROBABLE_UNDERSTANDING', 62), ('FUTURE_WORK', 161), ('IMPORTANT_CONSIDERATION', 177)]	3	[('GO_0007631', 'feeding behavior', 30, 'fed'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007631', 'feeding behavior', 153, 'feeding')]
PMC3668200	5/2013	S33-PMC3668200	['RECENTLY, aap RECOMMENDATION of 400 iu/day for Vitamin D supplementation was DOCUMENTED to maintain a 25(Oh)D Serum concentration higher than 50 nmol/l in exclusively Breast-Fed infants15).']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 14), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 102, '25(OH)D'), ('UBERON_0001977', 'blood serum', 110, 'serum'), ('GO_0007567', 'parturition', 167, 'breast'), ('UBERON_0000310', 'breast', 167, 'breast'), ('GO_0007631', 'feeding behavior', 174, 'fed')]
PMC3672018	5/2013	S8-PMC3672018	['also, OTHER health outcomes can subsequently be studied to generate multiple health research OPPORTUNITIES involving Vitamin D. finally, the results of the study will justify the DEBATE of danish health authorities whether to resume Vitamin D supplementation policies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('FUTURE_WORK', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC3672018	5/2013	S45-PMC3672018	['furthermore, large-scale interventional STUDIES ARE NEEDED to examine HOW Vitamin D exposure during Pregnancy AFFECTS long-term health outcomes of offspring.']	[('FUTURE_WORK', 40), ('EXPLICIT_QUESTION', 70), ('SUPERFICIAL_RELATIONSHIP', 110)]	3	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy')]
PMC3672018	5/2013	S82-PMC3672018	['in the FUTURE, a third phase will be PLANNED and will examine ASSOCIATION between additional exposure to Vitamin D in fetal Life and later development of other Immunological disorders, including severe asthma, crohn’s disease, Inflammatory Bowel diseases, and juvenile idiopathic arthritis.']	[('FUTURE_WORK', 7), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life'), ('UBERON_0003222', 'flexor digitorum superficialis', 160, 'immunological'), ('UBERON_0001782', 'pigmented layer of retina', 227, 'inflammatory bowel')]
PMC3691177	6/2013	S126-PMC3691177	['ALTHOUGH the Vitamin D doses used in this trial were greater than the current RECOMMENDED intake for Pregnant women of 400 iu/day during Pregnancy in the united kingdom[14],[17], and 600 iu in the united states[25], ONLY a small percentage of offspring had Cord 25(Oh)D levels in the sufficient range (13% daily group, 3% bolus group).']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 216)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnant'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 257, 'cord'), ('CHEBI_71657', 'versiconol acetate', 262, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 262, '25(OH)D')]
PMC3773018	4/2013	S7-PMC3773018	['conclusions\nPrenatal and early Postnatal Vitamin D levels, along with individual Genetic susceptibility, SHOULD BE CONSIDERED in assessing the ROLE of Vitamin D in the development of fs and Food allergy.']	[('FUTURE_WORK', 105), ('FUTURE_WORK', 115), ('SUPERFICIAL_RELATIONSHIP', 143)]	3	[('GO_0007565', 'female pregnancy', 12, 'Prenatal'), ('GO_0007567', 'parturition', 31, 'postnatal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('SO_0000704', 'gene', 81, 'genetic'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_33290', 'food', 190, 'food')]
PMC3821254	4/2013	S70-PMC3821254	['[12] vitamin p ENHANCES the action of Vitamin C and for this REASON they SHOULD BE taken together.']	[('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 61), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin C')]
PMC3827489	10/2013	S2-PMC3827489	['PREVIOUS STUDIES SUGGEST that sufficient Serum Vitamin D levels SHOULD BE maintained in order to enhance normal Calcification of the Growth Plate and bone mineralization.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 64)]	3	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0051301', 'cell division', 112, 'calcification'), ('UBERON_0002516', 'epiphyseal plate', 133, 'growth plate')]
PMC3827489	10/2013	S103-PMC3827489	['from a perspective of integrative childhood care, it MAY BE advantageous to RECOMMEND more time spent in outdoor activity for sunlight exposure and increased Vitamin D supplementation to achieve OPTIMAL health in children and adolescents.']	[('INCOMPLETE_EVIDENCE', 53), ('FUTURE_WORK', 76), ('IMPORTANT_CONSIDERATION', 195)]	3	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3873449	12/2013	S26-PMC3873449	['FURTHER INVESTIGATION IS NEEDED in order to confirm the EFFECT of Vitamin D deficiency during Pregnancy on various diseases in childhood.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC3873449	12/2013	S192-PMC3873449	['measures SHOULD BE taken to improve their knowledge about Vitamin D. treatment SHOULD BE paired with health education and advice and basic knowledge of the role of Vitamin D.\nin the study, the 25(Oh) D level was low in all subjects, but was PARTICULARLY low in less educated women.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 79), ('ANOMALY_CURIOUS_FINDING', 241)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH) D')]
PMC3901983	1/2013	S108-PMC3901983	['to avoid SEVERE malnutrition and Vitamin K depletion, the authors of THIS PAPER RECOMMEND close followup with specialized team.']	[('IMPORTANT_CONSIDERATION', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('FUTURE_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin K')]
PMC4018592	4/2014	S114-PMC4018592	['[43] in tanzania, when Micronutrient supplements providing amounts twice the RECOMMENDED dietary allowance (rda) for Vitamin E and 6-10 times for Vitamin C and several b Vitamins were administered, mean Birth weight increased by 67 g.[36] finally, the provision of multivitamin and multivitamin-Mineral supplements from two different Pharmaceutical companies MIGHT be INFLUENCED infants’ size.']	[('FUTURE_WORK', 77), ('INCOMPLETE_EVIDENCE', 359), ('SUPERFICIAL_RELATIONSHIP', 368)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 23, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin C'), ('CHEBI_33277', 'gamma-tocotrienol', 170, 'vitamins'), ('GO_0007567', 'parturition', 203, 'birth'), ('CHEBI_46662', 'mineral', 295, 'mineral'), ('CHEBI_52217', 'pharmaceutical', 334, 'pharmaceutical')]
PMC4113768	7/2014	S6-PMC4113768	['finally sessions on the economy of Vitamin D and public health, along with FUTURE DIRECTIONS for RESEARCH were held.']	[('FUTURE_WORK', 75), ('FUTURE_WORK', 82), ('FUTURE_WORK', 97)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4113768	7/2014	S246-PMC4113768	['strategies aimed at improving maternal Vitamin D status during Pregnancy, especially in the winter months, ARE NEEDED and MIGHT decrease the RISK of lrti in early childhood.']	[('FUTURE_WORK', 107), ('INCOMPLETE_EVIDENCE', 122), ('IMPORTANT_CONSIDERATION', 141)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
PMC4113768	7/2014	S462-PMC4113768	['Retinol-x receptors heterodimerize with Retinol-A receptors and the availability of rxr falls in the presence of excessive Vitamin A. westernized populations OFTEN ingest more Vitamin a than is ADVISABLE and up to 30% have circulating concentrations above the recommended maximum level (e.g., in nhanes111).']	[('PROBABLE_UNDERSTANDING', 158), ('FUTURE_WORK', 194), ('IMPORTANT_CONSIDERATION', 194)]	3	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('CHEBI_26536', 'retinoic acid', 40, 'retinol'), ('PR_000004370', 'asialoglycoprotein receptor 2', 48, 'A'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 176, 'vitamin')]
PMC4113768	7/2014	S1114-PMC4113768	['a minority of cases did not receive the RECOMMENDED type or dose of Vitamin D treatment, SUGGESTING a NEED to improve paediatricians’ knowledge regarding vdd management.']	[('FUTURE_WORK', 40), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 102)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4113768	7/2014	S1461-PMC4113768	['there is a NEED for randomised controlled Human intervention trials to investigate WHETHER improving Vitamin D status in men ameliorates vasculogenic ed and reduces the RISK of cvd.']	[('FUTURE_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('IMPORTANT_CONSIDERATION', 169)]	3	[('NCBITaxon_9606', 'Homo sapiens', 42, 'human'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4113768	7/2014	S2367-PMC4113768	['increased Vitamin D supplementation is THUS RECOMMENDED to maintain OPTIMAL Serum 25(Oh) Vitamin D levels during the summer season.']	[('PROBABLE_UNDERSTANDING', 39), ('FUTURE_WORK', 44), ('IMPORTANT_CONSIDERATION', 68)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_30778', 'gallic acid', 82, '25(OH)'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4113768	7/2014	S2587-PMC4113768	['in denmark, THEREFORE, national programs for Food fortification with Vitamin D are CONSIDERED.']	[('PROBABLE_UNDERSTANDING', 12), ('FUTURE_WORK', 83), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_33290', 'food', 45, 'food'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S3177-PMC4113768	['intervention STUDIES ARE REQUIRED to more fully explore the EFFECTS on Vitamin D on Intestinal inflammation in cd.']	[('FUTURE_WORK', 13), ('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000160', 'intestine', 84, 'intestinal')]
PMC4169453	9/2014	S218-PMC4169453	['our results INDICATE that the pth concentration SHOULD NOT BE considered a reliable functional MARKER of Vitamin D status in newborn infants.']	[('INCOMPLETE_EVIDENCE', 12), ('FUTURE_WORK', 48), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4210927	10/2014	S146-PMC4210927	['[65] FOUND that ONLY 36% of Lactating women meet energy, calcium and Vitamin D RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 16), ('FUTURE_WORK', 79)]	3	[('GO_0007594', 'puparial adhesion', 28, 'lactating'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4221707	11/2014	S18-PMC4221707	['in a swedish survey on diet intake conducted in 2010 to 2011, Childbearing-aged women had lower than recommended intake of fruit, berries, vegetables, and whole grain products, BUT a higher than RECOMMENDED intake of fatty foods and Sugar and lower than RECOMMENDED intake of Folate, Vitamin D, and iron [7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 177), ('FUTURE_WORK', 195), ('FUTURE_WORK', 254)]	3	[('GO_0007129', 'homologous chromosome pairing at meiosis', 62, 'childbearing'), ('CHEBI_24870', 'ion', 233, 'sugar'), ('CHEBI_30863', '5-azaorotic acid', 276, 'folate'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC4221707	11/2014	S189-PMC4221707	['in addition, the nnr RECOMMENDS that women of Childbearing age SHOULD consume 10\xa0μg of Vitamin D per day and for People with little or no sun exposure per day Vitamin D intake SHOULD BE increased to 20\xa0μg per day.']	[('FUTURE_WORK', 21), ('FUTURE_WORK', 63), ('FUTURE_WORK', 176)]	3	[('GO_0007129', 'homologous chromosome pairing at meiosis', 46, 'childbearing'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 113, 'people'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4256222	12/2014	S129-PMC4256222	['it would be OF great INTEREST to conduct similar analysis to investigate the ASSOCIATION between maternal status of Vitamin D and offspring Forearm fractures in a study population large enough to allow such subdivision of fractures and further stratification by Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 12), ('FUTURE_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002386', 'forelimb zeugopod', 140, 'forearm'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D')]
PMC4340999	3/2015	S99-PMC4340999	['FURTHER STUDIES ARE WARRANTED to test the ASSOCIATION between Prenatal Vitamin D status and Adult adiposity in an Adult population older than 35 years.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0007023', 'adult organism', 92, 'adult'), ('UBERON_0007023', 'adult organism', 114, 'adult')]
PMC4383226	2/2015	S131-PMC4383226	['moreover, BECAUSE of the observational nature of our study design, high-quality randomized clinical TRIALS ARE NEEDED to confirm the efficacy of Vitamin A in preventing malaria, PARTICULARLY among children exposed to Placental malaria.']	[('PROBLEM_COMPLICATION', 10), ('FUTURE_WORK', 100), ('ANOMALY_CURIOUS_FINDING', 178)]	3	[('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('UBERON_0001987', 'placenta', 217, 'placental')]
PMC4383226	2/2015	S132-PMC4383226	['this includes FURTHER CLARIFICATION regarding OPTIMAL dosages and the time sequence in which Vitamin A is administered in relation to other vaccines, as well as more accurate measures with regard to hbs and G6Pdd Allele frequency.']	[('FUTURE_WORK', 14), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 46)]	3	[('CHEBI_27300', 'vitamin D', 93, 'vitamin A'), ('PR_000007897', 'glutamate--cysteine ligase catalytic subunit', 207, 'G6PDd'), ('SO_0001023', 'allele', 213, 'allele')]
PMC4417995	4/2015	S29-PMC4417995	['the american academy of pediatrics RECOMMENDS a daily intake of 400\u2009iu of Vitamin D for infants and children, WHEREAS the institute of medicine and the Endocrine society RECOMMEND 400\u2009iu daily for infants and 600\u2009iu daily for children of 1 to 18 years old [16].']	[('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('FUTURE_WORK', 170)]	3	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 152, 'Endocrine')]
PMC4427001	4/2015	S94-PMC4427001	['in addition, Vitamin D MAY also be NEEDED to ensure a normal rate of Calcium Flux Across Cell Membranes and maintenance of an adequate Cytosolic calcium pool, which is IMPORTANT for Insulin-mediated Intracellular Signalling in Insulin-responsive Tissues [35].']	[('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 168)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_1990171', 'SCF complex disassembly in response to cadmium stress', 69, 'calcium flux across cell membranes'), ('GO_0005886', 'plasma membrane', 89, 'cell membranes'), ('GO_0005829', 'cytosol', 135, 'cytosolic'), ('PR_000045358', 'insulin family protein', 182, 'insulin'), ('GO_0005622', 'intracellular anatomical structure', 199, 'intracellular'), ('GO_0035556', 'intracellular signal transduction', 199, 'intracellular signalling'), ('PR_000045358', 'insulin family protein', 227, 'insulin'), ('UBERON_0000479', 'tissue', 246, 'tissues')]
PMC4476607	1/2015	S166-PMC4476607	['BASED ON their dietary habits, many children with fasd are not Consuming adequate or daily-RECOMMENDED amounts of Omega-3 Fatty Acids, Vitamin D, and Choline (figure 5a) (fuglestad et al 2013;werts et al.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('FUTURE_WORK', 91)]	3	[('GO_0007631', 'feeding behavior', 63, 'consuming'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 114, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_15354', 'choline', 150, 'choline')]
PMC4488777	5/2015	S176-PMC4488777	['COMPLEX evaluation of Vitamin D activity mechanism on fertility REQUIRES FURTHER STUDIES.']	[('DIFFICULT_TASK', 0), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4488777	5/2015	S190-PMC4488777	['administration of Vitamin D is RECOMMENDED in the case of CONSIDERABLE deficiency, PARTICULARLY in obese, Insulin resistant women with low Amh levels, as well as in men with oligo- and asthenozoospermia.']	[('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('PR_000045358', 'insulin family protein', 106, 'insulin'), ('CHEBI_16027', "adenosine 5'-monophosphate", 139, 'AMH')]
PMC4499946	7/2015	S77-PMC4499946	['TO ASSESS the EFFECT of Prenatal Vitamin D, we PLAN TO perform five primary between-group analyses, comprising each Vitamin D dose versus placebo (three comparisons) and comparisons between adjacent doses (two comparisons).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('FUTURE_WORK', 47)]	3	[('GO_0007565', 'female pregnancy', 24, 'prenatal'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4499946	7/2015	S229-PMC4499946	['TO ASSESS the EFFECT of Prenatal Vitamin D on mean Laz at 1 year of age, we PLAN TO perform five primary between-group analyses: each Prenatal Vitamin D dose versus placebo (three pairwise comparisons), as well as comparisons between all adjacent Vitamin D doses (two pairwise comparisons).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('FUTURE_WORK', 76)]	3	[('GO_0007565', 'female pregnancy', 24, 'prenatal'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000009655', 'laminin subunit beta-2', 51, 'LAZ'), ('GO_0007565', 'female pregnancy', 134, 'prenatal'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D')]
PMC4595656	10/2015	S6-PMC4595656	['FURTHER AVENUES OF FUTURE RESEARCH are outlined including Animal studies on the EFFECTS of Vitamin D deprivation and inadequacy on early hippocampal biochemistry and function, e.g., measurement of Bdnf levels, Gabaergic activity, long-term potentiation (ltp) and spatial Navigation.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('NCBITaxon_33208', 'Metazoa', 58, 'animal'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('PR_000004716', 'brain-derived neurotrophic factor', 197, 'BDNF'), ('CHEBI_86629', 'G b H', 210, 'GABAergic'), ('GO_0009647', 'skotomorphogenesis', 271, 'navigation')]
PMC4595656	10/2015	S93-PMC4595656	['apart from ELUCIDATING valuable data on the direct EFFECT of Vitamin D on Neurotransmitter levels within the hippocampus, such studies carried out on young Animals COULD also shed valuable light on Hippocampal Development when combined with behavioral testing.']	[('FUTURE_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 164)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 74, 'neurotransmitter'), ('NCBITaxon_33208', 'Metazoa', 156, 'animals'), ('GO_0003163', 'sinoatrial node development', 198, 'hippocampal development')]
PMC4624803	10/2015	S18-PMC4624803	['the levels of Vitamin D at Birth SHOULD BE a good ESTIMATE of the child’s Vitamin D levels, AT LEAST in the later part of the Gestation.']	[('FUTURE_WORK', 33), ('INCOMPLETE_EVIDENCE', 50), ('PROBABLE_UNDERSTANDING', 92)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007567', 'parturition', 27, 'birth'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestation')]
PMC4670104	12/2015	S19-PMC4670104	['also, apps are OFTEN RECOMMENDED for use in population studies as correction factors for assessing status with respect to Micronutrients, whose indicator concentrations MAY decrease (e.g., Serum Retinol for Vitamin A) or rise (e.g, Serum ferritin for iron) with inflammation [13–15].']	[('PROBABLE_UNDERSTANDING', 15), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 169)]	3	[('CHEBI_33839', 'macromolecule', 122, 'micronutrients'), ('UBERON_0001977', 'blood serum', 189, 'serum'), ('CHEBI_26536', 'retinoic acid', 195, 'retinol'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A'), ('UBERON_0001977', 'blood serum', 232, 'serum')]
PMC4691762	12/2015	S111-PMC4691762	['furthermore we are uniquely placed internationally TO ASSESS the ROLE of Vitamin D in Early Life development since australia does not currently RECOMMEND universal infant Vitamin D supplementation and is one of the few countries where there is no routine fortification of the Food chain supply.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 65), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 86, 'early life'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_33290', 'food', 276, 'food')]
PMC4719746	1/2016	S50-PMC4719746	['the RECOMMENDATION of Vitamin D supplementation\npre-planned, and ACCORDING TO the protocol, women with 25(Oh)D less than the laboratory’s lower reference range (<37\xa0nmol/l) at Gestational week 15 were provided with written information describing their 25(Oh)D D concentration, and they were RECOMMENDED to consult their general practitioner (gp) for treatment.']	[('FUTURE_WORK', 4), ('INCOMPLETE_EVIDENCE', 65), ('FUTURE_WORK', 291)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('GO_0007565', 'female pregnancy', 176, 'gestational'), ('CHEBI_29156', 'Gly-tRNA(Gly)', 252, '25(OH)D D'), ('PR_000007367', 'fibrosin-1-like protein', 252, '25(OH)D D')]
PMC4719746	1/2016	S118-PMC4719746	['women with <37\xa0nmol/l at baseline were RECOMMENDED 20\xa0μg or 30\xa0μg Vitamin D daily\n\ndiscussion\n\nmain findings\nin THIS cohort study we FOUND a high prevalence of Vitamin D deficiency (<50\xa0nmol/l) in early Pregnancy among women from south asia, middle east and sub-saharan africa, and severe deficiency (<25\xa0nmol/l) was prevalent among women from these regions.']	[('FUTURE_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 133)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC4719746	1/2016	S161-PMC4719746	['this cost-effective, and easy-to-administer RECOMMENDATION LIKELY CONTRIBUTED the most to the improved Vitamin D status later in Pregnancy for these women.']	[('FUTURE_WORK', 44), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC4729160	1/2016	S128-PMC4729160	['MORE STUDIES ARE NEEDED to understand the INFLUENCE FACTORS of Vitamin A status of chinese Pregnant women.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnant')]
PMC4764019	1/2016	S18-PMC4764019	['the eurodiab STUDY5SHOWED that 7 european centers that practiced regular Vitamin D supplementation during infancy had a 33% lower incidence of juvenile diabetes prior to age 15 years than centers that DID NOT ENCOURAGE regular supplementation.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 201), ('FUTURE_WORK', 209)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4778858	3/2016	S106-PMC4778858	['THUS, well-designed, interventional studies, with both neonatal and longitudinal follow up outcomes, are NECESSARY in order to provide improved RECOMMENDATIONS for Vitamin D supplementation in Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 105), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC4785305	3/2016	S19-PMC4785305	['the findings of this trial will help guide the public health policymaker regarding Vitamin D supplementation in Pregnant women and will allow a step forward in EVIDENCE-BASED RECOMMENDATIONS SPECIFIC to the middle east.']	[('INCOMPLETE_EVIDENCE', 160), ('FUTURE_WORK', 175), ('FUTURE_WORK', 191)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC4785305	3/2016	S172-PMC4785305	['the findings of this trial will help guide the public health policymaker regarding Vitamin D supplementation in Pregnant women and will allow a step forward in EVIDENCE-BASED RECOMMENDATIONS SPECIFIC to the middle east.']	[('INCOMPLETE_EVIDENCE', 160), ('FUTURE_WORK', 175), ('FUTURE_WORK', 191)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC4811441	3/2016	S167-PMC4811441	['another STRENGTH is that Blood samples were taken in both early and late Pregnancy, enabling INVESTIGATION of changes in Vitamin D status in RELATION to pe and bp.']	[('IMPORTANT_CONSIDERATION', 8), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 141)]	3	[('UBERON_0000178', 'blood', 25, 'blood'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4896250	4/2016	S2806-PMC4896250	['FURTHER RESEARCH SHOULD BE focused on Vitamin D supplementation for the PREVENTION of childhood asthma.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC4896250	4/2016	S6539-PMC4896250	['FURTHER STUDIES ARE NEEDED to clarify the clinical EFFICACY of Vitamin D in this disorder.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4897523	10/2014	S109-PMC4897523	['ON THE OTHER HAND, the involvement of maternal Vitamin D during Pregnancy in autism REQUIRES PROPER INVESTIGATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 84), ('FUTURE_WORK', 93)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy')]
PMC4908484	6/2016	S176-PMC4908484	['the results SUPPORT the POTENTIAL use of Vitamin D supplementation as a therapeutic STRATEGY in neurodegeneration disorders.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('FUTURE_WORK', 84)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4930210	7/2016	S27-PMC4930210	['ALTHOUGH the literature regarding Vitamin D in Pregnancy is growing rapidly, several gaps in our knowledge REMAIN, including the prevalence of Vitamin D deficiency/ insufficiency during Pregnancy and the intake of Vitamin D during Pregnancy NEEDED to ensure optimal status.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 107), ('FUTURE_WORK', 241)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D'), ('GO_0007565', 'female pregnancy', 231, 'pregnancy')]
PMC4934634	11/2015	S32-PMC4934634	['BASED ON lower circulating 25(Oh)D concentrations at a given Vitamin D supplement level in obese and overweight subjects compared to normal weight subjects, ekwaru and coworkers RECENTLY RECOMMENDED that “Vitamin D supplementation be 2–3 times higher for obese subjects and 1.5 times higher for overweight subjects relative to normal weight subjects” [10].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 178), ('FUTURE_WORK', 187)]	3	[('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC4934634	11/2015	S111-PMC4934634	['the THEORY that Vitamin D supplementation CAN help normalize Blood Glucose levels and reduce the incidence of Gestational diabetes is an active AREA of research.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 42), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_17234', 'glucose', 67, 'glucose'), ('GO_0007565', 'female pregnancy', 110, 'gestational')]
PMC4934634	11/2015	S252-PMC4934634	['similarly, STUDIES ARE NEEDED to address WHETHER women who are Vitamin D sufficient at Conception and receiving high doses of Vitamin D (≥4000 iu/daily) have adverse Pregnancy outcomes.']	[('FUTURE_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007620', 'copulation', 87, 'conception'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC4934634	11/2015	S296-PMC4934634	['additional fortification or supplementation STRATEGIES WOULD BE NEEDED to reach rda levels of Vitamin D intake CONSISTENTLY, especially in Individuals with low intakes of fish/seafood or fortified dairy foods, other fortified foods (e.g., breakfast cereals) and beverages”.']	[('FUTURE_WORK', 44), ('FUTURE_WORK', 55), ('PROBABLE_UNDERSTANDING', 111)]	3	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('NCBITaxon_1', 'root', 139, 'individuals')]
PMC4944244	7/2016	S226-PMC4944244	['health care workers SHOULD also know the functions and the sources of Vitamin D, so that ADVICE COULD BE given to patients especially those with Lactose intolerance or low Milk Consumption during Pregnancy.']	[('FUTURE_WORK', 20), ('FUTURE_WORK', 89), ('INCOMPLETE_EVIDENCE', 96)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 78, 'D'), ('CHEBI_17716', 'lactose', 145, 'lactose'), ('GO_0001774', 'microglial cell activation', 172, 'milk consumption'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC4949006	7/2016	S4-PMC4949006	['Folic Acid SHOULD BE supplemented prior to Conception and continued through AT LEAST the first 28 days of fetal Life to prevent Neural Tube defects, and Vitamin C SHOULD be given to women who smoke to lower the incidence of asthma and wheezing in the children.']	[('FUTURE_WORK', 11), ('PROBABLE_UNDERSTANDING', 76), ('FUTURE_WORK', 163)]	3	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('GO_0007620', 'copulation', 43, 'conception'), ('UBERON_0000104', 'life cycle', 112, 'life'), ('UBERON_0001049', 'neural tube', 128, 'neural tube'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin C')]
PMC4973215	8/2016	S96-PMC4973215	['if Vitamin D supplementation does not occur during Pregnancy, it MAY BE IMPERATIVE to identify and offer additional supplementation beyond the routinely recommended 400\u2009iu per day for all infants.28\nthere were several LIMITATIONS to our study.']	[('FUTURE_WORK', 65), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 218)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC4989298	8/2016	S355-PMC4989298	['IS the administration of Vitamin D RECOMMENDED during Pregnancy to prevent allergic diseases in children?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 35), ('EXPLICIT_QUESTION', 104)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy')]
PMC4989298	8/2016	S379-PMC4989298	['on BASIS of the AVAILABLE EVIDENCE, the use of Vitamin D supplementation is not RECOMMENDED for the primary prevention of allergic disease.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5014971	8/2016	S90-PMC5014971	['physicians who indicated that Vitamin D insufficiency is a PROBLEM in their patient population were more LIKELY to agree or strongly agree that Vitamin D supplementation during Pregnancy is safe and that all Pregnant women SHOULD BE screened.']	[('IMPORTANT_CONSIDERATION', 59), ('PROBABLE_UNDERSTANDING', 105), ('FUTURE_WORK', 223)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('GO_0007565', 'female pregnancy', 208, 'pregnant')]
PMC5014971	8/2016	S95-PMC5014971	["the greater the CONCERN is over their patients' Vitamin D status, the more LIKELY the physician is to RECOMMEND supplementation."]	[('PROBLEM_COMPLICATION', 16), ('PROBABLE_UNDERSTANDING', 75), ('FUTURE_WORK', 102)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5014971	8/2016	S100-PMC5014971	['there is CONTINUING CONTROVERSY over the APPROPRIATE levels of Vitamin D supplementation and of the levels of circulating 25-Hydroxyvitamin D that represent good health.']	[('FUTURE_WORK', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 41)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 122, '25-hydroxyvitamin D')]
PMC5014971	8/2016	S132-PMC5014971	['ALTHOUGH few screen most of their Pregnant patients for Vitamin D status, most would RECOMMEND Vitamin D supplementation EVEN without screening.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 85), ('ANOMALY_CURIOUS_FINDING', 121)]	3	[('GO_0007565', 'female pregnancy', 34, 'pregnant'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5024431	9/2016	S105-PMC5024431	['Eating Out less/Eat at home morei want to only dine out for 1 meal a weekeat more at home\u2003evening/night time Eating (e.g., healthier and/or restricting)no Eating after 8:00pmlimit snacks at night\u2003follow\xa0canada’s Food guidefollow canada’s Food guide\u2003follow \ufeffvegetarian/vegan dietseat mostly vegan\u2003follow\xa0fad diets (not gluten free)more alkaline and less Acidic Foods\u2003gluten free (includes wheat free)follow celiac diet\u2003follow\xa0other plans (includes fodmap guidelines, Heart healthy, diabetes, optifast®, weight watchers®, dash, dietitian meal plans, weight lifting, Pregnancy diet, unspecified diet plans)following the dietitian’s plan, eat only my shakes this week, follow diet, follow diabetes diet\u2003glycemic indexkeep a low glycemic index diet\u2003clean Eating (includes unprocessed, whole, fresh, raw, natural foods)Eating cleaner, eat as much raw as possible, to eat fresh Food\u2003supplementstake 600-800 iu Vitamin D daily\u2003planning and preparing Food†cook dinner from scratch a minimum of 3 times per week, plan 4–5 smaller meals per daybetter Planning and Preparing Of Food, plan healthy meals, plan meals\u2003goals describing when Food is Eaten or not Eaten/Eating patternseat breakfast, Lunch, dinner & snack every day, not to eat in between mealseat more regularly, try not to snack so much throughout the day\u2003breakfasteating healthy breakfastincorporate cereal or smoothies more often for breakfast\u2003psychological aspects of Eatingdon’t binge, drink Water or 0 cal drink when hungry, stop emotional eatingto Control Food Intake, respect Food AS a means of nutrition and to satisfy hunger\u2003general Eating improvementseat healthy meals and snacks, eat the RECOMMENDED dv of Minerals and Vitamins, eat a variety of foodseat healthy, eat a balanced diet, eat right to avoid ibs symptoms\noverall, there were n\u2009= \u20091,986, n\u2009= \u2009614, n\u2009= \u2009233, and n\u2009= \u20091,134 daily, weekly, monthly, and one-time write your own goal statements, respectively (excluding irrelevant to health/Nonsense goals); these goals were RARELY tracked.']	[('PROBABLE_UNDERSTANDING', 1538), ('FUTURE_WORK', 1649), ('INCOMPLETE_EVIDENCE', 1993)]	3	[('GO_0006897', 'endocytosis', 0, 'Eating out'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 16, 'Eat'), ('GO_0051318', 'G1 phase', 109, 'eating'), ('GO_0051318', 'G1 phase', 155, 'eating'), ('CHEBI_33290', 'food', 212, 'Food'), ('CHEBI_33290', 'food', 238, 'food'), ('CHEBI_37527', 'acid', 353, 'acidic'), ('CHEBI_33290', 'food', 360, 'foods'), ('UBERON_0000948', 'heart', 466, 'heart'), ('GO_0007565', 'female pregnancy', 564, 'pregnancy'), ('GO_0051318', 'G1 phase', 750, 'eating'), ('GO_0007568', 'aging', 813, 'Eating'), ('CHEBI_33290', 'food', 871, 'food'), ('CHEBI_27300', 'vitamin D', 903, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 911, 'D'), ('CHEBI_33290', 'food', 942, 'food'), ('GO_0006260', 'DNA replication', 1040, 'planning'), ('GO_0007565', 'female pregnancy', 1053, 'preparing of food'), ('CHEBI_33290', 'food', 1066, 'food'), ('CHEBI_33290', 'food', 1125, 'food'), ('GO_0036268', 'swimming', 1133, 'eaten'), ('GO_0036268', 'swimming', 1146, 'eaten'), ('GO_0051318', 'G1 phase', 1152, 'eating'), ('UBERON_0010164', 'collection of hairs', 1182, 'Lunch'), ('GO_0050957', 'equilibrioception', 1421, 'eatingDon'), ('CHEBI_15377', 'water', 1446, 'water'), ('GO_0065007', 'biological regulation', 1504, 'control'), ('CHEBI_33290', 'food', 1512, 'food'), ('GO_0007631', 'feeding behavior', 1512, 'food intake'), ('CHEBI_33290', 'food', 1533, 'food'), ('GO_0051318', 'G1 phase', 1592, 'eating'), ('CHEBI_46751', 'quinolizidine', 1667, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 1680, 'vitamins'), ('GO_0001967', 'suckling behavior', 1959, 'nonsense')]
PMC5085625	9/2016	S126-PMC5085625	['to summarize, the LINK between Vitamin D and Glucose Metabolism REQUIRES FURTHER STUDIES on larger populations of Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_17234', 'glucose', 45, 'glucose'), ('GO_0006006', 'glucose metabolic process', 45, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 114, 'pregnant')]
PMC5146866	12/2016	S25-PMC5146866	['improved understanding of FACTORS ASSOCIATED with development of Vitamin D deficiency/ insufficiency will facilitate the creation and implementation of appropriate preventive STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 34), ('FUTURE_WORK', 175)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC5155676	12/2016	S137-PMC5155676	['AS SUCH, personalized Vitamin D supplementation ADVICE MIGHT become part of future Antenatal care.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 48), ('INCOMPLETE_EVIDENCE', 55)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007567', 'parturition', 83, 'antenatal')]
PMC5264377	7/2016	S37-PMC5264377	['IN FACT, the benefits ASSOCIATED with Gestational Vitamin D supplementation are debatable, and MORE RESEARCH IS WARRANTED (dalgard et al ., 2016;dressler et al ., 2016).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 95)]	3	[('GO_0007565', 'female pregnancy', 38, 'gestational'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5385921	4/2017	S132-PMC5385921	['DEFINING the precise CRITICAL window during which developmental Vitamin D deficiency adversely AFFECTS Brain Development at this stage would be premature.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 21), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007420', 'brain development', 103, 'brain development'), ('UBERON_0000955', 'brain', 103, 'brain')]
PMC5418719	5/2017	S7-PMC5418719	['the clinical SIGNIFICANCE of optimal Vitamin D intake in vlbw infants NEEDS TO BE studied in larger controlled STUDIES.']	[('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 70), ('FUTURE_WORK', 111)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5418719	5/2017	S97-PMC5418719	['serial measurements of Serum 25(Oh)D to evaluate Vitamin D status during hospitalization MAY HELP to identify preterm infants AT RISK of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 126)]	3	[('UBERON_0001977', 'blood serum', 23, 'serum'), ('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 29, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5418719	5/2017	S140-PMC5418719	['longitudinal extension of this study and randomized controlled STUDIES ARE REQUIRED to explore the efficacy and clinical benefits of daily supplementation of Vitamin D in dose of 800\xa0iu in a larger cohort.']	[('FUTURE_WORK', 63), ('FUTURE_WORK', 71), ('IMPORTANT_CONSIDERATION', 75)]	3	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC5436890	5/2017	S30-PMC5436890	['the KEY STRATEGIES of the nns includes growth monitoring and promotion, ENCOURAGING behaviour change to improve good nutritional practices, Vitamin A supplementation, zinc supplementation during treatment of diarrhoea and Iron/Folic Acid supplementation for Pregnant women.']	[('IMPORTANT_CONSIDERATION', 4), ('FUTURE_WORK', 8), ('FUTURE_WORK', 72)]	3	[('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('CHEBI_24870', 'ion', 222, 'iron'), ('CHEBI_30751', 'formic acid', 227, 'folic acid'), ('GO_0007565', 'female pregnancy', 258, 'pregnant')]
PMC5524288	7/2017	S112-PMC5524288	['IMPROVING the Vitamin D status of women with underlying conditions MAY AVERT the need for a medically indicated Preterm Delivery.']	[('FUTURE_WORK', 0), ('FUTURE_PREDICTION', 67), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'preterm'), ('GO_0007567', 'parturition', 120, 'delivery')]
PMC5539754	8/2017	S158-PMC5539754	['at present, there REMAINS a LACK OF CONSENSUS regarding RECOMMENDATIONS for uvb exposure for the Production Of Vitamin D for Pregnant Women [46].']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('FUTURE_WORK', 56)]	3	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 97, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant women')]
PMC5539754	8/2017	S160-PMC5539754	['thus, RECOMMENDATIONS for Vitamin D supplementation to improve Glucose Homeostasis in Pregnancy CANNOT BE made BASED ON our results.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 111)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_17234', 'glucose', 63, 'glucose'), ('GO_0042593', 'glucose homeostasis', 63, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC5623264	9/2017	S93-PMC5623264	['multiple Micronutrient supplementation\nthe EFFECT of mmn supplementation on lbw, ptb and sga was assessed in three reviews (see\xa0onlinesupplementary table 8).35–37mmn supplementation provided one RECOMMENDED daily nutrient intake of Vitamin A, vitamin B1, vitamin B2, niacin, vitamin B6, Vitamin B12, Folic Acid, Vitamin C, vitamin d, Vitamin E, copper, Selenium and Iodine with iron and zinc to Pregnant women.47a significant reduction of lbw in the range of 11%–14%\u2009and a significant reduction of sga in the range of 10%–17%\u2009could BE observed following mmn supplementation in all three reviews.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('FUTURE_WORK', 195), ('ANOMALY_CURIOUS_FINDING', 532)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin A'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 251, 'B1'), ('CHEBI_18245', 'carboxylato group', 263, 'B2'), ('CHEBI_51231', 'DAPI', 283, 'B6'), ('CHEBI_33279', 'vitamin D5', 287, 'vitamin B12'), ('CHEBI_30751', 'formic acid', 300, 'folic acid'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 353, 'selenium'), ('CHEBI_24859', 'iodine atom', 366, 'iodine'), ('GO_0007565', 'female pregnancy', 395, 'pregnant')]
PMC5634602	10/2017	S0-PMC5634602	['randomized trial of two doses of Vitamin D3In preterm infants <32 weeks: dose IMPACT on achieving desired Serum 25(Oh)D3In a nicu population\n\nabstract\n\nbackground\nRECOMMENDATIONS for Vitamin D supplementation for preterm infants span a WIDE range of doses.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('FUTURE_WORK', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236)]	3	[('CHEBI_33229', 'vitamin (role)', 33, 'vitamin D3in'), ('PR_000017209', 'utrophin', 33, 'vitamin D3in'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('PR_000001883', 'lysosome-associated membrane protein', 112, '25(OH)D3in'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5634602	10/2017	S12-PMC5634602	['conclusions\nimprovement in 25(Oh)D3Levels at 4 weeks, bone density, and TRENDS towards improvement in linear growth SUPPORT CONSIDERATION of a daily dose of 800 iu of Vitamin D for infants <32 weeks cared for in the nicu.']	[('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 116), ('FUTURE_WORK', 124)]	3	[('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 27, '25(OH)D3levels'), ('PR_000001895', 'natural cytotoxicity triggering receptor 3', 27, '25(OH)D3levels'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC5634602	10/2017	S96-PMC5634602	['INITIAL STUDIES of and RECOMMENDATIONS for Vitamin D intake were designed to PREVENT rickets in term infants targeting a Serum 25(Oh)D level of >50 nmol/l [36,37].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 127, '25(OH)D')]
PMC5659607	10/2017	S152-PMC5659607	['FUTURE STUDIES SHOULD explore the OPTIMAL timing and level of Vitamin D supplementation during Pregnancy.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('IMPORTANT_CONSIDERATION', 34)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy')]
PMC5664622	9/2017	S6-PMC5664622	['THEREFORE, summer improves the levels of Vitamin D in the body but does not guarantee the RECOMMENDED concentration and supplementation throughout the whole year is ESSENTIAL.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 90), ('IMPORTANT_CONSIDERATION', 165)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5664622	9/2017	S15-PMC5664622	['AS dietary sources of Vitamin D have FAILED to meet the RECOMMENDED levels for years [12,13], Vitamin D concentration is in fact enhanced by supplementation and exposure to sunlight [2,5].']	[('PROBABLE_UNDERSTANDING', 0), ('DIFFICULT_TASK', 37), ('FUTURE_WORK', 56)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5679631	11/2017	S146-PMC5679631	['in a FUTURE STUDY, it would be PREFERABLE to investigate the IMPACT of Postnatal Vitamin D supplementation in older infants whose 25(Oh)D concentrations have reached a steady state.']	[('FUTURE_WORK', 5), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('GO_0007567', 'parturition', 71, 'postnatal'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D')]
PMC5716389	9/2017	S41-PMC5716389	["FURTHER, Vitamin A IS NEEDED in the Development and functioning Of the Cell-Mediated and humoral Immune Systems, with deficiency at Birth POTENTIALLY reducing the infant's response to vaccines."]	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('INCOMPLETE_EVIDENCE', 138)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0009566', 'fertilization', 36, 'development ... of ...'), ('GO_0007464', 'R3/R4 cell fate commitment', 71, 'cell-mediated ... immune systems'), ('UBERON_0002405', 'immune system', 97, 'immune systems'), ('GO_0007567', 'parturition', 132, 'birth')]
PMC5812027	2/2018	S122-PMC5812027	['WHETHER Vitamin D Metabolism is altered in Placental dysfunction in UNCLEAR and WARRANTS FURTHER INVESTIGATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 68), ('FUTURE_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 8, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 43, 'placental')]
PMC5838372	3/2018	S102-PMC5838372	['ALTHOUGH the ministry of health has RECOMMENDED a Vitamin D intake of 1200 iu/day, we FOUND that 12.4% of mothers never used Vitamin D Supplements and 73.2% used irregular or low doses.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 36), ('INCOMPLETE_EVIDENCE', 86)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 135, 'supplements')]
PMC5838372	3/2018	S105-PMC5838372	['these results SHOW that high dose Vitamin D support is NECESSARY during Pregnancy and that the support program SHOULD BE continued.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 55), ('FUTURE_WORK', 111)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy')]
PMC5941617	5/2018	S4-PMC5941617	['AT PRESENT, the prevalence of Vitamin D deficiency is high in italian children and adolescents, and national RECOMMENDATIONS on Vitamin D supplementation during pediatric age are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 109), ('FULL_UNKNOWN', 179)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5941617	5/2018	S98-PMC5941617	['THUS, dietary sources of Vitamin D SHOULD NOT BE considered significant for Humans except SOME populations living at higher latitudes where fish, fish oil and fish eggs are frequently Consumed [88].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'humans'), ('GO_0007631', 'feeding behavior', 184, 'consumed')]
PMC5941617	5/2018	S104-PMC5941617	['assuming minimal sunshine exposure, sacn RECOMMENDED a SAFE intake of 340–400\xa0iu/day of Vitamin D for infants under 1\xa0year of Life, a SAFE intake of 400\xa0iu/day for age 1 up to 4\xa0years, and a reference Nutrient intake of 400\xa0iu/day for the united kingdom population aged 4\xa0years and above [25].']	[('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 134)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0000104', 'life cycle', 126, 'life'), ('CHEBI_33284', 'nutrient', 201, 'nutrient')]
PMC5941617	5/2018	S106-PMC5941617	['WHILE there is sufficient global agreement in considering 400\xa0iu/day as dietary reference value for Vitamin D during the first year of Life, RECOMMENDED reference values for children and adolescents (1–18\xa0years) slightly differ between organizations and societies, reflecting DIFFERENT approaches and methods applied to calculate them.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 276)]	3	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC5941617	5/2018	S108-PMC5941617	['particularly, the Endocrine society guidelines focused on patients AT RISK for Vitamin D deficiency, RECOMMENDING a Vitamin D daily REQUIREMENT of 400–1000\xa0iu in the first years of Life and of 600–1000\xa0iu from 1 up to 18\xa0years [11].']	[('IMPORTANT_CONSIDERATION', 67), ('FUTURE_WORK', 101), ('IMPORTANT_CONSIDERATION', 132)]	3	[('UBERON_0005063', 'left ventricular compact myocardium', 18, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0000104', 'life cycle', 181, 'life')]
PMC5941617	5/2018	S129-PMC5941617	['we RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation, as the administration of these Compounds increases the RISK of hypercalcemia and is NOT ABLE to maintain and/or restore Vitamin D stores [118,119].']	[('FUTURE_WORK', 3), ('IMPORTANT_CONSIDERATION', 229), ('DIFFICULT_TASK', 258)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_25212', 'metabolite', 37, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 68, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 81, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 95, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 111, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_36357', 'polyatomic entity', 205, 'compounds'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin D')]
PMC5941617	5/2018	S143-PMC5941617	['DIFFERENTLY, CONSIDERING the high prevalence of Vitamin D deficiency during Pregnancy, the espghan RECOMMENDED for preterm infants a Vitamin D intake of 800–1000\xa0iu/day during the first months of Life to rapidly correct fetal low Serum 25(Oh)D levels [125].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('FUTURE_WORK', 99)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 230, 'serum'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 236, '25(OH ... D')]
PMC5941617	5/2018	S158-PMC5941617	['in the present consensus we RECOMMEND a total daily Vitamin D intake of 200–400\xa0iu (including the amount administered through parenteral nutrition, fortified Breast Milk, and preterm formula) for preterm infants with a Birth weight\u2009<\u20091500\xa0g. Vitamin D supplementation at 400–800\xa0iu/day is RECOMMENDED for vlbw infants when they reach a weight\u2009≥\u20091500\xa0g and full enteral nutrition, and for preterm infants with a Birth weight\u2009≥\u20091500\xa0g. after a post-Conceptional age of 40\xa0weeks, RECOMMENDATIONS for Vitamin D supplementation are equal to those for healthy term infants.']	[('FUTURE_WORK', 28), ('FUTURE_WORK', 289), ('FUTURE_WORK', 477)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000310', 'breast', 158, 'breast'), ('UBERON_0001913', 'milk', 165, 'milk'), ('GO_0007567', 'parturition', 219, 'birth'), ('CHEBI_28384', 'vitamin K', 242, 'Vitamin D'), ('GO_0007567', 'parturition', 411, 'birth'), ('GO_0007620', 'copulation', 447, 'conceptional'), ('CHEBI_27300', 'vitamin D', 497, 'vitamin D')]
PMC5941617	5/2018	S179-PMC5941617	['for example, arab emirates GUIDELINES RECOMMENDED Vitamin D supplementation between may and october BECAUSE arabian People avoid sun exposure during summer due to excessive heat [27].']	[('PROBABLE_UNDERSTANDING', 27), ('FUTURE_WORK', 38), ('PROBABLE_UNDERSTANDING', 100)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 116, 'people')]
PMC5941617	5/2018	S187-PMC5941617	['in cases of POOR compliance, supplementation with intermittent dosing (weekly or monthly doses for a cumulative monthly dose of 18000–30000\xa0iu of Vitamin D) can be CONSIDERED, starting from children aged 5–6\xa0years and PARTICULARLY during Adolescence.']	[('PROBLEM_COMPLICATION', 12), ('FUTURE_WORK', 164), ('IMPORTANT_CONSIDERATION', 218)]	3	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 238, 'adolescence')]
PMC5941617	5/2018	S198-PMC5941617	['we RECOMMEND against routine 25(Oh)D testing in children and adolescents, SUGGESTING to limit Serum 25(Oh)D levels evaluation in children and adolescents with multiple RISK FACTORS for Vitamin D deficiency.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 168)]	3	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC5941617	5/2018	S236-PMC5941617	['RECOMMENDED oral Calcium administration of 500\xa0mg/day in conjunction with Vitamin D REGARDLESS OF age or weight [28], WHILE misra et al.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	3	[('CHEBI_22313', 'alkaline earth metal atom', 17, 'calcium'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5941617	5/2018	S242-PMC5941617	['the administration of 1α-Hydroxylated Metabolites of Vitamin D MAY BE CONSIDERED in nutritional rickets ASSOCIATED with acute hypocalcemia or hypocalcemic cardiomyopathy [9,183].']	[('INCOMPLETE_EVIDENCE', 63), ('FUTURE_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('CHEBI_24669', 'hydroxy carboxylic acid', 25, 'hydroxylated'), ('CHEBI_25212', 'metabolite', 38, 'metabolites'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC5941617	5/2018	S255-PMC5941617	['THUS, Vitamin D supplementation during infancy is IMPORTANT to optimize bone mass acquisition and body composition, but high doses are not RECOMMENDED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 50), ('FUTURE_WORK', 139)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC5941617	5/2018	S451-PMC5941617	['clinical GUIDELINE for Skeletal health of children and adolescents with ibd RECOMMEND to treat Vitamin D deficiency and insufficiency administering a cumulative dose of AT LEAST 400000\xa0iu, and 250000\xa0iu of Vitamin D, respectively.']	[('PROBABLE_UNDERSTANDING', 9), ('FUTURE_WORK', 76), ('PROBABLE_UNDERSTANDING', 169)]	3	[('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC5941617	5/2018	S457-PMC5941617	['particularly, large rcts ARE NEEDED to BETTER investigate the ROLE of Vitamin D in disease remission and Control.']	[('FUTURE_WORK', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0065007', 'biological regulation', 105, 'control')]
PMC5941617	5/2018	S474-PMC5941617	['other authors REINFORCE that Vitamin D supplementation SHOULD BE offered to cd patients AT LEAST during the first years of gluten free diet [423].']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 55), ('PROBABLE_UNDERSTANDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5941617	5/2018	S507-PMC5941617	['similarly, obese children with Vitamin D deficiency SHOULD BE treated with Vitamin D at doses 2–3 times higher than those RECOMMENDED for non-obese pediatric population for at least 6\xa0weeks [11].']	[('FUTURE_WORK', 52), ('IMPORTANT_CONSIDERATION', 52), ('FUTURE_WORK', 122)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S526-PMC5941617	['THEREFORE, FURTHER rcts ARE NEEDED before RECOMMENDING routine Vitamin D supplementation in children with autism.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('FUTURE_WORK', 42)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5941617	5/2018	S639-PMC5941617	['in cases of POOR compliance, supplementation with intermittent dosing (weekly or monthly doses for a cumulative monthly dose of 18000–30000\xa0iu of Vitamin D) can be CONSIDERED, starting from children aged 5–6\xa0years and PARTICULARLY during Adolescence.']	[('PROBLEM_COMPLICATION', 12), ('FUTURE_WORK', 164), ('IMPORTANT_CONSIDERATION', 218)]	3	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 238, 'adolescence')]
PMC5941617	5/2018	S665-PMC5941617	['NO DEFINITIVE EVIDENCE exists to RECOMMEND Vitamin D supplementation for PREVENTION of Respiratory infections (non-associated with wheezing) or recurrent Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 87, 'respiratory'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory')]
PMC5941617	5/2018	S685-PMC5941617	['a short trial of Vitamin D supplementation CAN be CONSIDERED in patients with SEVERE ad unresponsive to common therapy, especially in the late winter-early spring period.']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5941617	5/2018	S698-PMC5941617	['after achieving Vitamin D sufficiency, we RECOMMEND to continue with Vitamin D supplementation at higher doses than those RECOMMENDED for age (AT LEAST 1000–1500\xa0iu/day).']	[('FUTURE_WORK', 42), ('FUTURE_WORK', 122), ('PROBABLE_UNDERSTANDING', 143)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5941617	5/2018	S701-PMC5941617	['RECOMMENDATIONS for treatment of Vitamin D deficiency in patients with newly diagnosed cd are equivalent to those for ibds patients, AS both these conditions are ASSOCIATED with Intestinal malabsorption.']	[('FUTURE_WORK', 0), ('PROBABLE_UNDERSTANDING', 133), ('SUPERFICIAL_RELATIONSHIP', 162)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000160', 'intestine', 178, 'intestinal')]
PMC5941617	5/2018	S702-PMC5941617	['AS gluten-free diet restores normal Intestinal absorption, after treatment of deficiency we RECOMMEND Vitamin D supplementation according to the modalities and REQUIREMENTS for otherwise healthy children and adolescents.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 92), ('IMPORTANT_CONSIDERATION', 160)]	3	[('UBERON_0000160', 'intestine', 36, 'intestinal'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5941617	5/2018	S707-PMC5941617	['we SUGGEST Vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) in obese children and adolescents to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('FUTURE_WORK', 64)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D')]
PMC5956785	5/2018	S67-PMC5956785	['the society RECOMMENDS that AT-RISK populations, including “obese children and Adults and children and Adults on Anticonvulsant medications, Glucocorticoids, antifungals such as Ketoconazole, and medications for acquired immune deficiency syndrome be given at least two to three times more Vitamin D for their age group to satisfy their body’s Vitamin D REQUIREMENT” [20].']	[('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 354)]	3	[('UBERON_0007023', 'adult organism', 79, 'adults'), ('UBERON_0007023', 'adult organism', 103, 'adults'), ('CHEBI_35624', 'azaspiro compound', 113, 'anticonvulsant'), ('CHEBI_36597', 'phthalazine', 141, 'glucocorticoids'), ('CHEBI_47519', 'ketoconazole', 178, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
PMC5956785	5/2018	S229-PMC5956785	['they FOUND that the MAJORITY of pediatric rheumatologists are RECOMMENDING Vitamin D for patients who were on long-term Corticosteroids [76].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 20), ('FUTURE_WORK', 62)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_50850', 'etabonate ester', 120, 'corticosteroids')]
PMC6039335	7/2018	S263-PMC6039335	['continuous dietary Vitamin A restriction during the late fattening phase is not RECOMMENDED because prolonged Vitamin A restriction MAY lead to health PROBLEMS and retard growth rate [130].']	[('FUTURE_WORK', 80), ('INCOMPLETE_EVIDENCE', 132), ('PROBLEM_COMPLICATION', 151)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin A')]
PMC6039335	7/2018	S283-PMC6039335	['FURTHER STUDY IS NEEDED to clarify the EFFECTS of dietary Vitamin D on ms and qg in beef cattle.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC6039335	7/2018	S294-PMC6039335	['FURTHER STUDY is NECESSARY to clarify the EFFECTS of dietary Vitamin C on ms and qg in other breeds of beef cattle.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 17), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C')]
PMC1852384	1/2007	S29-PMC1852384	['over time, ADDITIONAL preoperative STUDIES, including serum Insulin, iron, ferritin, Vitamin B12, 25-Oh Vitamin D, and Thiamine (Vitamin B1) were added.rygb was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided Stomach, ta 90b (us surgical, norwalk, ct, usa) applied twice; (3) hand-sewn two-layer retrocolic, Antegastric Gastrojejunostomy, 12\xa0mm in length, tested with Methylene Blue under pressure intraoperatively; (4) side-to-side, functional end-to-end Jejunojejunostomy with dispsable Gia (us surgical) or lc (ethicon endosurgery, sommerville, nj, usa) 75\xa0mm staplers, and ta55 (us surgical) or Tx 60 (ethicon endosurgery) staplers and routinely oversewn with 3–0 silk lembert Sutures.']	[('FUTURE_WORK', 11), ('FUTURE_WORK', 35)]	2	[('PR_000045358', 'insulin family protein', 60, 'insulin'), ('CHEBI_33279', 'vitamin D5', 85, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 85, 'vitamin B12'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 98, '25-OH'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_26948', 'vitamin B1', 119, 'thiamine'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 129, 'vitamin B1'), ('UBERON_0000945', 'stomach', 280, 'stomach'), ('UBERON_0008960', 'melon organ', 379, 'antegastric'), ('UBERON_0003487', 'skin sebaceous gland', 391, 'gastrojejunostomy'), ('CHEBI_6872', 'methylene blue', 439, 'methylene blue'), ('UBERON_0003655', 'molar tooth', 527, 'jejunojejunostomy'), ('UBERON_0003631', 'pedal digit 1', 560, 'GIA'), ('CHEBI_9750', 'Triton X-100', 670, 'TX'), ('UBERON_4200215', 'suture', 752, 'sutures')]
PMC2151954	10/2007	S176-PMC2151954	['FUTURE STUDIES would ideally examine the RELATIONSHIP between maternal Vitamin D status and neonatal anthropometry across time (e.g.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 41)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC2290997	4/2008	S34-PMC2290997	['with shorter winter days and insufficient solar radiation in the uvb wavelengths NEEDED to stimulate Vitamin D synthesis, dietary sources such as fatty fish became increasingly IMPORTANT.']	[('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 177)]	2	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 109, 'D')]
PMC2798111	12/2010	S15-PMC2798111	['Human Milk, THOUGH replete in most Nutrients, is sorely lacking in Vitamin D at the current maternal intake RECOMMENDATION of 400\u2009iu/day.']	[('ANOMALY_CURIOUS_FINDING', 12), ('FUTURE_WORK', 108)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0001913', 'milk', 6, 'milk'), ('CHEBI_33284', 'nutrient', 35, 'nutrients'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC2821652	2/2010	S31-PMC2821652	['EXISTING guidelines RECOMMEND that Pregnant women receive 400\u2009iu of Vitamin D per day via an oral supplement [17,18].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 20)]	2	[('GO_0007565', 'female pregnancy', 35, 'pregnant'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC2841444	2/2010	S506-PMC2841444	['there is a strong RECOMMENDATION for Postnatal Vitamin K, and a weak RECOMMENDATION in favor of Antenatal Vitamin K for women in premature labor.']	[('FUTURE_WORK', 18), ('FUTURE_WORK', 69)]	2	[('GO_0007567', 'parturition', 37, 'postnatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin K'), ('GO_0007567', 'parturition', 96, 'antenatal'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin K')]
PMC2872349	4/2010	S87-PMC2872349	['Calcium and Vitamin D, being key Nutrients in the process of bone formation, are prime CANDIDATES for INVESTIGATION.']	[('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 102)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33284', 'nutrient', 33, 'nutrients')]
PMC3034879	12/2010	S142-PMC3034879	['finally, 20% of the children had S-25-Ohd below 50\xa0nmol/l at 14\xa0months of age, ALTHOUGH their median total intake of Vitamin D was 12.2 (3.0) μg, which meets the nordic RECOMMENDATION for this age group [23].']	[('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 169)]	2	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 33, 'S-25-OHD'), ('PR_000001900', 'neuropilin-1', 33, 'S-25-OHD'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3034879	12/2010	S178-PMC3034879	['in the present study, 85% of infants had total Vitamin D intake that was IN LINE WITH the nordic RECOMMENDATION [23].']	[('INCOMPLETE_EVIDENCE', 73), ('FUTURE_WORK', 97)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3034879	12/2010	S199-PMC3034879	['it CAN BE concluded that Postnatal Vitamin D supplementation improved Vitamin D status in infants and PARTLY eliminated the differences in bone variables that had resulted from maternal Vitamin D status during the fetal period.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 102)]	2	[('GO_0007567', 'parturition', 25, 'postnatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC3103150	3/2011	S118-PMC3103150	['the current RECOMMENDATION of american academy of pediatrics is that all infants and children, including adolescents, SHOULD have a minimum daily intake of 400 iu of Vitamin D beginning soon after Birth28.']	[('FUTURE_WORK', 12), ('FUTURE_WORK', 118)]	2	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'birth28')]
PMC3103150	3/2011	S126-PMC3103150	['in the united states, the CURRENTLY RECOMMENDED adequate intake for Vitamin D during Pregnancy as well as Lactation is 200 iu/day34.']	[('INCOMPLETE_EVIDENCE', 26), ('FUTURE_WORK', 36)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('GO_0007595', 'lactation', 106, 'lactation')]
PMC3257641	3/2010	S154-PMC3257641	['women AT RISK of Vitamin D deficiency SHOULD BE monitored and treated during Pregnancy for Vitamin D deficiency [22].']	[('IMPORTANT_CONSIDERATION', 6), ('FUTURE_WORK', 38)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC3277098	12/2011	S133-PMC3277098	['in this cohort 6.5% of women took a Vitamin D-containing Supplement, a FACTOR that was borderline significant for Vitamin D status, and only 3 women met the uk dietary RECOMMENDATION of 10 µg/day.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('FUTURE_WORK', 168)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 57, 'supplement'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC3347007	4/2012	S79-PMC3347007	['67.6% of participants reported use of Vitamin D supplements in any dose (table 1) and 36.9% reported use of Vitamin D supplements of AT LEAST 10 µg, which is the dose now RECOMMENDED during Pregnancy by the danish national board of health .']	[('PROBABLE_UNDERSTANDING', 133), ('FUTURE_WORK', 171)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy')]
PMC3347007	4/2012	S131-PMC3347007	['none of the participants reported dietary intakes that match the RECOMMENDED intake level in Pregnancy of 10 µg per day, which underlines the NECESSITY of Vitamin D supplementation.']	[('FUTURE_WORK', 65), ('IMPORTANT_CONSIDERATION', 142)]	2	[('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC3347007	4/2012	S132-PMC3347007	['the RECOMMENDATIONS for Pregnant women in most northern countries include a Vitamin D supplement of 10 µg per day.']	[('FUTURE_WORK', 4), ('IMPORTANT_CONSIDERATION', 4)]	2	[('GO_0007565', 'female pregnancy', 24, 'pregnant'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC3355895	1/2011	S80-PMC3355895	['Calcium and Vitamin D, being key Nutrients in Bone Development, are prime CANDIDATES FOR INVESTIGATION.']	[('INCOMPLETE_EVIDENCE', 74), ('FUTURE_WORK', 85)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33284', 'nutrient', 33, 'nutrients'), ('GO_0048539', 'bone marrow development', 46, 'bone development')]
PMC3356951	4/2012	S17-PMC3356951	['many health care providers have increased their RECOMMENDATIONS for Vitamin D supplementation to AT LEAST 1000 iu.']	[('FUTURE_WORK', 48), ('PROBABLE_UNDERSTANDING', 97)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC3366289	7/2011	S141-PMC3366289	['the intake of Β-Carotene-rich vegetables, oils and fruits is RECOMMENDED in order to meet the Vitamin A REQUIREMENT for mothers and their Breast-Fed infants whose diet excludes the Consumption of meat, Liver and eggs [41].']	[('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 104)]	2	[('CHEBI_28064', 'cyanidin 3-O-rutinoside', 14, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin A'), ('GO_0007567', 'parturition', 138, 'breast'), ('UBERON_0000310', 'breast', 138, 'breast'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('GO_0007631', 'feeding behavior', 181, 'consumption'), ('UBERON_0002107', 'liver', 202, 'liver')]
PMC3407995	7/2012	S433-PMC3407995	['independent researchers have RECOMMENDED up to 100 μg (4000 iu) daily to increase maternal and neonatal Vitamin D status to OPTIMAL levels [171].']	[('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 124)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC3424155	8/2012	S22-PMC3424155	['therefore, the adverse EFFECTS of Vitamin D restriction during Kidney Development NEED FURTHER exploration.']	[('SUPERFICIAL_RELATIONSHIP', 23), ('FUTURE_WORK', 82)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0001822', 'kidney development', 63, 'kidney development'), ('UBERON_0002113', 'kidney', 63, 'kidney')]
PMC3427192	4/2012	S56-PMC3427192	['ultimately, randomized controlled trials of Vitamin D ARE NEEDED in Adults with asthma to determine the causal ASSOCIATIONS between Vitamin D and asthma and to develop an evidence base for treatment.']	[('FUTURE_WORK', 54), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0007023', 'adult organism', 68, 'adults'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3427250	8/2012	S12-PMC3427250	['a targeted screening STRATEGY to detect and treat women at high risk of severe Vitamin D deficiency IS NEEDED in belgium and in europe.']	[('FUTURE_WORK', 21), ('FUTURE_WORK', 100)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3427250	8/2012	S32-PMC3427250	['the adequacy of the current Vitamin D dietary RECOMMENDATIONS to reach an optimal Vitamin D status during Pregnancy HAS BEEN QUESTIONED[24].']	[('FUTURE_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
PMC3427250	8/2012	S127-PMC3427250	['given the high prevalence of Vitamin D deficiency in Pregnant women in belgium and PROBABLY in many european countries, a Vitamin D nutrition policy IS NEEDED at the country and european level.']	[('PROBABLE_UNDERSTANDING', 83), ('FUTURE_WORK', 149)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 53, 'pregnant'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC3427250	8/2012	S132-PMC3427250	['a targeted screening STRATEGY to detect and treat women at high risk of severe Vitamin D deficiency IS clearly NEEDED in belgium and in other european countries.']	[('FUTURE_WORK', 21), ('FUTURE_WORK', 100)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3476426	8/2012	S111-PMC3476426	['FOR THIS REASON, in 2007, the canadian paediatric society RECOMMENDED 2000 iu/day, or more, to prevent Gestational Vitamin D deficiency [25].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 58)]	2	[('GO_0007565', 'female pregnancy', 103, 'gestational'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3552819	12/2012	S66-PMC3552819	['confirmed hypercalcemia was A priori defined as albumin-adjusted Serum calcium concentration > 2.60 mmol/l on both specimens, SINCE hypercalcemia caused by Vitamin D intoxication would not be expected to resolve within a few days without intervention.']	[('FUTURE_WORK', 28), ('PROBABLE_UNDERSTANDING', 126)]	2	[('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC3629265	4/2013	S2-PMC3629265	['CURRENTLY, Vitamin D supplementation is RECOMMENDED in canada for Breast Fed infants.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 40)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'breast'), ('UBERON_0000310', 'breast', 66, 'breast'), ('GO_0007631', 'feeding behavior', 73, 'fed')]
PMC3629265	4/2013	S67-PMC3629265	['the canadian paediatric society statement does not clearly differentiate Breast-Fed vs. formula-Fed infants but does SUGGEST that infant formulas SHOULD BE an adequate source of Vitamin D as long as the infant consumes “adequate quantity” (23).']	[('INCOMPLETE_EVIDENCE', 117), ('FUTURE_WORK', 146)]	2	[('GO_0007567', 'parturition', 73, 'breast-'), ('UBERON_0000310', 'breast', 73, 'breast'), ('GO_0007631', 'feeding behavior', 80, 'fed'), ('GO_0007631', 'feeding behavior', 96, 'fed'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3629265	4/2013	S93-PMC3629265	['attention also NEEDS to be focused on the PREVENTION of maternal Vitamin D deficiency.']	[('FUTURE_WORK', 15), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3641012	4/2013	S234-PMC3641012	['CONCLUDED from their trial findings “that the current Vitamin D ear and rda for Pregnant women issued in 2010 by the iom SHOULD BE raised to 4000\xa0iu of Vitamin D per day” [13].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 121)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnant'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 160, 'D')]
PMC3659910	1/2013	S9-PMC3659910	['STUDIES ARE UNDERWAY to establish the RECOMMENDED daily doses of Vitamin D in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 38)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnant')]
PMC3668200	5/2013	S31-PMC3668200	['the american academy of pediatrics (aap) PREVIOUSLY RECOMMENDED a daily Vitamin D intake of 200 iu for exclusively Breast-Fed infants.']	[('INCOMPLETE_EVIDENCE', 41), ('FUTURE_WORK', 52)]	2	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 115, 'breast'), ('UBERON_0000310', 'breast', 115, 'breast'), ('GO_0007631', 'feeding behavior', 122, 'fed')]
PMC3705320	3/2013	S206-PMC3705320	['FUTURE TRIALS in dhaka will address the dose-dependency of the EFFECTS of Prenatal Vitamin D supplementation on infant growth and morbidity.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('GO_0007565', 'female pregnancy', 74, 'prenatal'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3717170	5/2013	S45-PMC3717170	['the extent to which Vitamin D deficiency is a cause of Immune disease has yet to be demonstrated and will REQUIRE new prospective clinical trials of Vitamin D supplementation.']	[('FUTURE_WORK', 106), ('IMPORTANT_CONSIDERATION', 106)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 55, 'immune'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC3773018	4/2013	S68-PMC3773018	['given that fewer than 10% of our subjects were exclusively Breastfed (table 1), these infants and toddlers SHOULD have had the highest intake of Vitamin D via fortified formulas, which, in the u.s., all contain AT LEAST 400 iu/l of Vitamin D (29).']	[('FUTURE_WORK', 107), ('PROBABLE_UNDERSTANDING', 211)]	2	[('GO_0007567', 'parturition', 59, 'breastfed'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC3827489	10/2013	S98-PMC3827489	['the daily Vitamin D RECOMMENDATION for women during Pregnancy and Lactation is 600 iu (15 µg) ACCORDING TO the u.s. Food and Drug administration.']	[('FUTURE_WORK', 20), ('INCOMPLETE_EVIDENCE', 94)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0007595', 'lactation', 66, 'lactation'), ('CHEBI_33290', 'food', 116, 'Food'), ('CHEBI_23888', 'drug', 125, 'Drug')]
PMC3873449	12/2013	S189-PMC3873449	['FURTHER high quality randomized TRIALS ARE REQUIRED to evaluate the SAFETY and effectiveness of Vitamin D supplementation in Pregnancy.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 68)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy')]
PMC3888066	12/2012	S35-PMC3888066	['brief survey of potential maternal sources of Vitamin A\n\nexplanation of rda for Vitamin A in foods\nthe RECOMMENDED daily allowance (rda) for Vitamin A in foods is defined as the amount needed to provide 97% or more of all groups with a sufficient quantity of Vitamin A to stay healthy.33since male Adults have the highest REQUIREMENT for Vitamin A, which is 3,000 iu, the rda is calculated to this group (table 2).']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 322)]	2	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 46, 'Vitamin A'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin A'), ('UBERON_0007023', 'adult organism', 298, 'adults'), ('CHEBI_27300', 'vitamin D', 338, 'vitamin A')]
PMC3901983	1/2013	S109-PMC3901983	['HOWEVER, there are no RECOMMENDATIONS about supplementation of the Vitamin K [22].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 22)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin K')]
PMC4071151	6/2014	S96-PMC4071151	['when no deficits are detected, a complete Blood count and measurement of iron, ferritin, Folic Acid, Vitamin B12, Vitamin A, 25-Hydroxyvitamin D, calcium, and Parathyroid hormone levels SHOULD BE performed every trimester.']	[('FUTURE_WORK', 186), ('IMPORTANT_CONSIDERATION', 186)]	2	[('UBERON_0000178', 'blood', 42, 'blood'), ('CHEBI_30751', 'formic acid', 89, 'folic acid'), ('CHEBI_33279', 'vitamin D5', 101, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin A'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 125, '25-hydroxyvitamin D'), ('UBERON_0001132', 'parathyroid gland', 159, 'parathyroid')]
PMC4113768	7/2014	S760-PMC4113768	['this is a multi-year effort, which NEEDS to the support of Vitamin D researchers around the world.']	[('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 35)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4113768	7/2014	S827-PMC4113768	['the audit was based on two standards: (1) antenatal standard nice 62- at booking women SHOULD BE given information and advice on the IMPORTANCE of taking a 10 microgram Vitamin D supplement per day during Pregnancy and whilst breastfeeding.']	[('FUTURE_WORK', 87), ('IMPORTANT_CONSIDERATION', 133)]	2	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy')]
PMC4113768	7/2014	S878-PMC4113768	['well-designed rcts that include assessments of proximal muscle function ARE NEEDED to clearly determine the EFFECT of Vitamin D on muscle function in young People.']	[('FUTURE_WORK', 72), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 156, 'people')]
PMC4113768	7/2014	S1402-PMC4113768	['FUTURE STUDIES will be directed to analysis of EFFECTS of Vitamin D on enzyme activities.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4113768	7/2014	S1881-PMC4113768	['by proving the effectiveness of Food fortification in this manner, the OPPORTUNITY now exists to increase the diversity and range of Foods available to the population that could provide adequate Vitamin D. population groups TYPICALLY resistant to traditional methods of supplementation ( i.e.']	[('FUTURE_WORK', 71), ('PROBABLE_UNDERSTANDING', 224)]	2	[('CHEBI_33290', 'food', 32, 'food'), ('CHEBI_33290', 'food', 133, 'foods'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC4113768	7/2014	S1910-PMC4113768	['from this simulation we conclude that a daily Consumption of 300 ml fortified gum CAN HELP increase nutritional intakes of Vitamin D in young uk children.']	[('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 86)]	2	[('GO_0007631', 'feeding behavior', 46, 'consumption'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4113768	7/2014	S2087-PMC4113768	['higher doses of Vitamin D AS a means to prevent or correct privational Vitamin D deficiency or to attain supraphysiological levels SHOULD BE avoided.']	[('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 131)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4113768	7/2014	S2467-PMC4113768	['use of Vitamin D supplements is RECOMMENDED and NEEDS to be consistent to avoid risk of Vitamin D deficiency in this population.']	[('FUTURE_WORK', 32), ('FUTURE_WORK', 48)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC4113768	7/2014	S2992-PMC4113768	['assessment and correction of Vitamin D status SHOULD BE CONSIDERED in addition to the current routine treatment of secondary hyperparathyroidism.']	[('FUTURE_WORK', 46), ('FUTURE_WORK', 56)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC4188019	1/2010	S69-PMC4188019	['NO CONSENSUS exists on the RECOMMENDED intake and supplementation of 25-Oh Vitamin D during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 27)]	2	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 69, '25-OH'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 92, 'pregnancy')]
PMC4188019	1/2010	S79-PMC4188019	['ALTHOUGH most of the Vitamin D production comes from skin conversion, the dietary intake of Vitamin D is something we’ll have to examine in FURTHER STUDIES, as well as darkness of skin and nationality.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 140)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4329745	10/2014	S99-PMC4329745	['we would RECOMMEND fortification of daily Food with Vitamin D and ENCOURAGING women to spend more time in direct sunlight.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 66)]	2	[('CHEBI_33290', 'food', 42, 'food'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4377879	3/2015	S181-PMC4377879	['oral supplementation of urban indian women with Vitamin B-12 throughout Pregnancy and early Lactation significantly increased Vitamin B-12 status of both mothers and infants [9] and so WORTH CONSIDERING where Vitamin B12 intakes are marginal.']	[('IMPORTANT_CONSIDERATION', 185), ('FUTURE_WORK', 191)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 48, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007595', 'lactation', 92, 'lactation'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 126, 'vitamin B-12'), ('CHEBI_33279', 'vitamin D5', 209, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 217, 'B12')]
PMC4448820	5/2015	S1194-PMC4448820	['this phenomenon SHOULD BE evaluated closely, particularly in light of the EXPANDING INTEREST in Vitamin D supplementation to boost Immune function and for use in numerous conditions including hiv and other infections.']	[('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 74)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0002405', 'immune system', 131, 'immune')]
PMC4448820	5/2015	S1535-PMC4448820	['caption (table-wrap): table 12\n\nsummary of key Nutrient biomarkers1nutrientcommonly used biomarker/indicatorsmagnitude and direction of inflammation effectsettings where usednotesironferritin+++clinical, research, populationstfr+research, populationstfr assays are not yet standardized and compare poorlyhemoglobinclinicalbody Iron+research, populationratio of tfr:ferritin+researchtfr index+research, clinicalzpp+clinical, populationhepcidin0researchvitamin Aretinol−clinical, research, populationrbp−research, populationbreast-milk Retinolresearchretinol dose response testresearchzincserum/Plasma zinc−clinical, populationnot reliable in clinical settings if patient inflamedfolateerythrocyte Folate+clinical, populationplasma or Serum Folate−clinical, populationvitamin B-12serum/Plasma total cobalamin0clinical, populationserum holotranscobalaminresearchsuperior diagnostic performance of holotranscobalamin is controversialplasma/Urine mma0clinical, populationmma assay is more expensiveplasma total Homocysteine+clinicalelevated in both Folate and Vitamin B-12 deficiencyiodineurinary Iodine0Populationno known ASSOCIATION with inflammationvitamin D25(Oh)D−clinical, populationvitamin B-6plasma Pyridoxal 5-Phosphate−research, populationvitamin cserum Ascorbic Acid−research, populationfreshly prepared Serum NEEDS to be promptly Acidified with Meta-Phosphoric Acid and frozen to stabilize Ascorbic Acid\nMma, Methylmalonic Acid; Rbp, Retinol Binding Protein; Stfr, soluble Transferrin Receptor; tfr, Transferrin Receptor; zpp, Zinc Protoporphyrin; 0, no change; 25(Oh)D, 25-Hydroxyvitamin D; −, decrease; +, increase; +++, major increase.']	[('SUPERFICIAL_RELATIONSHIP', 1118), ('FUTURE_WORK', 1316)]	2	[('CHEBI_33284', 'nutrient', 47, 'nutrient'), ('CHEBI_24870', 'ion', 327, 'iron'), ('CHEBI_80843', 'Leonurine', 459, 'ARetinol'), ('CHEBI_67264', 'geranic acid', 534, 'retinolResearchRetinol'), ('UBERON_0001969', 'blood plasma', 593, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 696, 'folate'), ('UBERON_0001977', 'blood serum', 733, 'serum'), ('CHEBI_30863', '5-azaorotic acid', 739, 'folate'), ('PR_000000037', 'BMP receptor type-2', 774, 'B'), ('UBERON_0001969', 'blood plasma', 784, 'plasma'), ('UBERON_0001088', 'urine', 936, 'urine'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 1006, 'homocysteine'), ('CHEBI_30863', '5-azaorotic acid', 1044, 'folate'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 1055, 'vitamin B-12'), ('CHEBI_30593', 'disilanyl', 1092, 'iodine0PopulationNo'), ('PR_000001177', 'D(2) dopamine receptor', 1155, 'D25'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1159, 'OH)D'), ('PR_000000037', 'BMP receptor type-2', 1192, 'B'), ('CHEBI_18335', "pyridoxamine 5'-phosphate", 1202, 'pyridoxal 5-phosphate'), ('CHEBI_22652', 'ascorbic acid', 1259, 'ascorbic acid'), ('UBERON_0001977', 'blood serum', 1310, 'serum'), ('CHEBI_34520', 'acephate', 1337, 'acidified'), ('CHEBI_25286', 'methylbutanoyl-CoA', 1352, 'meta-phosphoric acid'), ('CHEBI_22652', 'ascorbic acid', 1397, 'ascorbic acid'), ('CHEBI_34840', 'methyl methacrylate', 1411, 'MMA'), ('CHEBI_30860', 'methylmalonic acid', 1416, 'methylmalonic acid'), ('PR_000013830', 'calcipressin-2', 1436, 'RBP'), ('CHEBI_26536', 'retinoic acid', 1441, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 1441, 'retinol binding protein'), ('PR_000015619', 'sorcin', 1466, 'sTfR'), ('PR_000001679', 'trace amine-associated receptor 5', 1480, 'transferrin receptor'), ('PR_000001679', 'trace amine-associated receptor 5', 1507, 'transferrin receptor'), ('CHEBI_28783', 'zinc protoporphyrin', 1534, 'zinc protoporphyrin'), ('CHEBI_71657', 'versiconol acetate', 1569, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 1578, '25-hydroxyvitamin D')]
PMC4499946	7/2015	S121-PMC4499946	['from a practical standpoint, the INVESTIGATION of Vitamin D supplementation in the context of routine Calcium supplementation will facilitate the translation of trial findings into anticipated FUTURE contexts in which supplemental Calcium is more routinely provided.']	[('FUTURE_WORK', 33), ('FUTURE_WORK', 193)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 102, 'calcium'), ('CHEBI_22313', 'alkaline earth metal atom', 231, 'calcium')]
PMC4586450	10/2015	S251-PMC4586450	['in ndns 2008–2012, young children obtained only a quarter of the Vitamin D intake RECOMMENDED to be obtained from diet and only 12% took dietary supplements102; thus, there is a continuing PROBLEM in the united kingdom.']	[('FUTURE_WORK', 82), ('IMPORTANT_CONSIDERATION', 189)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4645901	8/2014	S2-PMC4645901	['prior to our newly designed INTERVENTION, those babies with low Vitamin D levels would be given a letter to ENCOURAGE collection of supplementation from their gp.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('FUTURE_WORK', 108)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4645901	8/2014	S88-PMC4645901	['conclusion\ndesigning a leaflet to ENCOURAGE patients and clinicians to increase uptake of Vitamin D had a positive IMPACT on the number of babies having correct supplementation.']	[('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4673623	11/2015	S131-PMC4673623	['Vitamin B-12 supplementation) MAY BE WARRANTED.']	[('FUTURE_WORK', 30), ('INCOMPLETE_EVIDENCE', 30)]	2	[('CHEBI_27300', 'vitamin D', 0, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 0, 'vitamin B-12')]
PMC4719746	1/2016	S7-PMC4719746	['ethnicity, education, season and intake of Vitamin D were independently ASSOCIATED with 25(Oh)D. at gw 28, the mean 25(Oh)d had increased from 23 (sd:7.8) to 47 (27) nmol/l ( p \u2009<\u20090.01) in women who were RECOMMENDED Vitamin D supplementation, with small or no change in women with sufficient Vitamin D levels at baseline.']	[('SUPERFICIAL_RELATIONSHIP', 72), ('FUTURE_WORK', 204)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('CHEBI_51686', 'haematoxylin', 118, '(OH'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 292, 'vitamin D')]
PMC4719746	1/2016	S142-PMC4719746	['GUIDELINES from scandinavia and uk RECOMMEND all Pregnant women supplement intake with 10\xa0μg (400\xa0iu) Vitamin D daily to prevent Vitamin D deficiency [21,34,35].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 35)]	2	[('GO_0007565', 'female pregnancy', 49, 'pregnant'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC4719746	1/2016	S150-PMC4719746	['in women who were RECOMMENDED daily Vitamin D supplements of 20\xa0μg or 30\xa0μg due to low values in early Pregnancy, we OBSERVED an increase in self-reported use of supplements at the follow-up visit.']	[('FUTURE_WORK', 18), ('INCOMPLETE_EVIDENCE', 117)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy')]
PMC4770602	1/2016	S24-PMC4770602	['furthermore, because Vitamin D supplementation is simple and cost-effective with a low LIKELIHOOD of toxicity, increased supplementation in Pregnant women is RECOMMEND previously.']	[('PROBABLE_UNDERSTANDING', 87), ('FUTURE_WORK', 158)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnant')]
PMC4785305	3/2016	S0-PMC4785305	['EFFECT of Vitamin D replacement on maternal and neonatal outcomes: a randomised controlled trial in Pregnant women with hypovitaminosis D. a protocol\n\nabstract\n\nintroduction\nthe Vitamin D RECOMMENDED doses during Pregnancy differ between societies.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('FUTURE_WORK', 188)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 136, 'D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy')]
PMC4785305	3/2016	S39-PMC4785305	['hypothesis\nthe study HYPOTHESIS is that a high dose of Vitamin D, equivalent to 3000\u2005iu/day, is NEEDED to optimise maternal Vitamin D level and neonatal Musculoskeletal parameters, compared to a low dose of 600\u2005iu/day.']	[('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 96)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 153, 'musculoskeletal')]
PMC4877864	6/2015	S80-PMC4877864	['(2009) [21] compared the dietary Intake of children with autistic-spectrum disorders to that of children with typical development, they NOTED that large proportions of children did not meet the national RECOMMENDATIONS for daily intake of Vitamin D and Calcium.']	[('ANOMALY_CURIOUS_FINDING', 136), ('FUTURE_WORK', 203)]	2	[('GO_0007631', 'feeding behavior', 33, 'intake'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 253, 'calcium')]
PMC4896250	4/2016	S3562-PMC4896250	['a policy on Vitamin D supplementation is RECOMMENDED in this population to mitigate the IMPACT of Vitamin D deficiency especially on chronic non-communicable diseases.']	[('FUTURE_WORK', 41), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4930210	7/2016	S132-PMC4930210	['canadian community nutrition intakes data for non-Pregnant women of Child-Bearing age (19–50 years) REPORTED that 90% of canadian women are not Consuming the current RECOMMENDATIONS for Vitamin D through their diet [25].']	[('INCOMPLETE_EVIDENCE', 100), ('FUTURE_WORK', 166)]	2	[('GO_0007565', 'female pregnancy', 50, 'pregnant'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 68, 'child-bearing'), ('GO_0007631', 'feeding behavior', 144, 'consuming'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC4934634	11/2015	S24-PMC4934634	['increased time spent indoors, dermatologist RECOMMENDATIONS of daily sunscreen application, geographical location (northern latitude) and seasonal changes (winter) CAN reduce exposure to uvb radiation and subsequently lower Vitamin D Synthesis leading to lower Vitamin D levels [6].']	[('FUTURE_WORK', 44), ('INCOMPLETE_EVIDENCE', 164)]	2	[('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 224, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D')]
PMC4934634	11/2015	S178-PMC4934634	['Breast Milk is low in Vitamin D concentration and is the primary source of Vitamin D in breastfed infants [36] AS it is RECOMMENDED that infants younger than 6 months be kept out of direct sunlight and the exposure to sun be minimized with the use of protective clothing, hats and sunscreen [66].']	[('PROBABLE_UNDERSTANDING', 111), ('FUTURE_WORK', 120)]	2	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4934634	11/2015	S241-PMC4934634	['POTENTIAL consequences of excess Vitamin D intakes: maternal and infant\nduring Pregnancy, the current RECOMMENDED dietary intake of Vitamin D and upper limit ranges from 200 to 2000 iu/day and 3200 to 10,000 iu/day, respectively (table 2).']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 102)]	2	[('CHEBI_28384', 'vitamin K', 33, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4944244	7/2016	S9-PMC4944244	['conclusion\nawareness SHOULD BE raised among malay and indian Pregnant women with secondary and tertiary education who consumed Vitamin D (ESPECIALLY milk) poorly in order to prevent adverse health outcomes.']	[('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 138)]	2	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4944244	7/2016	S227-PMC4944244	['Calcium supplement with Vitamin D SHOULD BE given earlier to those who do not Consume adequate milk during Pregnancy to prevent adverse health EFFECTS to the mother and fetus.']	[('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 143)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007631', 'feeding behavior', 78, 'consume'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy')]
PMC4990268	8/2016	S325-PMC4990268	['these results SUPPORTS the current RECOMMENDATION of treating Pregnant women with Vitamin A who present with night blindness.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 35)]	2	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin A')]
PMC5014971	8/2016	S1-PMC5014971	['RECOMMENDATIONS for adequate levels of circulating 25-Hydroxyvitamin D and appropriate Vitamin D supplementation during Pregnancy DIFFER between the institute of medicine and the Endocrine society.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 130)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 51, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy'), ('UBERON_0005063', 'left ventricular compact myocardium', 179, 'Endocrine')]
PMC5014971	8/2016	S5-PMC5014971	['half (52.5%) would RECOMMEND Vitamin D supplementation during Pregnancy to some patients, BUT ONLY 16.8% to all.']	[('FUTURE_WORK', 19), ('ANOMALY_CURIOUS_FINDING', 90)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC5045784	10/2016	S81-PMC5045784	["the pediatric Endocrine society RECOMMENDS targeting Serum 25(Oh) level of >20\u2009ng\u2009ml−1for children of all ages.35at brigham and women's hospital, we AIM to provide 400\u2009iu Vitamin D daily."]	[('FUTURE_WORK', 32), ('FUTURE_WORK', 149)]	2	[('UBERON_0005063', 'left ventricular compact myocardium', 14, 'Endocrine'), ('UBERON_0001977', 'blood serum', 53, 'serum'), ('CHEBI_30778', 'gallic acid', 59, '25(OH)'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5045784	10/2016	S92-PMC5045784	["the CURRENT PRACTICE of TARGETING nutritional Intake of 400\u2009iu per day Vitamin D is sufficient to achieve Serum 25(Oh)D levels >30\u2009ng\u2009ml−1at 36 weeks' corrected age."]	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 24)]	2	[('GO_0007631', 'feeding behavior', 46, 'intake'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 112, '25(OH)D')]
PMC5084016	10/2016	S134-PMC5084016	['prophylaxis with Vitamin D SHOULD BE planned from the beginning and throughout the Pregnancy, as underlined also in the recent consensus document from the italian pediatric societies [61].']	[('FUTURE_WORK', 27), ('IMPORTANT_CONSIDERATION', 27)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC5118763	12/2016	S173-PMC5118763	['FURTHER FOLLOW-up of this cohort will be helpful to evaluate the EFFECT of high Folate and low Vitamin B-12 status of mothers on their offspring.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_30863', '5-azaorotic acid', 80, 'folate'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 95, 'vitamin B-12')]
PMC5129897	10/2016	S184-PMC5129897	['supplements are RECOMMENDED BECAUSE getting Vitamin D from foods alone is hard.']	[('FUTURE_WORK', 16), ('PROBABLE_UNDERSTANDING', 28)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5322422	2/2017	S64-PMC5322422	["to prevent all forms of vkdb, administration of intramuscular Vitamin K at Birth HAS BEEN a standard practice in the united states since 1961 when the american academy of pediatrics' RECOMMENDED the injection for all newborns [5]."]	[('INCOMPLETE_EVIDENCE', 81), ('FUTURE_WORK', 183)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin K'), ('GO_0007567', 'parturition', 75, 'birth')]
PMC5381088	4/2017	S82-PMC5381088	['THUS, an increase in Intake of various Nutrients, including protein, Folate, calcium, Vitamin C and Vitamin D, is RECOMMENDED [47].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 114)]	2	[('GO_0007631', 'feeding behavior', 21, 'intake'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 69, 'folate'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5410409	4/2017	S185-PMC5410409	['recommendation 17: prebiotics, Vitamin D, and virgin coconut oil (vco) to prevent allergic diseases are not RECOMMENDED (strong RECOMMENDATION / low quality evidence).']	[('FUTURE_WORK', 108), ('FUTURE_WORK', 128)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5418719	5/2017	S95-PMC5418719	['the POTENTIAL benefits derived from adequate Vitamin D levels WARRANT assessment the Vitamin D levels in preterm infants.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 62)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5418719	5/2017	S107-PMC5418719	['HOWEVER, RECOMMENDED oral Vitamin D supplementation to attain adequate Serum 25(Oh)D concentrations has not been recognized in vlbw infants with underlying level of Vitamin D deficiency from Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001977', 'blood serum', 71, 'serum'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 83, 'D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007567', 'parturition', 191, 'birth')]
PMC5426325	4/2017	S15-PMC5426325	['in denmark, the reintroduction of fortified Foods to improve the general population’s Vitamin D status is currently being CONSIDERED, and its justification is part of an ongoing international DEBATE.']	[('FUTURE_WORK', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	2	[('CHEBI_33290', 'food', 44, 'foods'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5513133	7/2017	S237-PMC5513133	['additionally, investigators SHOULD ATTEMPT to assess Preconception and early Pregnancy dietary intake, sun exposure or baseline Vitamin D status.']	[('FUTURE_WORK', 28), ('DIFFICULT_TASK', 35)]	2	[('GO_0007565', 'female pregnancy', 53, 'preconception'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5524288	7/2017	S131-PMC5524288	['FURTHER evaluation of the Vitamin D testing and supplementation protocol is PLANNED.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 76)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC5634602	10/2017	S23-PMC5634602	['the endocrine society also RECOMMENDS a target level of >75 nmol/l and espghan an EVEN higher target of >80 nmol/l.10.1371/journal.pone.0185950.t001\n\ncaption (table-wrap): table 1\nrecommendations for Vitamin D supplementation.recommending bodypatient agerecommended supplementationrecommended target Serum levelcommentsyear of publication american academy of pediatrics—section of breastfeeding and committee on nutrition healthy infants Birth– 12 months of age400 iu daily>50 nmol/l (targeting bone health)*begin soon after Birth, in the first few days of Life.']	[('FUTURE_WORK', 27), ('ANOMALY_CURIOUS_FINDING', 82)]	2	[('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001977', 'blood serum', 300, 'Serum'), ('GO_0007567', 'parturition', 438, 'birth'), ('GO_0007567', 'parturition', 525, 'birth'), ('UBERON_0000104', 'life cycle', 557, 'life')]
PMC5634602	10/2017	S125-PMC5634602	['supplementation of these patients with Vitamin D would NOT BE ADVISABLE.']	[('IMPORTANT_CONSIDERATION', 55), ('FUTURE_WORK', 62)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5664622	9/2017	S11-PMC5664622	['the literature offers NO CONSENSUS on the RECOMMENDED Vitamin D concentrations or unified diagnostic criteria.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('FUTURE_WORK', 42)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5664622	9/2017	S74-PMC5664622	['discussion\nIN LIGHT OF current RECOMMENDATIONS, mean maternal Vitamin D concentration in our study population was deficient.']	[('PROBABLE_UNDERSTANDING', 11), ('FUTURE_WORK', 31)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5682869	11/2017	S26-PMC5682869	['Vitamin B6, zinc, multi-Nutrient supplements and Vitamin D supplementation are NOT ADVOCATED as routine procedure.']	[('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 83)]	2	[('CHEBI_27306', 'vitamin B6', 0, 'Vitamin B6'), ('PR_000017269', 'ventral anterior homeobox 2', 0, 'Vitamin B6'), ('CHEBI_33284', 'nutrient', 24, 'nutrient'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC5707701	11/2017	S163-PMC5707701	['the intake of 4 mg/day of Vitamin E (Α-Tocopherol) for infants aged less than six months is RECOMMENDED BASED ON a value of adequate intake (ai) in the dietary reference intakes (dris) [61].']	[('FUTURE_WORK', 92), ('PROBABLE_UNDERSTANDING', 104)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin E'), ('CHEBI_27725', 'butin', 37, 'α-tocopherol')]
PMC5941617	5/2018	S107-PMC5941617	['HOWEVER, various dietary reference values for Vitamin D are useful to guide local STRATEGIES for Vitamin D supplementation, but are not directly comparable.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 82)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC5941617	5/2018	S124-PMC5941617	['the endocrine society RECOMMENDED a daily intake of 400–1000\xa0iu of Vitamin D in children under 1\xa0year of age at RISK for Vitamin D deficiency [11].']	[('FUTURE_WORK', 22), ('IMPORTANT_CONSIDERATION', 112)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5941617	5/2018	S128-PMC5941617	['infants Born at term without risk factors for Vitamin D deficiency SHOULD receive 400\xa0iu/day of Vitamin D, while in the presence of RISK factors for vitamin d deficiency (table\xa06) up to 1000\xa0iu/day of Vitamin D can be administered.']	[('FUTURE_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 132)]	2	[('GO_0007567', 'parturition', 8, 'born'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC5941617	5/2018	S140-PMC5941617	['RELATIVELY few international scientific societies gave RECOMMENDATIONS on Vitamin D supplementation in preterm infants.']	[('IMPORTANT_CONSIDERATION', 0), ('FUTURE_WORK', 55)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5941617	5/2018	S146-PMC5941617	['HOWEVER, total Vitamin D intake from supplementation and Feeding SHOULD BE assessed to avoid excess, particularly in vlbw infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 65)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007631', 'feeding behavior', 57, 'feeding')]
PMC5941617	5/2018	S152-PMC5941617	['RECENTLY RECOMMENDED Vitamin D supplementation at 800\xa0iu/day to enhance Vitamin D status during early hospitalization in vlbw infants with Serum 25(Oh)D levels <\u200910\xa0ng/ml at Birth [142].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 9)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 145, '25 ... OH ... D'), ('GO_0007567', 'parturition', 174, 'birth')]
PMC5941617	5/2018	S169-PMC5941617	['several international societies RECOMMENDED Vitamin D supplementation in children older than 1\xa0year and adolescents with RISK FACTORS for Vitamin D, such as reduced sun exposure or dark skin pigmentation [8,9,11,18,19,23,28,30,114].']	[('FUTURE_WORK', 32), ('SUPERFICIAL_RELATIONSHIP', 121)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC5941617	5/2018	S170-PMC5941617	['particularly, the espghan reinforced that first of all a healthy lifestyle ASSOCIATED with a normal body mass index and including a healthy diet with Vitamin D-containing foods and adequate outdoor activities SHOULD BE promoted in healthy children and adolescents [19].']	[('SUPERFICIAL_RELATIONSHIP', 75), ('FUTURE_WORK', 209)]	2	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC5941617	5/2018	S171-PMC5941617	['moreover, pediatricians SHOULD periodically evaluate Vitamin D intake from diet and Supplements [23,28].']	[('FUTURE_WORK', 24), ('IMPORTANT_CONSIDERATION', 24)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 84, 'supplements')]
PMC5941617	5/2018	S175-PMC5941617	['public health england also RECOMMENDED that Individuals with darker skin and People with reduced sun exposure SHOULD receive Vitamin D supplementation throughout the year [115].']	[('FUTURE_WORK', 27), ('FUTURE_WORK', 110)]	2	[('NCBITaxon_1', 'root', 44, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'people'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC5941617	5/2018	S184-PMC5941617	['in the present consensus we RECOMMEND Vitamin D supplementation in children and adolescents with RISK FACTORS for Vitamin D deficiency (table\xa07), at doses ranging from 600\xa0iu/day (i.e.']	[('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 97)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5941617	5/2018	S189-PMC5941617	['continuous supplementation SHOULD BE reserved to children with permanent RISK FACTORS for Vitamin D deficiency.']	[('FUTURE_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5941617	5/2018	S191-PMC5941617	['as REPORTED for infants in the first years of Life, we RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 55)]	2	[('UBERON_0000104', 'life cycle', 46, 'life'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_25212', 'metabolite', 89, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 120, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 133, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 147, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 163, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D')]
PMC5941617	5/2018	S196-PMC5941617	['Ketoconazole)\nAT PRESENT, population screening for Vitamin D deficiency in healthy Individuals is not RECOMMENDED.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 102)]	2	[('CHEBI_47519', 'ketoconazole', 0, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 83, 'individuals')]
PMC5941617	5/2018	S233-PMC5941617	['after rickets healing, Vitamin D supplementation SHOULD continue according to age (AT LEAST 400\xa0iu/day in the first year of Life and 600\xa0iu/day from 1 to 18\xa0years) [11,23,28,183,188].']	[('FUTURE_WORK', 49), ('PROBABLE_UNDERSTANDING', 83)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life')]
PMC5941617	5/2018	S432-PMC5941617	['HOWEVER, Vitamin D deficiency SHOULD BE avoided in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 30)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5941617	5/2018	S440-PMC5941617	['clinical GUIDELINE for Skeletal health of children and adolescents with ibd in 2011 RECOMMENDED monitoring Vitamin D levels at least yearly, at the end of winter/beginning of spring, especially in dark skinned subjects.']	[('PROBABLE_UNDERSTANDING', 9), ('FUTURE_WORK', 84)]	2	[('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC5941617	5/2018	S453-PMC5941617	['the endocrine society RECOMMENDS to treat Vitamin D deficiency in patients with malabsorption with Vitamin D at doses 2–3 times higher than those RECOMMENDED for otherwise healthy pediatric population for at least 6\xa0weeks, followed by Vitamin D supplementation at doses 2–3 times higher than those recommended for age [11].']	[('FUTURE_WORK', 22), ('FUTURE_WORK', 146)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D')]
PMC5941617	5/2018	S475-PMC5941617	['expert RECOMMENDATIONS for the management of cd in children RECOMMENDED to provide counselling on age-appropriate intake of Calcium and Vitamin D supplementation by a dietitian to cd children both at diagnosis and follow-up (grade of evidence high, strength of statement strong) [430].']	[('FUTURE_WORK', 7), ('FUTURE_WORK', 60)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 124, 'calcium'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5941617	5/2018	S476-PMC5941617	['FUTURE RESEARCH will clarify the IDEAL Vitamin D dosing regimen to treat Vitamin D deficiency and to maintain Serum 25(Oh)D levels ≥30\xa0ng/ml in cd children and adolescents [406].']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 33)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001977', 'blood serum', 110, 'serum'), ('CHEBI_71657', 'versiconol acetate', 116, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 116, '25(OH ... D')]
PMC5941617	5/2018	S508-PMC5941617	['similarly, guidelines for central europe RECOMMENDED in obese children Vitamin D supplementation (1200–2000\xa0iu/day depending on severity of obesity) between september and april, or throughout the whole year IF sufficient Skin Synthesis Of Vitamin D is not ensured in the summer [20].']	[('FUTURE_WORK', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0034205', 'amyloid-beta formation', 221, 'skin synthesis of'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
PMC5941617	5/2018	S515-PMC5941617	['MORE rcts ARE NEEDED to evaluate the INFLUENCE of Vitamin D supplementation on Controlling Metabolic syndrome.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0065007', 'biological regulation', 79, 'controlling'), ('GO_0008152', 'metabolic process', 91, 'metabolic')]
PMC5941617	5/2018	S566-PMC5941617	['veiled women) and/or constant use of sunscreens• Malabsorption syndromes• chronic therapies AFFECTING Vitamin D Metabolism• obesity• risk of pre-eclampsia• Alcohol abuse• bone pain• hypocalcemia• a previous child with rickets• Pregnant adolescents\nin the present consensus we RECOMMEND Vitamin D supplementation in all Pregnant and breastfeeding women since the beginning of Pregnancy at a dose of 600\xa0iu/day.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('FUTURE_WORK', 276)]	2	[('GO_0046661', 'male sex differentiation', 49, 'Malabsorption'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 102, 'vitamin D metabolism'), ('CHEBI_30879', 'alcohol', 156, 'Alcohol'), ('GO_0007565', 'female pregnancy', 227, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0007565', 'female pregnancy', 319, 'pregnant'), ('GO_0007565', 'female pregnancy', 375, 'pregnancy')]
PMC5941617	5/2018	S567-PMC5941617	['women with RISK FACTORS for Vitamin D deficiency SHOULD receive higher dosages (1000–2000\xa0iu/day).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('FUTURE_WORK', 49)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5941617	5/2018	S571-PMC5941617	['the aap RECOMMENDED to treat Vitamin D deficiency administering 2000\xa0iu/day or 50,000\xa0iu/week of Vitamin D2Or D3(independent of weight) for 6\xa0week in infants (0–12\xa0months) and for 6–8\xa0weeks in children and adolescents (1–18\xa0years), SUGGESTING that Vitamin D3May be more potent than Vitamin D2[23].']	[('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 232)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_72759', 'N-(pentadecanoyl)sphinganine-1-phosphocholine', 97, 'vitamin D2or D3'), ('PR_000017050', 'UDP-glucuronosyltransferase 1A3', 97, 'vitamin D2or D3'), ('CHEBI_64367', 'N-ethyl-L-asparagine', 248, 'vitamin D3may'), ('CHEBI_28934', 'vitamin D2', 282, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 282, 'vitamin D2')]
PMC5941617	5/2018	S572-PMC5941617	['after completion of treatment, Serum 25(Oh)D concentrations SHOULD BE revaluated, AS it is not unusual for a second course of treatment to be necessary to achieve adequate Vitamin D status [23].']	[('FUTURE_WORK', 60), ('PROBABLE_UNDERSTANDING', 82)]	2	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 37, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC5941617	5/2018	S611-PMC5941617	['particularly, Vitamin D supplementation SHOULD BE RECOMMENDED in all infants in the first year of Life, independently of the type of Feeding.']	[('FUTURE_WORK', 40), ('FUTURE_WORK', 50)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life'), ('GO_0007631', 'feeding behavior', 133, 'feeding')]
PMC5941617	5/2018	S612-PMC5941617	['supplementation SHOULD BE subsequently individualized in terms of regimen and duration on the basis of the presence of RISK FACTORS for Vitamin D deficiency.']	[('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 119)]	2	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5941617	5/2018	S624-PMC5941617	['infants Born at term without risk factors for Vitamin D deficiency SHOULD receive 400\xa0iu/day of Vitamin D.\nin the presence of RISK FACTORS for Vitamin D deficiency (table\xa06) up to 1000\xa0iu/day of Vitamin D can be given.']	[('FUTURE_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('GO_0007567', 'parturition', 8, 'born'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S625-PMC5941617	['in the first year of Life we RECOMMEND daily administration of Vitamin D.\nwe RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation.']	[('FUTURE_WORK', 29), ('FUTURE_WORK', 77)]	2	[('UBERON_0000104', 'life cycle', 21, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_25212', 'metabolite', 111, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 142, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 155, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 169, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 185, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC5941617	5/2018	S631-PMC5941617	['we RECOMMEND Vitamin D supplementation at 400–800\xa0iu/day for preterm infants with Birth weight\u2009≥\u20091500\xa0g.\nafter a post-Conceptional age of 40\xa0weeks, RECOMMENDATIONS for Vitamin D supplementation are equal to those for healthy term infants.']	[('FUTURE_WORK', 3), ('FUTURE_WORK', 148)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 82, 'birth'), ('GO_0007620', 'copulation', 118, 'conceptional'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC5941617	5/2018	S633-PMC5941617	['1–18\xa0years\n\nwe RECOMMEND Vitamin D supplementation in children and adolescents with RISK FACTORS for Vitamin D deficiency (table\xa07).']	[('FUTURE_WORK', 15), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5941617	5/2018	S686-PMC5941617	['in presence of documented Vitamin D deficiency, we RECOMMENDED adequate treatment to restore Vitamin D status, followed by supplementation at doses RECOMMENDED for age.']	[('FUTURE_WORK', 51), ('FUTURE_WORK', 148)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5941617	5/2018	S697-PMC5941617	['intermittent bolus doses of Vitamin D for a cumulative dose of AT LEAST 400000\xa0iu SHOULD BE reserved for ibds patients with Vitamin D deficiency and poor compliance with daily treatment.']	[('PROBABLE_UNDERSTANDING', 63), ('FUTURE_WORK', 82)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC5941617	5/2018	S722-PMC5941617	['women with RISK FACTORS for Vitamin D deficiency SHOULD receive higher dosages (1000–2000\xa0iu/day).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('FUTURE_WORK', 49)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5941617	5/2018	S727-PMC5941617	['in presence of adequate Vitamin D status [25(Oh)D\u2009≥\u200930\xa0ng/ml], we RECOMMEND to continue Vitamin D supplementation as RECOMMENDED for age.']	[('FUTURE_WORK', 66), ('FUTURE_WORK', 117)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 42, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC6039335	7/2018	S262-PMC6039335	['oka et al [134] RECOMMENDED selective restriction of dietary Vitamin A from 14 to 22 or 25 months of age to improve ms and qg without adverse health effects (blindness, arthritis, and muscular edema), given the EFFECT of Vitamin A restriction from 23 months of age in improving ms is minimal.']	[('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 211)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin A')]
BMJ_2008_Nov_7_337_a2001	11/2008	S52-BMJ_2008_Nov_7_337_a2001	['the multiple Micronutrient supplements were formulated to contain approximately the who/unicef RECOMMENDED dietary allowances for each of 15 Minerals or Vitamins as follows: 30 mg iron, 400 µg Folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg Selenium, 150.0 µg Iodine, 800.0 µg Vitamin A, 1.4 mg Vitamin B-1 (Thiamine), 1.4 mg Vitamin B-2 (riboflavin), 1.9 mg Vitamin B-6, 2.6 µg Vitamin B-12, 5.0 µg Vitamin D, 70.0 mg Vitamin C, 10.0 mg Vitamin E, and 18.0 mg niacin.12iron-Folic Acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple Micronutrients) and 400 µg Folic Acid.']	[('FUTURE_WORK', 95)]	1	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 13, 'micronutrient'), ('CHEBI_46751', 'quinolizidine', 141, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 153, 'vitamins'), ('CHEBI_30863', '5-azaorotic acid', 193, 'folate'), ('CHEBI_27568', 'selenium atom', 238, 'selenium'), ('CHEBI_24859', 'iodine atom', 257, 'iodine'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 282, 'A'), ('CHEBI_27300', 'vitamin D', 292, 'vitamin B'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 292, 'vitamin B-1'), ('CHEBI_26948', 'vitamin B1', 305, 'thiamine'), ('CHEBI_27300', 'vitamin D', 323, 'vitamin B'), ('PR_000000037', 'BMP receptor type-2', 331, 'B'), ('PR_000010222', 'muscleblind-like protein 2', 333, '2'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin B'), ('CHEBI_27300', 'vitamin D', 376, 'vitamin B'), ('PR_000000037', 'BMP receptor type-2', 384, 'B'), ('CHEBI_37983', 'sulfur-35 atom', 386, '12'), ('CHEBI_27300', 'vitamin D', 397, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 416, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 435, 'vitamin E'), ('CHEBI_30751', 'formic acid', 472, 'folic acid'), ('CHEBI_33839', 'macromolecule', 568, 'micronutrients'), ('CHEBI_30751', 'formic acid', 595, 'folic acid')]
PMC2606998	6/2007	S72-PMC2606998	['relative to the RECOMMENDATIONS for planning a diet (% of ri), the studied women had low intakes of Folate, Vitamin\u2009D, Selenium, Vitamin\u2009E and iron both before and at 18–22 weeks of Pregnancy (table4).']	[('FUTURE_WORK', 16)]	1	[('CHEBI_30863', '5-azaorotic acid', 100, 'folate'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 119, 'selenium'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy')]
PMC2606998	6/2007	S96-PMC2606998	['with regard to Vitamin\u2009D RECOMMENDATIONS, this Vitamin is not only obtained from the diet, but also produced in the skin by sun exposure6.']	[('FUTURE_WORK', 25)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 47, 'vitamin')]
PMC2841444	2/2010	S492-PMC2841444	['since 1961 the committee on nutrition of the american academy of pediatrics has RECOMMENDED that prophylactic Vitamin K be administered parenterally to all newborns, primarily for preventing Intracranial hemorrhage [249].']	[('FUTURE_WORK', 80)]	1	[('CHEBI_27300', 'vitamin D', 110, 'vitamin K'), ('UBERON_2000442', 'supraneural bone', 191, 'intracranial')]
PMC2963768	10/2010	S95-PMC2963768	['an exogenous Vitamin D source is RECOMMENDED for all infants in north america.']	[('FUTURE_WORK', 33)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3004407	12/2010	S151-PMC3004407	['women taking their Prenatal Vitamins SHOULD BE counseled that the amount of Vitamin D contained in their Prenatal Vitamin will not affect their Vitamin D status [33,56,57].']	[('FUTURE_WORK', 37)]	1	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 28, 'vitamins'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 114, 'vitamin'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC3032617	5/2010	S23-PMC3032617	['presently, the internationally validated RECOMMENDED Vitamin C intake ranges between 15-25mg/day in children 0-6 months to be gradually raised with age.']	[('FUTURE_WORK', 41)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin C')]
PMC3347007	4/2012	S22-PMC3347007	['in scandinavia, all Pregnant women are RECOMMENDED 10 µg of Vitamin D per day to ensure sufficient Vitamin D status [14].']	[('FUTURE_WORK', 39)]	1	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC3417531	7/2012	S119-PMC3417531	['a periconceptual diet higher in Folate and Vitamin A was RECOMMENDED to reduce Birth defects.']	[('FUTURE_WORK', 57)]	1	[('CHEBI_30863', '5-azaorotic acid', 32, 'folate'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('GO_0007567', 'parturition', 79, 'birth')]
PMC3476426	8/2012	S147-PMC3476426	['treatment of Vitamin D deficiency in patients with 2,000 to 7,000 iu Vitamin D per day SHOULD BE sufficient to maintain year-round levels between 40 and 70 ng/ml [49].']	[('FUTURE_WORK', 87)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3509518	11/2012	S76-PMC3509518	['in the majority of Pregnant women dietary intakes of antioxidants well met the RECOMMENDED daily intake (rdi) except for Vitamin E and zinc (table 2) [18].']	[('FUTURE_WORK', 79)]	1	[('GO_0007565', 'female pregnancy', 19, 'pregnant'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin E')]
PMC3629265	4/2013	S64-PMC3629265	['the current statement put forth by the canadian paediatric society, dieticians of canada, and health canada on nutrition for term infants RECOMMENDS supplementing with 400 iu/day of Vitamin D only for Breast Fed infants (22).']	[('FUTURE_WORK', 138)]	1	[('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0007567', 'parturition', 201, 'breast'), ('UBERON_0000310', 'breast', 201, 'breast'), ('GO_0007631', 'feeding behavior', 208, 'fed')]
PMC3629265	4/2013	S70-PMC3629265	['the american academy of paediatrics now RECOMMENDS that formula-Fed newborns who do not consume a minimum of 1 litre of formula per day receive supplementation to achieve an intake of 400 iu Vitamin D/day (24).']	[('FUTURE_WORK', 40)]	1	[('GO_0007631', 'feeding behavior', 64, 'fed'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3635901	4/2013	S40-PMC3635901	['moreover, the cost–benefit ratio of providing Vitamin D as a preventative medicine to the general population SHOULD BE evaluated, together with the routine monitoring of Gestational Vitamin D levels [20].']	[('FUTURE_WORK', 109)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC3659910	1/2013	S174-PMC3659910	["national osteoporosis foundation's (nof) RECOMMENDS 400-800iu Vitamin D for Pregnant women."]	[('FUTURE_WORK', 41)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnant')]
PMC3660294	5/2013	S200-PMC3660294	['in canada, a daily supplement of Vitamin D (400\xa0iu) is RECOMMENDED for all breastfed full-term infants as a way to compensate for minimal exposure to sunlight [21,64,65], to promote health and to prevent deficiency.']	[('FUTURE_WORK', 55)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3662163	3/2013	S54-PMC3662163	['Folic Acid and Vitamin D are Vitamins which are ADVISED in the netherlands during Pregnancy [10].']	[('FUTURE_WORK', 48)]	1	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 29, 'vitamins'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy')]
PMC3668200	5/2013	S25-PMC3668200	['formula-Fed infants SHOULD Ingest nearly 1,000 ml of formula for a Vitamin D intake of 400 iu/day.']	[('FUTURE_WORK', 20)]	1	[('GO_0007631', 'feeding behavior', 8, 'fed'), ('GO_0007631', 'feeding behavior', 27, 'ingest'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3728489	7/2013	S320-PMC3728489	['the american academy of pediatrics RECOMMENDS that all breastfed infants receive a daily Vitamin D supplement of 400 iu, beginning in the first few days of Life (wagner et al.,2008).']	[('FUTURE_WORK', 35)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000104', 'life cycle', 156, 'life')]
PMC3829207	11/2013	S146-PMC3829207	['again, strict monitoring IS NEEDED to prevent Vitamin A and D toxicity in case of excessive Supplements [39].']	[('FUTURE_WORK', 25)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 60, 'D'), ('CHEBI_33341', 'titanium atom', 92, 'supplements')]
PMC3829803	11/2013	S34-PMC3829803	['since the mid-1990s, the who and unicef have RECOMMENDED Vitamin A treatment for acute measles in regions of the developing world with high mortality rates [20].']	[('FUTURE_WORK', 45)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A')]
PMC3901983	1/2013	S58-PMC3901983	['it is RECOMMENDED to increase the intake from 1000\u2009mg of calcium Citrate with 10\u2009mcg Vitamin D to 2000\u2009mg of calcium Citrate with Vitamin D (50–150\u2009mcg).']	[('FUTURE_WORK', 6)]	1	[('CHEBI_17120', 'hexanoate', 65, 'citrate'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_17120', 'hexanoate', 117, 'citrate'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4113768	7/2014	S13-PMC4113768	['finally, the meeting also addressed STRATEGIES to tackle Vitamin D deficiency at the population level, by alteration of sun-seeking behaviour, use of Nutritional Supplements and Food Fortification.']	[('FUTURE_WORK', 36)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_7495', 'nefazodone hydrochloride', 150, 'nutritional'), ('CHEBI_33341', 'titanium atom', 162, 'supplements'), ('CHEBI_33290', 'food', 178, 'food'), ('GO_0031318', 'detection of folic acid', 178, 'food fortification')]
PMC4113768	7/2014	S2554-PMC4113768	['we RECOMMEND that 25(Oh)D and Serum calcium be monitored when supplementing higher doses of Vitamin D.\n\n2.123.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_71657', 'versiconol acetate', 18, '25(OH)D'), ('UBERON_0001977', 'blood serum', 30, 'serum'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4113768	7/2014	S2834-PMC4113768	['conclusions: the Vitamin D ffq has now been validated for use in FUTURE STUDIES interested in assessing habitual Vitamin D intake within the general Adult population.']	[('FUTURE_WORK', 65)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0007023', 'adult organism', 149, 'adult')]
PMC4169453	9/2014	S187-PMC4169453	['our study was designed at the beginning of 2009, when RECOMMENDED supplemental doses of Vitamin D were around 400–600 iu/d.']	[('FUTURE_WORK', 54)]	1	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC4196482	11/2014	S63-PMC4196482	['on average, treatment snacks contained 10–23% of the who/fao RECOMMENDED reference Nutrient intakes for Β-Carotene, riboflavin, Folate, Vitamin B-12, calcium, and iron (table 2) (15).']	[('FUTURE_WORK', 61)]	1	[('CHEBI_33284', 'nutrient', 83, 'Nutrient'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 104, 'β-carotene'), ('CHEBI_30863', '5-azaorotic acid', 128, 'folate'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin B')]
PMC4221707	11/2014	S17-PMC4221707	['the nnr RECOMMENDS that Pregnant women increase their Folate intake by 65%, Selenium by 40%, iron, zinc, and Vitamin D by 25 - 30%, and Calcium, Phosphorus, and most other Minerals and Vitamins by 20% [3].']	[('FUTURE_WORK', 8)]	1	[('GO_0007565', 'female pregnancy', 24, 'pregnant'), ('CHEBI_30863', '5-azaorotic acid', 54, 'folate'), ('CHEBI_27568', 'selenium atom', 76, 'selenium'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 136, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 145, 'phosphorus'), ('CHEBI_46751', 'quinolizidine', 172, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 185, 'vitamins')]
PMC4377879	3/2015	S91-PMC4377879	['there was an earlier RECOMMENDATION by the fao (food and agricultural organization)/who of a 40% increase in the Vitamin B-12 dietary allowance to meet foetal demands and increased Metabolic needs [21].']	[('FUTURE_WORK', 21)]	1	[('CHEBI_27300', 'vitamin D', 113, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 113, 'vitamin B-12'), ('GO_0008152', 'metabolic process', 181, 'metabolic')]
PMC4427001	4/2015	S47-PMC4427001	['study participants were not reporting Vitamin D or multivitamin supplementation on top of routinely RECOMMENDED Folic Acid supplementation.']	[('FUTURE_WORK', 100)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_30751', 'formic acid', 112, 'folic acid')]
PMC4488777	5/2015	S182-PMC4488777	['during the preparation for Pregnancy in vd-deficient females (with Serum vd 50–125nmol/l), it is ADVISED to supplement Vitamin D prior to the first visit in a Fertility clinic.']	[('FUTURE_WORK', 97)]	1	[('GO_0007565', 'female pregnancy', 27, 'pregnancy'), ('UBERON_0001977', 'blood serum', 67, 'serum'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0009566', 'fertilization', 159, 'fertility')]
PMC4645901	8/2014	S18-PMC4645901	['[1] currently, the department of health RECOMMENDS 10 micrograms (400 units) of Vitamin D daily for Pregnant and breastfeeding mothers, and 8.5 micrograms (340 units) daily for breastfed babies under the age of 6 months.']	[('FUTURE_WORK', 40)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnant')]
PMC4691762	12/2015	S68-PMC4691762	["Vitamin D deficiency : infant 25Ohd3 levels and Metabolites including the c3-epimer of 25Ohd3 will be measured using liquid chromatography-tandem mass spectrometry.22the method will be referenced to the joint commission for traceability in laboratory medicine's RECOMMENDED reference standard to provide accuracy for the Vitamin D result."]	[('FUTURE_WORK', 262)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 30, '25OHD3'), ('CHEBI_25212', 'metabolite', 48, 'metabolites'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 87, '25OHD3'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D')]
PMC4719746	1/2016	S9-PMC4719746	['the Serum levels of 25(Oh)D increased significantly from gw 15 to 28 in Vitamin D deficient women who received a RECOMMENDATION for supplementation.']	[('FUTURE_WORK', 113)]	1	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 22, '('), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4719746	1/2016	S10-PMC4719746	['this RECOMMENDATION of Vitamin D supplementation increased Vitamin D levels in deficient women.']	[('FUTURE_WORK', 5)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4719746	1/2016	S46-PMC4719746	['according to national clinical guidelines for antenatal care, the RECOMMENDATION of Vitamin D intake during a normal Pregnancy is 10\xa0μg/day [21].']	[('FUTURE_WORK', 66)]	1	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy')]
PMC4719746	1/2016	S115-PMC4719746	['women with <37\xa0nmol/l at baseline were RECOMMENDED 20\xa0μg or 30\xa0μg Vitamin D daily.']	[('FUTURE_WORK', 39)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4719746	1/2016	S160-PMC4719746	['after identifying participants with low 25(Oh)D values at study inclusion, and RECOMMENDING treatment with daily moderate doses of Vitamin D, the daily intake of Supplements significantly increased and the prevalence of severe Vitamin D deficiency was substantially reduced.']	[('FUTURE_WORK', 79)]	1	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 162, 'supplements'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC4785305	3/2016	S36-PMC4785305	['neither addresses the applicability of iom Vitamin D dose RECOMMENDATIONS in Pregnant women in the middle east.']	[('FUTURE_WORK', 58)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnant')]
PMC4785305	3/2016	S156-PMC4785305	['in addition, women with a 25(Oh)D level >75\u2005nmol/l will be excluded in order to prevent reaching supranormal levels of 25(Oh)D SHOULD they be allocated to the high-Vitamin D dose.']	[('FUTURE_WORK', 127)]	1	[('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 26, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 122, 'OH)D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4891833	6/2016	S147-PMC4891833	['a household survey will be administered with the following questionnaires:\n\ncaption (table-wrap): table 3\n\noutcomes of interestoutcomeinstrumentnotestiming of data collectionnutritional outcomes: \u2002height/lengthstadiometer (children and caregivers) (locally made, with 1\xa0mm gradations)length/height will be measured to the nearest 0.1\xa0cmbaseline, midline, endline\xa0(mothers/caregivers at endline only)\u2002weightelectronic mother-baby weighing scale with reading increments of 10\xa0g (seca model 874)weight will be measured to the nearest 100\xa0g. duplicate measures will be repeated if the difference between the measurements is >0.1\xa0kg.baseline, midline, endline\u2002anemia/hemoglobinhemocue hb 301 portable photometermeasurements will be obtained to the nearest 0.1\xa0g/dlbaseline, midline, endline\xa0(subsample)\u2002iron and Vitamin A statusenzyme-linked immunoassay (elisa) methodcapillary Blood samples in children 18-24 monthsendline (subsample) Child Development outcomes: \u2002Language and Cognitive and socio-Emotional Developmentages and stages questionnaire: inventory [51]combination of primary caregivers report and direct observation of children 0–36 mo [52]baseline, midline, endlinebayley scale [53]direct assessment\xa0(children 28-34 months)endline (subsample) intermediate indicators \u2002household Food securityhousehold Food security questionnaire (fanta)questions adapted and modified to reflect the cultural context, as NEEDED.']	[('FUTURE_WORK', 1411)]	1	[('CHEBI_27300', 'vitamin D', 807, 'vitamin A'), ('UBERON_0000178', 'blood', 873, 'blood'), ('GO_0007417', 'central nervous system development', 931, 'Child development'), ('GO_0040011', 'locomotion', 960, 'Language ...'), ('GO_0002553', 'histamine secretion by mast cell', 973, 'cognitive ... emotional developmentAges'), ('CHEBI_33290', 'food', 1286, 'food'), ('GO_0007631', 'feeding behavior', 1286, 'food'), ('CHEBI_33290', 'food', 1309, 'Food')]
PMC4896250	4/2016	S3550-PMC4896250	['data regarding the magnitude of Vitamin D deficiency among exclusively breastfed infants in kenya IS NEEDED to inform supplementation policies.']	[('FUTURE_WORK', 98)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4896250	4/2016	S5552-PMC4896250	['low values of Vitamin A and Vitamin D values in astmatic patients ENCOURAGE astmatic symptom severity, in addition to exhaustion, fatigue, bone ache and Eye diseases.']	[('FUTURE_WORK', 66)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 22, 'A'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000970', 'eye', 153, 'eye')]
PMC4930210	7/2016	S11-PMC4930210	['health canada [3] and the institute of medicine (iom) [4] have RECOMMENDED 600 iu/day intake of Vitamin D during Pregnancy.']	[('FUTURE_WORK', 63)]	1	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC4976416	7/2016	S84-PMC4976416	['[63]\n\ncontraindications or special precautions\nthere are no contraindications to the use of Vitamin E. patients with Coagulation disorders or taking Anticoagulant medications SHOULD BE monitored for increased bleeding tendencies.']	[('FUTURE_WORK', 175)]	1	[('CHEBI_27300', 'vitamin D', 92, 'vitamin E'), ('GO_0050817', 'coagulation', 117, 'coagulation'), ('CHEBI_50249', 'anticoagulant', 149, 'anticoagulant')]
PMC4992225	8/2016	S94-PMC4992225	['intervention in the Supplement consumer (Vitamin D) group: in 2007 and 2010, the canadian pediatric association RECOMMENDED a daily amount of 2000\xa0iu of Vitamin D for Pregnant and breast-feeding women [47,46].']	[('FUTURE_WORK', 112)]	1	[('CHEBI_16158', 'steroid sulfate', 20, 'supplement'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnant')]
PMC5014971	8/2016	S71-PMC5014971	['more respondents disagreed (41.6%) than agreed (22.8%) that all Pregnant women SHOULD BE screened for Vitamin D deficiency.']	[('FUTURE_WORK', 79)]	1	[('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5014971	8/2016	S82-PMC5014971	['about half of respondents RECOMMEND additional Vitamin D supplementation to their Pregnant patients (always = 16.8%, often = 11.9%, and sometimes = 23.8%).']	[('FUTURE_WORK', 26)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant')]
PMC5084734	5/2016	S20-PMC5084734	['for several Micronutrients, the relative increase in RECOMMENDED intake is ≥50%, such as for Folate and iron during Pregnancy and for Vitamin A, Vitamin C, Vitamin B6, Iodine and zinc during Lactation.']	[('FUTURE_WORK', 53)]	1	[('CHEBI_33839', 'macromolecule', 12, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 93, 'folate'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin C'), ('CHEBI_33237', 'vitamin D4', 156, 'vitamin B6'), ('CHEBI_24859', 'iodine atom', 168, 'iodine'), ('GO_0007595', 'lactation', 191, 'lactation')]
PMC5093678	10/2016	S66-PMC5093678	['the control group will be provided with the usual Antenatal dietary advice as per nice guidelines on Antenatal care, weight management in Pregnancy and hypertension in Pregnancy.15–17Folic Acid and Vitamin D supplementation will be provided as per national RECOMMENDATIONS for all participants.']	[('FUTURE_WORK', 257)]	1	[('GO_0007567', 'parturition', 50, 'antenatal'), ('GO_0007567', 'parturition', 101, 'antenatal'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('CHEBI_39159', '(S)-trichostatic acid', 181, '17Folic acid'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5372327	3/2017	S23-PMC5372327	['despite these RECOMMENDATIONS, 20% of children were shown to be Vitamin D deficient (<50\xa0nmol/l) at 14\xa0months of age [8].']	[('FUTURE_WORK', 14)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5405075	4/2017	S103-PMC5405075	['any intervention SHOULD BE individualized to initial maternal Vitamin D status and be followed up.']	[('FUTURE_WORK', 17)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5539754	8/2017	S156-PMC5539754	['in the clinical setting, Pregnant women SHOULD receive advice about Vitamin D, especially during winter.']	[('FUTURE_WORK', 40)]	1	[('GO_0007565', 'female pregnancy', 25, 'pregnant'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5623264	9/2017	S61-PMC5623264	['caption (table-wrap): table 2\n\ncharacteristics of interventionsreviewinterventionpopulationdose (mean range)frequencystart of interventionmccauley\xa0 et\xa0al 24vitamin alow-risk and high-risk (women with no, moderate, or severe Vitamin A deficiency)great variation between trials: 3000–600\u2009000 iudaily or weeklymost studies in second Trimesterrumbold\xa0 et\xa0al 45vitamin clow-risk and high-risk (nine studies recruited women with high or increased risk of pre-eclampsia)common dosage 1000\u2009mg (100–2000\u2009mg)dailymost studies in second Trimesterrumbold\xa0 et\xa0al 46vitamin elow-risk and high-risk (nine studies recruited women with high or increased risk of pre-eclampsia)common dosage 400 iu (100\u2009mg, 200–800 iu)dailymost studies in second Trimesterde-regil\xa0 et\xa0al 25Folic Acidwomen with and without history of Neural Tube defects0.4–4.0\u2009mgdailypericonceptional period (before Pregnancy until 12\u2009weeks of Pregnancy)lassi\xa0 et\xa0al 26Folic Acidlow riskcommon dosage 5\u2009mg (range 0.01–400\u2009mg)dailyinitiation varied from 8\u2009weeks of Pregnancy until 3\u2009days Postpartuman\xa0 et\xa0al 27calciumlow-risk1.0–2.0\u2009gdaily11–24\u2009weeks of Pregnancybuppasiri\xa0 et\xa0al 28calciumlow-risk and high-risk (three trials recruited only adolescents)1.0\u2009g (range 0.3–2.0\u2009mg)dailymost trials at or after 20\u2009weeks’ Gestational agehofmeyr\xa0 et\xa0al 29calciumlow-risk and high-risk (high-risk of pre-eclampsia; adolescents)high dose:\xa0≥1\u2009g/day (1.5–2.0\u2009g), low-dose:\xa0<1\u2009g/daydailysecond Trimesterpeña-rosas\xa0 et\xa0al 30ironlow-risk and high-risk (anaemic and non-anaemic women)9–900\u2009mgdailymost trials before 20\u2009weeks’ Gestationharding\xa0 et\xa0al 31iodinelow-risk75–300\u2009µgdailyduring Pregnancy, Postpartum, or Pregnancy and Postpartummakrides\xa0 et\xa0al 32magnesiumlow-risk and high-risk (Pregnancy-induced hypertension, risk of ptb365\u2009mg (64–1000\u2009mg)dailymost trials in first Trimesterota\xa0 et\xa0al 33zinclow-risk and high-risk (one trial recruited women with high risk of sga)5–44\u2009mg (90\u2009mg in one trial)Dailybefore Conception (two trials from 26\u2009weeks’ Gestation)soltani\xa0 et\xa0al 34zincna20\u2009mgdaily6–20\u2009weeks until Deliveryfall\xa0 et\xa0al 35mmnmainly low-riskmmn formulation that Delivered approximately 1 rdadailyin Pregnancyhaider\xa0 et\xa0al 36mmnlow-risk and high-riskdifferent Mmn composition in all trials (14 trials included Iron and Folic Acid in Mmn)dailyvaried (first, second or third Trimester)ramakrishnan\xa0 et\xa0al 37mmnlow-risk and high-riskmost trials used unimmap (1–2\u2009rad) formulation with 30\u2009mg or 60\u2009mg irondailyfirst or second Trimesterota\xa0 et\xa0al 38proteinlow-risk and high-risk (well-nourished and undernourished women)nutritional educationbalanced energy/protein: 118–1017 kcal/6–44\u2009ghigh protein: 40\u2009gmonthlydailydailysecond trimestersecond to third trimesterbefore 30\u2009weeks’ Gestationmakrides et al 39prostaglandinlow-risk and high-risk Pregnanciescommon dosage: 2.7\u2009g of Epa and dhadailycommonly after 16\u2009weeks’ Gestationsalvig\xa0 et\xa0al 40n-3 Fatty Acidslow-risk and high-risk (previous ptb or iugr)2.7\u2009gdailylow-risk: week 30, high-risk: week 18–21duley\xa0 et\xa0al 41reduced Saltlow-risklow dietary Salt: 20 or 50\xa0mmol/daydaily12–20\u2009weeks’ Gestationsalam et\xa0al 42antihelminthicslow-risk and high-risk (infected with Intestinal Helminth)400\u2009mg Albendazole with or without iron/Folate or 500\u2009mg Mebendazole with ironsingle-dose (iron daily)second trimesterradeva-petrova et al 43antimalarialslow-risk and high-risk(1)\xa0Chloroquine: 300\u2009mg(2)\xa0Pyrimethamine: 100\u2009mg/25\u2009mg(3)\xa0Proguanil: 100\u2009mg(4)\xa0Pyrimethamine-Dapsone: 25\u2009mg/100\u2009mg or 12.5\u2009mg/100\u2009mg(5)\xa0Sulfadoxine-Pyrimethamine: 1500\u2009mg/75\u2009mg(6)\xa0Meﬂoquine: 500\u2009mg loading dose, 250\u2009mg weekly for 4\u2009weeks, 125\u2009mg weekly until Delivery(1)\xa0weekly(2)\xa0monthly/weekly(3)\xa0daily(4)\xa0every 2\u2009weeks or weekly(5)\xa0up to four doses(6)\xa0weeklyfrom first Prenatal visitmuanda\xa0 et\xa0al 44antimalarialslow-risk and high-riskany type of Antimalarial Drug (Chloroquine, Sulfadoxine-Pyrimethamine, Mefloquine, Dapsone-Pyrimethamine)two to three doses or more, weekly or dailyduring Pregnancy (no specification)\nDha, Docosahexaenoic Acid; Epa, Eicosapentaenoic Acid; iu, international units; iugr, Intrauterine growth restriction; lbw, low Birth weight; mmn, multiple Micronutrients; na, not available; ptb, Preterm Birth; rad, RECOMMENDED dietary allowance; sga, small-for-Gestational age; unimmap, united nations multiple Micronutrient antenatal preparation.']	[('FUTURE_WORK', 4187)]	1	[('CHEBI_27300', 'vitamin D', 224, 'vitamin A'), ('GO_0035146', 'tube fusion', 330, 'trimesterRumbold'), ('GO_0035146', 'tube fusion', 526, 'trimesterRumbold'), ('GO_0043033', 'isoamylase complex', 728, 'trimesterDe'), ('CHEBI_51593', '3,5-dibromopyridine', 753, '25Folic acidWomen'), ('UBERON_0001049', 'neural tube', 799, 'neural tube'), ('GO_0007565', 'female pregnancy', 865, 'pregnancy'), ('GO_0007565', 'female pregnancy', 893, 'pregnancy'), ('CHEBI_75626', 'oleyl oleate', 916, '26Folic acidLow'), ('GO_0007565', 'female pregnancy', 1013, 'pregnancy'), ('GO_0007596', 'blood coagulation', 1036, 'postpartumAn'), ('GO_0007605', 'sensory perception of sound', 1102, 'pregnancyBuppasiri'), ('GO_0007565', 'female pregnancy', 1264, 'gestational'), ('GO_0043143', 'regulation of translation by machinery localization', 1430, 'trimesterPeña'), ('GO_0007530', 'sex determination', 1559, 'gestationHarding'), ('GO_0007565', 'female pregnancy', 1620, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1631, 'postpartum'), ('GO_0007565', 'female pregnancy', 1646, 'pregnancy'), ('GO_0007598', 'blood coagulation, extrinsic pathway', 1660, 'postpartumMakrides'), ('GO_0007565', 'female pregnancy', 1721, 'pregnancy'), ('GO_0042790', 'nucleolar large rRNA transcription by RNA polymerase I', 1809, 'trimesterOta'), ('CHEBI_34674', 'dextran sulfate', 1935, 'DailyBefore'), ('GO_0007620', 'copulation', 1947, 'conception'), ('GO_0007565', 'female pregnancy', 1985, 'gestation'), ('GO_0007567', 'parturition', 2045, 'deliveryFall'), ('GO_0007567', 'parturition', 2106, 'delivered'), ('GO_0001523', 'retinoid metabolic process', 2143, 'pregnancyHaider'), ('UBERON_0003109', 'parapophysis', 2203, 'MMN'), ('CHEBI_24870', 'ion', 2253, 'iron'), ('CHEBI_30751', 'formic acid', 2262, 'folic acid'), ('UBERON_0003109', 'parapophysis', 2276, 'MMN'), ('GO_0009294', 'DNA mediated transformation', 2316, 'trimester'), ('GO_0042790', 'nucleolar large rRNA transcription by RNA polymerase I', 2465, 'trimesterOta'), ('GO_0007565', 'female pregnancy', 2717, 'gestationMakrides'), ('GO_0007602', 'phototransduction', 2779, 'pregnanciesCommon'), ('CHEBI_34733', 'EPN', 2814, 'EPA'), ('GO_0007565', 'female pregnancy', 2855, 'gestationSalvig'), ('CHEBI_50484', 'hepta-2,4,6-trienoic acid', 2884, 'fatty acidsLow'), ('CHEBI_33462', 'phosphonate(1-)', 3013, 'saltLow'), ('CHEBI_24866', 'salt', 3037, 'salt'), ('GO_0007565', 'female pregnancy', 3078, 'gestationSalam'), ('UBERON_0000160', 'intestine', 3154, 'intestinal'), ('NCBITaxon_10036', 'Mesocricetus auratus', 3165, 'helminth'), ('CHEBI_16664', 'albendazole', 3181, 'albendazole'), ('CHEBI_30863', '5-azaorotic acid', 3214, 'folate'), ('CHEBI_6751', 'mepanipyrim', 3231, 'mebendazole'), ('CHEBI_3637', 'chloroprocaine hydrochloride', 3354, 'Chloroquine'), ('CHEBI_8665', 'Pyridostigmine', 3377, 'Pyrimethamine'), ('CHEBI_8494', 'Propiverine hydrochloride', 3408, 'Proguanil'), ('CHEBI_8665', 'Pyridostigmine', 3429, 'Pyrimethamine'), ('CHEBI_4325', 'dapsone', 3443, 'dapsone'), ('CHEBI_9328', 'sulfadiazine', 3486, 'Sulfadoxine'), ('CHEBI_16610', 'spermidine', 3498, 'pyrimethamine'), ('CHEBI_6723', 'megestrol acetate', 3530, 'Meﬂoquine'), ('GO_0007567', 'parturition', 3609, 'delivery'), ('GO_0007565', 'female pregnancy', 3722, 'prenatal'), ('CHEBI_35443', 'anthelminthic drug', 3799, 'antimalarial drug'), ('CHEBI_3638', 'chloroquine', 3818, 'chloroquine'), ('CHEBI_9322', 'sulbenicillin', 3831, 'sulfadoxine'), ('CHEBI_16610', 'spermidine', 3843, 'pyrimethamine'), ('CHEBI_63609', 'mefloquine', 3858, 'mefloquine'), ('CHEBI_4325', 'dapsone', 3870, 'dapsone'), ('CHEBI_16610', 'spermidine', 3878, 'pyrimethamine'), ('GO_0007565', 'female pregnancy', 3942, 'pregnancy'), ('CHEBI_17874', 'dihydrozeatin', 3971, 'DHA'), ('CHEBI_36003', 'decenoic acid', 3976, 'docosahexaenoic acid'), ('CHEBI_34733', 'EPN', 3998, 'EPA'), ('CHEBI_36003', 'decenoic acid', 4003, 'eicosapentaenoic acid'), ('UBERON_0022293', 'reproductive gland secretion', 4057, 'intrauterine'), ('GO_0007567', 'parturition', 4099, 'birth'), ('CHEBI_33839', 'macromolecule', 4127, 'micronutrients'), ('GO_0007565', 'female pregnancy', 4167, 'preterm'), ('GO_0007567', 'parturition', 4175, 'birth'), ('GO_0007565', 'female pregnancy', 4233, 'gestational'), ('CHEBI_6956', 'Mitragynine', 4283, 'Micronutrient')]
PMC5664622	9/2017	S37-PMC5664622	['as for Umbilical Cord Blood, ≥20 ng/ml was the RECOMMENDED level and lower values signified Vitamin D deficiency [15,16].']	[('FUTURE_WORK', 47)]	1	[('UBERON_0012168', 'umbilical cord blood', 7, 'umbilical cord blood'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5831579	3/2018	S40-PMC5831579	['daily intake of energy, Carbohydrate, protein, fat, Alcohol, Caffeine, Sodium, iron, calcium, Vitamin D, Docosahexaenoic Acid (Dha), dietary Folate equivalents (dfe), natural Folate, synthetic Folate (from fortified foods), methionine, Choline, betaine, and Vitamins b6 and b12 were analyzed, since those Nutrients are part of the nutritional RECOMMENDATION for a healthy Pregnancy [9,17–20].']	[('FUTURE_WORK', 343)]	1	[('CHEBI_16730', 'chloramphenicol 3-acetate', 24, 'carbohydrate'), ('CHEBI_30879', 'alcohol', 52, 'alcohol'), ('CHEBI_27732', 'caffeine', 61, 'caffeine'), ('CHEBI_52632', 'potassium-39 atom', 71, 'sodium'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_36003', 'decenoic acid', 105, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 127, 'DHA'), ('CHEBI_30863', '5-azaorotic acid', 141, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 175, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 193, 'folate'), ('CHEBI_15354', 'choline', 236, 'choline'), ('CHEBI_33277', 'gamma-tocotrienol', 258, 'vitamins'), ('CHEBI_33284', 'nutrient', 305, 'nutrients'), ('GO_0007565', 'female pregnancy', 372, 'pregnancy')]
PMC5838372	3/2018	S79-PMC5838372	['the Vitamin D dose that the world health organization RECOMMENDS for Pregnant women is 200 iu/day (17).']	[('FUTURE_WORK', 54)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant')]
PMC5838372	3/2018	S85-PMC5838372	['the RECOMMENDED value for Serum Vitamin D level is lower in children than Adults.']	[('FUTURE_WORK', 4)]	1	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0007023', 'adult organism', 74, 'adults')]
PMC5941617	5/2018	S120-PMC5941617	['various international scientific societies agree to RECOMMEND Vitamin D supplementation during the first year of Life [9,12–15,19,20,22,23,27,28,30,112–116].']	[('FUTURE_WORK', 52)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000104', 'life cycle', 113, 'life')]
PMC5941617	5/2018	S121-PMC5941617	['particularly, the global consensus on prevention of nutritional rickets RECOMMENDED the administration of 400\xa0iu/day of Vitamin D for all infants from Birth to 12\xa0months of age, independently of their mode of Feeding [28].']	[('FUTURE_WORK', 72)]	1	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007567', 'parturition', 151, 'birth'), ('GO_0007631', 'feeding behavior', 209, 'feeding')]
PMC5941617	5/2018	S127-PMC5941617	['in the present consensus we RECOMMEND Vitamin D supplementation in all newborns independently of the type of Feeding, starting from Birth and continuing throughout the first year of Life.']	[('FUTURE_WORK', 28)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007631', 'feeding behavior', 109, 'feeding'), ('GO_0007567', 'parturition', 132, 'birth'), ('UBERON_0000104', 'life cycle', 182, 'life')]
PMC5941617	5/2018	S443-PMC5941617	['a dietary assessment SHOULD also be routinely performed in ibd children, paying close attention to the Consumption of Vitamin D-containing Foods and dairy products [404].']	[('FUTURE_WORK', 21)]	1	[('GO_0007631', 'feeding behavior', 103, 'consumption'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 139, 'foods')]
PMC5941617	5/2018	S509-PMC5941617	['regarding Adolescence, the society for adolescent health and medicine RECOMMENDED that obese adolescent without a 25(Oh)D measurement empirically receive Vitamin D supplementation at 1000\xa0iu/day [21].']	[('FUTURE_WORK', 70)]	1	[('GO_0048848', 'neurohypophysis morphogenesis', 10, 'adolescence'), ('CHEBI_71657', 'versiconol acetate', 114, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 120, 'D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5941617	5/2018	S518-PMC5941617	['obese subjects with reduced sun exposure during summer SHOULD receive Vitamin D supplementation throughout the year.']	[('FUTURE_WORK', 55)]	1	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5941617	5/2018	S556-PMC5941617	['the royal college of obstetricians & gynaecoloists RECOMMENDED Vitamin D supplementation with 400\xa0iu/day for all Pregnant women.']	[('FUTURE_WORK', 51)]	1	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnant')]
PMC5941617	5/2018	S605-PMC5941617	['the society for adolescent health and medicine RECOMMENDED to supplement Vitamin D insufficient with Vitamin D 1000\xa0iu/day for at least 3\xa0months [21].']	[('FUTURE_WORK', 47)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5941617	5/2018	S614-PMC5941617	['summary of RECOMMENDATIONS\n\ndefinition of Vitamin D status\n\nindividual Vitamin D status can be assessed evaluating Serum circulating 25(Oh)D levels.']	[('FUTURE_WORK', 11)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 115, 'serum'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 139, 'D')]
PMC5941617	5/2018	S621-PMC5941617	['Vitamin D supplementation\n\n0–12\xa0months\n\nwe RECOMMEND Vitamin D supplementation in the first year of Life to ensure an adequate Vitamin D status and to prevent nutritional rickets.']	[('FUTURE_WORK', 43)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5941617	5/2018	S622-PMC5941617	['we RECOMMEND Vitamin D supplementation in all newborns independently of the type of Feeding.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007631', 'feeding behavior', 84, 'feeding')]
PMC5941617	5/2018	S636-PMC5941617	['we RECOMMEND daily Vitamin D supplementation ranging from 600\xa0iu/day (i.e.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5941617	5/2018	S644-PMC5941617	['we RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_25212', 'metabolite', 37, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 68, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 81, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 95, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 111, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC5941617	5/2018	S657-PMC5941617	['we RECOMMEND against the administration of a single large dose of Vitamin D\u2009>\u2009300000\xa0iu.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5941617	5/2018	S658-PMC5941617	['after rickets healing, we RECOMMEND to continue Vitamin D supplementation according to age (400–1000\xa0iu/day in the first year of Life and 600–1000\xa0iu/day from 1 to 18\xa0years).']	[('FUTURE_WORK', 26)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0000104', 'life cycle', 129, 'life')]
PMC5941617	5/2018	S673-PMC5941617	['we RECOMMEND against Vitamin D supplementation to reduce incidence or severity of non-Respiratory infections in children.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 86, 'respiratory')]
PMC5941617	5/2018	S690-PMC5941617	['RECOMMENDATIONS for Vitamin D treatment in subjects with t1dm and Vitamin D deficiency are the same as those for the healthy pediatric population.']	[('FUTURE_WORK', 0)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5941617	5/2018	S708-PMC5941617	['obese subjects with reduced sun exposure during summer SHOULD receive Vitamin D supplementation throughout the year.']	[('FUTURE_WORK', 55)]	1	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5941617	5/2018	S718-PMC5941617	['we RECOMMEND against Vitamin D administration to improve mood.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5941617	5/2018	S721-PMC5941617	['we RECOMMEND Vitamin D supplementation in all Pregnant and breastfeeding women at a dose of 600\xa0iu/day.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnant')]
PMC5941617	5/2018	S725-PMC5941617	['management of asymptomatic Vitamin D deficiency and insufficiency\n\nin children and adolescents with asymptomatic Vitamin D deficiency [25(Oh)D\u2009<\u2009\xa020\xa0ng/ml] we RECOMMEND the administration of 2000\xa0iu/day or 50000\xa0iu/week of Vitamin D2Or d3for 6–8\xa0weeks (8\xa0weeks in adolescents) in order to obtain a sufficient Vitamin D status [25(Oh)D\u2009≥\u200930\xa0ng/ml].']	[('FUTURE_WORK', 159)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 135, '25 ... OH ... D'), ('CHEBI_27329', 'xanthosine phosphate', 223, 'vitamin D2or'), ('PR_000017209', 'utrophin', 223, 'vitamin D2or'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 327, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 333, 'D')]
PMC5956785	5/2018	S65-PMC5956785	['the current RECOMMENDED dietary allowances (rad) of Vitamin D are 400\xa0iu from 0 to 12\xa0months of age and 600\xa0iu per day from 1 to 18\xa0years of age [19].']	[('FUTURE_WORK', 12)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC6039335	7/2018	S269-PMC6039335	['oka [134] RECOMMENDED that Vitamin A-deficient levels not fall below 30 iu/dl to enhance ms and maintain health.']	[('FUTURE_WORK', 10)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A')]
